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ABSTRACT 
This study explored the experience of women living with lymphangioleiomyomatosis (LAM) 
over their life course. LAM is a rare, chronic, potentially life limiting, multisystem condition. 
It affects almost exclusively women and is characterised by progressive cystic lung disease. 
This study was undertaken to understand the meaning of women’s experiences of living with 
LAM over time and how these experiences were affected by the rarity of LAM. 
Life history methodology was used to explore illness experience across their life course. 
Gadamer’s hermeneutic philosophy and Rosenthal’s (1993) biographic interpretive method of 
narrative analysis provided the theoretical framework for the study. Semi-structured life 
history interviews were conducted with 19 women living with LAM. Factual data was 
extracted from the medical record of each participant. Data analysis involved constructing a 
biographical account of the objective facts of each woman’s illness and analysing each life 
story for turning points and themes. Following cross case analysis, a collective life history 
which focused on the participants’ illness experiences, was constructed.  
An understanding of the complexity of their experiences from the onset of symptoms to the 
late stage of their illness was uncovered. The participants showed that they lived with LAM 
in a context of constant change, from the day to day fluctuations of everyday life to turning 
points of significant change related to their illness or social world. Diagnosis, a long hospital 
admission, commencing oxygen therapy, experiencing respiratory failure, and receiving a 
transplant were turning points when they experienced significant life disruption. The rarity of 
LAM created feelings of isolation and uncertainty at diagnosis and a need for self-reliance 
and self-advocacy to access appropriate information, care and treatment. 
This study illuminates the process of how the participants developed resilience as they adapted 
to their illness in a period of transition. Resilience was a dynamic learning process and 
outcome by which they gained knowledge and competence in illness self-management, and 
found meaning through their experiences of autonomy, agency, social connectedness, 
spirituality and personal growth. It accumulated throughout life through everyday experiences 
as well as adversity. Resilience was associated with positive self-beliefs and enabled them to 
experience wellness and constructively manage illness-related and social changes over the 
course of their illness.  
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Chapter 1 
INTRODUCTION 
  
1.1 Introduction 
This life history study explores women’s experiences of living with 
lymphangioleiomyomatosis (LAM) over their life course. It illuminates the meaning of their 
experiences through the progressive stages of LAM as they lived their everyday lives within 
their individual social contexts, and interacted with health professionals in healthcare 
settings. This research highlights the complex issues related to women’s experiences of 
living with LAM, including how their experiences were affected by the rarity of LAM.  
This chapter is an introduction to the thesis. It begins with a background to the study, 
including an account of how this research journey began. The literature review which was 
conducted to locate and analyse the available literature related to the lived experience of 
women with LAM to determine the need for the study is presented. The literature review is 
followed by a statement of the aims of the study, the research question to be answered, and 
significance of the research. The chapter concludes with an overview of the structure of the 
thesis. 
1.2 Background 
LAM is a rare multisystem disease affecting almost exclusively women and characterised 
by progressive cystic lung disease (Ryu et al. 2006). LAM lung disease occurs sporadically, 
or in 26-38% patients with tuberous sclerosis complex (TSC), an inherited genetic disease 
characterised by mental retardation, autism, and lesions in various organs, and which can 
also affect men (Johnson et al. 2010; Taveira-DaSilva & Moss 2015). Sporadic LAM is not 
inherited and predominantly affects women (Taveira-DaSilva & Moss 2015). There has 
been only one case documented of a man without TSC diagnosed with LAM (Schiavina et 
al. 2007). While targeted therapies have recently been developed to treat symptoms of LAM, 
there is no cure. Women with advanced disease may be prescribed supplementary oxygen 
therapy and those with severe disease may be recommended for lung transplantation 
(Johnson et al. 2010). 
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The first case of LAM in a TSC patient was documented in 1918, and in a patient without 
TSC by Van Stossel in 1937 (Glassberg 2004; LAM Foundation 2015). The medical 
literature on LAM was limited to a few reviews and case reports until the establishment of 
the LAM Foundation in the US in 1995 by Sue Byrnes whose daughter had LAM, and the 
US National Registry for LAM in 1997 which provided a database for research. Since 1997 
the LAM Foundation has raised over $15 million dollars to fund research which led to the 
discovery of a genetic link between LAM and TSC (LAM Foundation 2015; Tattersfield & 
Glassberg 2006). 
1.2.1 Epidemiology 
LAM was previously considered to be a fatal condition that affected women of childbearing 
years. It is now regarded as a chronic disease of both pre- and post-menopausal women 
(Taveira-DaSilva & Moss 2015), with a median transplant-free survival time of 29 years 
from the onset of symptoms (Oprescu et al. 2013). The prevalence of sporadic LAM 
worldwide has been estimated at 3.3-7.7 per million women, and in Australia 5.17 per 
million women (Harknett et al. 2011). While the number of women diagnosed with LAM 
who registered with the US LAM Foundation and UK LAM Action databases increased 
over the years 1995-2005, Cohen et al. (2005) could not state that the incidence of LAM 
was increasing. Rather, they attribute these increases to improved recognition of milder 
LAM symptoms and subsequent diagnosis in women over 40 years. Harknett et al. (2011) 
estimated there are between 15,000 and 23,000 patients with LAM worldwide, while in 
Australia 104 women are known to be living with LAM (LAM Australia Research Alliance 
2015). According to the LAM Foundation (2015) there may be 250,000 women with LAM 
worldwide who are undiagnosed or have been misdiagnosed with asthma, emphysema or 
bronchitis. LAM is not specific to any race or ethnic group (Taveira-DaSilva et al. 2010). 
1.2.2 LAM as a disease 
1.2.2.1 Pathology 
LAM is characterised by a proliferation of abnormal smooth muscle cells called LAM cells 
which surround, infiltrate and obstruct airways, blood and lymph vessels (Glassberg 2004). 
Thin-walled cysts in the lung, ranging in size from a few millimetres to a few centimetres 
in diameter, are formed by the degradation of the collagen and elastin fibres of the lung and 
obstruction of the terminal airways by LAM cells and nodules (Taveira-DaSilva et al. 2006). 
The cysts can rupture into the pleural space causing spontaneous lung collapse 
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(pneumothorax) (Almoosa et al. 2006). Changes in the lung can cause abnormalities in lung 
function, including airflow obstruction, reduced lung diffusing capacity, and gas exchange 
abnormalities (Taveira-DaSilva & Moss 2015). Receptors for oestrogen, progesterone and 
growth factors have been identified on LAM cells (Taveira-DaSilva et al. 2006). 
Blockages of the lymph channels cause the formation of chyle-filled lymphatic masses 
called lymphangioleiomyomas most frequently in the peritoneum, pelvis and mediastinum 
(Taveira-DaSilva & Moss 2015). LAM cells also cause thickening of the thoracic duct, 
dilation of lymph channels, and the formation of multiple narrow channels causing chylous 
pleural effusions and chyloptysis (Taveira-DaSilva et al. 2006). Angiomyolipomas, tumours 
in the kidney, are composed of LAM cells, fat cells, and poorly differentiated vascular 
structures (Taveira-DaSilva et al. 2006). Blockages in the blood vessels in the lung cause 
haemoptysis (Johnson 1999). 
1.2.2.2 Pathogenesis 
Research conducted over the last 15 years has found that LAM is caused by mutations in 
the tuberous sclerosis tumour suppressor genes, TSC1 and TSC2 (LAM Foundation 2015; 
Taveira-DaSilva et al. 2006). These mutations cause the proliferation of LAM cells by 
dysregulating the mTOR (mammalian target of rapamycin) signalling pathway, a protein 
complex which regulates cell growth, metabolism, proliferation and survival (LaPlante & 
Sabatini 2009;Taveira-DaSilva & Moss 2015). LAM cells have metastatic properties, shown 
by the detection of LAM cells in the donor lungs of patients who had received lung 
transplants (McCormack 2008), and, while there is not general agreement, it has been 
suggested that LAM be reclassified as a “low-grade, destructive, metastasizing neoplasm” 
(McCormack et al. 2012, p.1210).  
1.2.2.3 Clinical Features of LAM 
There is a high level of clinical variability with LAM (Cohen et al. 2005). Patients frequently 
present with recurrent pneumothoraces (57%) or progressive breathlessness (73%), and may 
also experience a chylous effusion (12%), abdominal masses (29%), bleeding from a 
ruptured angiomyolipoma in the kidney or abdomen (32%), or haemoptysis (32%) as their 
first sign of LAM (Ryu et al. 2006; Taveira-DaSilva & Moss 2015). Cough (6%), chest pain 
(5%), chyloptysis, and wheeze are much less common symptoms (LAM Foundation 2015). 
The average number of recurrent pneumothoraces for an individual woman is 4.4 
(McCormack 2008). Angiomyolipomas occur more frequently in patients with TSC-LAM 
(93%) than those with sporadic LAM (32%) while lymphangioleiomyomas and chylous 
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effusions are more common in sporadic LAM (Ryu et al. 2006; Taveira-DaSilva & Moss 
2015). There is also a high level of variability in the rate of progression of LAM. For some 
women, LAM progresses slowly over many years while for others, usually younger women, 
it can advance rapidly (Taveira-DaSilva & Moss 2014). Johnson et al. (2004), in an analysis 
of 57 patients in the UK LAM database, reported that 23% of those patients required home 
oxygen after ten years. 
1.2.2.4 Diagnosis 
There is generally a delay from onset of symptoms to diagnosis due to the more general 
nature of early clinical findings and many physicians’ lack of knowledge of LAM which 
can lead to misdiagnosis of asthma, emphysema or chronic bronchitis (Glassberg 2004). 
Johnson (1999) reported the mean interval between onset of symptoms and diagnosis was 4 
years but ranged from 0 to 25 years. LAM is usually diagnosed by high resolution CT 
scanning (HRCT) and/or lung biopsy (Johnson et al. 2010). Recent research has discovered 
that VEGF-D (a lymphatic vascular growth factor), at a serum level of >800pg/ml, is a 
valuable biomarker in diagnosing LAM (Young et al. 2013). 
1.2.2.5 Medical management of LAM 
Until recently there was no effective therapy for LAM and lung transplantation was the only 
treatment option (Taveira-DaSilva & Moss 2014). The discovery of the role of the mTOR 
pathway in the pathogenesis of LAM has led to the development of therapies which target 
this pathway to treat LAM. Two mTOR inhibitors, sirolimus and everolimus, have been 
found to be “effective in stabilising lung function, and reducing the size of chylous 
effusions, lymphangioleiomyomas, and angiomyolipomas” (Taveira-DaSilva & Moss 2014, 
p.116). Like cancer, it is believed that LAM may be best treated with therapies targeted at 
pathways involved in the pathogenesis of the disease, and research is continuing into other 
treatments (Taveira-DaSilva & Moss 2014).  
A pneumothorax is treated initially by chest tube drainage but, as the risk of recurrence is 
greater than 70%, a woman may undergo a chemical or surgical pleurodesis (Taveira-
DaSilva & Moss 2014). Chylothorax is treated by chest tube drainage and possibly a fat free 
diet (Johnson et al. 2010). Renal angiomyolipomas are monitored and those more than 4cm 
in diameter, which are at greater risk of bleeding, may be embolised (Johnson et al. 2010). 
Lung transplantation is considered when a woman’s lung function is less than 30% of the 
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predicted value for her age, sex, and size, and she is unable to carry out activities of daily 
living (Taveira-DaSilva & Moss 2014).   
Pregnancy has been associated with an increased risk of pneumothorax and chylothorax 
(Johnson et al. 2010). The European Respiratory Society, in its Guidelines for the Diagnosis 
and Management of LAM, while stating that becoming pregnant is the patient’s decision 
and advice should be given on an individual basis, recommends that women with moderate 
to severe disease or rapidly declining lung function pregnancy avoid pregnancy (Johnson et 
al. 2010). Women with mild disease are warned of the potential risks of pregnancy (Taveira-
DaSilva & Moss 2014). Women with well-preserved lung function may travel by air, those 
with advanced disease need to be evaluated for the need for oxygen during the flight, and 
women with a recent or known untreated pneumothorax are advised not to fly at all (Johnson 
et al. 2010). 
1.2.3 LAM as a rare disease 
The US definition of a rare disease is one that affects less than 200,000 individuals. This 
corresponds to 2000 in Australia and a prevalence of 1-8 in 10,000. The European Community 
definition is less than 5 in 10,000 (Aronson 2006). LAM is readily classified as a rare disease 
by these criteria. There are more than 6,000 known rare diseases (Rare Disease UK 2016). 
While the prevalence of each rare disease is low, rare diseases in total affect a significant 
number of people. It has been estimated that there are 29 million people living with rare 
disease across the European member states (EURORDIS 2009). In Australia it is estimated 
that there are 1.2 million people living with a rare disease (Department of Health Western 
Australia 2013), representing six to eight per cent of the Australian population (Rare Voices 
Australia 2013).   
A rare disease such as LAM may also be referred to as an orphan disease or “neglected disease” 
(Aronson 2006, p.127). Because of their rarity orphan diseases have difficulty attracting 
funding for research as it is not profitable for drug companies to research and manufacture drugs 
that would benefit people suffering from these diseases (Gericke et al. 2005). Gericke et al. 
(2005) argued that rare diseases merit scientific study not only for moral reasons but because 
research into rare diseases often provides valuable insights into more common conditions as 
many rare diseases result from a single genetic alteration. Research into LAM has already 
benefited other rare diseases such as Cowden disease, Peutz-Jeghers syndrome and Proteus 
syndrome and it is hoped will give insights into other proliferative disorders such a cancer and 
asthma (Juvet et al. 2007; McCormack 2008). 
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Since 2003 LAM has come under the umbrella of the Rare Lung Diseases Consortium, part 
of the US Rare Diseases Clinical Research Network. This consortium collects clinical data 
from around the world into a centralised database and conducts clinical trials testing 
treatments for rare lung diseases (Rare Lung Diseases Consortium 2015). This allows areas 
with much lower numbers of individuals with LAM to contribute data for research and 
benefit from such research. 
In Europe and North America patient-driven alliances have formed to represent and 
advocate for people living with rare diseases. The National Organisation for Rare Disorders 
(NORD), formed in the US in 1983, has more than 230 patient organisation members and 
runs education, advocacy and research programs (NORD 2015). The European Organisation 
for Rare Diseases (EURORDIS) was founded in 1997 and represents 30 million people, 692 
rare disease patient organisations in 63 countries, and more than 4000 rare diseases 
(EURORDIS 2009). Rare Disease UK was established in 2008 to represent over 160 
organisations of people with rare conditions (Rare Disease UK 2016). Rare Voices Australia 
formed in 2012 to advocate and promote health policy to benefit people with rare diseases 
(Rare Voices Australia 2013). Australia has yet to put in place a National Rare Disease Plan 
even though a 2013 scoping paper recognised the need for one (Department of Health 
Western Australia 2013). Patients with LAM are represented by the US LAM Foundation 
and LAM patient organisations in individual countries worldwide. The LAM Australia 
Research Alliance (LARA) has represented women living with LAM in Australia since 2006 
and is a member of the Worldwide LAM Patient Coalition, formed by the LAM Foundation 
in 2007 to facilitate clinical research into LAM (LARA 2015; LAM Foundation 2015). 
1.2.4 Beginning the research journey 
My personal interest in LAM began nine years ago when I viewed a television documentary 
about two women who were living with LAM. I became aware that the hospital where I was 
working as a cardiothoracic nurse was a centre of LAM medical expertise where a number 
of women with LAM were treated. At that time, I had never heard of this rare disease 
although I recalled in the past a young female patient on the ward who had written the very 
long name of her illness on a piece of paper so that staff would know how to spell and 
pronounce it. On reflection, it is possible the word was ‘lymphangioleiomyomatosis’.  
Subsequently I informally met a woman with LAM in an outpatient clinic. This had a deep 
impact on me as a brief meeting stretched into more than two hours during which time the 
woman told me her story with great feeling and, at the end of our meeting, handed me a 
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typed version she had been carrying with her. Listening to her story and being entrusted 
with it convinced me that it was important to hear what these women had to say about their 
lives with LAM. I wanted to understand more about how women experienced living with 
this rare disease. I embarked on an Honours thesis as the first stage of pursuing my nursing 
inquiry. The study involved conducting two life history interviews with one woman with 
LAM as a single case study. This doctoral thesis now forms the second stage of the inquiry.  
1.3 The Literature Review 
This literature review aimed to locate and review the literature on the lived experience of 
women with LAM in order to identify gaps in the research literature. The systematic search 
process is illustrated in Figure 1.1 and the results of the individual database searches are 
shown in Table 1.1. A paucity of literature was found on women’s experiences of living 
with LAM. As LAM is both a progressive disease with significant effects on lung function 
and a rare disease, the literature search was expanded to include literature on the experience 
of living with other rare diseases, including rare lung diseases. The LAM literature was 
examined in relation to this wider body of rare disease research. The literature reviewed 
which related to the experiences of women living with LAM is summarised in Table 1.2, 
located in this chapter. Two additional tables located in Appendix 2 summarise the literature 
related to the experiences/perspectives of people living with a rare lung disease – pulmonary 
hypertension and idiopathic pulmonary fibrosis, and the literature related to the 
experiences/perspectives of people living with a rare disease. The literature search and 
review is discussed below, firstly in relation to the lived experience of LAM and, secondly,  
in relation to the experience of living with a rare disease.   
1.3.1 Living with LAM 
The literature search for the available literature on the experience of living with LAM was 
conducted using CINAHL, MEDLINE, PsycINFO, Sociological Abstracts, Expanded 
Academic ASAP, and ProQuest Dissertation and Theses databases (see Table 1.1). A search 
of each database was conducted using the keyword ‘lymphangioleiomyomatosis’. The 
MEDLINE search (with limits “English” and “humans”) revealed 1033 citations related to 
LAM; CINAHL, 113; Expanded Academic ASAP, 168; PsycINFO, 6; and ProQuest 
Dissertation and Theses, 164 theses. Sociological abstracts yielded no literature on LAM. 
The majority of citations located were biomedical and documented the epidemiology, 
physiology, pathology, pathogenesis, radiological investigation, diagnosis and management 
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of the disease, and included scientific research, clinical trials, case reports, observational 
studies, and cross-sectional surveys.   
Additional keywords of qualitative, interview*, narrative*, experience*, quality of life, 
perspective*, subjective, survey*/surveys and questionnaires, and focus group* were 
applied individually to the MEDLINE search as separate searches in order to capture 
literature related to the lived experience of women with LAM. These searches yielded a total 
of 129 citations that were screened. The limited number of citations retrieved from 
CINAHL, Expanded Academic ASAP, PsycINFO, and ProQuest Dissertation and Theses 
databases were screened for relevance without applying additional keywords. Figure 1.1 is 
a PRISMA diagram which illustrates the systematic processes of the literature search 
(Moher et al. 2009). A total of 580 citations were identified from the databases and screened. 
After screening, 560 citations were excluded, including reports of scientific and medical 
research, clinical trials, case reports, an article which was not in English, and a book chapter 
on qualitative methodology. Twenty citations remained after exclusion. When duplicates 
were removed from these, 12 full-text articles and two doctoral theses were assessed for 
eligibility for inclusion in the literature review. Two articles (a book review and an 
evaluation of clinical data) were excluded. An additional citation was identified in the 
reference list of one article (Carel et al. 2010). This was Carel’s (2008) longer personal 
narrative and philosophical phenomenological reflection on her LAM illness experience 
published as a book entitled Illness. A second edition of this book was published in 2013 
(Carel 2103b) and this more recent edition was included in the review. A total, therefore, of 
13 pieces of literature (nine full-text articles, one book, and two doctoral theses) were related 
to women’s experiences and perspectives on living with LAM and included in the literature 
review. Table 1.1 displays the database search for literature. It contains six duplicates as it 
shows the search and retrieval of relevant literature from each database. Five references 
were present in more than one database. Table 2.1, Appendix 2, summarises the literature 
included in the review following the removal of the duplicates. 
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Table 1.1: Database search for literature on the experience of living with LAM 
Database Keywords 
Available 
Literature  
on LAM 
Literature on 
Experiences/ 
perspectives 
of women 
with LAM 
References 
MEDLINE 
lymphangioleiomyomatosis 
(limits: English, human) 
1033   
MEDLINE 
lymphangioleiomyomatosis 
qualitative, interview*, 
narrative*, experience*, 
quality of life, perspective*, 
subjective,  
survey*/surveys and 
questionnaires, 
focus group* 
129 9 
Hoy 2016; 
Walker et al. 
2015; Belkin et 
al. 2014; Carel 
et al. 2010; 
Cohen et al. 
2009; Young et 
al. 2006; Ryu et 
al. 2006; 
Pollock-BarZiv et 
al. 2005; Cohen 
et al. 2005 
CINAHL lymphangioleiomyomatosis 113 5 
Hoy 2016; Carel 
et al. 2010: 
Haylen et al. 
2009; Ryu et al. 
2006; Young et 
al. 2006 
Expanded 
Academic 
ASAP 
lymphangioleiomyomatosis 168 1 
Young et al. 
2006 
PsycINFO lymphangioleiomyomatosis 6 1 Vafamand 2014 
Sociological 
Abstracts 
lymphangioleiomyomatosis 0   
ProQuest 
Dissertation 
and Theses 
lymphangioleiomyomatosis 164 2 
Vafamand 2014; 
Pollock-BarZiv 
2005 
Additional 
citation  
  1 Carel (2013b) 
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The literature search yielded only two qualitative studies on women’s experiences of living 
with LAM. Belkin et al.’s (2014) focus group study involved 37 participants, aged 34-68 
years and diagnosed between 4.8 months and 39 years (mean 7.0 years). This study focused 
on symptoms and psychosocial experiences at the time the focus groups were conducted. 
Breathlessness and fatigue were the dominant symptoms experienced by the participants. 
Fatigue significantly affected their activities of daily living. The study did not examine the 
participants’ experiences of diagnosis and, although sixteen women were using 
supplementary oxygen, their perspectives on their experiences of using oxygen therapy were 
not elicited. Belkin et al. (2014) reported that the primary psychological experience of LAM 
was one of “getting stuck with LAM”. Fewer participants had adapted to living with LAM 
but it was not revealed how this was achieved.  
Pollock-BarZiv’s (2005) doctoral thesis employed mixed methods to elucidate the quality 
of life and psychosocial impact of LAM on lung transplant candidates and recipients. The 
exploratory, descriptive, qualitative arm of the study, using a narrative approach, involved 
11 transplant recipients aged 33-55 years, two to 13 years post-transplant, and described the 
women’s experiences from diagnosis to life after transplant. The study focused on 
participants’ experiences while waiting for transplant and post-transplant. Many  
participants received little information and support when they were diagnosed. While one 
participant reported adapting to her illness, most, who were living with severe disease prior 
to transplant, felt unable to adjust to living with LAM and their subsequent loss of function.  
Most experienced anxiety and depression while waiting for a transplant, and stigma in 
relation to their use of supplementary oxygen. The participants’ experiences of transplant 
varied but commonly they experienced both physical and emotional difficulties adjusting to 
their drug therapy, particularly steroid therapy. The quantitative arm of the study surveyed 
31 women waiting for a transplant and 43 women who had received a lung transplant. 
Results reflected the qualitative findings. Pre-transplant quality of life was impaired by 
limited function, fatigue, anxiety and isolation, and improved after transplant.  
Three personal narratives were located (Carel et al. 2010; Carel 2013b; Hoy 2016). Carel’s  
narratives concerned her experiences of living with LAM from the onset of her illness when 
she was 35 to the time of writing the second edition of her book, Illness, seven years later. 
Carel et al. (2010) was a brief narrative written for a collection titled “A Patient’s Journey”, 
published in the British Medical Journal between 2007 and 2013 (Jessop 2014). Her book 
(Carel 2013b) is a more detailed narrative and reflection on her illness experience. Carel 
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was initially misdiagnosed as asthma and was given a prognosis of ten years when she was 
diagnosed in 2006. Hoy (2016), a physician with access to expert medical facilities, was 
diagnosed in a timely manner within six days in 2014. Carel used supplementary oxygen. 
She reported stigma in relation to her oxygen use, and miscommunication and being made 
to feel alienated by healthcare professionals. In contrast to the findings of Belkin et al. 
(2014) and Pollock-BarZiv (2005), Carel’s (2013) narrative focused on her ability to adapt 
to living with her illness and experience health and wellbeing. Similarly, in her short 
personal narrative, Hoy (2016) reported accepting and adjusting to living with LAM and 
feeling comfortable with her new normality.   
Seven quantitative studies were reviewed in relation to women’s experiences and 
perspectives. Vafamand’s (2014) doctoral thesis, through quantitative methodology 
employing predetermined questionnaires, examined statistically the effect of knowledge, 
attitude and lifestyle practices on the quality of life of 143 LAM patients. It concerned 
health-related attitudes and behaviours related to physical activity, diet and smoking. This 
study reported that the majority of respondents had positive attitudes towards being 
physically active, eating healthily and stopping smoking. More positive attitudes towards 
physical activity were associated with higher quality of life. There was no significant 
relationship between quality of life and attitudes and intent to change diet or smoking 
behaviours. Although Vafamand (2014) reported that confidence in handling the disease 
was associated with higher quality of life, the study found that greater knowledge of the 
disease was associated with lower quality of life. Lower quality of life was also associated 
with more severe symptoms and more restricted activity. It was observed that this finding 
contradicted earlier studies which found that increased knowledge was associated with 
better quality of life. Vafamand concluded there was a significant positive relationship 
between attitude, lifestyle practices and quality of life, and a negative relationship between 
knowledge and quality of life.  This study did not elicit the participants’ personal responses, 
and, confined to health-related attitudes and behaviours, did not explore other attitudes, 
practices or factors which might influence women’s quality of life.  
Ryu et al. (2006) outlined the baseline characteristics of 243 patients with LAM at the time 
of enrollment in the LAM Registry between 1998 and 2001. Using the SF-36 health survey 
and the St George’s Respiratory Questionnaire (SGRQ), they found that LAM patients 
experienced impaired quality of life as lung function decreased. Results of both tests were 
compared with those of patients with chronic obstructive pulmonary disease (COPD). The 
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SF-36 physical and mental component scores were better for LAM patients than COPD 
patients. The lack of correlation between physical and mental components suggested both 
groups develop mechanisms to cope with the impact of their diseases. However, the results 
could not easily be interpreted due to a marked difference in age, sex and lung function 
between the two cohorts (Tattersfield & Glassberg 2006, p.3). The nature of the coping 
mechanisms was not investigated.  
Walker et al. (2015) developed a Tool to Assess Quality of life in LAM (ATAQ-LAM) and 
surveyed a convenience sample of 69 LAM patients attending a LAM conference to test the 
tool. They reported that participants using supplementary oxygen and with reduced lung 
function had more impaired health-related quality of life than those not requiring 
supplementary oxygen. The main focus of the article was the development and validation 
of the tool and its ability to discriminate between patients with differing levels of LAM 
severity and health-related quality of life. How the women experienced life with 
supplementary oxygen was not explored in this quantitative study. 
Cohen et al. (2009), in a survey of 328 women with LAM, reported that 55% of respondents 
avoided pregnancy due to concerns about the effect it might have on their condition. Women 
with mild disease were more likely to have favourable pregnancy outcomes. Women 
diagnosed before (n=12) or during pregnancy (n=15) had poorer lung function than women 
diagnosed after pregnancy (n=178). In addition, those diagnosed during pregnancy had 
increased premature births and miscarriages, and more breathlessness, pneumothorax and 
chylothorax. However, they found that there was no difference in quality of life, general 
wellbeing, depression and anxiety between women who had children and those who didn’t. 
These findings demonstrate the complex issues involved in pregnancy for women with LAM 
and support the European Respiratory Society guidelines for the management of LAM 
which recommend women are offered individualised counselling regarding pregnancy 
(Johnson et al. 2010). The study did not reveal women’s personal experiences or decision-
making regarding pregnancy. 
Three studies emphasised the need to take into account patients’ subjective views of their 
disease, supporting the need for this current study. Pollock-BarZiv et al. (2005), in a cross-
sectional study evaluating the functional status of 74 patients with LAM, reported that 
certain objective measurements of function (spirometry and six minute walk test) did not 
correlate well with patients’ perceptions. They recommended that clinicians consider LAM 
patients’ subjective assessment of their function to focus interventions and improve quality 
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of life. Similarly, Young et al. (2006), evaluating the opinions of 314 LAM respondents to 
a questionnaire on the management of pneumothorax, found a difference in opinion between 
LAM patients and their physicians, with most patients favouring more conservative 
management initially. One third of these respondents believed their physicians did not 
consider their preferences in this regard. Young et al. (2006) stated that understanding 
patients’ perspectives enables cooperative decision-making and improves clinical outcomes 
related to the management of pneumothorax.  
Cohen et al. (2005), in a cross-sectional survey of 328 women listed with the US LAM 
Foundation database and the UK LAM Action group, reported fatigue as a common 
symptom of LAM which negatively affected quality of life for 71.9% of their respondents, 
It occurred independent of lung function across all age groups and was not addressed by 
healthcare professionals. They concluded that further research was needed to explain and 
reduce fatigue experienced by women with LAM. Pollock-BarZiv (2005) and Belkin et al. 
(2014) similarly reported that fatigue was a prominent symptom causing significant 
impairment for their participants. This corresponds with other studies that have found that 
fatigue is a common aspect of many chronic illnesses and negatively affects quality of life 
for these people (Kralik et al. 2005; Small & Lamb 1999).  
In summary, four quantitative studies and one mixed methods study examined quality of 
life in women with LAM and found that it was impaired. Only Vafamand (2014) measured 
the relationship of attitudes and lifestyle practices to quality of life. In the studies reviewed, 
lower quality of life was associated with reduced lung function and the use of supplementary 
oxygen (Ryu et al. 2006; Walker et al. 2015); severe symptoms, restricted activity, and 
knowledge of the disease (Vafamand 2014); fatigue (Cohen et al. 2005); and function and 
depression (Pollock-BarZiv 2005). Higher quality of life was associated with confidence in 
handling the disease and a positive attitude to physical activity (Vafamand 2014). Post-
transplant respondents scored high levels of self-rated quality of life associated with lower 
anxiety and depression scores and higher energy/vitality levels and functional status 
(Pollock-BarZiv 2005). Two quantitative studies found that patients’ perspectives of their 
function (Pollock-BarZiv et al. 2005) and medical management (Young et al. 2006) differed 
from objective measurements and physician perspectives and recommended these should be 
taken into account in clinical decision-making. The personal narratives of Carel (2010; 
2013b) and Hoy (2016) revealed their ability to adapt to their limitations and experience 
health and wellbeing. These experiences contradict the findings of Belkin et al. (2014) of a 
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primary negative psychological experience of feeling “stuck” and frustrated associated with 
physical limitations and fatigue.  
The review of the LAM literature revealed a limited understanding of women’s experiences 
of living with this condition. The quantitative studies demonstrated the association between 
quality of life and the physical symptoms of LAM, confidence and knowledge of the disease 
and attitude to physical activity; and the discrepancy between patient perspectives and 
medical assessments. They did not, however, uncover women’s personal experiences of 
living with their illness or how the rarity of their condition might affect their experience. 
Only two personal narratives and one qualitative focus group study revealed differing 
aspects of the experience of living with LAM. This review concluded there was a paucity 
of literature on women’s experiences of living with LAM. 
1.3.2 Living with a rare disease 
As such limited literature was found on the experience of living with LAM, it was decided 
to extend the literature search to include people’s experiences of living with other rare 
diseases, including rare lung diseases, and review the LAM literature in relation to this body 
of literature. Literature was sought which focused on the influence of the rarity of the 
condition on people’s illness experiences. The search for rare lung diseases also 
encompassed people’s experiences of progressive respiratory illness. There are more than 
6000 rare diseases and many of these are genetic and affect individuals from birth (Rare 
Disease UK 2016). For the purposes of this study and because LAM is a disease of adult 
onset, the search was limited to adults’ experiences of living with rare disease, except for 
studies which were inclusive of a range of rare diseases affecting both children and adults. 
Literature on the experience of living with other respiratory diseases, chronic obstructive 
pulmonary disease (COPD), asthma, and cystic fibrosis, was not specifically reviewed. 
COPD is a disease commonly caused by smoking and primarily affects an older population. 
Asthma is common and treatable. Cystic fibrosis affects people from birth. 
The search for literature on living with a rare disease was conducted using databases 
(MEDLINE, CINAHL, Expanded Academic ASAP, PsycINFO, ProQuest Dissertation and 
Theses, and Google Scholar), journal reference lists, and a journal specialising in rare 
disease, the Orphanet Journal of Rare Diseases. The database search terms used were rare 
lung disease* and rare disease*, with additional terms of qualitative or narrative* or 
interview* or experience*. This search aimed to extract a range of literature which focused 
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on the experience of rarity in a variety of diseases, including rare lung diseases, in order to 
provide a background of literature against which the literature on LAM could be further 
examined.  
The search yielded 15 articles on the experience of living with two rare lung diseases, 
pulmonary hypertension (n=8) and idiopathic pulmonary fibrosis (n=7). See Appendix 2, 
Table 2.1. There was scant literature on the experience of living with other rare lung 
diseases. The search was limited to pulmonary hypertension and idiopathic pulmonary 
fibrosis as they were similar in character to LAM.  Like LAM, pulmonary hypertension and 
idiopathic pulmonary fibrosis are rare, incurable, progressive lung diseases of adult onset, 
unrelated to smoking, and with similar common symptoms of breathlessness and fatigue, 
and may also affect younger people. See Appendix 2, Table 2.2, for a comparison of the 
characteristics of LAM, idiopathic pulmonary fibrosis and pulmonary hypertension. While 
pulmonary hypertension and idiopathic pulmonary fibrosis have significantly worse median 
survival times, these conditions can be compared with women’s experiences of living with 
LAM. Idiopathic pulmonary fibrosis will be referred to as pulmonary fibrosis in this thesis 
for ease of reading.  
Of the 15 articles reviewed on pulmonary hypertension (n=8) and pulmonary fibrosis (n=7), 
there were ten qualitative studies (Overgaard et al. 2016; Duck et al. 2015; Yorke et al. 2014; 
Kingman et al. 2014; Armstrong et al. 2012; Matura et al. 2012; Schoenheit et al. 2011; 
McDonough et al. 2011; Flattery et al. 2005; Swigris et al. 2005), two quantitative studies 
(Taichman et al. 2005; De Vries et al. 2001), one survey (Collard et al. 2007), one literature 
review (Belkin & Swigris 2014), and one  mixed methods study (Pulmonary Hypertension 
Association Europe 2016). See Appendix 2, Table 2.1. 
Twenty pieces of literature were retrieved which related to the experiences and perspectives 
of people living with other rare diseases (see Appendix 2, Table 2.3). Twelve studies were 
concerned with multiple rare diseases. These included three surveys conducted by rare 
disease associations (EURORDIS 2009; Rare Disease UK 2016; Rare Voices Australia 
2013), one mixed methods study (Caputo 2014), five qualitative studies (Budych et al. 2012; 
Garrino et al. 2015; Huyard 2009; Jaeger et al. 2015; Jessop 2014), two quantitative studies 
(Molster et al. 2016; Wallenius et al. 2009), and one literature review (Cohen & Biesecker 
2010). Six studies related to rare cancers: neuro-endocrine tumour (Feinberg et al. 2013), 
vulval cancer (Jefferies & Clifford 2009/2011), penile cancer (Gordon 2013), mycosis 
fungiodes – a rare skin lymphoma (Vitale 2005), leiomyosarcoma (Garau 2016 – a personal 
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narrative), and gallbladder cancer (Dockser Marcus 2010 – a personal narrative). Joachim 
and Acorn’s (2003) study on scleroderma was included as it focused on the experience of 
living with a rare disease. Oksel & Gunduzoglu’s (2014) article on women’s experiences of 
living with scleroderma provided a further comparison of this condition. 
The literature on the lived experience of LAM is now discussed in relation to the rare disease 
literature that was retrieved. Discussion concerns the experience of living with an incurable 
lung condition and how the rarity of a disease affects the illness experience. Four significant 
aspects of experience emerged from the rare disease literature: searching for a diagnosis, 
receiving the diagnosis, daily struggles, and searching for expert care and treatment in the 
healthcare system. While the issue of the effect of rarity on the illness experience was not 
specifically discussed in the literature on the lived experience of pulmonary hypertension 
and pulmonary fibrosis, in common with the rare disease literature, these studies revealed 
these aspects of experience to be important for participants.  
1.3.2.1 Searching for a diagnosis 
A period of misdiagnosis or delayed diagnosis was reported as a common experience for 
people with rare diseases in the majority of studies examined in this literature review.  The 
participants of Pollock-BarZiv’s (2005) study experienced variable onset of symptoms from 
sudden onset with lung collapse to gradual development of breathlessness over a period 
years which was difficult to diagnose. Most experienced multiple medical consultations and 
investigations with delays in diagnosis and being misdiagnosed before they received their 
diagnosis.  Carel (2013b) was originally misdiagnosed with asthma.  
Pollock-BarZiv’s (2005) findings and Carel’s (2013b) experience are reflected in two 
surveys conducted between 2003 and 2008 by the European Organisation for Rare Diseases, 
EURORDIS, on the experiences and expectations of 12,000 patients with 16 rare diseases 
on diagnosis and care in Europe (EURORDIS 2009). Patients with LAM were not included 
in these surveys. The results revealed 40% of patients were initially misdiagnosed and 
received inappropriate medical and psychological treatment, including psychiatric 
medication. Diagnosis was delayed between five and 30 years for 25% of patients. Similar 
findings are reported in surveys conducted by Rare Diseases UK (2016) and Rare Voices 
Australia (2013). 
 Misdiagnosis and delays in diagnosis were also found in studies of other rare diseases in 
various countries (Feinberg et al. 2013; Garau 2016; Garrino et al. 2015; Gordon 2013; 
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Molster 2016; Vitale 2005), pulmonary hypertension (Armstrong et al. 2012; Kingman et 
al. 2014), and pulmonary fibrosis (Belkin & Swigris 2014; Duck et al. 2015; Overgaard et 
al. 2016;  Schoenheit et al. 2011), as were symptoms being attributed to psychosomatic 
causes (Armstrong et al. 2012; Duck et al. 2015). Jessop (2014, p. 108), in a narrative 
typology exploring how people with rare diseases structured their narrative accounts, 
referred to searching for a diagnosis in the context of a rare disease as “the quest for 
diagnosis”. 
1.3.2.2 Receiving the diagnosis 
Receiving their diagnosis had a significant impact on women with LAM and people with 
pulmonary hypertension and pulmonary fibrosis. They experienced shock and uncertainty 
(Carel 2013b; Flattery et al. 2005; Kingman et al. 2014; Overgaard et al. 2016; Pollock-
BarZiv 2005); fear (Armstrong et al. 2012; Hoy 2016; McDonough et al. 2011; Swigris et 
al. 2005); anger and grief (Carel 2013b; Hoy 2016; Pollock-BarZiv 2005); anxiety 
(McDonough et al. 2011; Swigris et al. 2005); and isolation (Belkin & Swigris 2014; 
Kingman et al. 2014; Pollock-BarZiv 2005). People with other rare diseases also reported 
feeling isolated because of their diagnosis (Garrino et al. 2015; Huyard 2009; Jefferies & 
Clifford 2011). 
A significant aspect of being diagnosed with a rare disease was the manner in which the 
diagnosis was delivered. Women with LAM and people with other rare diseases reported 
being given their diagnosis in an insensitive manner and in insufficient time (Carel 2013b; 
Schoenheit et al. 2011), and in inadequate or inappropriate conditions (EURODIS 2009). 
Multiple studies reported that participants were provided with little information (Carel 
2013b; Collard et al. 2007; Duck et al. 2015; EURORDIS 2009; Garau 2016; Garrino et al. 
2015; Gordon 2013; Jefferies & Clifford 2009; Pollock-BarZiv 2005; Rare Diseases UK 
2016; Rare Voices Australia 2013) or emotional support (Armstrong et al. 2012; Belkin & 
Swigris 2014; Carel 2013b; EURORDIS 2009; Garau 2016; Garrino et al. 2015; Gordon 
2013; Pollock-BarZiv 2005). According to EURORDIS (2009), problems with diagnosis 
arise from healthcare professionals’ general lack of awareness and knowledge of rare 
diseases. 
When their information and support needs were not met by healthcare professionals many 
people with rare diseases and their families embarked on an independent search for 
information and support. This was reported by women with LAM (Carel 2013b; Hoy 2016) 
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and vulval cancer (Jefferies & Clifford 2009), people with pulmonary hypertension 
(Armstrong et al. 2012), mycosis fungoides (Vitale 2005), and other rare diseases (Rare 
Diseases UK). The internet became a significant but not always reliable source of 
information for these people. Although a physician herself, Hoy (2016) referred to 
Wikipedia and read outdated information of a ten year survival period for LAM, rather than 
consulting medical publications available at that time which indicated a median survival 
time of 29 years from diagnosis (Oprescu et al. 2013). While peer support organisations are 
a valuable source of information and support, a survey conducted by Rare Diseases UK 
(2016) found that four out of five respondents were not referred to these groups by their 
physicians when they were diagnosed. Similarly, women with vulval cancer (Jefferies & 
Clifford 2009) and people with neuro endocrine tumour (Feinberg et al. 2013), mycosis 
fungoides (Vitale 2005), and pulmonary fibrosis (Schoenheit et al. 2011) reported having 
difficulty finding others with their condition and disease specific support.  
When they were diagnosed, women with LAM (Carel 2013b; Pollock-BarZiv 2005), and 
people with pulmonary hypertension (Kingman et al. 2014), pulmonary fibrosis (Duck et al. 
2015; Schoenheit at al. 2011; Swigris et al. 2005) and scleroderma (Oksel & Gunduzoglu 
2014) experienced disruption of their sense of self, and social roles, relationships, and 
interactions. Disruption was accompanied by feelings of loss of their previous life (Carel 
2013b; Duck et al 2015), independence (Duck et al. 2015; Overgaard et al. 2016; Pollock-
BarZiv 2005; Schoenheit et al. 2011; Swigris et al. 2005), friends and social participation 
(Carel 2013b; Swigris et al. 2005), spontaneity (Carel 2013b; Duck et al. 2015; McDonough 
et al. 2011), and financial status (Carel 2013b; Schoenheit et al. 2011). Loss of independence 
and needing help from others was accompanied by feelings of guilt (Belkin et al. 2014; Duck 
et al. 2015; Pulmonary Hypertension Association Europe 2016), being a burden (Schoenheit 
et al. 2011), and loss of control (Pollock-BarZiv 2005; Duck et al. 2015).  
1.3.2.3 Daily struggles  
Four studies examined quality of life for people living with pulmonary hypertension and 
pulmonary fibrosis and found that it was impaired (Belkin & Swigris 2014; De Vries et al. 
2001; Swigris et al. 2005; Taichman et al. 2005). The findings were associated with the 
effects of the disease rather than its rarity and reflected the quality of life findings in the 
LAM literature. For people with pulmonary fibrosis, reduced quality of life was associated 
with physical symptoms, fatigue and using supplementary oxygen (Swigris et al. 2005); and 
depression, anxiety and isolation (Belkin & Swigris 2014). De Vries et al. (2001), in a 
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quantitative study examining the relationship between quality of life, depressive symptoms 
and breathlessness inpatients with pulmonary fibrosis, reported that impaired quality of life 
for these people was associated with physical symptoms, fatigue, reduced mobility, limited 
activities of daily living and working capacity, and depression. Taichman et al. (2005), in a 
cross-sectional survey of health-related quality of life in patients with pulmonary 
hypertension, reported that respondents had severe impairments in both physical and 
emotional domains of health-related quality of life associated with measurements of reduced 
functional status. 
Seven studies found that women with LAM and people with pulmonary hypertension 
managed symptoms of breathlessness and fatigue and the limitations these imposed on their 
activities and lifestyle (Armstrong et al. 2012; Belkin et al. 2014; Carel 2013b; Kingman et 
al. 2014; McDonough et al. 2011; Pollock-BarZiv 2005). They did this by pacing and 
adjusting their activity levels (Carel 2013b; McDonough et al. 2011), developing other 
hobbies (Carel 2013b; Kingman et al. 2014; McDonough et al. 2011), and redefining life 
(Carel 2013b; Flattery et al. 2005; McDonough et al 2011).  
The sense of disruption experienced by Carel (2013b) and other people with rare disease is 
common to chronic illness. Bury’s (1982, p.169) seminal study of rheumatoid arthritis 
recognised that chronic illness was a form of “biographical disruption”, in that its disruptive 
effects encompassed a person’s identity, relationships and everyday life within their social, 
cultural and familial contexts which may change over time. He found that a person’s 
response to chronic illness involved searching for meaning, and an attempt to adjust and 
mobilise physical, cognitive, spiritual, social, material or financial resources. Further, 
Williams (1984) claimed people attempt to repair the disruption of chronic illness by 
reinterpreting their biography in a process of narrative reconstruction. Williams (2000) 
extended the concept of biographical disruption to include the concept of biographical 
continuity where people might apply a range of meanings to their illness depending on the 
timing, context and circumstances in which the illness occurs. 
Reflective of these concepts, chronic illness has been described as a complex, shifting, 
multidimensional and disruptive experience for women living with various illnesses and 
conditions, including breast cancer, diabetes and fibrocystic breast disease (Packard et al 
1991), rheumatoid arthritis (Plach et al. 2004), chronic fatigue syndrome and fibromyalgia 
(Asbring 2001), premature menopause (Boughton 2002) and ovarian cancer (Ryan 2005). 
Similarly, Levealahti et al. (2007), in a qualitative study exploring how people with 
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inoperable lung cancer conceptualize the onset of their illness, found that participants 
viewed their symptoms as having different meanings ranging from disruption to continuity 
of various aspects of their lives depending on their lifestyles and history. Kralik (2002, 
p.146), in a narrative inquiry into the meaning of 81 midlife women’s experiences of living 
with chronic illness, extended the concept further, finding that women reconstructed their 
lives disrupted by illness in a fluctuating process of moving from a state of 
“extraordinariness” to “ordinariness”. 
In line with Kralik’s (2002) findings, Carel (2013b) was able to experience health and 
wellbeing while living with LAM when her lung function stabilised due to treatment with 
sirolimus medication, and by focusing on being positive and living in the present. Hoy 
(2016, p. 238) described sirolimus as a source of hope in its ability to stabilise her LAM and 
improve her health. Like Carel (2013b), Cohen and Biesecker (2010), in a systematic review 
of quality of life in rare genetic conditions, and Caputo (2014), in a content analysis of 
written illness stories of 32 people with four rare diseases, found that people with rare 
diseases were able to experience good quality of life in spite of serious disability. According 
to their personal narratives, sirolimus was significant for Carel (2013b) and Hoy (2016) but 
no other studies have sought women’s perspectives on this new treatment.  
In contrast with the above studies which found that people with chronic illness can move 
from feelings of disruption to continuity, Belkin et al. (2014, p.3) reported that, while several 
participants adapted to their illness and showed defiance, most experienced “getting stuck 
with LAM” and felt frustration, resentment, worry and fear. Forty three percent of Belkin et 
al.’s (2014) participants were using supplementary oxygen and it is not clear if these feelings 
were related to their stage of illness or oxygen therapy. According to Duck et al. (2015), in 
a qualitative study of the experiences of people with pulmonary fibrosis, people with 
pulmonary fibrosis, with a low mean life expectancy of two to four years, felt a sense of loss 
and reported struggling with living with their illness, and being dependent on their oxygen 
to manage their breathlessness.  Similarly, Pollock-BarZiv (2005) found that most of her 
participants were unable to adjust to their advancing disease before transplant as they 
experienced uncertainty, fear, anxiety, struggling to stay alive, and being completely 
dependent on others. It is not known how women with LAM who do not receive a transplant 
and progress to respiratory failure experience this stage of their illness. 
The rarity of a disease can negatively affect people’s social lives and create feelings of being 
stigmatised and isolated due to a lack of knowledge and understanding of rare disease in the 
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community. Pollock-BarZiv (2005) reported that when participants started oxygen therapy 
they felt an altered sense of self, took on a ‘sick’ role, and experienced stigma using oxygen 
in public. Carel (2013b) also felt stigmatised but she looked healthy when not using oxygen 
and subsequently also felt a lack of empathy from others. Yorke et al. (2014), in a qualitative 
study of the experience of living with pulmonary hypertension, found this effect was 
compounded by the lack of knowledge of their disease for people with pulmonary 
hypertension. Tattersfield and Glassberg (2006), in an editorial article on a national registry 
for LAM, noted that women with LAM can find that their local doctors and friends have not 
heard of the condition and their specialist physician may not previously have treated a 
patient with LAM. Joachim and Acorn (2003), in a focus group study of women living with 
scleroderma, found that this created feelings of social isolation and fear of rejection. 
Similarly, Jaeger et al. (2015), in a focus group study of the experiences of adults living with 
different rare diseases, reported that lack of understanding in the community affected the 
ability of their participants to participate in activities. Further, according to a survey 
conducted by Rare Voices UK (2016), social, educational and employment opportunities 
are restricted for people with rare disease. Vitale (2005), in a phenomenological study of the 
experience of living with mycosis fungoides as a rare disease, found that social isolation 
was compounded when people with mycosis fungiodes were geographically isolated. In this 
context, patient organisations (Belkin et al. 2014; Carel 2013b; Duck et al. 2015) and online 
communities and forums (Kingman et al. 2014; Matura et al. 2012; Vitale 2005) have been 
found to be a valuable source of support for people with rare diseases.  
Three studies revealed that participants’ sexual lives were altered by the effects of their 
illness and that it was an important aspect of their experience. Oksel & Gunduzoglu (2014), 
in a phenomenological study of the experiences of 20 women living with scleroderma, 
reported that women with scleroderma experienced sexual dysfunction when their sexual 
lives were disrupted by their physical symptoms and altered body image. Similar findings 
were reported in a mixed methods study conducted by the Pulmonary Hypertension 
Association Europe (2016) for people living with pulmonary hypertension (2016) and in a 
qualitative study on quality of life for people with pulmonary fibrosis (Swigris et al. 2005). 
These studies found that their participants’ illness caused a decrease in sexual activity and 
loss of libido which had a significant effect on their daily life. No studies have reported how 
LAM affects women’s sexual lives.   
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Women with LAM face decision-making regarding pregnancy and options for having 
children.  Carel (2013b) accepted the recommendation of her physicians to avoid pregnancy, 
prioritising staying alive over having children. Hoy (2016) and her partner harvested eggs 
and froze embryos but did not discuss their decision-making on this issue. In contrast to 
Carel (2013b), the participants of Boughton’s (2002) phenomenological study of premature 
menopause, a non-life-threatening condition, felt the disruption of their expected plans for 
procreation as a sense of alienation and loss of their female identity. Pollock-BarZiv (2005) 
and Belkin et al.’s (2014) participants did not reveal their perspectives on this issue.  
Women with LAM may be working and raising children born prior to diagnosis. Pollock-
BarZiv (2005) reported that their participants perceived their identities changed as they had 
to relinquish or alter work and family roles as their illness progressed. They found it 
eventually impossible to carry out their mothering duties. Belkin et al. (2014), Carel (2013b) 
and Pollock-BarZiv (2005) did not discuss how women with LAM managed work and 
parenting while living with their illness. 
1.3.2.4 Searching for expert care and treatment in the healthcare system 
According to surveys conducted by EURODIS (2009), healthcare professionals’ lack of 
awareness and knowledge is a significant barrier to people with rare disease being able to 
access quality health care and improve their quality of life. Similarly, Joachim and Acorn 
(2003, p.605), in a focus group study of the experience of living with scleroderma, stated 
that the “knowledge, attitudes and behaviour” of healthcare professionals play an important 
role in assisting people with rare conditions adjust to their illness. They asserted that nurses’ 
ignorance of rare diseases produces stigmatising responses to patients, compounding 
patients’ complex experience and creating misunderstanding. Joachim and Acorn (2003, 
p.605) summarised the experience of living with scleroderma as “complex” and one made 
“more complex” by the rarity of the condition.  
Patients with rare diseases and their families feel marginalised in the health care system and 
frequently have to search for expert care and advocate for appropriate treatment 
(EURORDIS 2009). EURODIS (2009) reported that more than 25% of the respondents to 
their surveys struggled to access services and preferred to be managed in centres of 
expertise. Many relocated for this purpose. According to Vitale (2005), people with mycosis 
fungoides felt it was a burden to travel considerable distances to receive specialised care. In 
addition, people with rare diseases experience a lack of holistic, multidisciplinary care 
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(Jaeger et al. 2015; Rare Diseases UK 2016), difficulty in accessing social services 
(Wallenius et al. 2009; Yorke et al. 2014), and poor communication between medical 
specialists (Jaeger et al. 2015; Molster et al. 2016). Duck et al. (2015), in a qualitative study 
on the experience of living with pulmonary fibrosis, found that their participants similarly 
were frequently faced with poor service provision. Inequities in accessing effective therapy 
were also reported in the Australian context. According to Rare Voices Australia (2013), 
less than 1% of the Australian rare disease population is able to access effective treatment. 
It is not known how this applies to women living with LAM in Australia.  
Huyard (2009), in a qualitative study examining to what extent people with rare disease 
think the rarity of their disease contributes to their difficult experiences, argued that difficult 
rare disease experience was a result of healthcare professionals failing to meet the moral 
needs of their patients rather than the rarity of the disease itself. This view recognises the 
influence of healthcare professionals on the experience of people with rare disease but does 
not take account of the impact, reported in the studies above, of the rarity of the condition 
on people’s social lives in the broader community due to the lack of understanding they 
experience.  
People with rare diseases, including women with LAM, advocate collectively, through 
patient organisations, to raise funds for research into their condition (LAM Foundation 
2015; Joachim & Acorn 2003). In this way, Ayme et al. (2008), in an essay on patient 
empowerment for people with rare diseases, claimed people with rare diseases are 
empowered by their active participation in research and contribute to the development of 
scientific knowledge. Finn (2008), in an ethnographic study of empowerment in the alpha-
1 antitrypsin community, found that advocacy and networking with other patients and care 
providers contributed to patients’ empowerment. Carel (2013b) reflected on the stigma and 
lack of empathy she experienced in her interactions with healthcare professionals and stated 
that she had become her “own advocate” and “a patient activist” through her involvement 
with the UK LAM peer support organisation (p.156). Belkin et al. (2014) and Pollock-
BarZiv (2005), however, did not explore women’s experiences of advocacy or their 
encounters with healthcare professionals. 
1.3.3 Summary  
This review of the available literature on the experience of women living with LAM 
revealed a paucity of qualitative literature concerned with women’s subjective illness 
experiences. Four quantitative studies and one mixed methods study reported quality of life 
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was impaired for women with pulmonary LAM (Cohen et al. 2005; Pollock-BarZiv 2005;  
Ryu et al. 2006; Vafamand 2014; Walker et al. 2015) Three quantitative studies sought 
women’s perspectives on fatigue (Cohen et al. 2005), functional status (Pollock-BarZiv et 
al. 2005), and management of pneumothorax (Young et al. 2006), and supported the view 
that taking patients’ subjective perspectives into account can improve clinical management, 
outcomes, and quality of life for women with LAM.  
Only two qualitative studies (Belkin et al. 2014; Pollock-BarZiv 2005) and two women’s 
personal narratives (Carel 2013b; Carel et al. 2010; Hoy 2016) were located. These 
described aspects of women’s LAM illness experiences and were reviewed in relation to 
literature on other rare diseases. Carel (2013b) and Pollock-BarZiv (2005) demonstrated that 
receiving a diagnosis of LAM created a sense of disruption and feelings of isolation. Carel’s 
(2013b) narrative focused on her ability to adapt to her illness and experience health and 
wellbeing. Similarly, Hoy (2016, p.238) was able to accept and adjust to her “new 
normalcy”. In contrast, Pollock-BarZiv (2005) and Belkin et al. (2014) found that most of 
their participants had difficulty adjusting. It is not clear if this was related to the stage of 
illness of the participants.  
Many areas remain unexplored. While Pollock-BarZiv (2005) explored the experiences of 
women from onset of symptoms to following lung transplantation, the study was focused 
on experiences of transplant and did not include women who reached the late stage of LAM 
and did not receive a transplant. It is not known whether most women with LAM adapt to 
their illness, as was the case for Carel (2013b) and Hoy (2016), or how the stage of their 
illness affects their ability to adapt. Many aspects of living with LAM have not been 
explored, for example, managing oxygen therapy, personal relationships, sexuality, the need 
to avoid pregnancy, parenting and working. While Carel (2013b) reflected on her experience 
of stigma in her relations with healthcare professionals, women’s experiences of advocacy 
and interactions with healthcare professionals, identified as significant aspects of living with 
a rare disease in other studies, have not been explored in detail in relation to LAM. Carel 
(2013b) and Hoy (2016) benefited from stabilised lung function due to sirolimus therapy 
but no studies sought women’s perspectives on this significant new treatment for women 
with LAM. Women’s experiences in the Australian context, where the numbers of women 
with LAM are so limited, have not been investigated.  
This literature review found a significant gap in the available literature on women’s 
experiences of living with LAM and identified a clear need for further qualitative research 
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to address the lack of understanding in this area. Considering LAM is a chronic illness with 
marked clinical variability and rate of progress, a broad range of women’s personal views 
of their illness is needed in order to understand the meaning of their experiences in their 
individual social contexts and healthcare settings at different stages of their illness across 
time. 
1.4 Aims of the study and research question 
The purpose of this nursing research is to explore and capture a comprehensive view of the 
experiences of women living with LAM over their life course. Specifically, the research 
aims to: 
 increase understanding of the meaning of women’s experiences of living with LAM over 
time across the illness trajectory; 
 understand how the rarity of LAM affects the women’s experiences; 
 identify issues of concern for women living with LAM; 
 enhance the existing body of nursing knowledge to inform the practice of nurses and other 
healthcare professionals and improve the care and support provided to women with this 
disease. 
To address these aims, the study seeks to answer the following research question: 
What are women’s experiences of living with LAM over their life course? 
1.5 Significance of the research 
Although LAM is rare, increasing numbers of women are being diagnosed with this 
condition. Nurses may encounter LAM patients in community and hospital inpatient and 
outpatient settings as they are treated for LAM, undergo transplant workup or receive a 
transplant. As a rare disease it is not uncommon for nurses caring for these patients to have 
not heard of LAM or know very little about the disease and its impact on these women.  
This research will provide accessible information for nurses, physicians and other healthcare 
professionals to increase the current limited understanding of women’s experiences of living 
with LAM across their illness trajectory. The addition of the experiential dimension of LAM 
to the body of biomedical knowledge may improve clinical management, outcomes and 
quality of life for these women. Furthermore, informing healthcare professionals of the 
problems women encounter as they live with LAM may increase empathy and support for 
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them and reduce their sense of isolation in living with a rare disease. This study enables 
women living with LAM to have their voices heard and their needs addressed. Finally, the 
insights gained from this research may illuminate the experience of living with other rare 
diseases.  
1.6 Overview of the thesis 
The thesis is presented eight chapters.  
Chapter 1 has introduced the thesis and provided a background to the study and an account 
of its origins. It has presented the literature review conducted to locate the available 
literature on women’s experiences of living with LAM, demonstrated a paucity of literature 
on this subject, and established a need for further research. It has stated the aims of the study, 
the research question, and significance of this research.  
Chapter 2 discusses the life history methodology used in this thesis in relation to its 
theoretical framework, recruitment of participants, data collection and analysis, rigor, and 
ethical considerations. The participants are introduced in brief biographies at the end of the 
chapter.  
Chapters 3 to 6 present the findings of the study as a constructed, collective life history 
focused on women’s experiences of living with LAM at significant turning points and 
periods of their illness. Chapter 3 presents women’s experiences of being diagnosed with 
LAM. Chapter 4 concerns their life after diagnosis as they learned to live with their illness. 
Chapter 5 investigates their experiences of interacting with healthcare professionals. 
Chapter 6 explores their experiences of living with advanced disease, including experiences 
of oxygen therapy, respiratory failure and lung transplantation. 
Chapter 7 discusses the findings in relation to existing theory and illness literature in order 
to link this research to broader issues and knowledge.  
Chapter 8 discusses the implications of this research for nursing practice and directions for 
further research. The life history method is reviewed and limitations of the study considered. 
The thesis concludes with a personal reflection and concluding remarks.  
1.7 Conclusion 
This chapter has introduced the thesis, provided a background to the study and presented 
the literature review which was conducted to locate and analyse the available literature on 
the experiences of women living with LAM. Due to the paucity of literature identified, the 
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literature review was expanded to include the lived experience of other rare diseases. The 
LAM literature reviewed was then examined within this broader body of research. 
Significant gaps were identified in the literature on LAM and a need was established for this 
study on women’s experiences of living with LAM. The aim of the study, research question 
and significance of the research were presented. Finally, an overview of the thesis was 
provided. The life history methodology used in the thesis is highlighted in the next chapter. 
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Chapter 2 
METHODOLOGY 
 
2.1 Introduction 
Life history methodology was used in this study to answer the research question:                        
What are women’s experiences of living with LAM over their life course? 
The literature review undertaken in the previous chapter revealed a paucity of qualitative 
literature on this topic and suggested that understanding women’s perspectives of their 
illness may improve support, clinical management and quality of life for women with LAM. 
This chapter presents the life history methodology used in the study. It is discussed in 
relation to the theoretical framework provided by Gadamer’s (2004) hermeneutic 
philosophy and Rosenthal’s (1993) biographical interpretive method of narrative analysis, 
followed by discussion of the research process, including participant recruitment, data 
collection and analysis, rigor, and ethical considerations. Finally, the participants are 
introduced in alphabetical order with a brief biography and factual account of their illness. 
2.2 Theoretical framework 
The studies of LAM and rare disease examined in the literature review reflected the concept 
of chronic illness experience as biographical, involving a person’s identity, interactions, and 
everyday life in their individual social contexts over time (Bury 1982). To understand 
women’s experiences of living with LAM from their perspective, this study is therefore 
concerned with personal meaning and subjective biographical knowledge situated in context 
and across time. Steger (2012, p.165) defined meaning as “the web of connections, 
understandings, and interpretations that help us comprehend our experience and formulate 
plans directing our energies to the achievement of our desired future”. This definition of 
meaning alludes to the complex, interpretive nature of experience and provided direction in 
selecting the methodology of the study. To address the complex, meaning-focused, 
biographical nature of the research question, the methodology of this study adopted a life 
history approach and hermeneutic interpretive theoretical framework. The reasons for this 
are explained below. 
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Life history methodology explores human experience as part of a person’s whole life. 
Denzin (2009) asserted that central features of life history are its focus on the individual and 
their interpretations of their life, and its capturing of events over time. Furthermore, 
according to Cole and Knowles (2001), it provides insights into the meaning of experience 
by examining how it is shaped by the complex interaction between personal, social, 
contextual and historical influences. In this way, according to Josselson (1995), life history 
increases understanding by revealing the multidimensional character of human meaning. 
Smulyan, (as cited in a personal opinion in Hatch & Wisniewski 1995, p.120), claimed that 
it can “demonstrate forces and powers that shape experience”, and, as Denzin (1989) 
highlighted, give voice to marginalised people. A life history approach was therefore 
determined appropriate for this study as it aimed to give voice to women living with LAM 
who, as the literature review demonstrated, can feel isolated in communities and health care 
settings. 
Denzin (1989, p.70) argued that life history reveals turning points, epiphanies and 
transformations by examining events and how they impact on an individual and their life 
trajectory. He regarded epiphanies as “moments of crisis altering the fundamental meaning 
structures in an individual’s life”. Similarly, McAdams et al. (2001) viewed turning points 
as life transitions involving significant change. Wethington (2003) claimed that identifying 
these points provides insights into how a person makes meaning in challenging life 
situations, and, according to Sparkes (as cited in Hatch & Wisniewski 1995), how they 
reconstruct identity and self over time. Life history, therefore, is a source of rich data to 
understand women’s experiences of living with LAM at different stages of their illness over 
time. 
According to Denzin (1989), life history constructs an account of a person’s life based on 
their life story narrated in interviews.  Widdershoven (1993, p.2) argued life history is 
hermeneutic because a person interprets their life and creates meaning as they tell their life 
story. As such, he claimed, human life is a “process of narrative interpretation”. In light of 
the hermeneutic nature of life history, Gadamer’s hermeneutic philosophy and theory of 
interpretation was adopted as the theoretical framework for this study. 
2.2.1 Gadamer’s hermeneutic philosophy 
Gadamer (2004, p.390) claimed that “understanding occurs in interpreting” and “language 
is the universal medium in which understanding occurs”. A central tenet of Gadamer’s 
philosophy was the concept of prejudice.  For Gadamer (2004), the prejudices of an 
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individual are their background understandings – that of the family, society, and state in 
which one lives. He argued that these form the historical reality of a person’s being and 
always influence any experience. In this way, according to Koch (1996), a person’s 
prejudices affect their interpretation of an interaction or text. Gadamer’s philosophy can be 
applied to personal experience and the life history research process. A person understands 
their life as they tell their life story and a researcher gains understanding in interpreting the 
life story. Further, a person interprets their experiences through the lens of their prejudices 
as they tell their life story. Similarly, a researcher brings their prejudices to the interaction 
and interpretation of the life story. 
When interpreting and understanding a text, Gadamer (2004, p.271) emphasised that one 
must “remain open to the meaning of the other person or text....this openness always 
includes our situating the other meaning in relation to the whole of our own meanings or 
ourselves in relation to it”. He argued we do not exclude ourselves from the interpretation 
of a text but rather acknowledge our prejudices so that the text can present its own truth and 
otherness against our prior understandings.  
In this study, as researcher, my own prejudices included my background as a practising 
clinical nurse; my experience of being in close contact with my father as he lived with late-
stage Parkinson’s disease; and my professional and personal values of respect for the 
dignity, values and beliefs of each participant, honesty, ethical awareness, reflexivity and 
empathy. In having met only one woman with LAM previously in the hospital clinic, I did 
not have preconceived ideas of the participants’ illness experiences. I was, however, 
motivated by my experience of listening to the woman’s story to hear the participants’ 
stories and understand their experiences and concerns. I was also aware from the literature 
I had reviewed that my own lack of knowledge could contribute to the sense of isolation 
which women with LAM and other people with rare diseases can experience in healthcare 
settings. Therefore, committed to contributing a deeper understanding of their experiences 
to nursing knowledge, I brought a sense of curiosity and openness to uncovering meaning 
in this study.  
The concept of prejudice and acknowledging one’s background understandings is reflected 
in Frank’s (2000, p.356) term “standpoint”. According to Frank, a standpoint represents a 
person’s perspectives and position in the world. These evolve through the person’s 
individual and shared life experiences and the choices they make.  Frank (2000) argued that 
taking a standpoint in narrative research involves an ethical act of self-reflecting on the 
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experiences and choices which have shaped one’s perspectives and choosing to give 
precedence to some to inform the approach one takes to the research. Frank’s (2000) 
standpoint, for example, of privileging a person’s illness story over academic analysis as a 
means of informing clinical understanding reflected his own lived experience of serious 
illness and work as a therapist. Similarly, Thomas (2010) examined how her own life 
experiences of living with personal and family illness and disability and working as a 
sociologist shaped her approach to narrative research in her aim to improve cancer services 
by giving precedence to people’s narratives of their illness experience and broader social 
contexts. Likewise, my work as a nurse, position as a PhD student, and experience of 
meeting a woman with LAM in the hospital clinic shaped my standpoint of prioritising the 
voices of my participants within the academic conventions of a doctoral thesis as a means 
of informing nursing practice to improve support for women with LAM.  
Gadamer (2004, p.301) referred to the concept of “horizon” which he defined as “the range 
of vision that includes everything that can be seen from a particular vantage point”. A 
person’s horizon is their perspective and this is formed with the past as they continually test 
their prejudices. Gadamer (2004, p.305) claimed that understanding is always the fusing of 
past and present horizons, a “fusion of horizons”.  Applying this concept, Widdershoven 
(1993), held that, in telling a story of an experience, a person fuses their present view with 
their past perspective to change and enrich the meaning of the story. Gadamer (2004, pp.307, 
309) asserted that “the meaning of a text goes beyond its author” so that “understanding 
is…always a productive activity”. Further, he argued, “the discovery of the true meaning of 
a text…is an infinite process…new sources of understanding are continually emerging that 
reveal unsuspected elements of meaning”. This can be seen when, in reading and 
interpreting a text, the perspectives or horizons of text and reader are fused to form a new, 
more encompassing meaning (Widdershoven 1993).  Understanding, therefore, is never 
complete as it continually evolves with new experiences and interpretations.  
The hermeneutic circle, a key concept of hermeneutics, describes “the experience of moving 
dialectically between the part and the whole” (Koch 1996, p.176). Gadamer (2004, p.302) 
argued “we must understand the whole in terms of the detail and the detail in terms of the 
whole”. Narrative is interactive, and narrator, researcher and reader all take part in what 
Sandelowski (1991, p.162) referred to as the “hermeneutic circle of interpretation”. Each 
brings their particular background/prejudices and prior perspectives/horizons to the 
interaction, influencing interpretation of the story. Rosenthal (1993) argued this is not a 
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problem but part of the interaction of the narrator with their social world. The hermeneutic 
circle can be seen in the interaction between participant and researcher during the interview, 
in the process of interpretation which involved moving between narrative segments and the 
whole of each participant’s life story, and between each life story and the constructed life 
history.  
According to Gadamer’s philosophy, each participant’s life story in this study reflected their 
prejudices and a fusion of their past and present perspectives. In turn, through the process 
of analysing and interpreting the life stories, my perspective as researcher was fused with 
the perspective of each participant. Further, in constructing the life history, meaning was 
created in fusing the multiple interpretations, perspectives and realities of the participants 
with my interpretations. Readers of the research will further enrich its meaning as they fuse 
their own perspectives with the interpretations presented in the thesis. 
In deciding which approach to adopt for analysis the level of interpretation to be 
undertaken was considered. Plummer (2001, p. 179) suggested “a continuum of 
‘construction’” ranging from the unedited life history in which the participant’s life story 
is not interpreted and speaks for itself, to the researcher’s theoretical construction made 
independently of the participant’s account. In between, the construction involves the 
participants speaking for themselves but their accounts are organised around themes and 
linked to theory. It was decided this level of interpretation was appropriate in meeting the 
aim of the study to give voice to the participants but also interpret their stories to uncover 
deeper levels of understanding. 
2.2.2 The biographical interpretive method, Rosenthal (1993) 
In accordance with the study aim and the hermeneutic interpretive framework, the 
biographical interpretive method of analysis, using Rosenthal’s (1993) approach, was 
selected as the framework to guide the process of data collection and analysis. 
Chamberlayne et al. (2000) argued that the strength of this method is its ability to uncover 
deeper levels of personal meaning. The unit of analysis is the life story. Rosenthal (1993, 
p.61) believed that life history and life story are “continuously and dialectically linked and 
produce each other”, but distinguished between life story and life history.  According to 
Rosenthal (1993, p.89) the life story is narrated and constructed in the present moment at 
the time of the interview, while life history is the experienced “lived through life”. 
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In line with Gadamer’s (2004) concepts of prejudice and horizon, Rosenthal (1993, p.62) 
regarded a life story as a process influenced by a person’s “biographical construct” or 
structure of meaning, comprising their past experiences, present perspective and anticipated 
future, within the context of their interaction with the researcher. According to Rosenthal, 
in telling their life story, a person is orientated by their “biographical construct” and selects 
what they interpret are biographically and thematically relevant experiences. Before 
analysing the thematic aspects of the life story, Rosenthal’s method involved firstly 
extracting objective biographical data from the interview to determine which of these, and 
in what order, were relevant to the narrator and consequently selected for narration. In this 
study, objective facts would also be obtained from each participant’s medical record.  
According to Rosenthal (1993, p.60), the life story forms the “data base” from which the 
life history can be reconstructed. In this process experiences are reconstructed in the 
chronological sequence in which they occurred. The reconstructed life history represents the 
past perspective and “the biographical meaning that the experiences had at the time they 
happened”, and reveals “transformation processes” in a person’s life history (Rosenthal 
1993, p. 67-69). Rosenthal viewed the reconstruction of the life story and the life history as 
hermeneutic as both are interpretations.  
The layers of analysis involved in Rosenthal’s method offered a number of benefits for 
answering the research question of this study. Firstly, it offered a clear process to uncover 
present and past meaning and therefore changes in meaning over time, as well as each 
participant’s individual background/prejudices and how they influenced their interpretation 
of their experiences. It was additionally a way to examine the relationship between the 
objective disease process and participants’ subjective experience of their illness. Finally, it 
allowed the participants’ perspectives/horizons, revealed in the interviews, to be compared 
with the objective facts contained in their medical records.  
Examining the participants’ medical records was a means of gathering data related to their 
medical assessments and the chronological progress of their LAM. This data could then be 
compared with the participants’ subjective views as narrated to reveal how the participants 
prioritised their illness experiences and any differences between their perspectives and the 
objective assessments recorded in their medical notes. The collection of the participants’ 
medical data is consistent with life history research. According to Denzin (2009), life history 
materials consist of any documents that are related to a person’s experiences and may 
include both public and private archival material, including secondary sources written by a 
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third person. The participants’ life stories were the primary source of data while their 
medical records were secondary sources of data. Denzin (2009, p.224) argued that “a 
complete life history will combine as many primary and secondary sources as possible”, 
while focusing on a person’s personal account. 
2.3 Recruitment of the participants 
Originally it was proposed to use purposive sampling for this study. Participants of varying 
ages, social and cultural backgrounds, and at different stages of the disease were sought to 
give as broad a range as possible of experiences of living with LAM. It was intended to 
include participants with advanced disease who were using supplementary oxygen therapy, 
and who had received a lung transplant.  
In accordance with HREC (Human Research Ethics Committee) approval, a physician at a 
hospital which provided a clinic for LAM patients agreed to send out invitations to potential 
participants to join the study. The aim of the study was explained to the physician and it was 
requested that potential participants were purposively selected. The physician, however, 
randomly invited women on the clinic register to participate in the study. Over a period of 
three months only five participants consented to join the study.  
It was decided that it was necessary to find alternative means of recruitment. Following 
approval for an amendment to the research protocol by the HREC, the peer support 
organisation in Australia, the LAM Australia Research Alliance (LARA), was contacted for 
their assistance. The women welcomed someone taking an interest in their rare condition. 
The aim and design of the study was presented to a meeting of members and they indicated 
their support. Recruitment then became a process of network sampling as members of 
LARA networked within the organisation to inform other members of the study. Through 
this process a further fourteen women consented to participate in the study. Nineteen 
participants in total were recruited to join the study over a period of eight months. 
Although purposive sampling had not been possible, network sampling achieved the aim of 
recruiting participants with a broad range of experience of living with LAM. The nineteen 
women participating in the study ranged in age from 34 to 68 years and had been diagnosed 
with LAM from between 18 months and 16 years. They came from a range of cultural 
backgrounds including Australian [n=11], European [n=5], Asian [n=1], South Asian [n=1] 
and South American [n=1], and were at different stages of the illness. Five women were 
living with advanced disease and using oxygen therapy, two had received lung transplants, 
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and one had experienced respiratory failure. Nineteen participants were recruited as the 
recruitment aim of a diverse range of participants with varying and key aspects of illness 
experience had been achieved. This is consistent with life history research which provides 
“intensity sampling” whereby certain participants provide detailed information and insight 
into particular aspects of experience (Plummer 2001, p.133). According to Plummer (2001, 
p. 21), there have been many life history studies with a sample size as low as one, for 
example, Wladek Wisniewski (Thomas and Znaniecki 1958), Stanley (Shaw 1966), Jane Fry 
(Bogdan 1974) and Mrs Abel (Strauss and Glaser 1977). A sample size of 19 is considered 
large for life history research. In the context of this study the sample was robust as nineteen 
participants provided a full range of experience of living with LAM across the illness 
trajectory. 
2.4 Data collection 
Data collection took place over a period of 18 months between November 2010 and May 
2012. It involved conducting two interviews with each participant as well as accessing their 
hospital medical records.  
2.4.1 Medical record data 
Biomedical data was extracted from the participants’ medical records to provide a factual 
background to their illness experiences. It tracked the biomedical progress of their illness 
and included physician assessments, objective measurements of their lung function, records 
of investigations such as scans and six-minute walk tests, blood tests, treatments, procedures 
and hospital admissions. Notes were taken by hand from the medical records and de-
identified as they were written. As per Rosenthal’s (1993) method, this factual data allowed 
identification of which aspects of their illness the participants regarded as significant and 
chose to narrate in their life story. Ideally, medical records were accessed between the first 
and second interview. However, logistically, this was not always possible due to processes 
of gaining ethical approval from three additional hospitals and because of the long distance 
travel required in some cases. The medical records of some participants, of necessity, were 
accessed during the same trip in which their second interview was conducted.  
2.4.2 The Interviews 
The first interview, as per Rosenthal’s (1993) method, was an open style of interview. After 
informal, friendly, introductory conversation, the participant was invited to tell the story of 
her life in whatever way she chose. Looking interested and listening without interrupting, 
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except to give verbal signs of attentiveness and acknowledgement, allowed the woman to 
choose to narrate what she regarded were the significant aspects of her life story in her own 
time and manner. The participants were all articulate and spoke freely about their 
experiences.  
In keeping with Gadamer’s (2004) hermeneutic philosophy, this style of interviewing was 
totally focused on the participant and her perspective to maintain an openness to her truth.  
In Josselson’s (1995, p.30) words, an “empathic stance” was adopted. According to 
Josselson, an attitude of empathy involves continuity and receptivity, allowing aspects of 
the other to “permeate” one’s self to gain a clearer perception and deeper understanding of 
them. This enabled a rapport to be established with each of the participants. Josselson (1995) 
argued that the “empathic stance” is hermeneutic because, in the process of interpreting 
another, an empathic researcher is aware of the efforts of the person to make meaning as 
they interpret themselves in telling their story.  
The intended areas of focus for the first interview were life leading up to diagnosis, the 
process of diagnosis and how life changed with diagnosis, and for the second interview, life 
now and the issues living with a rare disease (see Interview Schedule, Appendix 1.4). The 
narratives of participants, however, did not necessarily follow linear time or the planned 
interview schedule. As Rosenthal (1993) observed, characteristic of life history interviews, 
narratives often flowed in subjective time, moving back and forth between the past and 
present in the first interview. Each interview was reflected on immediately after and notes 
were written of initial impressions of its content, context and participant/researcher 
interaction.  
The second interview, conducted later after further reflection on the first interview, allowed 
issues to be followed up and topics not covered in the first interview to be raised. It was also 
an opportunity to clarify initial interpretations of meaning derived from the first interview. 
The second interview, therefore, was semi-structured and conversational. Verbal prompts 
such as, “how did you feel about…? and “can you tell me more about…?” were used to 
explore topics in greater depth. Sensitive issues, for example, sexuality, were often 
discussed in the second interview after rapport had been established and the participant 
could feel a sense of trust and comfort with me. Interviews lasted between 49 and 240 
minutes, on average between 120 and 150 minutes each. All interviews were recorded and 
conducted without any issues. A minority of participants expressed emotions during their 
interviews. When this occurred, I offered to pause or stop the interview. All wished to 
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continue so I allowed them to freely express their emotions and take their time in resuming 
their narrative. A social worker was available to be contacted by phone for further support 
if needed but this service was not required by any of the participants. None became 
distressed and all were settled at the end of the interview Two participants specifically 
expressed that having the opportunity to reflect on, and talk about, their experiences was 
therapeutic. 
Two interviews were conducted with each of 16 participants and three participants were 
interviewed once. Carol, who was very mildly affected by LAM, felt she had covered her 
story in the first interview and declined a second interview. Deb lived interstate in an area 
where there had been extensive flooding and it was not possible to schedule a second 
interview in the time available. Anna was interviewed once as she had been interviewed two 
years previously for an earlier pilot study. When randomly sent an invitation by the hospital 
physician, she made contact and indicated she wished to meet again for this current study. 
Interviews were conducted at a time and place convenient to each participant and where 
they felt comfortable. Twenty seven interviews were conducted in the homes of the 
participants. Two interviews took place in hotel rooms, two in a private office of a 
workplace, one in a closed office of a university, and one in a private room of a hospital 
clinic. Each of these settings was quiet and private. One interview was conducted in a 
shopping mall and one in a cafe. These were less satisfactory due to the less private nature 
of the settings and the level of background noise. Each interview was transcribed verbatim 
and de-identified.  
2.4.3 Data collection and the challenge of a rare disease 
The rarity of LAM provided challenges for data collection. In the context of a rare disease, 
five participants lived in NSW and fourteen participants were located throughout Australia 
in four other states. Interviews had to be arranged for a time that was convenient to the 
participants and when I was able to travel to the relevant locations. Many of the participants 
were working or had other responsibilities or commitments that influenced scheduling of 
the second interview. For these reasons, the interval between the first and second interviews 
varied from two to 14 months. The mean interval was 7.5 months.  
Travelling long distances to five states of Australia to conduct 35 interviews was time 
consuming and costly. The medical record departments of four hospitals located in four 
different states were attended to access participants’ medical records. While long distance 
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interviews could alternatively have been conducted by phone or Skype it was felt to be 
important to be personally present with each woman to gain a deeper understanding of her 
experiences. This facilitated the building of excellent rapport with each participant and rich 
data collection. 
2.5 Data analysis 
Data analysis was carried out in three stages. For each participant, the data was analysed in 
two steps, by constructing a biographical account of their life, and analysing their life story. 
Comparing and contrasting the individual life stories in the third stage of analysis revealed 
common themes and points of difference. Following cross case analysis, the collective life 
history was reconstructed in chronological order.  
Firstly, for each participant, the biographical account was constructed to represent the 
objective facts of her life and illness trajectory. These were the facts documented in her 
medical record, including background and biomedical information, and those facts that were 
free of interpretation narrated in her life story. They were extracted from notes taken from 
the medical record and from her life story as told at the time of the interviews. This 
information was then constructed in chronological sequence to show the objective process 
of her illness trajectory (See Appendix 3 for an example of a biographical account). 
The second stage of analysis, using Rosenthal’s (1993, p.67) method, is the “thematic field” 
analysis. According to Rosenthal (1993, p.64), the narrated life story represents “a sequence 
of mutually interrelated themes” and the thematic field is defined as “the sum of events or 
situations presented in connection with the theme that form the background or horizon 
against which the theme stands out as the central focus”.  Rosenthal’s method of analysis 
involves a complex process of text sequentialisation whereby small sequences of text are 
interpreted in order through the generation and testing of hypotheses.  
Rosenthal’s process of thematic field analysis was modified at this stage of the analysis for 
the following reasons. Firstly, Rosenthal’s (1993, p.70) aim of the thematic field analysis 
was to “interpret the nature and function of the presentation in the interview and not the 
biographical experiences themselves”. This was not the primary aim of this study which 
sought to understand the meaning of illness experience.  Rosenthal’s method was directed 
at understanding the meaning of wartime experiences during the National Socialist era in 
Germany. It was developed as a way to uncover and interpret meanings that may be hidden 
from a narrator’s consciousness as a coping mechanism or because they wished to present 
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themselves differently from their past. In contrast, this study was focused on developing 
deeper levels of meaning rather than uncovering hidden agendas. 
Secondly. Rosenthal’s method of sequential analysis, concerned mainly with structure and 
representation, was very prescribed, rigid and difficult to undertake with a number of cases 
in the time allotted to a doctoral thesis conducted by a single researcher. It lacked flexibility 
and room for creativity. Similar concerns were expressed by Jones (2004, p.49) who 
modified the biographical interpretive approach in a study of identity and the informal care 
role by reducing strict adherence to text structure sequentialisation to allow a more creative 
approach to data analysis. King (2000), in a study of home-based caring in West Germany, 
also modified the method, noting that qualitative methods evolve and that the need to answer 
an individual research question may require modification of the research tools used. In line 
with these adaptations of the method, Rosenthal (1993, p.59) noted that “methodology and 
methods of reconstructing life histories…are being continuously developed”. It was decided 
that the process of sequential analysis would not provide meaningful interpretations in the 
context of this current study. Rosenthal’s method was therefore modified at this stage of the 
analysis. 
The data, instead, was explored for themes to uncover participant meanings.  Analysis 
focused on identifying stories within the whole transcript. Rosenthal (1993) emphasised that 
analysing stories in the context of the whole text and the whole life preserves the gestalt of 
the biography in the sense of the underlying structure of personal meaning which guided the 
selection of stories as narrated in each interview. This approach was holistic and interpretive 
and congruent with Rosenthal’s method and the underlying hermeneutic philosophy of the 
study. It was inductive in that themes came directly from the data.  
The data consisted of 35 transcripts of interviews (two each with 16 participants and one 
each with three participants) in hard copy and word document, and  deidentified notes made 
from each participant’s medical record in a hard copy to record objective facts such as 
symptoms, investigations, diagnosis and progress of the disease. Hard copies of the 
transcripts and handwritten notes were kept in an individual folder for each participant. The 
word document copies of the transcripts were imported into Scrivener writing software into 
an individual project file created for each participant. Folders were created within each 
participant’s project file for the transcripts, codes, turning points, and developing themes. 
Individual codes (e.g. breathlessness, fatigue, relationships, family, work), turning points 
(e.g. being diagnosed, starting oxygen therapy, finishing work, birth/death in family, being 
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listed for transplant) and emerging themes (e.g. loss, uncertainty, isolation, acceptance) were 
entered as a separate document within the folder to record relevant quotes, notes and 
reflections. Projects were also created for turning points and themes analysed across the 
participants. Blank-paged scrap books were used for drawing mind maps free hand. These 
were used to plot and develop my interpretation of themes. Electronic mind maps were 
created in iMindmap software to present the final themes (see Figures 3.1, 4.1, 5.1 and 6.1). 
The hard copy transcript was firstly read, reread and reflected upon. Words and phrases that 
seemed significant and provided insights were highlighted in the text. The structure of the 
text was examined to identify which segments of text were narrations or stories. As per 
Rosenthal (1993), these were identified as those segments of text, generally longer 
sequences, where the participant told a story and elaborated upon an experience or event. 
These were also highlighted in the transcript.  
Secondly, the narrative sequences were analysed intact, paying attention to their context in 
relation to the whole text, their temporal ordering within the text and their relationship to 
the initially highlighted words and phrases. The sequences were read more deeply to search 
for emerging patterns of meaning or themes. This method kept me immersed in the 
individual life and the data within the transcript, avoided fracturing the data, and kept a 
sense of the whole narrative and the context of individual stories within it. It also enhanced 
intuitive and creative responses which, according to Plummer (2001) and Cole and Knowles 
(2001), are a feature of life history research. 
In particular, turning points, critical events or epiphanies were identified. Cole and Knowles 
(2001) and Denzin (1989) described these as organising constructs by which fundamental 
changes in meaning are conveyed within a life story. Following Rosenthal’s (1993) method, 
the biographical account was compared to the life story to correlate the objective medical 
perspective with each woman’s personal views and to see which events she had chosen to 
present, in what sequence, and their relative significance.  
The descriptive identification of themes was followed by a more interpretive analysis. This 
process was often iterative with deeper levels of interpretation emerging with reflection and 
writing over time. Interpretations remained grounded in the text and relevant quotes 
representing the themes were selected. Developing interpretations were checked and agreed 
upon within the supervisory team. Analysis of the life story was complete when no new 
themes emerged.  
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The third stage of analysis involved conducting analysis across cases after each life story 
had been analysed. Mind mapping was used to plot themes visually during analysis of 
individual life stories and across cases. This allowed relationships between themes to be 
identified and more abstract concepts and overarching themes developed. Areas of 
difference between cases were also analysed. In this way shared qualities of women’s 
experiences of living with LAM as well as unique features could be presented. Mind maps 
also provided a visual representation of the interpreted themes of the collective life history 
following analysis (see Figures 3.1, 4.1, 5.1 and 6.1).  
Analysis of the participants’ life stories revealed common turning points representing times 
of significant life change and adjustment, themes conveying the meaning of each turning 
point, and how the rarity of LAM affected their experiences. The turning points marked the 
progression of their illness over time from onset to late stage, and included being diagnosed, 
commencing oxygen therapy, receiving a transplant and experiencing respiratory failure. 
Analysis also revealed individual turning points in the participants’ lives, for one a lengthy 
hospital admission, and for others significant changes in their personal social circumstances, 
as well as the importance of the women’s interactions with healthcare professionals in 
influencing their illness experience.  
Following cross case analysis, the collective life history was constructed to provide an 
understanding of the participants’ experiences of living with LAM over their life course. In 
this process the interpreted life stories were merged to present the women’s lives and illness 
experiences in chronological order, showing common turning points and experiences, their 
themes, areas of difference, and how meaning changed over time.  
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2.6 Rigor 
The trustworthiness of the study was ensured by applying a transparent framework and 
systematic approach to the research process, as described above. According to Meyrick 
(2006), this is a core principle of qualitative research quality. Variations were made to 
Rosenthal’s method to best allow the research question to be answered. This accords with 
Popay et al.’s (1998) claim that flexibility in the design of the research with evidence of 
adapting it to the context of the study is a mark of quality research. The procedures, decision-
making and interpretations were reflected upon, and discussed with the research supervisors. 
The use of mind mapping documented and demonstrated how interpretations were made.  
Transcripts and interpretations were not returned to the participants. This decision was made 
in keeping with the underlying assumption of life history research that the life story told at 
the time of the interview is true for the narrator at that time and that later, meaning may 
change in the light of new experiences. Sandelowski (1993), Plummer (2001), and De 
Chesnay & Fisher (2015) similarly expressed this view. It is also consistent with Gadamer’s 
(2004) hermeneutic view that meaning changes as a story is told and the horizon of the past 
is fused with the horizon of the present.  
A key practice throughout the study was reflection and reflexivity. Reflections were 
recorded in field notes after each interview. Reflexivity, as described by Parahoo (2014), 
involved critically reflecting on my role as researcher, my background as a clinical nurse, 
my own values, beliefs, behaviours and presence, and how these might influence my 
interactions with each participant and interpretation of their stories. Reflexivity also 
included maintaining ethical awareness. A reflexive journal recorded reflections I made 
during the research.  
Holloway (2005, p.276) stressed that the credibility of the research should be evident in its 
“truth-value” through interpretations that accurately reflect the participants’ experiences. 
This research attempted to capture the participants’ truth through the style of the interviews, 
the process of analysing the data, and presentation of the research. In the interviews, effort 
was made to be present in an open, empathic and friendly manner that privileged the 
participants’ accounts of their lives. In the interviews with the participants I presented 
myself as a researcher. The participants were aware of my background as a practising 
clinical nurse but my role in interviewing them was as a researcher. While they did not 
 
 
45 
 
comment on this specifically, on reflection, I believe it may have created a level of comfort, 
openness and rapport as they narrated their stories to know that, as a nurse, I understood the 
biomedical aspects of their rare illness and they did not have to explain these to me, but also 
that, as a researcher, I was interested in knowing how their illness affected their lives beyond 
their physical symptoms. These factors and a prolonged period of engagement with the 
participants through two interviews and, within each interview, allowing them as much time 
as they needed to narrate their stories, enhanced the credibility of the study by enabling each 
woman time to reflect on the meaning of her experiences and express herself fully. 
Credibility was further strengthened by the process of analysis which involved long periods 
of immersion with the data. This allowed the time to take all aspects of the participants’ 
lives into account, including the dynamic and changing nature of their subjective experience 
and meaning, and finding meaning in different as well as common experiences and so reach 
a deeper level of understanding. 
The life history was constructed to allow each woman’s voice to be heard and interpretations 
presented are supported by the participants’ own words. Some participants are, of necessity, 
represented more often in the thesis due to their having experienced a wider range of aspects 
of living with LAM, for example, using oxygen therapy, experiencing respiratory failure, 
receiving a transplant, and undergoing an extended stay in hospital. This is in keeping with 
the aim of the study to explore a broad range of women’s experiences of living with LAM 
and is consistent with the “intensity sampling” approach of life history research to provide 
comprehensive insight into certain aspects of experience (Plummer 2001, p. 133). It does 
not diminish the experiences of those with few symptoms or limitations and particular care 
was taken to ensure each participant’s experience was included in the life history with at 
least one direct quote. 
According to Polkinghorne (1995), Dollard’s (1935) criteria for judging life history are 
relevant. As per Dollard (1935), the life history of this study encompassed the participants’ 
social and cultural context, their embodied nature, their relationships, their choices and 
actions, and their history and past experiences. As claimed by Popay et al. (1998) and 
Streubert Speziale (2003), the potential for the research to be transferred to other situations 
was strengthened by articulating the findings of the study in relation to theory and previous 
knowledge and the implications for policy and practice.  
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2.7 Ethical considerations 
Ethics approval for the study was granted by the HREC of St Vincent’s Hospital in Sydney 
and was ratified by the ethics committee of the University of Sydney at which I am a doctoral 
candidate. All participants were over 18 years of age and spoke English. They received a 
Participant Information and Consent Form which informed them in a clear and easily 
understood manner of the nature, aims and process of the research project, and that they 
were able to withdraw consent at any time without any penalty and without their care being 
affected in any way. Participants freely gave their consent to be interviewed, for their 
interviews to be audiotaped and transcribed, and to have their medical records accessed. 
(See Appendix 1 for ethics documents) 
During the recruitment process, a complaint was made to the HREC by a physician who was 
concerned that patients attending the public hospital clinic, who they considered to be under 
their care, had been recruited to the study without their prior approval. A second concern 
was that participation in the life history study would interfere with a concurrent clinical trial 
in which some patients were also participating. The matter was resolved following HREC 
review by a change to the research protocol whereby, within the hospital, individual 
physicians would be notified of the study and, at their own discretion, would choose to invite 
potential participants to join the study. Women who were willing to participate in the study 
were asked to contact the researcher to arrange mutually convenient times and places to 
obtain informed consent and conduct the interviews. An independent third party was 
preferred to sign the consent form as a witness to the signature of the participant. The 
majority of participants met me alone so a third party was not available to witness the 
consent. In this case the HREC approved that a file note could be made to that effect. 
When participant consents had been received, ethical approval to access medical records 
also had to be sought from three other hospitals attended by some participants in Victoria, 
Western Australia, and Queensland. All provided access to the relevant medical records on 
the basis of the consent given by the participants and the ethics approval granted by the 
HREC of St. Vincent’s.   
Audiotapes and transcripts were available only to myself and my two university supervisors. 
During the research process data was stored on a password protected computer. Hard copies 
of the transcripts were stored in a locked desk in a locked room at the university. Data from 
the medical records was stored with the transcripts. At the completion of the study the 
research data will be deleted from the computer and audio recordings and transcripts will be 
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then located to a locked cupboard in a university office where they will be stored for seven 
years and then destroyed.  
An ethical consideration in conducting research with a small group in the context of a rare 
disease is that some participants were known to each other and particular care had to be 
taken with de-identification of the data while at the same time preserving the meaning of 
each participant’s narrative. This was achieved through the use of pseudonyms and changing 
or generalising identifying details such as nationality (e.g. Asian rather than specific 
nationality), and location (e.g. urban or regional rather than a specific state or city). The 
range of the participants’ occupations are revealed in Chapter 4 but are not attributed to 
specific women. Particular caution was taken when discussing sensitive topics such as 
sexual relations and contraception. In this case the participants’ quotes were not identified 
by their pseudonyms to further ensure their privacy.  
These steps to preserve the participants’ privacy were taken throughout the thesis, including 
the brief introductory biographies of each participant given below. As this is a life history 
study concerning how women experience living with LAM in the setting of their whole life, 
the biographies were needed to give context to the participants’ experiences and the 
concerns they expressed and assist understanding of the interpreted themes within the 
collective life history. Further, the interpretations themselves will be presented collectively 
for future publication rather than as complete individual life histories so that individual lives 
are not identifiable. The privacy of the participants’ physicians was also considered. Both 
male and female physicians are referred to as ‘he’ to avoid identifying particular physicians.  
2.8 Introducing the participants  
The participants are introduced in the following brief biographies which provide a factual 
account of their illness. These are summaries of the biographical accounts constructed from 
the participants’ medical records and their narratives. Their subjective interpretations of 
their experiences are presented in the next four chapters. Summaries of the participants’ 
social and medical backgrounds are provided in Appendix 3, Tables 3.1-3.4. Some 
participants were prescribed sirolimus and others everolimus for treatment of LAM. Both 
medications are mTOR inhibitors and have similar effects. For ease of reading sirolimus is 
the term used in this thesis for this class of medication.  
Aiko is a 64 year old Asian woman. She is an only child. Her parents died within weeks of 
each other shortly before she was diagnosed. Aiko is married to an 88 year old Caucasian 
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man with multiple health issues including early cognitive impairment and limited mobility. 
She lived with her husband and cared for him until, after organising home nursing care for 
him, she moved to an interstate city to support her daughter and grandchild after her son-in-
law’s sudden death between our first and second interviews.  Aiko was university educated 
and worked fulltime until she was diagnosed. Her interests include walking, yoga, and 
painting. She was fit and healthy and experienced only minor breathlessness for a number 
of years prior to being diagnosed. She was diagnosed when she was 52 following an open 
lung biopsy after an episode of pneumonia. She was found to have renal angiomyolipomas. 
Ten years after her diagnosis she was prescribed home oxygen to be used at night and when 
needed. She is now retired and was well at the time of interview.  
Anna is a 37 year old Australian woman. Her parents had migrated from Eastern Europe. 
She has two sisters. She was married two years before she was diagnosed and divorced three 
years after her diagnosis. She currently lives in an urban area with her partner of six years. 
She is university educated and works fulltime. She enjoys walking, fashion, and sewing. 
She was fit and healthy and played various sports before she experienced her first 
pneumothorax when she was 23, the year she was married. Over the next two years she had 
further lung collapses. She was diagnosed at 25 following a lung biopsy taken during 
pleurodesis surgery. Six years after being diagnosed she was coughing up blood every day 
and had developed an abdominal lymphangioleiomyoma. This resolved after treatment with 
sirolimus. She experienced a major episode of depression and anxiety eight years after her 
diagnosis. This resolved with cognitive behaviour therapy and anti-depressants. At the time 
of interview she had been well and stable for three years. 
Carol is a 66 year old Australian woman. She is a widow and lives alone in an urban area. 
She has two adult children and two grandchildren. She worked four days a week until she 
retired when she was 64. She currently does volunteer work. Her interests include walking, 
yoga and singing. She has osteoarthritis of the knee but is otherwise fit and healthy. She was 
diagnosed when she was 57 following a chest CT to investigate minor breathlessness 
(initially misdiagnosed as asthma) and a small pneumothorax. Carol has mild LAM and has 
been well and stable in the ten years since she was diagnosed. 
Clare is a 34 year old Australian woman. She grew up on a rural property with her parents 
and brother. She lived with her partner in an urban area at the time of the first interview. In 
between the interviews she separated from her partner and was living with her parents at the 
time of the second interview. She has diploma level education. Her interests include walking 
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and painting. She had travelled extensively and worked overseas in a variety of jobs, and 
was fit and healthy and played various sports before the onset of LAM. She started to 
experience exhaustion and breathlessness when she was 31 and reduced her work to part 
time. She was misdiagnosed as having a chest infection. Her symptoms did not resolve and 
she was diagnosed a year later when she was 32 following a chest CT, and advised she 
would need a transplant in one to two years. Two months after her diagnosis she was found 
to have a chylous effusion and spent the following five months in hospital when the 
effusions persisted. The effusions finally resolved after she was treated with sirolimus. She 
only used oxygen at home for walking in the initial period after her discharge. At the time 
of the second interview she was well, working one day a week and investigating other 
possibilities for work. 
Deb is a 52 year old Australian woman. Her parents are deceased and she has five siblings. 
She is divorced, has three adult children and lives alone in a regional town. She has 
professional training and works full time. She was fit and healthy before the onset of LAM. 
She enjoys being fit and outdoor activities such as camping, hiking, biking and gardening. 
Deb experienced breathless and chest pain walking uphill when she was 48. Her symptoms 
were thought to be cardiac in origin. She was diagnosed one year later following a lung 
biopsy. She is treated with doxycycline. She has experienced a gradual decrease in her 
exercise tolerance since her diagnosis but has otherwise been well and stable. 
Eva is a 38 year old Eastern European woman. She came to Australia as a refugee fleeing 
civil war in her own country when she was 19. She lives with her husband in an urban area. 
Her mother and brother also live in Australia. She has Masters level university education 
and works fulltime. Her interests include meditation, yoga, and walking. She was fit and 
healthy and enjoyed dancing before the onset of LAM. She began to experience occasional 
chest pain and breathlessness, and a reduction in her exercise tolerance when she was 31. It 
was felt to be nerve pain. One year later she experienced acute breathlessness and panic 
during a plane flight. A chest X-ray showed pneumothoraces in both lungs. Bilateral 
pleurodeses were performed. A lung biopsy provided a diagnosis of LAM. Her lung function 
and exercise tolerance deteriorated significantly over the next two years. She was also found 
to have extensive abdominal lymphangioleiomyomas. After she commenced sirolimus her 
symptoms and lung function markedly improved. She has been well and stable in the five 
years since then. 
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Helen is a 40 year old woman, born in Australia to European parents. She lived most of her 
life overseas. Her father died when she was 25. Her mother and brother still live overseas. 
Helen lives with her partner and two preschool aged children in a city suburb. She is 
university educated and has been working part time, two days per week, since her diagnosis. 
She was fit and healthy and enjoyed running, gym, dancing, swimming, yoga, and horse 
riding before the onset of LAM. She experienced breathlessness during both of her 
pregnancies. It was attributed to anxiety and depression. Her breathlessness continued after 
the birth of her second baby when she was 39. Three months later she was found to have a 
low oxygen saturation when she was taken to hospital with severe back pain. She was 
diagnosed with advanced LAM following a CT scan and commenced on continuous oxygen 
therapy and sirolimus medication. She was advised she would need a lung transplant soon 
and has had a pre-transplant assessment. She continues to work part time and enjoys going 
to the gym and bike riding. 
Irena is a 47 year old woman, born in Australia to European parents. She has one older 
sister. She lives in a city suburb with her husband and adult stepchild. She is university 
educated and worked full time professionally until she retired when she was 45 due to her 
lung disease. Before the onset of LAM, she had been treated for some specific medical issues 
but was fit and healthy and enjoyed dancing and walking. She was diagnosed when she was 
37 following a chest CT to investigate the haemoptysis she had had for six months. She 
experienced ongoing haemoptysis and progressive breathlessness walking uphill over the 
following five years and was prescribed home oxygen for walking. One year later her 
exercise tolerance had deteriorated further and she was found to have an abdominal 
lymphangioleiomyoma. It reduced in size when she started sirolimus. When she 
independently stopped her sirolimus after one year her lung function deteriorated and her 
abdominal mass increased in size. Two years later, when she restarted her sirolimus, her 
exercise tolerance improved, her haemoptysis resolved, and her lung function stabilised.  
Jess is a 41 year old Australian woman. Her biological father (now deceased) and mother 
separated when she was four years old. Her mother remarried and later separated from Jess’s 
stepfather when she was 16. Jess has been estranged from her mother for two years. She 
lives with her partner in an urban area. Jess has an Honours level university education. She 
works full time. She was fit and healthy before the onset of LAM and enjoyed gym, bike 
riding and walking. Jess experienced a sudden onset of abdominal bloating when she was 
31. She was treated for a gut infection. Her symptoms did not improve and were attributed 
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to psychosomatic causes. Four years later, she again experienced abdominal bloating, 
accompanied by pain and fatigue, with her period. It was attributed to her appendix and later 
endometriosis. Twelve months later she was taken to hospital for severe abdominal pain. 
She was diagnosed with LAM following an abdominal ultrasound and lung biopsy. Her 
abdominal mass did not respond to treatment with radiotherapy and doxycycline over the 
next two years. Eight years after her initial onset of symptoms she experienced sudden 
breathlessness, chest pain and cough and was found to have a chylous effusion. A 
pleurodesis was performed. Some months later she commenced sirolimus after consulting a 
second physician. Within twelve months her abdominal mass had resolved, her lung 
function had improved and she was well and stable.  
Julie is a 46 year old Australian woman. Her parents and sister live interstate. She lives with 
her husband and two adolescent children in a small country town. Julie has a college 
education and works part time. She smoked from when she was 18 until 41. She was 
otherwise fit and healthy and enjoyed a wide variety of sports before she was diagnosed. 
Julie first experienced chest and back pain due to a pneumothorax when she was 25. Over 
the following twelve months she experienced multiple pneumothoraces and ongoing 
shoulder pain, and underwent a pleurodesis. A CT scan showed small cysts but her pain was 
attributed to psychological causes. Six years later when she was 32, during her second 
pregnancy, a second pleurodesis and lung biopsy were performed after another 
pneumothorax. She experienced ongoing pain for another four years and then breathlessness 
on steps and hills. Three years later after an attack of severe bronchitis, she was found to 
have reduced lung capacity and was misdiagnosed as emphysema. She was finally 
diagnosed with LAM when she was 41 after a CT scan. A partial nephrectomy was 
performed for a renal angiomyolipoma. It was discovered that the lung biopsy taken nine 
years earlier had indicated LAM but the results had not been communicated. She 
commenced sirolimus when she was 45 after her breathlessness increased and her lung 
function deteriorated significantly. Although she experienced side effects from the 
sirolimus, within four months her exercise tolerance and lung function had improved. She 
was well and stable at the time of interview. 
Louise is a 57 year old Australian woman. Her parents are deceased and she has two older 
siblings. She is university educated and had worked fulltime. At the time of her second 
interview she was not working after a change in the management of the organisation she 
was working for. She lives with her partner in an urban area and has two adult stepchildren. 
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She was fit and healthy before the onset of LAM. Her interests include art, reading, pets, 
gardening and walking. Louise first experienced intermittent haemoptysis, back pain and 
breathlessness while swimming when she was 38. She was diagnosed with LAM five years 
later when she was 43 following a CT scan. Since diagnosis she has been well and stable 
and felt a general improvement in wellbeing, exercise tolerance and lung function when she 
lost 10kg in weight as a result of diet and exercise. 
Margaret is a 45 year old woman, born in Europe. Her family moved to Australia when she 
was seven years old. She has one older sister. Her parents separated when she was 16. Her 
mother since remarried. Margaret has a high school education and worked fulltime until she 
retired from work when she was 38 due to the progression of her illness four years after she 
was diagnosed. After finishing work, she took on the voluntary role of caring for dog rescue 
puppies for six years. She is single and lives alone with her two pet dogs in public housing 
accommodation. She has lived with asthma since she was three years old. She smoked for 
twenty years until she was 37. She enjoys reading, art, crafts, music, meditation and caring 
for her dogs. Margaret’s symptoms started when she was 27 and developed gradually. She 
experienced breathlessness, abdominal pain, wheeze, haemoptysis, chest and renal pain over 
seven years. She was diagnosed with LAM when she was 34 following a CT of her chest 
and abdomen which showed lung cysts and multiple renal angiomyolipomas. Margaret’s 
LAM progressed slowly over the next seven years until she required continuous oxygen 
therapy when she was 41. According to her medical record, when she was 43 she was noted 
to be unsuitable for a lung transplant due to “multi organ system problems”. Two years later 
she was admitted to hospital for respiratory failure. She had decided she did not wish to be 
resuscitated if a life threatening situation arose. Multiple medical emergency calls were 
made for her respiratory distress and anxiety. At home she uses a motorised scooter to move 
about the house.  
Mia is a 38 year old South American woman who migrated to Australia with her husband 
when she was 31. Her parents are separated. Her mother lives in Australia and her father 
overseas. She lives with her husband and adopted child in an urban area. She is university 
educated and worked full time until after she adopted her son when she changed to part time 
after a period of maternity leave. She enjoys gym, travel, art and photography. Mia has a 
long history of asthma but no other significant medical history. She sought medical advice 
when she was 34 for breathlessness on stairs and a persistent cough. She was diagnosed with 
LAM following a CT scan. Mia and her husband decided to apply for adoption when she 
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was diagnosed. After a long process over four years they were advised they could collect 
their baby from overseas. Mia needed to be accompanied by a doctor and use oxygen on the 
plane flight. Six years after she was diagnosed Mia’s lung function had deteriorated and, 
although her physician had advised her to commence sirolimus and be assessed for 
transplant, Mia had not started sirolimus and had cancelled two appointments with the 
transplant physician. She was well at the time of interview. 
Patricia is a 62 year old Australian woman. Her mother is alive and father deceased. She 
has two siblings. Patricia lives with her husband in an urban area and has two adult children. 
Patricia has professional training. Her husband travelled overseas for work until his recent 
retirement and she worked two days a week when her husband was home. She is currently 
not working. She enjoys exercise, particularly walking, gym, ten pin bowling, yoga and 
swimming. Patricia has been hearing impaired since birth and is treated for epilepsy. She 
first became aware of her breathing when she was 25 and needed to stop while jogging. 
When she was 32 a tumour that was bleeding was removed from her kidney but not 
investigated further. Eight years later, when she was 40, her three year old son was 
diagnosed with tuberous sclerosis autism spectrum disorder and epilepsy. Patricia was 
herself diagnosed with tuberous sclerosis at the same time. Eleven years later, when she was 
51, she experienced breathlessness going up stairs and was diagnosed with LAM after a CT 
scan. She started using oxygen intermittently six months after she was diagnosed and 
continued to work one day a week for another five years. In this period she placed her son 
in residential care when his behavioural problems became difficult to manage. Patricia was 
listed for transplant two years after she stopped work. She was using oxygen continuously 
by this time. She continued to exercise throughout her illness. Patricia received a lung 
transplant one year after being listed. She recovered without complications. Four months 
after transplant she had recommenced bowling and bike riding and was competing in 
sporting competitions after twelve months. At the time of interviews she was three years 
post-transplant and well and stable.  
Ruth is a 64 year old Australian woman. She lives in an urban area with her husband. She 
has two adult children and two grandchildren. She is university educated, works four days 
a week in her husband’s business, and also does volunteer work. She enjoys walking, 
swimming and travel. She had asthma as a child, a hysterectomy when she was 53, breast 
cancer when she was 59, and osteoarthritis in her knee. Ruth’s first symptom of LAM was 
the sudden, acute onset of severe left flank pain. She was diagnosed with a ruptured renal 
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angiomyolipoma. Four years later she experienced the same problem in her right kidney. In 
the same year, when she was 58, a routine chest CT following treatment for breast cancer 
revealed LAM. Her diagnosis was confirmed by a physician expert in LAM. Since then, 
Ruth’s angiomyolipomas have been monitored and treated intermittently with embolisation. 
She experiences only mild breathlessness when walking quickly or uphill. She is well and 
stable. 
Sarah is a 36 year old Australian woman. Her parents are alive and she has two siblings. 
She lives with her husband and two children, aged seven and five years, in an urban area. 
She is university educated and works part time. Before the onset of LAM she was fit and 
healthy and enjoyed exercising by walking, hiking, Pilates, tennis and the gym. Other 
interests included painting, travel and theatre. Sarah first experienced breathlessness when 
she was 29 during her second pregnancy two and a half years before her diagnosis. It was 
attributed to her pregnancy. After the birth she continued to become breathless when 
exercising, coughed frequently and had an episode of haemoptysis. She was misdiagnosed 
as being depressed and having asthma. After two further episodes of haemoptysis, a CXR 
showed atypical pneumonia. After not improving, she was diagnosed following a chest CT 
and lung biopsy. She was 32. She received doxycycline for six months but her lung function 
and exercise tolerance continued to deteriorate significantly in the twelve months after her 
diagnosis. She started sirolimus one year later. After four months her exercise tolerance and 
lung function had improved markedly, and her cough and haemoptysis had resolved. She 
uses a treadmill at home for exercise and although she did not fit the criteria for oxygen 
prescription, she purchased an oxygen concentrator to use while exercising on her treadmill.  
Eighteen months later she remains well and stable. 
Ursula is a 51 year old Australian woman. Her parents are alive and she has three siblings. 
She lives with her husband and three adult children in an urban area. She is high school 
educated and works part time. She was diagnosed with asthma when she was 29 but was 
otherwise fit and healthy. She enjoys walking and painting. Her first symptom of LAM was 
sudden breathlessness due to a pneumothorax when she was 30. A pleurodesis was 
performed. Although multiple lung cysts were noted at the time, no biopsy was taken. Seven 
years later she experienced another pneumothorax. A repeat pleurodesis was performed and 
she was diagnosed from the lung biopsy taken at that time. Since diagnosis, Ursula’s LAM 
has progressed very slowly. She is well and stable and has good exercise tolerance. 
Veronica is a 68 year old Australian woman. She lives with her husband in an urban area. 
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She has two adult children and one grandchild. She has a graduate diploma level of 
education and worked full time until she retired when she was 62. She has a history of 
hypertension and anxiety but was otherwise fit and healthy before the onset of LAM. She 
enjoys walking, socialising, theatre, movies and cultural events. When she was 62, a routine 
CT scan following the removal of skin lesions showed a mass on her left kidney. Her kidney 
was removed for possible cancer. Pathology showed the growth was a benign renal 
angiomyolipoma. Later in the same year she experienced severe breathlessness walking 
uphill and was found to have chylous effusions in both her lungs. A pleurodesis was 
performed on each lung. She was diagnosed at this time. Since her surgery, Veronica has 
remained stable and has good exercise tolerance. 
Vidu is a 48 year old South Asian woman. Her parents are alive and live in her home 
country. She has three siblings who also live overseas. She lives with her husband and adult 
child in an urban area. She is university educated and enjoys walking, yoga and dancing. 
Vidu and her family lived in different countries due to her husband’s work. She travelled 
frequently to visit her family in South Asia. When she 31, on a visit to her family, she 
developed sudden back pain due to pneumonia and a small pneumothorax. The following 
year she became breathless and fatigued walking uphill and had a second pneumothorax. 
She was misdiagnosed as asthma. She was diagnosed three years later, when she was 36, 
after a CT scan to investigate her symptoms. Vidu’s lung function gradually deteriorated 
over the next ten years and she developed an abdominal lymphangioleiomyoma. At this 
stage she was using oxygen continuously and, later that year, was listed for transplant. A 
few months later Vidu was admitted to hospital twice for a pneumothorax and pleural 
effusion. Vidu received a lung transplant one month later, eleven years after she was 
diagnosed. She was 47. Her recovery was delayed by chylothoraces, a pneumothorax, and 
side effects from her medications. She was well and stable at the time of interview twelve 
months later. 
2.9 Conclusion 
This chapter has presented the life history methodology employed by this study to explore 
women’s experiences of living with LAM over their life course. Firstly, the methodology 
was discussed in relation to Gadamer’s hermeneutic philosophy and Rosenthal’s (1993) 
biographic interpretive method of narrative analysis which provided a theoretical framework 
for the study. This was followed by discussion of the research process, including participant 
recruitment, data collection and analysis, construction of the collective life history, rigor, 
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and ethical considerations. Rosenthal’s method was modified to analyse the participants’ 
life story narratives and decision-making concerning this process was explained. Individual 
brief biographies and factual accounts of their illness, summarising the biographical 
accounts, introduced the participants.  
The following four chapters will present the collective life history of the participants that 
was constructed following cross case analysis of their life stories. It is focused on the period 
from the onset of their symptoms to the late stage of LAM. The structure of the thesis 
represents the chronological sequence of the life history as follows: Chapter 3, Being 
Diagnosed; Chapter 4, Life after Diagnosis and Learning to Live with LAM; Chapter 5, 
Interacting with Healthcare Professionals; Chapter 6, Living with Advanced LAM and 
Experiences of Oxygen Therapy, Respiratory Failure and Lung Transplant. Each chapter 
includes a figure of a mind map to provide a visual representation of the themes of that 
chapter as a guide for the reader.  
In Chapter 7, the findings of the thesis are examined in the light of existing literature and 
theories to extend the analysis and link the interpretations of the participants’ experiences 
to broader issues and more general knowledge. The final chapter of the thesis discusses the 
implications of the findings for practice and future research, reflects on the life history 
method used, and presents a personal reflection on the research process and concluding 
remarks. The following chapter will reveal the participants’ experiences of being diagnosed, 
from the onset of their symptoms to the immediate period after. 
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Chapter 3   
BEING DIAGNOSED 
 
3.1 Introduction 
This chapter presents the first of four chapters of the collective life history of the participants 
which convey the meaning of their experiences of living with LAM across the illness 
trajectory. Meaning was reflected in their narratives as they prioritised their experiences and 
narrated at length issues they perceived to be important. They revealed how they 
experienced diagnosis, a long hospital admission [n=1], commencing oxygen therapy [n=7], 
developing respiratory failure [n=1], and lung transplantation [n=2]. These were turning 
points which involved significant life changes. The chapters present the participants’ 
experiences at these turning points, in their everyday life after diagnosis, and in their 
interactions with healthcare professionals. They reveal how the meaning of their illness 
changed over time, and the process of adaptation and development of resilience which 
emerged as marked features of the participants’ experiences.  
Being diagnosed was the first turning point in their illness trajectory. Whilst a number of 
participants experienced variable symptoms some time before diagnosis, for most the onset 
of symptoms was gradual and, while they knew something was wrong, they did not associate 
the changes in their body with a serious condition. Being given a diagnosis not only labelled 
the disease but also made them aware of potential implications for their daily lives and the 
future. It was the formal identified point of separation from their familiar world of health 
and wellness to the unknown territory of illness.  
This chapter presents the participants’ experiences of being diagnosed and how these were 
affected by the rarity of LAM. Figure 3.1 displays the women’s experiences from the onset 
of their symptoms when they became aware of changes in their bodies, through a period of 
knowing something else was wrong when they were misdiagnosed or treated and not 
investigated further, to the delivery of their diagnosis, its impact on them, and how they 
dealt with it. Table 3.2 (see Appendix 3) summarises the biomedical facts from onset of 
symptoms to diagnosis for each of the participants.   
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3.2 Becoming aware of a changed body 
All nineteen participants described how they initially became aware of changes in their 
bodies. They felt a variety of changes consistent with the clinical variability characteristic 
of LAM. Nine women experienced a combination of symptoms including breathlessness, 
chest/back pain, haemoptysis, cough, wheeze, and fatigue. Ten women experienced 
isolated symptoms of breathlessness [n=4], chest pain/pneumothorax [n=3], haemoptysis 
[n=1], flank pain/renal angiomyolipoma [n=1], and abdominal bloating and pain 
/lymphangioleiomyoma [n=1]. 
Thirteen women described gradually becoming aware of being more breathless than usual 
when they were exercising at the gym, or walking uphill or upstairs. Louise became 
breathless while swimming and felt “like a truck sitting on my chest”. Helen, Sarah and 
Ursula all experienced breathlessness during, or following, pregnancy. Clare’s 
breathlessness was preceded by feelings of exhaustion and she felt she “must be just really 
unfit because I’m not working as much”. Her breathlessness was later found to be due to a 
collection of lymph fluid in the lung (chylothorax).   
Two women described how their breathlessness had occurred suddenly and acutely with 
feelings of   anxiety, panic, and impending loss of consciousness. Deb thought she was 
having a heart attack when her breathlessness was accompanied by chest pain. She described 
feeling like she was “going to pass out because I really couldn’t breathe and I was really 
stressed”. Eva experienced acute severe breathlessness that made her “panic” and feel she 
“would lose consciousness” while flying interstate.  She was diagnosed a day later as having 
a pneumothorax in each lung. 
Anna, Vidu and Julie initially felt chest and/or back pain only due to a pneumothorax. They 
developed breathlessness later over a period of years as their LAM progressed. Jess 
experienced abdominal bloating and pain due to a lymphangioleiomyoma as a result of 
blockages in the lymph channels. She described her lymphangioleiomyoma as “a wine 
bladder in my stomach…With my period it was like something was expanding…It was 
extremely painful”. Five years later she also experienced breathlessness and was 
subsequently diagnosed with a chylothorax. Ruth’s only symptom was “excruciating pain” 
in her lower back from a ruptured angiomyolipoma on her kidney. 
3.3 Knowing something’s wrong 
Ten participants sought medical advice when their symptoms of breathlessness, chest and 
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back pain, or abdominal pain persisted. These more generalised symptoms were commonly 
misdiagnosed and often attributed to psychosomatic causes. Six women continued to search 
for an answer for their symptoms for between two and 16 years, knowing something was 
physically wrong. Breathlessness was misdiagnosed as asthma [n=4], chronic bronchitis 
[n=1] emphysema [n=1], chest infection [n=1], anxiety [n=1] and depression [n=2]. Chest 
and back pain were misdiagnosed as cardiac pain [n=1], nerve pain [n=1] and psychosomatic 
pain [n=1].  Jess’s abdominal bloating and pain was misdiagnosed on four occasions as 
having a gut infection, psychosomatic pain, appendicitis and endometriosis.  
Helen and Sarah refused to accept a diagnosis of depression and anti-depressant medication 
when they experienced breathlessness during and after pregnancy: 
I know myself really well. I’m not depressed, I just can’t breathe. Something’s 
wrong, I’m breathless… I didn’t know what was happening. (Sarah) 
After my baby was born I just suddenly started becoming really breathless all 
the time…So I kept going back to the doctor's and he just said it was anxiety… 
he sent me to counselling… He wanted to put me on anti-depressants but I just 
refused. (Helen) 
Similarly, Julie’s persistent chest pain and Jess’s abdominal pain were attributed to 
psychosomatic causes and they also refused antidepressants. Each of these women knew 
they were not depressed and that something else was wrong.  
Before 2001 LAM was a rare and poorly understood disease and consequently diagnosis 
was delayed when acute problems such as pneumothorax or ruptured angiomyolipoma were 
treated and not investigated further. Anna, Julie, Ursula and Vidu’s pneumothoraces were 
managed with a drain or surgical pleurodesis without further investigation between 1990 
and 1998. Similarly, a thoracic surgeon performing Ursula’s pleurodesis in this period 
observed multiple small cysts on the lung but did not take a lung biopsy.  
Ruth, Veronica and Patricia initially presented with renal tumours or bleeding from these 
tumours. Ruth was diagnosed correctly as having a ruptured renal angiomyolipoma but was 
found incidentally to have LAM four years later on a follow up CT scan after breast cancer. 
Veronica’s renal tumour was misdiagnosed as cancer resulting in the unnecessary removal 
of her kidney. She was diagnosed with LAM when she developed breathlessness later in the 
same year and was found to have a chylothorax.  
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Julie searched for 16 years for an answer to her persistent chest pain following a left 
pleurodesis for multiple pneumothoraces. Her pain was medically diagnosed as 
psychosomatic. Seven years after the initial surgery, during her second pregnancy, a right 
pleurodesis was performed for a pneumothorax and a lung biopsy was taken. However, the 
results of the lung biopsy were never followed up and Julie continued to have ongoing pain. 
After four years she developed breathlessness climbing hills and steps and was 
misdiagnosed as having emphysema three years later. She was finally diagnosed with LAM 
following a chest CT 16 years after her initial surgery. At this time her specialist sought, 
and located, the results of the lung biopsy taken nine years earlier and discovered that LAM 
had been reported at that time. Julie expressed strong feelings of shock and anger that the 
results had not been communicated to her and her diagnosis subsequently delayed. A 
medical opinion was sought from an interstate respiratory specialist who implied that Julie 
had not attended her follow up appointment and suggested that a diagnosis would not have 
changed the course of her illness. Julie felt victimised and that she was being blamed for the 
failure in communication: 
 It had actually been diagnosed then and nobody had told me… I was 
shocked…I was so angry…Then they wrote to someone interstate, some 
professor, about LAM and the treatment in the hospital.  That was like getting 
a slap in the face…They'd even put in it, if you had been told basically it 
wouldn’t have changed anything because it's an incurable disease.  Do you 
think when you're pregnant was a good time to know?  I just thought, that's not 
for you to judge at all…I just felt that everyone was blaming me.    
In contrast, nine women were diagnosed correctly in twelve months or less from the onset 
of their first symptom of LAM. Of these, four women were diagnosed between 1998 and 
2001 and five women after 2001. In Patricia’s case, her initial diagnosis of tuberous sclerosis 
was made eight years after bleeding and removal of a tumour from her kidney. Eleven years 
following her diagnosis of tuberous sclerosis, she was diagnosed with pulmonary LAM 
within twelve months of developing her first respiratory symptom of breathlessness between 
1998 and 2001. The correct diagnoses of LAM received by the women within twelve months 
occurred after the creation of the LAM Foundation in 1995 and associated database in 1997, 
and subsequent acceleration of scientific research into the condition (McCormack 2008; 
Tattersfield & Glassberg 2006). Respiratory specialists were the most likely physicians to 
access this knowledge as evidenced by the majority of correct diagnoses made by this group. 
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GPs (local doctors) and gynaecologists misdiagnosed participants’ symptoms on twelve 
occasions.  
Julie’s experience and that of Mia, who was misdiagnosed as having asthma and bronchitis 
for 15 years, raise the question of whether receiving a diagnosis of a rare incurable condition 
at a young age is desirable given the generally slowly progressive nature of LAM.  Julie 
would have been 32 years old if she had received her diagnosis when her biopsy was taken. 
She was already married and expecting her second child. Mia first experienced 
breathlessness when she was 19, unmarried and without children and had not established a 
career. The two women expressed different opinions regarding early diagnosis. Julie was 
adamant that it was her right to receive a correct diagnosis regardless of her stage of life. 
Mia, on the other hand, preferred a later diagnosis. Had she been diagnosed in her early 
twenties the limitations of having LAM would have meant that she would have been unable 
to pursue her career and its required overseas travel which she loved. She felt it may also 
have impacted on her ability to partner and marry: 
(If) they tell you that in your 20's and you start thinking you might die… and 
can’t have babies…you bring that baggage to a relationship… In my 20's it 
would have totally ruined my life.  I don't think I would have married (my 
husband), I would have to rethink my career too early.  It would have been 
horrible.  
While Helen was angry that her breathlessness had been wrongly attributed to anxiety after 
her first pregnancy and not investigated further, she also acknowledged that if she had been 
diagnosed at that point she would have been advised not to risk pregnancy again and would 
not have had her second child:  
I suppose there's two sides to it, you know.  If I had been diagnosed after my 
first baby I wouldn't have been able to have my daughter and my husband was 
of the opinion that I probably wouldn't have been this bad because definitely 
the pregnancies exacerbated the whole situation.  
These stories reveal the complex decision making that may be involved in investigating and 
diagnosing a rare incurable disease with uncertain course, and the ability to compromise 
lifestyle and impact on a woman’s plans for pregnancy. They suggest a need for full 
discussion to understand a woman’s life goals and priorities during the process of 
investigating and diagnosing LAM. 
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3.4 Life disrupted by diagnosis 
Receiving a diagnosis of LAM was unexpected and devastating news for the majority of 
participants. Most had been fit and healthy with no significant past medical history before 
the onset of their symptoms. Deb, for example, had “always been fit… hiking up mountains 
and… biking”. Sarah “was always a very active person…walking five or six times a week 
and doing weights classes”. They did not associate their symptoms with a serious condition 
and did not expect to be told they had a rare, incurable, progressive lung disease they had 
never heard of. According to Sarah, “there was not supposed to be something wrong”. Aiko 
“wasn’t expecting anything like this” and “could not believe it happened”.  
Each participant held a personal life meaning which they had accumulated over the course 
of their life. The women appraised their illness against their life meaning to determine the 
significance of the changes they were experiencing in their bodies, and the implications of 
their diagnosis for their future. Their life meaning encompassed their sense of self, values, 
beliefs, disposition, past experiences, present and future expectations, sense of life purpose, 
and life goals. It was shaped by their family, cultural and societal values, life experiences, 
and social interactions in the world. Each participant’s life meaning represented her beliefs 
about herself, the world, and her relatedness to the world. It was the structure of meaning 
which orientated her and gave her life coherence. The participants experienced levels of 
disruption which reflected their life meaning and the varied ways they were affected by 
LAM. 
Participants who were only mildly affected, with minimal impact on their daily life, 
experienced minor disruption. Others were able to reconcile their diagnosis with the 
meaning of their current expectations and other life experiences. Ruth and Carol were only 
mildly affected by LAM, were older and already had children. Ruth was 58 when diagnosed. 
She had only experienced symptoms twice when renal angiomyolipomas ruptured and 
caused severe back and flank pain. A routine chest CT following treatment for breast cancer 
had shown abnormalities in her lungs. Ruth felt her diagnosis provided her with a logical 
explanation for her angiomyolipomas and was consistent with her expectation that she 
would have developed cancer during her life. She had recovered from her cancer treatment, 
felt well and took a positive approach to her diagnosis: 
 It made the angiomyolipoma fall into place… I really hadn't had anything to 
make me feel that my lungs were impaired… I wasn't surprised… since I'd just 
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been diagnosed with and treated for breast cancer which I'd fully expected 
would be my lot at some stage… I'm quite positive about making the most of 
life… I think I'd be in a different situation if my lungs were deteriorating 
fast…for me there's a bit of a holding pattern.  
Carol was diagnosed at 57 with very mild LAM that it was predicted would cause her little 
problem in her life. She was well and her only symptom was a minor inconvenience of some 
mild breathlessness while talking. Diagnosis, while a shock, gave her an explanation for her 
problem: 
It was a bit of a shock, but it was good to know what the problem was.  I've only 
had probably maybe a dozen instances when I couldn't finish a sentence and I 
know what it is… as long as it doesn't affect me anymore that it does now, I'll 
be quite happy. 
Ursula was diagnosed when she was 37 following a pneumothorax and pleurodesis. It was 
the same day that a well-known young celebrity died suddenly and tragically. She felt 
fortunate that she “was still alive… we didn’t feel like I was going to die in ten years because 
I didn’t feel that bad”. 
Fifteen participants experienced diagnosis as a major disruption of their life meaning. 
Thirteen of these were younger women aged between 25 and 41 years old when they were 
diagnosed. This period was described by many as “one of the hardest times” and a “struggle” 
to deal with. They were told their illness was incurable. Ten women were given expected 
lifespans of between one and ten years, and five were told to prepare for a lung transplant 
from “fairly soon” to within ten years. This dramatic and unexpected news disrupted their 
expected future and life plans of having children, work, leisure and travel, and, in turn, their 
sense of self and being in the world 
The women felt a sense of shock, uncertainty, and loss, with strong emotions of grief, 
sadness, fear and anger. Helen described being diagnosed as “a huge loss and grief”. Anna 
remarked that “what happens emotionally and mentally to anyone, to me in particular, is 
far worse than what’s going on physically”. The rarity of LAM heightened the disruption of 
their diagnosis by creating feelings of isolation and loneliness. Being diagnosed with LAM 
constituted a turning point in life for these women because it was a point of all-
encompassing change in body, mind, emotions, spirit, and social relations.  
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3.4.1 Feeling shell shocked 
Many participants expressed the significance of receiving a diagnosis of LAM through their 
use of metaphor. Images of war conveyed the unexpectedness of their diagnosis, their initial 
feelings of shock and devastation, and the impact of LAM as an all-encompassing disruption 
of their familiar worlds. Anna “was very angry and shell shocked and almost devastated…I 
literally felt like my whole world fell apart”. Eva was “so shocked… It was very difficult first 
of all to think… everything is turned upside down”.   
The sense of “shell shock” and trauma also affected partners and children. Deb’s teenage 
daughters were “shell shocked”, having only seen their mother as fit and healthy. Sarah’s 
whole family, including her husband, two children and parents, “went into shell shock… and 
just shut everything out and that was very disturbing”. For Sarah’s husband, her diagnosis 
“was the biggest thing that happened to him”: 
It’s very traumatic to be told that your wife’s got a condition that’s going to 
mean that she’s not probably going to be around…We were going along with 
our lives and really everything was great - and someone put a bomb under 
him… this destroyed his life.  
Diagnosis was an extreme disruption for Helen and her family. When she was diagnosed 
she was a 39 year old mother with a twenty month old child and a three month old baby 
who she was still breastfeeding. Her breathlessness during each of her pregnancies had 
been attributed to anxiety. She was diagnosed after being admitted to hospital with 
severe back pain and found to have a low oxygen saturation of 88%. A chest CT 
revealed advanced LAM. Helen’s life was disrupted in terms of both her future and her 
present life. She was told she would now need to use oxygen continuously, would have 
to wean her baby, would require a lung transplant soon, and was given an expected 
lifespan of two to five years. She described the impact of her diagnosis: 
My partner just burst into tears…When he came the next day he'd obviously 
been crying all night, he looked terrible…They said you're going to be on 
oxygen now all the time. I had gone from fit and active to being on oxygen. They 
said you're going to have to stop breastfeeding because we're putting you on to 
sirolimus. I was just devastated…A double lung transplant is the only option 
and that will probably be fairly soon.  
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3.4.2 Uncertainty - the ‘not knowing’ of being diagnosed with a rare disease 
Being diagnosed with a rare disease created a high level of uncertainty. The participants did 
‘not know’ what this disease was, how it would progress, how long they would live, what 
their life would be like, if and when they would need a transplant, and what that would mean 
for them. Most were given their diagnosis by physicians who had either not heard of or knew 
very little about LAM. The manner in which many women were delivered their diagnosis 
added to its negative impact and exacerbated their uncertainty. Eleven women were given 
their diagnosis alone without support. Of these, Eva, Ursula and Aiko were told late at night 
while in hospital. Eva and Ursula were recovering from surgery. Louise and Sarah received 
their diagnosis alone by phone. Twelve women indicated they received minimum 
information and fifteen women a lack of emotional support from their physicians who spent 
only a brief time delivering the diagnosis. No explanation or discussion occurred about the 
possible progress of the illness. Helen’s doctor “spent two seconds with me just saying we're 
looking at lung transplant”.  
Prior to 1998 there was no information available to the participants at all apart from a limited 
number of published medical articles. Louise was told, “there is no cure so just go and enjoy 
your life if possible”. Margaret was told only, “it’s just a disease that women get and you’re 
going to die from it…you’ll be dead by fifty”. Anna’s physician said to her, “You know my 
colleague’s daughter had this and she was gone in five years and she was about your age”.  
Louise and Deb were given the name of the disease but advised initially not to read more 
about it. Jess was given the name lymphangioleiomyomatosis by a specialist physician but 
spelt incorrectly so that neither she nor her GP could find information about the condition. 
Shortly after, by chance, she viewed a documentary on television featuring the stories of 
two women with LAM and recognised the similarities with her own story. She was 
distressed to work out her diagnosis in this way:  
 I just happened to watch Australian Story… it was saying, this woman has this 
incredibly rare lung disease…Then they said the name and it just turned out 
that the doctor had misspelt it and that's why we couldn't look it up… I was 
absolutely, absolutely shocked watching that program.  It was really the worse 
way to find out. 
Most of the participants, or their families, referred to the internet and commonly read 
outdated information about survival rates of between one and ten years. They were generally 
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not referred to reputable websites with up to date information such as the LAM Foundation. 
Even in the later period, 2005-2010, Helen, Clare and Eva were given little information and 
were not referred to LAM peer support groups. Helen was “just left…we had nothing”. Eva 
described how her physicians handed her information taken from the internet: 
The diagnosis was really bad…It's 10 o'clock (at night), the day after my 
surgery…I was by myself… He decided to tell me that here's a sheet of paper 
that I found on the Internet. It's some information for you. I know nothing about 
this disease but you’d better start preparing for a lung transplant because you 
will need one within five years. That's all he told me.  
The manner in which participants were delivered their diagnosis created feelings of distress, 
confusion, and fear. The women who had children didn’t know whether they would survive 
to see their children grow up. Most women, having already experienced symptoms for some 
time, assumed the worst of a dramatically reduced lifespan. Louise felt “my life’s ending …I 
just thought I’m doomed”. Irena conveyed her distress: 
It rings in my mind all the time when he said, you've got between one and ten 
years of life…That really upset me obviously.  I just thought I'm too young to 
die and obviously I focused on the one instead of the ten or in between.  I 
thought, well, is there anything that I can do, anything I can take?  Apparently 
nothing.  
There was an added layer of uncertainty and anxiety for women who were told to prepare 
for a lung transplant. This was particularly the case for Helen who was told she would 
need a transplant soon. She conveyed the uncertainty, fear and anxiety surrounding the 
process and timing of transplant in her war metaphor of “ticking time bomb”: 
 That's the worst thing, this ticking time bomb… I don’t know what's going to 
happen tomorrow…There's no end date. It's not like I know that in four months' 
time I'm going to have a lung transplant. It could be four years, it could be 14 
months, it could be four months. It's just that whole ticking - you always have 
that little anxiety in your head… what's going to come?  
Uncertainty was reduced for participants who received their diagnosis and adequate 
information in a manner which suited their individual personality and needs. Sarah, Ruth 
and Mia consulted LAM experts (respiratory physicians with a special interest in LAM) at 
diagnosis, Margaret and Anna later after diagnosis. LAM experts provided the women with 
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reassurance and accurate, up to date information. Margaret was relieved to find out that she 
could hope to live for longer than she had originally been told: 
He was the best and he did say… yes, there is no cure for this disease but you 
know some people can die quite young, some can live for more years…People 
get told once they’ve been diagnosed they’ve got ten years and he goes, that’s 
a myth. 
Deb felt she was given adequate, honest information and explanations and appreciated 
structured meetings with relevant healthcare professionals present and inclusion, with her 
family, in clinical decision making: 
He (my physician) came back and sat down and explained the whole thing to 
me…(He) organised that the head of the heart-lung transplant unit… a social 
worker, a psychologist… were there…and brought my brother and the girls 
down… He had all the x-ray scans, blood results and just explained… so then 
they had a debate whether I should have a thoracotomy.  
Vidu was a South Asian woman who received her diagnosis from her respiratory specialist 
of the same cultural background. She felt the information given to her was adequate. She 
was discouraged from seeking further information or discussing her condition with others. 
She was rather encouraged to lead her life as normal. Vidu felt that her doctor knew her as 
a person and that his advice was personally and culturally appropriate for her: 
 He explained everything… He told me one thing, don’t talk about this with your 
friends… because I don’t want anyone to treat you as a patient. I want you to 
live your life. I want you to forget about this… you have to be positive. You 
have to fight it. He was just giving me moral support… Lead the same life as 
you did before… He knows that I’m a bit of a weak person…He knew about 
me… He didn’t want me to have contact with other LAM patients because… 
knowing you, if you hear about the dark side of it you will be totally negative… 
He is also a Buddhist so… according to our religion… he advised me… For 
me… I think it’s good.  
3.4.3 Layers of loss 
The participants revealed the disruption of multiple aspects of life in the layers of loss which 
they experienced at diagnosis. At this turning point most focused on the future, in the loss 
of their expected lifespan and plans for family, work and travel. Younger women, who were 
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advised not to become pregnant once they were diagnosed, particularly felt a sense of loss 
of their life goal of having children and seeing them grow up. This was felt acutely by both 
women who had not yet had children and those who had. The forced loss of such a 
fundamental aspect of female identity struck at the core of their sense of self and many found 
this the most difficult aspect of diagnosis to deal with. Margaret, 34 when diagnosed, single 
and without children, spoke with emotion of her loss: 
 I actually cried more when I got told basically don’t have kids than when… 
(my doctor) explained to me about the death ratio… All I ever wanted to do was 
get married and have children and that was my life’s hope… and then to get 
told, no don’t have kids… I was angry, I was really angry. (Quivery, teary 
voice) 
Sarah, 32 when diagnosed, was married and had two children. She had “just assumed that 
I’d have more than two kids”. She and her husband struggled for a year with decision 
making around IVF, surrogacy and adoption: 
At the time my lung function was degenerating very quickly and I… realised the 
IVF surrogacy process would have been overwhelming… I thought I really had 
better focus on my kids… Someone said to me I could adopt… It was a debate 
between us… We just decided it was all too much, the emotions of the whole 
thing would have been too much. 
Irena conveyed the combined shock, shattering of life’s plans and struggle in her use of 
‘battling’ as a war metaphor in confronting her illness and the issue of not having her own 
child:  
Do I allow this child to grow up without a mother?  Do I allow my husband to 
have the burden on his own of raising this child? …I just thought I was really 
selfish wanting a child so badly.  Then I thought I was selfish not going ahead 
with it in the hope that I won't get worse…  I was toying and battling with it.  
Even if having a child was not a primary aim, diagnosis and the subsequent inability to have 
children represented the loss of choice and possibility as an aspect of self and normal life. 
While Jess was “not really one of those women who always wanted to have a kid”, not being 
able to become pregnant became “part of not really having a real life…. it was part of not 
knowing if you'll be able to walk in five years or will you be able to work”.  Similarly, 
although Louise was 41 and had not had children when she was diagnosed, she felt that 
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“part of my life hasn't been expressed and I feel a bit incomplete”. 
Anna and Eva reflected on the possibility of adoption and dealt with it by considering their 
current priorities, how they would care for a child in the context of possible deteriorating 
health, whether their partner would be able to care for a child on his own, and the fairness 
of potentially leaving a child either without a mother or as a carer for their mother. Anna 
prioritised her health, and Eva her marriage and Buddhist faith. Eva was able to separate her 
female identity from being a mother, “I don't identify being a mother necessarily with being 
a woman”. The two women described their decision-making: 
I have those moments where I think I’m missing out big time. Then I think if I 
was to bring a child into the world, I have bad days as it is, that’s not fair on 
the child…and I don’t think it’s a child’s place to be the carer. (Anna) 
What if I start declining again?…What's going to happen to this poor child? Is 
my husband ready to take care of it on his own?… I may have a limited time to 
what I once thought I would have to live. So do I want to use the time raising a 
child?… It's not something that is at the top of my list. (Eva) 
The necessity to avoid pregnancy was not a loss for all women. Five women were post-
menopausal and already had adult children. Ursula’s family was complete before she was 
diagnosed. Mia felt that having to avoid pregnancy “wasn’t a big deal” as her life plan had 
included adopting a child. 
Helen experienced both a loss of career opportunities and financial loss. Her disease was 
already advanced and she needed to reduce her work hours when she was diagnosed: 
I have worked for ten years to get to a senior position. I really like my work and 
it's important to me…My partner and I had this great plan that suddenly we 
were going to have some money … I'm on quite a good wage if I was working 
full time but that's now not happening…I have to now realise my career as such 
at this point is on hold. 
 
Mia, Anna and Helen were advised not to undertake air travel due to the risk of 
pneumothorax. This represented the loss of an expected future when holiday plans they had 
made with their partners would not be realised.  Mia’s work involved frequent travel and, 
as well, she was now isolated from her family overseas. Mia reflected on this loss: 
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The other factor that was really shocking and that had a big impact in our lives 
was that I travelled a lot… Travelling is one of the things I love the most…we 
always wanted to travel together… Boats are really expensive and you really 
need to take three times more time off to get somewhere… My family was so far 
away. It was very hard because I knew that I couldn’t go and visit them as often. 
Louise and Aiko felt a loss of hope and a sense of life ending. They became acutely aware 
of their breathing and experienced anxiety and panic. At the time they were diagnosed 
(before 2001) having such a rare disease exacerbated their sense of hopelessness when there 
seemed no prospect of a cure. They felt engulfed by feelings of blackness, depression, fear, 
anger, loneliness and having no control over their situation. Louise said:  
I started having panic attacks… I felt like I had to make myself breathe… I 
remember being on a tram one day and thinking I’m going to suffocate… I 
remember just feeling so bleak and alone. I just felt like I'd fallen down a black 
hole and there was just no hope, there was no one who could pull me out of it. 
I was just going to die… I just thought well, there's no hope really, is there? 
Absolutely no hope, because no one's going to research a disease that's so rare. 
Aiko considered ending her own life. She used the metaphor of “corpse” to describe both 
her physical appearance and loss of will to live:  
When I was in hospital, I had that not much choice, not much hope.  Then, I 
became like depression, like panic attack.  Suddenly I can’t breathe… I was 
just so struggling.  I was quite angry about everything… One time I was 
thinking, if I’m going to die, can I commit suicide?…I lost so much weight….a 
corpse - just bone and skin…I was very depressed. 
3.4.4 Feeling “so alone” 
Receiving a diagnosis of a rare disease was isolating on a number of levels. As a rare disease 
there were so few other women with LAM, particularly in the Australian context. Before 
1998 there was no support group in Australia and most physicians, even in later years, did 
not refer their patients to the LAM Foundation or the Australian organisation after it was 
formed. Being given the diagnosis alone, with little information or support, was a lonely 
experience. Louise “felt so alone.  It was just awful”.  Helen’s doctor “wouldn't put me in 
touch with anybody and I said, well could you pass my number on and ask them if they would 
contact me, and he never did that…it was just really frustrating”.   
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Geographically, many women living in other states or rural areas were isolated from the two 
centres of LAM expertise in Australia as well as from other women living with LAM.  This 
was especially pertinent to Helen who lived a considerable distance from LAM experts, was 
unable to fly, and was further isolated by knowing of no other women on oxygen with young 
children with whom she could share her experiences.  
Socially, a diagnosis of LAM was isolating when most people the participants met, 
including their own local doctors and other healthcare professionals, had no awareness or 
knowledge of LAM. Other than her partner, Jess “didn't really have anybody who 
understands the disease”.  A woman’s particular social circumstances could exacerbate the 
sense of isolation.  Aiko, for example, was particularly alone and isolated by her diagnosis. 
Her husband was elderly and in poor health and her only child was living overseas. In 
addition she was culturally isolated as an Asian woman living with an Australian husband. 
Her parents were recently deceased and she had no real contacts with a cultural community 
in Australia. She described herself as a cultural “alien”. These feelings were only 
accentuated by her diagnosis: 
 I feel really strange… (Asian) people think I’m not typical (Asian)… but I 
think Australian people don’t believe I’m Australian… I feel like an alien.  
Not belonging anywhere… I don’t have really my own group…I have no… 
(Asian) contact at all…  
The doctor came very late in the night…just the two of us… I didn’t have any 
family…I have to face things by myself.    
 
3.4.5 A shifting sense of self 
When they received their diagnosis the participants entered a period of transition between 
separation from their old life and previous state of health, and passage to a new way of 
being. For six participants entering transition was an existential experience in which they 
reflected on their existence. As they perceived life itself becoming more tenuous and 
uncertain they experienced an unsettling, shifting sense of self. They had an awareness of 
separation and uncomfortable feelings of instability, ambiguity and paradox, of being in 
between states and neither one thing nor the other.  
The women expressed a sense of disembodiment and separation of body and self. Anna 
spoke of her diagnosis as being “like an out of body experience”. The body took on an alien 
identity and seemed no longer a part of the self. Jess felt “trapped” in this foreign body. It 
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had become a burden, “I felt like I was carrying my body around”. The uncertainty of illness 
and the future created in Louise an “emotional disconnection” that made her feel less 
confident and impacted on her relationship with her partner. Aiko felt she had lost herself 
in her disease, “I became LAM”. 
They experienced a similar shift in their relatedness of self to the world. There was a new 
world of illness, hospitals and healthcare professionals they would have to negotiate within 
their everyday world. While they remained situated in the world there was a sense of not 
being fully part of it. Eva felt that the limitations of her illness removed her from familiar 
life:  
My life's going to be like this from now on. I'm going to be someone sitting in a 
chair when my friends are outside, dancing or going wherever they're going… 
All of a sudden, from feeling like you can do everything… these are my limits 
now and you have to deal with that. It's quite hard. 
Feeling both in the world and yet at the same time outside of it engendered a sense of 
unreality.  Helen described life at diagnosis as “surreal”. An uncertain future shifted life out 
of balance so that it seemed less tangible. There was a perception of instability, of moving 
between worlds. Eva “felt so lost”. For Louise “nothing felt very solid any more”. It was like 
being “on a slippery slope”.  Jess felt she had entered a “shadow life” of uncertainty that 
was out of context with her old life: 
Everything becomes de-contextualised, because I couldn't plan for a future.  I 
didn't know - in three years will I be working?  Will we be able to buy a flat?  
Will I still be able to be walk around?  Will I be dependent on … (my partner) 
for everything?  
The concept of liminality reflects this subjective state of ambiguity and uncertainty which 
the women were experiencing. Liminality was first described by Van Gennep (1960) in an 
anthropological study of initiation rites of passage in tribal communities. He conceptualised 
it as a phase of ambiguity and being at the margin of normal life during a transition or 
passage from one age or social situation to another. According to Van Gennep (1960), there 
are three phases of transition: separation from the old life, a liminal period, and passage to 
a stable state during incorporation. All the participants demonstrated the phase of separation 
as they entered transition in this immediate period surrounding their diagnosis. The themes 
of disruption, loss, uncertainty and isolation which they revealed were indicative of the 
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unsettling, indeterminate and marginal quality of this period. The women above who 
experienced liminality conveyed it in their metaphors of instability and darkness.  
Not all participants experienced a state of liminality during their transition. Women with 
mild disease for whom diagnosis was minimally disruptive were able to transition quickly 
to a more stable physical and emotional state and adapt to their illness. The participants’ 
experiences of liminality after diagnosis and at later turning points are explored further in 
the next three chapters. 
 
3.5 Dealing with the diagnosis 
The participants dealt with the disruptive effects of their diagnosis by either actively 
engaging with their illness or intentionally avoiding it. Each approach, in different ways, 
was directed at restoring a sense of normality and control. The women made decisions that 
were consistent with their life meaning, including their disposition, past life experiences, 
self-efficacy and spiritual beliefs. Being able to mobilise social support assisted them in 
dealing with their diagnosis. 
3.5.1 Engaging with the illness 
Nine participants actively engaged with their illness, taking the first steps toward adapting 
to it in their lives, by conducting their own research, seeking expert medical care or 
contacting peer support groups to find information about LAM. Clare and Eva identified 
themselves as having curious dispositions. Clare described her personality as “inquisitive” 
and her “way of coping was just to find out a lot”.  
Margaret, Patricia and Eva had developed resilience from their past experiences of 
successfully managing adversity or illness over time. Resilience represented the knowledge, 
skills, competence and self-efficacy beliefs they had gained through these experiences. They 
took a positive approach and demonstrated confidence in their ability to cope with their 
diagnosis. While Margaret was “scared, worried, confused” when she received her 
diagnosis, she had lived with asthma all her life and “always had to be careful so in a way 
being an asthmatic has really helped me with this disease, to cope with it, cause I’ve always 
had restrictions in my life”.   
Eva had experienced civil war in her country before she came to Australia alone when she 
only 19. She had been through three bombings and a cousin had died on the war front. She 
found it a “shocking” experience. Eva’s experience gave her courage by showing her that it 
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was possible to survive and move on from severe adversity: 
 In civil war, people go through horrible stuff… you cannot fathom that 
someone would actually be able to survive. But you do. People move on. Just 
seeing that transformation, and how strong people really are. I think that 
teaches you you've got that inside of you as well… So it gives you a bit of 
courage.  
Patricia’s son, who was 25 at the time of interviews, had been diagnosed with tuberous 
sclerosis and severe autism spectrum disorder and epilepsy when he was three years old. 
She herself was diagnosed with tuberous sclerosis and epilepsy at the same time, and had 
lived with a hearing impairment all her life. Patricia had been successfully managing her 
own health and her son’s complex medical issues and challenging behaviours for many 
years. Her husband regularly travelled overseas for work. Patricia received and dealt with 
her diagnosis alone. Her ability to manage a difficult social and medical situation over a 
long period of time had developed her resilience and gave her the confidence she would be 
able to manage her LAM. She pragmatically accepted her diagnosis and adopted a positive, 
proactive approach to her illness by seeking expert medical care and continuing to exercise 
to keep fit for transplant. For Patricia, LAM was “just another step”. 
3.5.2 Striving to be ‘normal’ 
Eleven participants who were in the early stages of LAM protected their sense of self by 
avoiding associating themselves with being ill or anything related to LAM. They wanted to 
feel and be perceived as the same normal person as before their illness. They avoided 
thinking, talking, and seeking information about LAM to keep the disease separate and 
distance themselves from its   foreign and frightening implications. This provided a safe 
space to protect the self for a time. According to Jess: 
At that time I wanted the same things to be important…you want to be the 
same person… I just wanted to really be in a bit of denial…There will be a 
time when I can't disguise it.  But while I can, I'll just not mention it.  
Veronica could not connect with her illness, “I had difficulty applying it to myself… I didn’t 
relate it to myself”. She coped with diagnosis in a way that was usual for her, “head in the 
sand, bum up in the air.  I think that’s probably how I handle it… I didn’t want to read about 
it… It was very good self-talking, that it’s not necessarily going to happen”.  Deb “didn’t 
think about the disease… I just had too much to do… it was not going to be part of my life”.  
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Irena “wanted to shut myself off from anything LAM related” to preserve her emotional 
stability: 
I just didn't want to think about it.  Because I thought well I'm going to die… 
why should I research this?...  There's no cure, nothing's going to help me.  I 
just want my emotional state to be at a level where I can cope.   
Vidu understood herself to be a person prone to negative thoughts. Avoidance allowed her 
to protect herself from negativity and anxiety in a way that matched her personal 
disposition. She didn’t discuss her illness with anyone outside her family, and avoided 
reading about LAM and contacting other women with the condition. She forgot her LAM 
by avoiding thinking or talking about it and keeping busy with her everyday life: 
 I thought it’s better to lead my life like this, the same way that I lived my life 
before. I thought I will forget about it because actually I didn’t have… much 
pain… I didn’t feel that much.  
Avoidance manifested for Louise as recklessness, drinking too much and living for the day, 
believing she was to die prematurely anyway. She saw herself as fighting LAM as an enemy:  
 I think I had a bit of a drinking problem… that I’m invincible kind of thing. 
I’m just going to have a good time…I think also I felt careless because I 
thought I was going to die anyway… it’s also a way of denying the illness, you 
know it’s not going to get me.  
Avoiding being ill was a temporary response for the majority of these participants and they 
later engaged with their illness as their initial feelings of shock settled. Vidu, Irena and 
Veronica, however, continued to practise ongoing forms of avoidance in their life after 
diagnosis.  
3.5.3 Finding support 
Social support was a crucial means of coping with diagnosis. The majority of participants 
were supported by partners, husbands, parents, siblings and adult children. Family provided 
practical and emotional support, acted as advocates, sought further information on LAM, 
and contacted LAM peer support groups at the time of shock and disruption. Supporting 
each other was an important aspect of Anna and Vidu’s family and cultural values, as Anna 
said, “sticking together when things get hard”. Vidu’s family gave her advice and moral 
support. Her brother-in-law had taken responsibility in the role of eldest brother in her 
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family when she was young. When she was diagnosed he acted as Vidu’s advocate by 
communicating with her parents and health professionals, and researching necessary 
information on her condition. “When I was in hospital he was there. He did everything”. 
Not all participants received support. Aiko, as highlighted earlier, was socially and 
culturally isolated and did not have access to social support. Clare essentially dealt with her 
situation alone. Although she was living with her parents, she received little emotional 
support. Her father was seriously ill at the time and she modified her own emotional 
response out of concern for her parents, trying to be strong and positive so as not to add to 
their worry: 
The first month I was pretty much on my own… Dad was still quite critical 
….Mum and dad had been through so much - right from the word go I was 
trying to be positive for them…I just had to deal with it… I was trying to be 
strong for mum and dad. I just thought well, what will be will be. I'll just try 
and do the best with it…I tried not to cry either because I just didn't want her 
to get upset.  
The isolation Jess felt in having a rare disease was exacerbated by her estrangement from 
her family and feelings of being unsupported by them: 
On these sorts of occasions the conflicts become more…I’ve never had much 
support from them (my family)…My father was overseas…he hasn’t been 
there at the crucial bits…I haven’t spoken to my mother for about two years. 
Peer support groups organised by women with LAM themselves were a potential source of 
information and support for newly diagnosed women. The organisations which most 
participants had contact with were the US LAM Foundation, founded in 1995, and the 
Australian support organisations, LAM Australia (1998 - 2006) and the LAM Australia 
Research Alliance, LARA (from 2006). They could also communicate via social media on 
Facebook sites.  
The participants expressed a range of views on their experiences and need for contact with 
other women with LAM or LAM websites. Eight women chose initially not to contact a peer 
support group. Each of these women had either mild disease or were in the early stages of 
their illness with manageable symptoms. They did not want to be reminded of their illness 
or be confronted by women at the later stages which could evoke uncomfortable images of 
the potential progress of their own LAM. Deb was busy getting on with her life and keeping 
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LAM backgrounded. She had support of good friends and didn’t feel a need to make contact 
with other women. “I can't be bothered with it, it's all just too maudlin. I just don't want to 
know about it”. Later she occasionally looked at the Facebook site but tended to find it 
“depressing”. Irena preferred to deal with her diagnosis on her own. She felt looking at 
LAM websites and having contact with other women would foreground her illness and make 
her constantly relive it: 
 I didn't want to read things because every time I did I would read so-and-so 
passed away, this person has been diagnosed and she's on the transplant list.  
It just brought it all back home so I avoided the website as much as I could.  
Julie, Jess, Mia and Ursula met older women with advanced disease and on oxygen in 
hospital clinics and when invited to their homes. For each woman it was a confronting, 
frightening and depressing experience and did not assist them in dealing with their own 
diagnosis. They wanted to feel connected to life and health rather than sickness and the end 
of life which they sensed in the older women. As Julie said: 
It's easy for people to say you need to support each other, but it's also very scary 
when you go and see someone like that, because you're seeing a bit of the future.  It's 
actually a horrible feeling.  
They would have preferred to meet someone younger and managing their condition well 
who could give them a more positive view of the future and hope that some sense of 
normality in their life was possible. Ursula wanted to “be like the one that's going slowly… 
you want to be like the one that survives not the one that dies from it”. Mia would have been 
“happy with someone younger or in my same sort of age group with the same sort of 
situation… a positive outlook as opposed to worst case scenario”. Jess felt that being with 
the women grounded her in her illness at a stage when her own breathlessness was minimal: 
 She could barely walk.  She would walk a little bit and puff a lot.  I found that 
really quite horrifying… They didn't understand how normal I felt. I just didn't 
feel like them… I could walk around and not notice particularly being 
breathless… I was intellectually preparing for some of the symptoms, but I 
wasn't actually experiencing them.  
Eight women elected to contact a peer support group for information when they were 
diagnosed. When Louise was diagnosed prior to 1998 the LAM Foundation had only just 
been started. A formal support structure was not in place. Louise felt alone and isolated, “in 
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a closet all by myself”. The only information available to her was what she had gleaned from 
medical articles in a university library. Later, after LAM Australia started, Louise met other 
women with LAM. Although she feared meeting them would be confronting, she found it 
was “wonderful” and reduced her feelings of isolation.  
As the internet became more widely available, the participants were able to make contact 
with peer support groups through their own or their family’s search of the internet.  
Frequently the LAM Foundation was the first point of contact. By 1999 the LAM 
Foundation was well established and women were sent an information package and referred 
to the Australian support group. They could also register with both the US and Australian 
databases which provided data to support LAM research. Although Ursula had indicated she 
“didn't want to meet anyone sick when I first got diagnosed” her physician made contact 
with a woman with LAM through the Australian Lung Foundation and asked her to contact 
Ursula. Ursula was relieved that the woman was similar to herself, well and mildly affected. 
The interaction was helpful and a positive experience and the two women maintained 
ongoing contact.  
Julie and Helen, both geographically isolated, felt that the emotional support of other women 
with LAM was fundamental in managing their diagnosis. Helen acknowledged that the 
support of women from LARA (LAM Australia Research Alliance) was “how I got through 
it really”. For Julie, one particular woman had “been the best thing.  She's been my support 
through all this”.  
When women supported each other they could form relationships which lessened feelings 
of isolation and were encouraging and sustaining. However, because all were living with a 
life threatening condition, forming relationships had the potential to add to the losses 
experienced at diagnosis. This was compounded by the fact that, because there were so few 
women with the rare condition in Australia, one or two women only tended to take on the 
role of providing personal phone communication with newly diagnosed women. A member 
of LAM Australia provided crucial emotional support for Margaret and Aiko. Margaret 
spoke of becoming “close” to her and Aiko’s spirits were lifted by her support. She “cheered 
me up so much.  Hearing from her, I thought it’s just like bright light. The depression gone”. 
The relationship, however, came with risk of loss and this was realised when the woman 
who had provided such valuable support passed away from complications following lung 
transplant. Her death was “devastating” to both Margaret and Aiko and represented loss of 
friendship and support, confrontation of the risk of transplant, and a view of their own 
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potential future. In the context of a rare disease and the solo nature of the woman’s support 
work there was not awareness among other women of Margaret and Aiko’s emotional loss 
at this time. Consequently Aiko withdrew from contact with other women with LAM for 
nine years and Margaret maintained only very occasional contact. Aiko feared “losing them 
again, and how do I cope with that?”   
In recent years social media and email communication have become convenient ways for 
women diagnosed with LAM to overcome the isolation of a rare disease by connecting with 
a broader range of women both within their own country and internationally to share 
information and experiences and create a sense of community. ‘Lammies’ is a closed 
Facebook group providing a private forum for discussion. Through this online community 
participants gained access to new information and first hand experiences of new treatments 
such as sirolimus. This assisted with decision making in regard to their own illness 
management and gave women the confidence to discuss the possibility of treatments with 
their physicians. Social media was a safe forum to discuss common personal issues such as 
sexual intimacy and contraception that were difficult to raise with physicians during limited 
appointment times. There was also an immediacy to social media so that a woman could 
express her feelings and receive support from women who understood when she was having 
a bad day.  Helen, who knew of no one else in Australia caring for young children while 
living with oxygen therapy, particularly found Facebook helpful in connecting with other 
women overseas who were in a similar situation to herself:  
I got on to Facebook Lammies… and that was brilliant because there were 
people my age or younger so I didn't think I was the only person with kids that 
had LAM…It's a really good site for asking questions and finding out about 
stuff… (When) I'm actually having a really shit day … I need to offload… I 
need some support…That's really good because they were, Helen, that's fine; 
just come on; you'll be all right; you've just got to work through this; 
tomorrow you'll feel better. 
Eva, Vidu and Anna drew on their personal belief systems for support during the period of 
diagnosis. Spiritual beliefs provided meaning and comfort at a time of suffering, direction 
for coping with their diagnosis, and a link to their familiar life before diagnosis. Eva had 
been practising meditation and had adopted the Buddhist faith two years before she was 
diagnosed. She credited her spiritual practice with giving her tools to enable her to cope 
with her diagnosis. In turn she felt her illness deepened her faith: 
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 People that are in trouble always seek religion because it's comforting. It was 
no different for me… I certainly did turn to it consciously to try and make it a 
tool for me to deal with this better. It certainly did help. I intensified my practice 
because I was sick. If I wasn't sick, I probably would have been halfway on the 
path now. 
Vidu was also Buddhist. At diagnosis, receiving her diagnosis and advice on managing her 
illness from a Buddhist doctor in a manner that fitted with her spiritual and cultural beliefs 
supported her coping. Anna’s Catholic faith, an important part of her family and cultural 
life, acted as an “anchor” and a “safety blanket” when she was diagnosed. She found some 
peace in the turmoil of diagnosis through her practice of going to Mass, prayer and the 
rosary. 
3.5.4 Deciding to conceal or disclose the diagnosis 
At diagnosis LAM was an invisible illness to outsiders for the majority of participants. 
Although they had a serious lung condition most appeared well and healthy. Only Helen, 
who was prescribed oxygen therapy when she was diagnosed, bore visible signs of LAM 
with her nasal prongs and oxygen cylinders. The invisibility of LAM meant that participants 
could choose with whom they would share news of their diagnosis. While this gave them 
some sense of control it could also mean that people could lack understanding of the 
seriousness of their condition and display less empathy. This created a tension between inner 
fragility and an outward appearance of normality, between a need for understanding and a 
fear of being treated differently. According to Aiko, “the problem is we don’t look bad at 
all although inside we are so fragile”.  
The participants did not want to be identified as a sick person or be regarded as a victim to 
be pitied. This was a prime motivating factor in concealing their illness from people they 
met. Most women chose to discuss their diagnosis only with partners, family and selected 
friends. As Julie said: 
I don’t want people to feel sorry for me.  I don’t want to be treated 
differently…So I don’t like everyone to know.  My friends know, my work 
colleagues know, but I don’t run around telling everyone I've got LAM.  
Looking healthy and concealing their LAM backgrounded their illness and was consistent 
with the coping mechanism of avoidance used by some of the women. Irena, Deb and Carol 
“didn’t talk much to anybody”, preferring to manage on their own and avoid worrying loved 
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ones. 
Concealing LAM was a means of avoiding stigma and being judged as less than competent 
because of their illness, especially in the workplace. This was a particular concern for Jess 
who worked full time and was concerned about how her work performance would be 
assessed and her prospects for future work assignments:  
 I've always been afraid that I won't get interesting work and that I'll just be 
treated as a bit of a basket case if I make too much fuss over the 
condition…you don't want to be judged on having something wrong with you 
in the future.   
Other women were selective in revealing their diagnosis at work to a few trusted colleagues 
or their manager only, when they felt it was necessary. This might occur when there was an 
atmosphere of trust or when they felt there was an obvious issue which required explanation. 
In Mia’s view: 
 When it's noticeable… then I feel the need of explaining it so that they realise 
that it's something that could be permanent…When there's a certain 
relationship of trust I feel okay to tell them. 
Other reasons for concealing their illness included maintaining privacy and avoiding the 
inevitable explanations of LAM required when revealing a rare disease to others. It was 
difficult to explain the condition casually to acquaintances. Often others confused LAM 
with asthma and Sarah and Jess found it easier not to correct that misconception. Sarah 
said: 
I just feel awkward having a conversation with someone in a casual way…A 
lot of people…want it to be asthma because they understand asthma…So you 
pretty much agree with them…I just can't be bothered to go into an 
explanation.  
There was also a sense that people were generally not interested in the illness or its 
associated problems. Patricia felt that “some people, you can talk about it to, and other 
people, you just leave it on the backburner… people don't want you to be talking about your 
problems”.  
Participants avoided lengthy explanations by referring people to the LAM Foundation or 
LARA website for information and providing an information sheet about LAM. Irena’s 
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main motivation in discussing her illness was to raise awareness of LAM in the community. 
Anna only shared thoughts about her illness if she felt it was of benefit to someone who 
might also be experiencing difficulties in their life. Eva, Ruth and Ursula felt comfortable 
in revealing their diagnosis to others. Ursula did not regard herself as a private person. 
Certain social contexts could hinder a woman from concealing her illness, for example, 
Clare lived in a small rural town where news of her illness was readily shared in the close-
knit community.  “It was a small town everybody knew I was sick…so there's no point hiding 
it”.  
3.6 Summary 
The participants’ narratives revealed that being diagnosed with a rare, degenerative, 
incurable illness was a critical turning point of significant change for their lives. Receiving 
a diagnosis, for the majority of participants, was a shock which profoundly disrupted their 
lives due to the absence of a cure, the limited lifespan most were given, the uncertainty of 
the rate at which their illness would progress, and the subsequent impact on their daily life 
and expected life plans. In this period, in the context of being given a predicted maximum 
life expectancy of ten years, the women particularly focused on their future and the losses 
which this implied. For younger women, the loss of their ability to choose to have children 
and, for those who already had children, the possibility that they may not live to see their 
children grow up was an especially devastating loss and disruption of their sense of self.  
The shock, uncertainty, and loss which the women experienced was accompanied by strong 
emotions of grief, sadness, fear, anxiety and anger.  
The rarity of LAM compounded the participants’ sense of disruption by exacerbating the 
uncertainty surrounding diagnosis and creating a sense of isolation. The lack of awareness 
and knowledge of LAM among physicians delayed diagnosis and affected the way it was 
delivered. Most participants were given their diagnosis alone, often in an insensitive 
manner, and provided with minimum and, at times, inaccurate information and no emotional 
support.  Most were not referred to peer support organisations. This increased the negative 
impact of the diagnosis itself. The women consequently had to rely on themselves or their 
families to access generally outdated information from the internet and eventually locate 
support from the peer support organisations. These findings are reflected in the results of 
two surveys of the experiences of almost 12,000 rare disease patients conducted by the 
European Organisation for Rare Diseases (EURORDIS) between 2003 and 2008 
(EURORDIS 2009), a study of the experiences of Australian families living with a rare 
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disease (Anderson et al. 2013), and Carel’s (2013b) experience of being diagnosed with 
LAM. 
Diagnosis marked entry to a period of transition between separation from familiar life and 
adaptation to a new way of being. Entering transition was, for some participants, an 
existential state of liminality in which they were aware of a shifting sense of self and feelings 
of disconnection and instability, of being in the world but simultaneously outside of it. 
Martin-McDonald and Biernoff (2002) also utilised Van Gennep’s (1960) rites of passage 
to explore the meaning of dialysis dependency and conceptualised transition as a liminal 
state of space, time and place. 
The participants revealed that they interpreted being diagnosed through the lens of their 
personal life meaning representing their values, beliefs, life purpose and goals. Other 
authors have referred to this as global meaning (Park and Folkman, 1997), biographical 
construct (Rosenthal 1993), life scheme (Thompson and Janigian 1988), and assumptive 
world (Murray Parkes 1971). The participants experienced disruption as they perceived a 
discrepancy between their life meaning and the implications of their diagnosis for their 
future. Similarly, Park and Folkman (1997) claimed that people interpret a stressful event 
by looking for congruence between global meaning and the situational meaning of a 
particular experience. They proposed that a perception of incongruence is associated with 
discontinuity and provides a motivation to reconcile the meanings in order to restore order 
and coherence.  
The participants strove to restore a sense of normality by either by engaging with their illness 
or avoiding it. Similarly, Bury (1982) claimed that the biographical disruption of chronic 
illness forces a person to evaluate their life plans and self-concept and attempt to normalise. 
The women demonstrated that resilience some had developed as a result of knowledge and 
self-efficacy gained through past experiences of adversity and illness reduced the disruption 
of diagnosis. 
Family support, and, for some, personal spirituality and religious beliefs, were crucial 
resources which assisted the participants to cope at this time. While a number of participants 
sought support from the peer support organisations, others avoided associating with other 
women with LAM to further preserve a sense of normality and avoid being confronted by 
oxygen therapy and experiences of advanced disease. They preferred support that was 
positive, hopeful and focused on health and wellness. Communication with other women 
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through online communities of women living with LAM was a valuable support for 
participants who were particularly isolated, geographically and socially.  
3.7 Conclusion 
This chapter has presented the participants experiences of being diagnosed with LAM. It 
covered the time span from the onset of their symptoms, an interval of misdiagnosis or 
delayed diagnosis, through to their diagnosis and the period immediately following it. For 
the majority of participants, being diagnosed signified a profound disruption of their life 
meaning, conveyed in feelings of shock, loss, fear, grief and anger. The rarity of LAM added 
dimensions of isolation and uncertainty. Many were given their diagnosis in an insensitive 
manner, and the majority received little information or emotional support from their 
physicians.  
Later, in their everyday lives after diagnosis, the participants learned to live with the changes 
associated with their illness and integrate them into their lives. Resilience developed through 
these processes and influenced their experiences at later turning points. The following 
chapter presents the participants’ experiences of adapting to their illness in their everyday 
lives after diagnosis and the growth of their resilience during this period.     
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Chapter 4 
LIFE AFTER DIAGNOSIS 
ADAPTING AND LEARNING TO LIVE WITH LAM 
 
4.1 Introduction 
This chapter presents the participants’ experiences following diagnosis to the moderate 
stage of their illness as they learned to live with LAM in their everyday world. The previous 
chapter revealed that, for the majority of women, being diagnosed with LAM was a turning 
point of profound disruption which was compounded by the rarity of their condition. When 
most of the women were given a predicted maximum lifespan of ten years they focused on 
their future and how their illness would impact on their life plans. Diagnosis marked their 
entry to a period of transition during which the participants’ focus shifted to the task of 
learning to adjust to its impact on their everyday lives. This was a dynamic process of 
adaptation which enabled them to passage from transition to a new way of being as their 
illness became an accepted and integrated part of their lives. Through this process they 
developed resilience which supported them in living with the permanent uncertainty of a 
progressive, incurable illness. Resilience represented the meaning, knowledge and skills that 
evolved throughout their lives and their experiences of learning to live with LAM.  
The participants’ experiences after diagnosis were embedded in their social worlds. While 
they identified the physical effects of their illness, their narratives were concerned primarily 
with the personal and social impact of LAM on their lives. Many indicated that these were 
more difficult to deal with than their physical symptoms. Adaptation involved learning to 
manage their symptoms, emotions, and social relations in the everyday fluctuations of life 
as well as times of illness-related or significant social change. Figure 4.1 guides the reader 
visually through these processes. The participants revealed how they learned to live with 
their changed bodies and manage their relationships and responsibilities and how these were 
influenced by the rarity of LAM. In living with illness in a changing world they encountered 
new turning points and varying experiences of liminality which affected their ability to 
adapt. They demonstrated how they built their resilience through adaptation and the first 
stage of illness progression. 
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4.2 Learning to live with a changed body 
Following diagnosis, the participants needed to learn to live with their changed bodies and 
acquire knowledge and skills to manage these changes over time. This involved their day to 
day experience of living with their illness symptoms and the limitations they imposed, as 
well as learning to understand and manage their rare disease. Breathlessness and fatigue 
were the most common symptoms of LAM which affected the majority of the participants, 
limiting many of their usual activities. The women regarded breathlessness as the most 
serious physical effect of LAM. They perceived it to be a sign of the extent of their lung 
disease and associated it with mortality, Being breathless could be a frightening sensation 
associated with anxiety and panic, particularly in the early stages of the illness when they 
were not familiar with how to manage it, and again at the late stage when it became more 
persistent. When feeling breathless their illness was in the foreground of their minds and 
they found it difficult to focus on wellness. According to Eva:  
Breathlessness is something that is quite a scary sensation. Because it's like… 
dying with every breath… you can't help thinking about just the disease. It 
becomes your whole focus… it makes it very hard to break out of feeling 
helpless and unwell and really get a strong sense of wellbeing. 
The women described feeling breathless when they walked up a hill or stairs or at a fast 
pace; performed actions such as pushing, bending over, carrying a weight or talking; were 
in hot or cold environments; and at night. This impeded their ability to perform home chores 
such as vacuuming, sweeping, mopping, and hanging out washing; leisure activities such as 
sports, swimming, hiking, and dancing; and other everyday activities such as work and 
shopping. They felt socially isolated and became observers rather than participants. This 
occurred when they were not included in certain activities or left behind when they could 
not maintain the faster pace of their friends or join in conversations while walking. Julie 
“used to love snorkelling. I can’t snorkel any more…I just have to watch now and take the 
photos”. Aiko found she started slipping out from the group”. Sarah said: 
 I stopped being able to walk with anyone because I stopped being able to 
walk and talk… I got upset… I used to try and exercise every day and so that 
was a bit of an impact. A lot of the people I used to see in that way I stopped 
being able to. 
At interview, most of the participants appeared well, even though they had a serious lung 
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condition. Other people tended to assume that their breathlessness was caused by a lack of 
fitness or lung problems due to smoking. Ursula felt that when she walked upstairs at work 
“they must hear me puffing. They probably just think I’m unfit”. In Sarah’s view: 
People make a real judgment. The judgment is you're young, your breathing is 
not good. You must have been a heavy smoker and you've caused yourself 
damage… I get quite offended by it. But I know that it's irrational…I didn't say 
anything.  
The majority of participants reported that fatigue interfered with their daily lives. Whilst 
they did not regard it as being as serious as their breathlessness, fatigue was more persistent 
and difficult to manage. They could objectively monitor their breathlessness by measuring 
their oxygen saturation levels but fatigue, in contrast, was highly subjective and could not 
be measured. The women often experienced breathlessness and fatigue together and found 
it hard to distinguish whether their fatigue was a product of their breathlessness, an effect 
of their illness on their bodies, or due to ageing or the daily demands of caring for children 
and working. Sarah said: 
I think I'm just generally a bit more tired… I just think sometimes you can't even 
distinguish what's what. How can you tell?… I used to be someone that could 
really burn the candle at both ends and make it all work - and now I just can't…I 
don’t know if that’s just because I’m getting older. 
Vidu associated being “tired” with her breathlessness and described this as her main 
symptom of LAM throughout her illness. She became progressively more “tired” as her 
illness progressed and interfered with her daily activities, I think due to breathlessness I got 
tired… when I was so tired I used the oxygen. 
Fatigue was Jess’s predominant symptom after her abdominal lymphangioleiomyoma 
resolved following treatment with sirolimus. Her low energy levels interfered with her 
ability to engage in activities and concentrate at work: 
Fatigue probably affects me more… it's frustrating and I wish that I didn't 
sleep so much or feel so tired.  I wish I had more energy… Not find everything 
so much of a struggle…One of the things that stops me exercising isn't really 
my lung capacity, it's my fatigue levels… the fatigue is the biggest obstacle. 
Anna’s fatigue was associated with anxiety and depression which she experienced eight 
years after diagnosis on the anniversary of her marriage breakup. It corresponded to a 
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progressive decline in her lung function but was not related to specific episodes of 
breathlessness. She felt that her fatigue had become so unrelenting that it permeated her 
whole self: 
It’s restrictive, it’s draining and I get frustrated…it makes you feel a bit 
down…I just want to feel ok and get that energy back…it’s almost like a 
monotone, the energy level in your body… I’m tired, I’m tired, I’m tired, and 
you know it feels like it becomes everything or it becomes you. 
Fatigue was rarely noted as an issue in the participants’ medical records and was not 
addressed by healthcare professionals. It was not mentioned at all in Vidu’s and Anna’s 
medical records and only once in Jess’s record but not at the time when it had the greatest 
impact on her life. Jess’s physician dismissed her fatigue when she attempted to raise the 
issue with him: 
 I was trying to get him (her doctor) to understand how tired I am. I said, 
sometimes I just come home from work and I go to bed at 7 o'clock. I just have 
to.  He said, half your luck.  
The subjective and invisible nature of fatigue meant that family and friends could also lack 
understanding of its impact, particularly when participants looked otherwise healthy. 
Sarah’s husband was “not so sure he believes me, he says everyone’s tired.” Louise felt that: 
I look well, you know, I don't look skinny and I don't get breathless sitting 
here and so people don't understand if you feel tired…I think tiredness can 
often lead to a bit of depression too because you just feel flat, you know, and 
you don't understand why.  
Sirolimus itself could contribute to fatigue as a side effect of the medication. Helen felt 
she was “exhausted all the time because of the immunosuppressants.” Julie remarked: 
 I don’t feel particularly well on it (sirolimus)… I started to sleep heaps more 
on my days off… I put the kids on the bus and I go back to sleep.  That might 
be eight o'clock. I wake up at one o'clock in the afternoon.  
Breathlessness and fatigue affected the majority of participants on a daily basis, limiting 
many of their regular activities. They felt breathlessness was more serious and saw it a sign 
of the extent of their lung disease. Fatigue, although not life threatening, was more persistent 
and difficult to manage. In learning to live with LAM, the women learned to manage these 
illness effects. 
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4.3 Finding motivation and direction  
After the initial shock of diagnosis had settled, the majority of participants actively engaged 
with managing their illness in an effort to regain wellness and a sense of stability, normality 
and control in their lives. Each participant’s personal life meaning motivated and directed 
their attitudes, decision-making and actions as they learned to live with LAM. When they 
were diagnosed most had experienced profound disruption as they perceived the stark 
discrepancy between their life meaning and the implications of their illness for their future. 
In their everyday lives following diagnosis they sought meaning in their illness that could 
be integrated into their life meaning to restore a sense of coherence and balance to their 
lives. The participants’ sense of self, purpose, beliefs, disposition, family and cultural 
values, and past experiences, as aspects of their life meaning, were reflected in the ways 
they managed and adapted to their illness and their individual responses to new turning 
points.  
The women were particularly motivated by the sense of purpose they felt in their family 
relationships and responsibilities, and their desire to work. Fifteen participants were married 
or living with partners. Seven were responsible for caring for dependent children, one for a 
disabled adult, one for an elderly husband, and one for an elderly parent. They wanted to be 
well to fulfil their responsibilities, participate in family life and see their children finish 
school and grow up. Sarah felt “if I can see them (her children) grow up it’ll be ok”. Mia 
sustained hope that she would live to fulfil her goals of travelling with her family and seeing 
her son get married: 
I never think that I'm not going to be there in the future basically.  So I just 
assume that I'm going to be there when he's 20, when he gets married… I 
want to make a trip around the world with (my husband) on a cruise, so 
maybe in 10 years…when we save and when (my son) is older so that we can 
take him with us. 
All the participants were working when they were diagnosed, in roles such as company 
CEO, lawyer, nurse, accountant, teacher, editor, engineer, social worker, child care worker, 
secretary, office manager, information technology manager, and project manager. The 
women felt a sense of purpose in their work for satisfaction, recognition of achievement, 
self-esteem, and to contribute to family finances, workplace and community. Work 
symbolised independence, control and normality, reduced isolation through social 
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connections in the workplace, and balanced the losses and uncertainty of living with LAM. 
Helen said: 
 I really like my work and it's important to me. It's just my sanity as well really 
because if I'm at home sitting thinking about LAM too much it can get to me… 
It's good for your mental health to work… and financially…it keeps me going. 
The majority of participants continued to work after diagnosis even though, for some, it was 
necessary to reduce their hours. Eleven women were working at the time of interview, four 
full time and seven part time. Carol and Veronica had retired as they were at retirement age. 
Irena, Margaret, Aiko, Patricia and Vidu had stopped work due to their illness. For Irena, 
“work was another way of saying well things are normal… at work I used to forget”. Anna’s 
attitude to work reflected her family’s strong work ethic and belief in one’s ability to get 
through hard times: 
My mother taught me to be strong…take the day as it comes…My job’s 
important to me and having that financial independence… trying to keep it 
balanced…My lung function is terrible but if I can go to work for five days 
then I feel like I can function.  
Having a sense of purpose enabled the participants to sustain hope for physical stability and 
wellness. In turn, they held hope for a life imbued with meaning and purpose despite the 
limitations of their illness. The women viewed hope as an essential element of living with 
uncertainty and moving on with life. Patricia believed “hope is so important… you've got to 
hold onto hope”. Sarah felt that “hope is the most powerful thing to have… If someone can 
give you a bit of hope you can actually move forward. If there’s no hope you start to just 
flounder”.  Eva associated hope with a sense of purpose: 
  It's necessary to have hope. For me, hope is… a peaceful life. A life that has 
purpose… looking after people; really sharing the potential that you have… I 
would consider my greatest hope is really that I'm of some use to other 
people. 
The participants possessed core self-efficacy beliefs which determined their confidence in 
their ability to manage the challenges associated with their illness. These had developed 
through their previous life experiences, managing challenging situations, and competently 
performing their work roles. When they were diagnosed, Patricia, Eva and Margaret had 
demonstrated high levels of self-efficacy gained from their past experiences of adversity 
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and illness. Sarah demonstrated self-efficacy in her belief that she was capable of managing 
her breathlessness when she attempted activities: 
 I’ll try almost anything… I never know what I’m going to be able to 
do…Everyone said… we’re going to go for a walk but if you want to stay and 
go for coffee… I said, no, I really want to go for a walk… I’ll just go up the 
stairs slowly…that actually was fine and then I walked away thinking, ok well 
I’m really happy with myself. 
In contrast, Veronica and Vidu showed lower self-efficacy and perceived themselves as 
lacking confidence. Both had chosen to avoid engaging with their illness when they were 
diagnosed. Veronica viewed herself as a gentle, timid person. She believed her lack of 
assertiveness may have stemmed from her early childhood living with an abusive father: 
He (my father) was very, very violent…I think he had a lot of anger in 
him…Also emotional cruelty. He used to yell and threaten…I think it has had 
an effect on me, lack of confidence. 
Vidu’s family and cultural values determined that her close family provided her with 
consistent moral, practical and economic support. However, her negative disposition and 
her reliance on them made her lose confidence in her ability to manage her illness herself: 
Always we have that bond with your parents. Even though we get married 
they just think that they have to look after us… she (my mother) did everything 
for me and even my dad did everything for me… I was not able to handle it by 
myself.  
Eva, Patricia and Margaret showed that having an optimistic disposition and sense of 
humour assisted them in managing their illness. Eva identified herself as having “always 
been a very positive person…I’ve just been born like that”. She felt her positive attitude 
contributed towards her maintaining a sense of hope. Patricia believed “you've got to have 
a sense of humour. You don't survive without it”. Margaret stated that she had “always been 
half full, not half empty”, and enjoyed having a joke and seeing the funny side of situations: 
I’d rather be happy…It’s still hard, every day I have problems breathing and 
I’m restricted in a lot of things I do… I can’t run but I can walk slowly. I can’t 
do certain things I used to but I can sit on a computer and design something… 
I’d rather look at things in a good way than a bad way… 
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I make jokes about it, even in the hospital… I wasn’t allowed out of bed for 
three weeks and I had to have a catheter and I said, oh this is great… I could go 
out and get drunk and I wouldn’t have to worry about going to the ladies 
(laugh). You know it’s just I use really sick humour. 
Throughout their illness the participants revealed their life meaning in their decision-making 
and their efforts to integrate the meaning of their illness and restore order to their lives. 
4.4 Learning to manage  
The participants learned to manage their illness through both their day to day experience of 
living with it, and employing active strategies. Over time they came to know their changed 
bodies well. They became familiar with breathlessness and when it occurred.  They learned 
to manage it by anticipating it and avoiding or pacing certain activities, or resolve it by 
slowing or stopping what they were doing. Normal activities could take much longer to 
perform. Mia said, “It takes me three hours to do what you would do in twenty minutes”. 
Many found this frustrating but adapted over time. Sarah said:  
I'm acutely aware of how far things are these days… I've made a conscious 
decision recently…my natural instinct is to go faster but I'm out of breath 
when I get there. So it's like just pace yourself a bit better… it is worth doing. 
In the context of living with an incurable disease with few treatment options, many 
participants demonstrated their agency in taking responsibility for their health by 
independently engaging in active strategies and alternative therapies. The women focused 
on general lifestyle measures such as exercising and eating a healthy diet. Eva and Louise 
reported losing excess weight improved their breathing. Deb found an alkaline diet gave her 
more energy, “I honestly felt like a gazelle just bouncing through the forest…It was fruit 
and vegetables”, and practised breathing exercises and meditation, “I do lots of breathing 
exercises. I do try to meditate… I'm slowly getting better at it and same with my breathing.” 
Exercising and being fit and active had been a normal part of life for many participants 
before the onset of LAM, and, for Patricia, Sarah, Julie and Helen, an important aspect of 
their identity and life meaning. When the women accepted that they needed to slow their 
pace and adjust their fitness goals and expectations they were able to enjoy and feel the 
benefits of exercise while living with their chronic lung condition. Fifteen women exercised 
regularly. All walked, either outdoors or indoors on a treadmill, Patricia, Julie and Helen 
cycled, and Patricia continued to swim. Exercise promoted fitness, improved their energy 
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levels and mood, and restored a sense of normality. This increased their confidence and 
happiness and gave them a sense of achievement and wellbeing. Mia found that “going to 
the gym…was really good for my emotional stability…I felt more energetic”. Jess said: 
Exercise…for me was really your sense of wellbeing… When I come home I 
can do a few exercises… so I have been feeling quite a bit healthier… and 
also started to stay up a bit later and feel a bit more like a normal 
person…Exercise is really crucial.  If I don't exercise I get much more tired… 
it does make you feel stronger and happier. 
Belkin et al. (2014) suggested that traditional pulmonary rehabilitation programs might 
benefit women living with LAM. Only Irena and Margaret reported attending a single 
pulmonary rehabilitation program and offered no comment about their experience. Most of 
the participants, in keeping with their striving for normality, chose to exercise outdoors or 
in environments such as gyms with other well people closer to their age. 
Five participants practised yoga and felt that the associated relaxation and stretching assisted 
their breathing, gave them more energy and improved their mood. Patricia found it “helped 
with the breathing…it has a positive effect mentally”. Eva felt: 
Yoga seemed to help my energy levels quite a bit… you open up your chest, 
and you relax… open up the lungs, and… breathe a bit better…the way you 
feel afterwards is just really uplifting. 
Five women meditated regularly. They found it facilitated processing of difficult emotions 
and improved their energy levels. Mia felt that “twenty minutes of meditation is like three 
hours of sleep”. Clare said: 
I just found it very powerful for me… it's all positive, as much as I may be 
going through rough times…I try to do a lot of visualisation… just letting 
your body be open to healing. 
Seven participants decided to try alternative therapies such as bush flower essences, 
vitamins and supplements, traditional Chinese medicine, acupuncture, kinesiology, spiritual 
healing and reiki. Clare, Deb and Mia found that bush flower essences and spiritual healing 
were effective for emotional healing. An important aspect of these therapies was their 
acknowledgment of the participants’ emotional health and the long consultation time with 
the therapist which allowed them to talk through their emotional issues and feel listened to. 
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In contrast, short consultation times with physicians did not allow for expression of 
emotional needs. As Mia recounted: 
I went to a man who advises on Australian Bush Flowers… It was like going 
to a psychologist basically. I sat there and talked to him for an hour and a 
half… I think that helped me a lot…cause I didn’t really have anyone to talk 
to about this, cause my doctor… I can’t sit and talk to him for an hour and a 
half, he doesn’t have the time.   
Engaging in creative activities such as painting, drawing and craft gave seven women a 
sense of wellbeing. For Aiko, painting was a means of expressing her feelings and finding 
a freedom in imagination that her physical condition had restricted:  
 I can look at myself too when I'm painting…Another world to step into, the 
inside of the canvas, to create something, paint something of my heart…I 
can’t fly to see the world… so I was longing to be free to fly like a bird… I like 
to paint something imaginary… which I don't have with me.   
The participants felt the strategies they employed gave them a sense of wellbeing, improved 
their breathing and energy levels, and helped settle the emotional disruption of diagnosis. 
There was a sense of taking some control and doing something of a healing nature for 
themselves. The confidence they gained from managing their illness symptoms effectively 
in turn strengthened their self-efficacy beliefs and self-esteem.  
4.5 Living with a rare disease  
Living with a rare disease stimulated the participants to become self-reliant in gathering 
information, and advocate for themselves to access treatment, have their needs met in their 
workplaces, and to raise awareness of LAM and funds for research in the community.  After 
the initial shock of diagnosis had settled many made contact with the LAM Foundation or 
the Australian support organisation or became familiar with medical websites to keep 
abreast of current research. Jess said: 
 The kind of patient I wanted to be was very well informed.  We read PubMed.  
We don't understand all the medical jargon, but we certainly try and 
understand as much as we can.  I think it's been really crucial.   
From their own research the women became aware of reports of the effectiveness of 
sirolimus in stabilising lung function and treating lymphangioleiomyomas. Anna and Jess 
advocated their physicians for a treatment prescription. Anna “had read and researched so 
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much about it. I was persistent with (my doctor). I said, you know, seriously, you need to get 
me on this”. The women who were prescribed sirolimus were vigilant and took 
responsibility for monitoring their drug levels. Not all physicians were aware of therapeutic 
levels and Helen and Julie also had to advocate for therapeutic medication doses. Helen felt 
she was always “dictating” to her doctors: 
I said to them, what are my trough levels meant to be? …I'd been fighting with 
them about even being on sirolimus…I just said I just don't feel comfortable 
going to three milligrams. I'd rather go to 2.5 milligrams just for a couple of 
weeks. So once again I'm dictating.  
While the majority of participants engaged with their illness in this way, others displayed 
varying levels of engagement. Veronica and Irena continued to avoid websites and 
information related to LAM as they had done when they were first diagnosed. However, 
they had now made contact with other women with LAM and Irena became involved in 
fundraising. Vidu still avoided thinking and talking about her illness and associating with 
other women, and relied on her family to gather information and advocate for her.   
4.5.1 Advocacy at work   
Breathlessness and fatigue could interfere with the participants’ ability to carry out their 
work commitments. Walking long distances or upstairs at work, carrying heavy loads of 
books, bending under desks, and needing to take time off for periods of illness were some 
of the issues they faced in the workplace. Jess found fatigue particularly affected her ability 
to concentrate at work, and open areas with higher noise levels exacerbated the problem. 
“I’m really tired at work…I find difficulties concentrating. (The people) I work next to… 
shout a lot… it distracts me more than other people”. These issues were, however, not 
necessarily visible to employers and work colleagues. 
Invisibility was, in Jess’s words, a “double-edged” sword. It had the dual effect of allowing 
the participants privacy if they chose to conceal their illness but could also limit support in 
the workplace. On the other hand, revealing their illness, while engendering support, could 
threaten their identity as competent individuals and accentuate feelings of being different or 
favoured. Irena was selective in disclosing her illness to her manager and few of her 
colleagues only, “I didn't want people thinking I was having favours done.  I can cope, I 
can cope, I'll be right, I'll just take things slower”.  
While Mia’s manager accommodated her needs, including extended maternity leave and 
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part time work, she struggled with conflicting feelings. She wanted to work effectively but 
felt limited by her illness. She appreciated the support of her employer but felt, at the same 
time, that her capable and resilient identity was reduced, and guilty that the concessions 
made for her were inconveniencing her colleagues. She would have preferred to stay at home 
to care for her young son but needed the income that work provided. She was also concerned 
about the effect the limitations of her illness would have on her ability to be successful in 
applying for a new position: 
 I don't feel as competent any more… Everyone has to sacrifice themselves to 
make room for me…The office has made so many alternative arrangements to 
accommodate my needs… I want to be mature as well, and resilient.  I don't 
want to be that typical, I can't deal with this, I can't cope, I have to quit. So 
it's been really hard…  
You're competing against so many people when you're applying (for a job). 
Truth is that life's like the survival of the fittest… you struggle with the 
competition factor versus the equity, inclusion factor. 
In contrast, when Jess advocated for more flexible arrangements to address her fatigue, she 
felt unsupported and stigmatised. She perceived that the subjective nature of her fatigue 
meant that it was discounted by her manager and accounted for her average work 
performance reviews. Through persistence she was finally able to negotiate working from 
home one afternoon a week. More flexible working arrangements had the additional benefit 
of promoting wellness by allowing her more time for exercise which increased her energy 
levels and made her feel healthier: 
 When I talked about my fatigue and my disease… my boss really didn't 
care… I would like fatigue to be taken more seriously…it's a double-edged 
thing, because I got quite a bad performance rating recently… obviously they 
view my performance through that…This is the first time I've had to go on 
about having a disease because it's such an unsupportive working 
environment…I did talk to my supervisor and she started a thing with me 
where I can come home on Wednesday afternoons and work from home for 
the rest of the afternoon…That's meant that I can exercise mid-week… So I 
have been feeling quite a bit healthier.  
4.5.2 Advocacy in the community   
Seven participants engaged in community advocacy by speaking publicly about LAM, 
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distributing information brochures, and raising funds to support LAM research. They did 
this for altruistic reasons and, in a positive sense, their activities provided a sense of purpose 
in their lives. However, this advocacy also raised dilemmas for the women due to the general 
invisibility and rarity of LAM. Women often looked healthy, even with advanced disease. 
In this context they were aware that, unless they appeared ‘sick’, they were unlikely to attract 
financial support for their rare condition. Often a woman using oxygen therapy would 
become a public face for LAM and could then feel burdened by a ‘sick’ identity. This was 
particularly the case for Clare who had used oxygen temporarily after being in hospital. She 
preferred to be seen as ‘well’ rather than ‘sick’:  
When I returned home after the hospital… I actually felt a bit awkward 
because I looked fine. People didn't really see me carrying around the oxygen 
for the first few months, because I just did that at home… I always wanted to 
perceive myself as healthy and not like that… I just had guilt over people 
thinking I did the fundraiser for the wrong reason…five months later, she's 
already fine, she walks round, she doesn’t even look like she's sick. 
Fundraising was a challenge as, being a rare disease, there were no large fundraising bodies 
and the women themselves raised funds within their own communities. It was difficult to 
keep asking the same people for donations. Some had limited social networks or felt these 
had shrunk since their diagnosis. Furthermore, they felt guilty and believed that people 
would be suspicious when their disease was progressing very slowly and they continued to 
look well even though they had a life threatening condition. Aiko said: 
The number of the LAM patients is so small…Even though I try to do the 
fundraising… I cannot keep asking the same people… I’m still not dead yet.  
They wonder, is she using all the money?…It’s not easy to be making friends, 
and if I make friends and then suddenly ask for a donation, they are 
wondering… I don’t want to do that to my friends.    
Fundraising took a toll in terms of time and energy. This was particularly the case for the 
small number of women who were active in the peer support organisation. In addition to 
fundraising they kept the website up-to-date, provided support and advocated for improved 
resources for women with LAM. At times they used their personal resources to support their 
work. According to Ruth: 
We don't have enough people on our committee. …We've got so many balls in 
the air, there's supporting women with LAM, there's maybe producing a new 
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brochure, there's getting the web site updated. We're looking for other ways 
of funding. There's the liquid air… It's a big pressure on us…I'm really glad 
to be doing such an important job. But from a point of view of my energy and 
where I spend my time, I can feel guilty doing something for myself instead of 
working on something that's needed for LARA. 
4.5.3 Benefiting from advocacy and medical research 
Nine women were prescribed sirolimus at the time of the interviews. Sirolimus was a 
product of medical research funded by women living with LAM. It assisted the participants 
who were taking it to adapt to living with LAM due to its positive stabilising effect on their 
physical symptoms and subsequent improvement in their quality of life. Not all women were 
assessed as suitable for the medication and some, already at a late stage of the illness or not 
in contact with a LAM expert, as was the case with Margaret, were not offered it. Aiko had 
only commenced sirolimus four weeks previously so was unable to report its effects. The 
other eight women all experienced positive effects, including improved or stabilised lung 
function, and resolution of their abdominal lymphangioleiomyomas, chylothoraces and 
haemoptysis (See Appendix 3, Table 3.4). Irena said: 
I'm living proof that ever since I have started taking sirolimus again, I rarely 
now cough up blood. I can actually go to bed now and I don't wake up every 
15 to 20 minutes coughing up blood… I used to bend over and it would come 
out like a tap.  It was so frightening…Since the sirolimus I'm feeling better. 
Only three participants reported side effects. Helen and Irena’s menstrual periods became 
irregular. Helen and Julie both experienced fatigue. Julie additionally had nausea, diarrhoea, 
shaking, hoarse voice and a constant cough. Helen experienced mouth ulcers, bloating, joint 
pain, delayed wound healing, and raised cholesterol. While these side effects were 
disruptive and limited the improvement in their quality of life, the women were nevertheless 
prepared to tolerate them for the benefits they derived from stable lung function. As Julie 
said: 
 I started on the medication…it's almost like swap one set of symptoms for all 
these other scary things, like increased lymphoma…(and) kidney 
damage…You just take it and go, that's that versus lung transplant.  You 
weigh it like that.  I don’t feel particularly well on it either. I started to sleep 
heaps more on my days off…  I get nauseous. I get diarrhoea and the 
shakes…I get a hoarse voice as well now… I tend to have this constant cough, 
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which I never had.  But my breathing tests have improved…now mopping and 
everything doesn't seem as bad.  I did actually go up a bit of a hill…If it's 
going to make my lung capacity better and that prolongs lung transplant, 
yeah, I'm just going to have to take that chance.  
Most women remarked on the enormous, even miraculous, improvement in their quality of 
life with feelings of wellness and stability. Anna believed that “sirolimus has given me my 
quality of life…the confidence and all that comes from having a better quality of life.” Being 
physically stable meant that the illness moved to the background of their thoughts allowing 
them to move on with their lives. Although they still had to modify the pace and manner in 
which they performed activities there was a renewed ability to engage with every day and 
enjoyable activities which restored a sense of self and normality. Eva said: 
They (measurements of lung function) kept declining until I started taking 
sirolimus. There was quite a fast decline. Within a year I lost about 30 per 
cent of my lung capacity…I regained most of it back. It was just a miracle…It 
saved my life pretty much… it's made me stable.  
Importantly, the improvements in lung function and resolution of other physical symptoms 
made women feel that the progress of their disease had slowed. Uncertainty and hope could 
more comfortably coexist. Although uncertainty remained, they had hope for the future that 
the need for a lung transplant would be delayed, their life expectancy would improve and 
they would maintain quality of life. There was also a sense of hope in knowing that research 
into a cure for LAM was being undertaken and empowerment in being conscious of their 
own role in enabling research. As Sarah said: 
I'm quite convinced that if I hadn't started on this medicine two years ago, I'd 
be very bad by now. I think I was rapidly, rapidly getting worse the first year 
after the diagnosis. I'd degenerated significantly…I think the key change is 
really the medicine and suddenly having this feeling of there will probably be 
a future, I think it's a huge, huge thing... I think knowing that there are people 
interested in it, working on it, trying to figure out how to do it, is also huge. 
4.6 Accepting and adapting with the passage of time 
The passage of time itself encompassed a healing quality for the participants, not as a 
biomedical cure, but rather coming to terms with their illness and learning to live with it 
over time. As they adapted to life with LAM its disruptive effects diminished. Ursula felt 
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she had “become a bit blasé about it, I've had it 13 years…With me it's just more annoying, 
it's not frightening because I'm used to it”. The women felt hope for the future when they 
had lived past their predicted lifespan and were physically stable. Reaching ten years, the 
common maximum lifespan they were given at diagnosis, was a significant milestone. As 
Irena said, “I don't think about it as much, because I've also beaten the odds, if you like. 
When they said between one and 10 years, well it is 10 years now”.  The passage of time 
allowed Anna to reflect on her illness experience and view it in a more positive light: 
As much as there are challenges with LAM…had you asked me when I was 
diagnosed I probably would have said it’s the worst thing ever, but as time 
passes and the saying time heals - it does, because you have that space to 
reassess what’s happened… I realise the more time goes on, it gives me that 
reflection to see it in a different way… As hard as this condition is, I’m glad 
what happened, happened because I think I feel more at peace with myself.  
The participants revealed that, over time, they had learned to live with their changed bodies 
and the limitations that these imposed. They gained knowledge and skills to manage their 
symptoms through their own experience and the active strategies they employed. The rarity 
of LAM stimulated them to develop additional skills of self-reliance and self-advocacy. 
Managing their illness effectively reduced its disruptive effects, increased their self-
efficacy, and generated positive feelings of stability and control. 
4.7 Managing relationships and responsibilities 
Illness disrupted the participants’ relationships with their partners, mothers and friends, and 
their ability to carry out their responsibilities of caring for their families. In managing their 
relationships and responsibilities they simultaneously had to manage the unsettled emotions 
and identity threat they experienced alongside them. At diagnosis, their partners and parents 
had offered unconditional support to many participants. After diagnosis, support became 
more complex and engendered both positive feelings of appreciation and closeness and 
negative feelings of vulnerability, guilt, and being a burden. 
4.7.1 Disrupted equilibrium 
Living with LAM disrupted the normal equilibrium of the participants’ relationships with 
their partners. Uncertainty made them feel vulnerable physically and emotionally, and 
introduced a fear for the future of their relationship as well as their health.  Sarah expressed 
the vulnerability she felt: 
 
 
103 
 
I'm sure that the whole diagnosis has changed our relationship completely… I 
felt for the first time very vulnerable…What if he suddenly decides he doesn't 
want to deal with this and he leaves?… It's all the doubts that it brings out. 
Fear of the possibility of an early death was a confronting topic to broach and it frequently 
sat unspoken and unresolved between a participant and her partner. Sarah and Mia reported 
that they and their partners avoided the conversation feeling it would create anxiety and 
worry that they could not deal with constructively. Mia said: 
 We talked about it (the future) a couple of times, but I think that men… avoid 
this kind of controversial issue.  So we never really debriefed on it very 
thoroughly… it's too scary… we didn't feel it was going anywhere 
constructive.  It was only making us anxious and worried about the future… It 
was very negative, so I think that we both agreed silently not to talk about it. 
While most participants continued to receive practical support from their partners, they 
found it difficult to elicit emotional support when their partners were themselves 
emotionally affected by their illness and unable to express their emotions. Helen said: 
My partner finds it very hard to talk about how he feels. As a result it really 
has impacted on our relationship. We do argue a heap. I initially just pushed 
him away… I just felt he deserved better… I didn't want him to see me 
deteriorate…He didn't get the job he was promised - which is a higher level - 
because they said let's put you in this job because it will be easier for you with 
what's going on at home. He’s really quite depressed about it now. 
The women felt their identity as being competent, independent and in control was threatened 
by their need for additional support and their inability to contribute to the family in the usual 
way. Disruption of their familiar roles created conflicting feelings including both positive 
emotions related to each woman’s appreciation of her partner’s support, and negative 
feelings of guilt, being a burden, and vulnerability through the loss of reciprocity in their 
relationship. Sarah felt her husband “was very tolerant. I actually can't fault him on it. I just 
felt very guilty”.  
Helen and Mia, having reduced their hours of work and being restricted in their ability to 
carry out household tasks, expressed feelings of guilt and being a burden because their 
partners were assuming greater financial responsibility yet reducing their own career 
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opportunities by spending more time on home chores and caring for their children. Mia 
expressed her feelings of being a burden: 
I feel bad getting sick so often and then he has to compensate for that…I've 
always been very self-confident and really proactive… and quite a leader in 
many aspects of my life, and I think that since I've found that I've got LAM it 
has made me feel more vulnerable… I feel that I am more of a burden to (my 
husband), to my mum... I felt more of an asset before. 
Jess felt that her illness had “totally dominated our relationship…he’s become more of a 
carer”. Clare believed that the patient/carer status that endured being in hospital contributed 
to the breakup of her relationship: 
I separated with my partner… I blame myself because… I lost a lot of 
confidence after I was sick, just even in my body image… I was pretty wilted 
away and not myself … I think he started to not see me as attractive either. 
Maybe it's that patient-carer relationship, it has a big impact on you. 
4.7.2 Altered sexuality  
Issues of sexual relations concerned the younger participants particularly. Of the ten 
participants who discussed the impact of LAM on their sexual relations, nine were between 
34 and 48 years old, seven were 40 or younger. One post-menopausal woman gave the 
perspective of a more mature woman. Of the remaining nine participants, five stated only 
that their sex lives were normal or satisfactory. Four of these women were older, between 
51 and 68 years old. Of the other four women, one was currently not living with her elderly 
husband, and three women were single and not in permanent relationships. Due to the very 
personal nature of this topic the women’s comments are not identified. 
LAM had a significant impact on the participants’ sexual relations. Sexual activity induced 
breathlessness which was uncomfortable and a source of fear and anxiety. Some women 
were unable to tolerate the weight of their partner on their chest. Fatigue reduced their libido 
and the women often felt so tired that they had little desire for sexual activity. The fear of 
becoming breathless and breathlessness itself was a “passion killer” which medicalised a 
personal moment of intimacy. This was accentuated by feelings of being unattractive after 
periods of being sick. One woman described the effect of sexual activity on her breathing: 
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 You're just worried about your breathing. You're going, hang on, you can't 
push on me too much… It becomes a bit medical almost because you're going, 
no, hang on, just wait - I need to get my breath back or stop for a minute. It's 
a bit of a passion killer… (We have sex) not that often. It's terrible. Sometimes 
just once a month. 
Two women reported experiencing persistent cough when having sex. One described how 
coughing affected her relationship: 
 It would be in the middle of a moment and I would completely lose it 
coughing and then I actually couldn’t get my breath back and that’s all very 
traumatic…You’re a wife and… you think, well at which point am I going to 
turn around and say to him, just don’t come near me …It is very destructive 
for a relationship I think. 
A third woman discussed the impact of fatigue and breathlessness on her relationship: 
 I just feel tired…I really have to make an effort to try to keep active and to try 
to get in the mood…I would honestly prefer just to sleep… once it happens, 
then I enjoy it but then I feel really breathless… I'm scared…It’s such an 
intimate moment that you don't want to pull out your inhaler in the middle of 
it because it ruins the whole thing. So I really struggle with that… I avoid 
anything that will bring that attack. I'm not attractive … I'm more passive.  
Most women reported that they did not initiate sex and sexual activity was therefore reduced 
to between once a week and once a month or less.  While partners were supportive in this 
situation the women felt guilty and worried that their partner’s sexual needs were not being 
met. A post-menopausal woman found that low libido which she attributed to menopause 
added to that associated with LAM: 
 I think I've got a very low libido and I could just not have it, you know? Then 
I know if I don't then it impacts on the relationship and we lose that intimate 
connection… I don't feel like being the one who initiates it…I don't want to 
get breathless…After menopause… I just don't have that sort of lusty feeling 
anymore …I feel guilty.  
Two women reported they were able to resume normal pre-illness levels of sexual activity 
with improvements in lung function after they commenced sirolimus medication. Three 
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women and their partners managed the problem of breathlessness by adopting more 
comfortable positions or by expressing intimacy in other ways. Being able to communicate 
openly and receiving expressions of acceptance and reassurance from their partners 
contributed to their satisfaction. As one woman said: 
I started declining, I was feeling quite guilty, not only I didn't have energy for 
sex, I didn't have energy for walking. So we weren’t doing anything…My 
husband was amazing… We found other ways to be intimate without having to 
do things that I can't do. 
Three participants commented that issues related to sex were not commonly discussed and 
were difficult topics to raise with their physicians in the limited time available for 
consultations. One woman felt that “everyone's quite prudish about it, they're not going to 
ask, does this and this and this happen?” Another reported that when problems concerning 
sex were raised on the LAM Facebook site there was a flood of responses indicating that 
this was a common issue. There was a sense of relief to share experiences and not feel alone 
with the problem: 
One of the girls on the Facebook site did actually say… I really want to know 
how people feel about having intimacy because, she said, I'm just exhausted, I 
can't catch my breath…It just opened up this whole massive debate… we all 
had the same issue but everyone was too scared to say it.  
Other authors have found, in common with this study, that sexuality was an important aspect 
of identity, health and quality of life for women living with long-term illness (Koch et al. 
2002; Kralik et al. 2001; Wilmoth 2007). Verschuren et al. (2010), in forming a conceptual 
framework for chronic disease and sexuality, argued that relational skills influence how the 
impacts of the illness are felt as a couple. Further, Badr and Taylor (2006), in a study of 
spousal communication in lung cancer, found that open communication assisted both 
partners to cognitively and emotionally process the illness. 
4.7.3 Risking pregnancy 
Contraception was an important issue for the participants who were premenopausal, had 
been advised not to become pregnant, and who were taking sirolimus which has 
immunosuppressive effects. The women expressed confusion around contraception and 
found it difficult to access relevant information. They wished to discuss their reproductive 
health collaboratively with their physicians but the topic was not raised by some physicians 
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and others had differing opinions. Some women sought information from other women 
through personal conversation or Facebook. In this context it was difficult for an individual 
woman to decide what was the most suitable form of contraception to use: 
The only time we discussed it with (the other doctor) is when he said, oh well, 
we can bring on early menopause…the dilemma of what you can take, 
because most of them are oestrogen based…I really need to talk about 
contraception, it's an ongoing issue on the Facebook sites… I don't know what 
to do about it…We need to have an answer about contraception because all 
the specialists have said something different. 
Seven participants discussed the contraceptive method they were using. Five women 
risked pregnancy, three due to their partners practising withdrawal and two by using no 
contraception at all. Two women and their partners used condoms. Both a woman and her 
partner could feel the pressure of being responsible for contraception. Younger men were 
reluctant to undergo vasectomy as a permanent surgical procedure. Two participants 
reported that it was up to them to explore other options for contraception because their 
partners disliked using condoms. The women feared using any hormone based 
contraception. They tended not to consider tubal ligation because they would need to stop 
sirolimus prior to the procedure due to its possible effect on wound healing and also 
because they preferred not to have sedation during the procedure when their lung function 
was compromised. They expressed a high level of indecision and a need for consistent 
professional advice. The women discussed their decision making regarding contraception: 
I did not take contraception… Condoms we'd be using but because I used to 
be so regular I'd look at the time of the month… withdrawal - I know that's 
not fool proof but it's served us well thus far… I know when I'm ovulating, I 
regulate it that way. (Withdrawal as contraception) 
You're supposed to use contraception on sirolimus. I wouldn't even expect to 
be fertile now.  But, nobody’s actually talked about it with me. (No 
contraception) 
We talked about it (vasectomy) but (my husband)… said no, I don't want to… I 
can't have the risk of being pregnant because of LAM… so we use condoms 
and he said, I really miss not having condoms…so I have to do something 
about that.  … I have no idea…Information about that… would be really good 
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to put out there for LAM patients…It's quite a taboo subject.  Some people 
wouldn't dare to ask publicly. (Condoms as contraception) 
Using an unreliable method or no contraception could result in added anxiety for a 
participant whose menstrual period was late arriving. This was particularly the case for two 
women whose periods had become irregular since they started on sirolimus therapy. Anxiety 
around contraception and possible pregnancy placed further stress on a couple’s 
relationship. One participant reported: 
 Basically, the specialist (physician) said to (my partner), she can't have any 
more children; it would kill her; and you're going to have to get the snip… It 
was that whole pressure - the responsibility's on you. It's horrible for him. He 
had never really thought about that. I was always on the pill. Now, we're in 
this position where I'm not on anything…we use condoms but it's that hit and 
miss thing. I'm just petrified all the time that I'm going to get pregnant. It is a 
responsibility for him and that's another passion killer… we kind of do 
withdrawal…He hates them (condoms)… It still petrifies me going on to some 
hormones… It has caused a bit of tension between us in terms of I don't want 
to pressure him to have a vasectomy. He's not really ready yet and I don't 
really want to go on the pill. 
One woman felt very emotional and had severe cramping after having the Mirena (an 
intrauterine device) inserted. Similarly, another found Implanon (a contraceptive implant 
placed under the skin) made her unacceptably highly emotional and she had it removed:  
I have given up on using any chemical contraception whatsoever… I have 
tried the implant - the under the skin one, Implanon. That made me feel 
miserable. I was overly emotional… I got it pulled out after two weeks.  
Although contraception is an issue of great concern to pre-menopausal women living with 
LAM, the only contraceptive advice offered by the European Respiratory Society 
Guidelines for the Diagnosis and Management of LAM is that oestrogens should be avoided, 
including the contraceptive pill and hormone replacement (Johnson et al. 2010). Lara et al. 
(2012), in a review of contraception, pregnancy and rare respiratory diseases, recognised 
that there is limited experience in managing the reproductive health of women with LAM 
and that advice regarding best contraception and pregnancy should be individualised and 
multidisciplinary. Thompson et al. (2008) further argued that it is important for women to 
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be given adequate time and space to discuss their concerns and share in decision-making 
regarding reproductive health.   
4.7.4 Balancing caring for others and caring for self 
The participants had to balance caring for their dependent children and elderly relatives with 
caring for their own health. Mia and Sarah revealed how they were able to care for their 
young children while managing the effects of their illness. Aiko, Patricia and Irena cared 
for elderly relatives. The particular issues which Helen faced in caring for her children while 
using oxygen therapy are discussed in Chapter 6,  Living with Advanced LAM. 
Mia and Sarah’s breathlessness made it difficult for them to pick up and carry their young 
children. They planned and minimised the number of times they went upstairs in a day and 
educated their children in simple terms that they could not expect to be always lifted and 
carried. Mia had not found any resources to assist her in explaining her limitations to her 
young son. She said: 
I think that being a mum with LAM you’re always reminded that there is a 
disability there because you cannot do some things. For instance I cannot go 
upstairs a thousand times during the day so I really think about how I do 
things and the routine is around that…I'm still having to carry him up the 
stairs and now he's almost 14 kilos…Those are the moments where I really 
struggle with LAM and with motherhood… Once I get up the stairs I am so 
breathless… Sometimes it's really scary, you know... You think about all of 
these things that other mums don't have to think about…You just adapt to it. 
Managing household chores caused the women to become breathlessness and added to the 
physical demands of mothering. Mia found “that the housework was the toughest”. Both 
women recognised that having regular help in the home allowed them to better manage 
caring for their children. Sarah could afford regular help in the home. Although it was an 
added financial burden, Mia “decided to pay for cleaners twice a month…I came to the 
realisation that I need to invest in that so that I don't get as breathless…It’s managing the 
health, literally ”. Both women were supported by their own mothers who minded the 
children, lifted them, and assisted with shopping and other practical tasks.  
Mia and Sarah both worked. In balancing the demands of work and mothering, the women 
also had to care for their own health. In order to keeping these three aspects of life in balance 
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they adjusted their work goals and reduced their hours of work which compromised their 
income and career advancement. Mia struggled with achieving a balance: 
 Most people have to think about motherhood and professional life.  We have 
to factor in health as well…We have an added thing to balance out…you 
struggle with doing that.  
Mia experienced multiple periods of illness during the year. These were usually due to chest 
infections and often she had to be hospitalised. While she was helped by her mother and her 
husband, she felt she needed additional services during this period of crisis but did not know 
how she could access them: 
I had a chest infection and the coughing was so bad that I ended up breaking 
a rib…I had to do all the mother things… It was so much pain that I wish I 
would have had some support…What you need, you know, when you get a 
crisis, is to get someone from the Department of Health and Ageing… get 
access to that support which we can’t because we’re not disabled as such. So 
that was really hard because I felt like I wasn’t able to be a good mother 
because of that.  
While modifying their activities, the women interacted with their children in ways that were 
consistent with their sense of self and identity. Sarah wanted her children to know and 
remember her as a fit, active person so continued to participate in exercise and family 
activities such as hiking, managing her breathlessness by slowing her pace. Mia felt her 
illness limited her ability to bond with her adopted son through vigorous play. She adjusted 
by altering her expectations and focusing on interacting with him through activities such as 
art and reading which she felt aligned with her sense of self: 
 In gymberoo I have to carry him and dance… I just warned the staff there 
right at the beginning, I have a lung condition… can you help me?…I guess 
that from the perspective of attachment it’s an obstacle…I still cuddle, I do 
everything else…Because I love reading and I’m very artistic I think my son 
relates to me through that. 
Aiko, Patricia and Irena had responsibilities of caring for older, dependent relatives who had 
poor mobility. In fulfilling these responsibilities, the women tended to ignore their own 
problems, pushing the elderly in wheelchairs and attending to their physical needs, even 
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though their breathing was compromised. Aiko’s husband was 88 years old and required 
assistance with activities of daily living:  
My husband is an elderly guy… he has heart failure.  So last year was I was 
busy looking after him, but at the same time I became sick and then I’m being 
hospitalised and my oxygen level is not so good…He’s alone, so I was also 
worrying he's not capable by himself.  
Patricia travelled weekly to assist her mother with caring for her seriously ill father before 
he died, washing him and turning him even when she was on oxygen herself. Irena’s mother 
had moved to a nursing home with dementia and Irena visited her daily, changing her and 
helping to dress her even though it made her breathless:  
Because I'm constantly with mum I don't think about my situation… It's only 
when I have to change her, when I have to bend, the coughing starts.  So that 
makes it a bit hard. 
4.7.5 Feeling ‘out of synch’  
Receiving their diagnosis shifted the participants’ perceptions of time. Before the onset of 
LAM, they had perceived their life being lived through in a linear fashion. They now felt a 
greater awareness of time, as Sarah said, “I’ve become more aware of the time…much more 
aware of how long it takes to get places”. Paradoxically the women felt time had both 
slowed to accommodate the slowing of activities compelled by their breathlessness and 
fatigue, and accelerated to project them forward on their life trajectory to a stage where they 
were confronting their mortality, an experience they had not expected until old age. Jess felt 
“as though I skipped middle age and I went straight into old age…I felt as though I’d almost 
accelerated”.  
Their paradoxical perception of time had the effect of making the participants feel ‘out of 
synch’ with their peers and their mothers. This was particularly the case for younger 
participants. They felt different to their peers for whom life in the modern world continued 
as normal, fast paced and active. Peers were proceeding along their expected life paths, 
working, socialising, partnering and having children. Being forced to confront one’s own 
mortality and dealing with issues that peers did not have to face was emotionally taxing but 
also a source of knowledge and wisdom usually associated with older people at the later 
stage of their life. Jess felt as though “they've overtaken me in some things” and, at the same 
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time, “I know something that they don't know yet”. Sarah had a sense of being emotionally 
older than her peers:  
You deal with your mortality. There's a whole lot of different issues that come 
up that most people your age don't deal with…I felt like I’d somehow aged 
emotionally terribly… I almost identified more with my grandmother who’s 
92…That’s distressing.  
While they felt older than peers, younger women still wished to associate with and be 
identified with their own age group and this provided a further incentive to health and 
wellness. Deb continued to go hiking with her friends: 
When I went hiking…normally I'd be the first in the pack…I've always been 
fit… I went with my brother and this other friend … I couldn't quite keep up to 
them as hard and fast as they were, but I did it and I was really quite pleased.  
While the participants felt ‘out of synch’ with their peers, conversely, most friends did not 
have the life experience or knowledge to understand the women’s situation. The invisibility 
of LAM contributed to misunderstandings and friends diminishing the impact of their 
illness. Jess felt “it’s impossible, if you’re looking healthy, to have people really 
understand”. Helen said: 
 I lost loads of friends because they just couldn't handle it and they just felt I 
was being really grumpy and I've got to pull myself together and a lung 
transplant is going to cure it all.  
In the context of living with the potential for their own life span to be shortened, the 
participants adopted a different attitude to ageing than their peers. Where some of their 
friends bemoaned their children growing up and their own advancing years, younger 
participants saw growing older and children growing up as the natural progression of life 
which they hoped to experience themselves. Growing old, for them, was an achievement to 
be celebrated. Sarah said:  
 I know that my anxieties are that I won’t see the kids grow up…It really 
accelerates a lot of things that most people don’t think about as they’re going 
through it…I’ve really changed my attitude to them growing up…When my 
older daughter… had her first day of school… and all these mothers are 
crying… I wanted to scream at these parents, it’s good they’re going to 
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school…they’re supposed to get older…your whole way you see the world 
changes.  
Younger participants compared themselves with their mothers. Their feelings of being ‘out 
of synch’ were highlighted by their mothers’ ability to physically support them. They felt a 
discrepancy between their own physical limitations and their mothers who were strong and 
capable, lifting heavier weights, walking faster, and in some cases, participating in activities 
which they had had to relinquish since the onset of their illness. There was a keen sense of 
roles being reversed. Sarah reflected: 
My mother…is super fit, she’s in amazing shape, she’s very strong… I found it 
stressful that it ended up being I still need her… because I should be the 
young, fit one at this point in time…This is all wrong you know, she’s sixty 
years old and it’s not supposed to be that way. There was a lot that we would 
have done together that she won’t do with me anymore which I think 
distresses me… She almost must feel like there was a role reversal you 
know...and I feel left out of that…she puts a contrast on it for me which is 
difficult. 
Mia felt, at her stage of life, she should be caring for her mother who had her own health 
issues, whereas her mother was still caring for her: 
I always felt that at this point in our lives I would be caring for her because 
she had a shoulder injury and you can tell that she has grown older and that 
she is weaker, but in no way, I don't have to care for her as she does for me 
when I have all of these crises. 
4.7.6 Balancing negative emotions  
The participants balanced their emotions as they adapted to their illness over time. 
Accepting their situation, adjusting their expectations and goals, effectively managing their 
illness, the strategies they employed such as meditation and yoga, and finding meaning and 
purpose through their relationships, spirituality and altruism restored a sense of coherence 
and increased their positive emotions and self-beliefs. Engaging affordable home services 
rather than relying on family support enabled them to manage their health while fulfilling 
their responsibilities and reduced feelings of guilt and dependency.  
Experiencing social connectedness in their incidental everyday social interactions enhanced 
their emotional wellbeing by directly inducing positive emotions of happiness and 
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contentment. These included sharing a coffee and a laugh with friends, going to the theatre, 
having dinner with a partner, and cuddling children and pets. Anna was “seeing my friends 
a lot more…I’ll make an effort to go because I’ll always feel better after I’ve been”. 
Experiences of social connectedness were a source of meaning in raising the women’s 
feelings of self-worth and belonging and generating a sense of normality. They differed 
from social support because they involved mutual feelings of companionship without the 
negative associations of loss of reciprocity. Margaret described how she enjoyed her simple 
social interactions: 
I have days where I actually kill myself laughing with my friends, doing 
something silly or just having a coffee… Every day I wake up it’s a bonus, every 
day I wake up and see these two pests (her pet dogs) in my face going, feed me. 
4.8 Living in a changing world – turning points and experiences of  
       liminality 
The participants lived with their illness in the context of constant change, from everyday 
disruptions to substantial physical, emotional or social changes. At their initial turning point 
of being diagnosed, six participants had experienced entry to transition as an existential state 
of liminality in which they felt a shifting sense of self and of separation from life, of 
paradoxically being in the world and yet not part of it. Liminality was a fluctuating state 
which resolved, persisted for extended periods, varied in intensity, or recurred in response 
to new turning points. The women demonstrated that change in one life dimension could 
instigate change in another, for example, physical changes could disrupt them emotionally 
and socially and vice versa. Aiko, Eva, and Anna experienced liminality as a period of 
personal and spiritual growth which shifted their perceptions and enabled them to complete 
their transition and live with contentment in the present.  
4.8 1 Experiencing spiritual growth and transformation  
Aiko had identified herself as socially and culturally liminal before she was diagnosed with 
LAM. As an Asian woman married to a Caucasian man she felt like an “alien” marginalised 
between two cultures. Being diagnosed with LAM had intensified her liminality and 
isolation. After diagnosis, Aiko’s liminality persisted. The death of the woman from LAM 
Australia who had befriended her after diagnosis and subsequent loss of her friendship and 
support was a turning point which made Aiko withdraw from contact with other women 
with LAM, “I closed my door”. She felt like a “bird in a cage”, demonstrating her 
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vulnerability and entrapment in liminality.  “For the last…nine years… I felt I didn’t care 
that the world was going on, because I was here still, but almost like everything was dead”. 
Aiko experienced two social turning points which enabled her to move from transition, 
resolving her liminality to finally accept and adjust to living with her illness, incorporating 
it into a new stage of life.  Firstly, the birth of her grandchild gave her a renewed will to live 
and hope for a future in which she perceived the possibility of participating in the life of her 
grandson. Her narrative shifted from metaphors of death to language of life indicating the 
beginning of her movement out of transition:  
 I thought I’d never see her (my daughter’s) wedding, her child. Now I’m going 
to witness new life… I thought well, life may not be too bad.  I may be able to 
see my grandchild go to kindergarten…I would like to give him my culture, to 
teach him… I started to want to live now … I felt like why am I giving up before 
the time comes?  
The second social turning point which completed Aiko’s movement from liminality was the 
sudden death of her son-in-law. Aiko’s reflection on this significant life crisis enabled her 
to find meaning in her existence, accept her illness, and cross the threshold of liminality to 
a new stage of her life. This process constituted an epiphany and spiritual passage through 
its profound transformation of her sense of self in the world. Her narrative reflected her 
transcendence of spirit above the impermanence of her body and material possessions, and 
her renewed desire to rise above the limitations of her illness and live in the present:  
He gave me, I think, more chance to live. Live until my end…he lived until the 
end… I feel whatever comes, I take it, and I try to battle through… wherever I 
live is my home… I don't need to carry the big suitcase with me… look at (my 
son-in-law). When he died, he couldn't take anything…We should let it go to 
live light…no purpose… (just) being…I accept what has been given now. I don't 
have any anger. I don't have any doubt…It's maybe the peace, acceptance I find 
this time…I feel more stable in a way…calm.  
Eva’s experience of meditation and spirituality transformed her sense of self and her 
perception of her illness. She referred to her intense meditation, in accordance with her 
Buddhist faith, as a spiritual “tool” which gave her mental strength and insight. This 
reflective space enabled her to feel a renewed sense of self-worth, accept her illness and 
view it as an opportunity to live in the present with greater contentment. She likened her 
 
 
116 
 
view of life before illness to a state of “dreaming”. She developed a sense of altruism in her 
passage through liminality. Subsequently pursuing volunteer work was empowering and 
gave her a sense of purpose and value:  
It’s changed me as a person…Meditation strengthened the way my mind works 
and how I feel…When you actually reflect on death and think about it, then you 
can much better prioritise your life …You realise you're not going to live 
forever…So you do with what you've got right now, you start living more in the 
present day… I focused on helping others…I went searching for volunteering 
jobs…It really… did wonders for me because I completely forgot about myself. 
Yes, I can't breathe very well, but I can do these things. I'm not completely 
useless…I needed to get that sense of worth. 
Anna had experienced liminality following a crucial social turning point of her marriage 
breakdown and divorce three years after her diagnosis. This had destabilised her 
emotionally, mentally and physically. Another critical turning point five years later shifted 
her perception and enabled her to move out of liminality. An acute, disabling attack of 
anxiety led her to discover a new personal spirituality and practice of meditation which 
transformed her and assisted her in an enduring way to accept her situation, balance her 
emotions and feel at peace: 
With the meditating, with the breathing…just about not getting so caught up 
in what’s supposed to be…trying to just be…you can feel that everything’s not 
going to fall apart around you…it helps you deal with the LAM a bit better… 
In an inner peace way I think I have more of an acceptance.  
4.8 2 Persisting in liminality   
Jess’s story revealed that her experience of liminality after diagnosis endured although it 
diminished in intensity. Jess viewed her illness as a “transition into a whole other world 
and becoming another person” and named her liminality as her “shadow life”. Being 
prescribed sirolimus was a physical turning point which, by resolving her abdominal 
lymphangioleiomyoma and improving her lung function, reduced the intensity of her 
liminality. This was evident in our second interview when she described being “back to 
being able to do just everyday things” and “feel(ing) solid now”. She was doing more 
exercise and “felt really good”. She felt a renewed sense of normality at a physical level but 
this did not transfer to the level of self. 
 
 
117 
 
Jess’s paradoxes in her narrative illustrated how her perceptions of herself and her 
continuing social isolation caused her to remain in a liminal state.  While she stated “I 
recognise myself more and feel more like myself”, she perceived that over the five years 
since her diagnosis her identity had altered.  “I’d come to think of myself as a patient…a 
sick person”. She felt “fit and healthy for me” yet “tired and sick all the time”. She thought 
she was “more attractive than I have been for a few years” but, at the same time, considered 
herself to be “more of a medical body and an old body…I’m always like a 70 year old”. 
Although Jess tried to appear the same, “I’ve never wanted to present myself as an ill 
person”, paradoxically she avoided social outings and felt estranged from peers. As a “sick 
person” her sense of self was anchored in her illness.  
Although she was managing her illness effectively and had successfully advocated for her 
sirolimus prescription and more flexible work arrangements, she saw herself as lacking 
agency and felt she had failed to advance in her career. “There is no way I would've wanted 
to end up (in this job)…which is a failure…The whole effort of getting a more demanding 
job… would probably be too hard for me”.  Feeling physically stable and healthier had 
shifted her to a less intense level of liminality but her self-perceptions and her ongoing social 
isolation prevented her at that time from completing her passage from transition:  
I think of myself in terms of other patients and other people with diseases and 
I feel as though normal people are quite different…I haven't gone anywhere 
or done anything…I have the lifestyle of an older person and I feel older… It 
is a form of social exclusion, because you can't talk about a lot of the same 
things… I haven't made personal friends… I don't have much in common with 
people in a lot of ways because I think they have more agency than I do. 
4.8.3 Recurring liminality   
Louise felt she had moved through liminality about three years after her diagnosis. At this 
stage she felt she had “adjusted and… backgrounded” her illness. Her passage had been a 
gradual process over time. Some years later Louise experienced a social turning point in her 
life which initiated a new transition and feelings of liminality that she was experiencing at 
the time of our second interview. The organisation she worked for had restructured and she 
was no longer required to perform a role she valued. This social change disrupted her sense 
of self. She felt unsettled and lost, no longer in her old role but not yet finding a new one: 
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 I just really am in a funny state of mind at the moment… I can't be bothered 
doing anything…I'm all over the place…I’m in between states at the moment. 
Social liminality also disrupted her physically. She had stopped exercising as much and felt 
more breathless which engendered feelings of anxiety that she was “going downhill”.  
These findings, that the participants created meaning in liminality while also experiencing 
negative feelings, are consistent with Turner’s (1967, p.96) view of liminality. Turner 
formed his views from anthropological studies of tribal rituals. He saw liminality as the 
“betwixt and between” period of transition between stable states, which could include 
physical, mental and emotional states. He proposed that liminality was a stage of reflection 
on existence. As the participants of this current study demonstrated, Turner (1967, p.96) 
claimed that it was “an inward and conceptual process” of transformation with potential for 
growth and possibility as old patterns are undone and reconfigured, new ideas emerge, and 
connection with the infinite is experienced.  
4.9 Building resilience 
The participants’ stories revealed that they built resilience over time through their 
experiences of adaptation. Life after diagnosis was not static. The women lived with and 
adapted to their illness in constantly changing environments with the day to day disruptions 
of everyday life, physical changes related to their illness, and at times more significant social 
changes. Resilience represented the learning they had actively engaged in which allowed 
them to ‘move on’ from adversity and forward with life. They had developed knowledge, 
skills and expertise as they learned to understand the changes in their bodies, and how to 
independently manage these within their personal context of mind and emotions and 
changing social worlds. The personal learning and spiritual growth which a number of 
women experienced while in a state of liminality was a source of meaning and purpose 
which enhanced their resilience. This accumulated learning achieved competence, 
confidence, and mental and emotional stability to restore coherence to their lives. With each 
turning point and transition new knowledge and skills expanded their resilience. Resilience 
could be seen in the positive feelings of wellness, control and normality which the 
participants experienced as they integrated their illness into their lives, and in their ability 
to adapt to changes that occurred as their illness progressed.  
Vidu, who continued to avoid anything related to LAM in her life after diagnosis, adjusted 
to her illness in a way that was consistent with her own life meaning and view of herself. 
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This was effective for her at this stage while her disease was stable. However, in not 
engaging in her illness and learning about it, she did not develop the same resilience as the 
other women. In Chapter 6, Living with Advanced LAM, Vidu demonstrated the effects of 
this as her illness progressed. 
4.9.1 Resilience through adaptation 
The participants who had passaged through transition and adapted to their illness displayed 
qualities that revealed that they had built their resilience through their experiences. Firstly, 
they felt generally positive about their life and experienced subjective wellness even while 
living with an incurable and life threatening illness. They had come to terms with their 
illness and modified their goals to reflect both their new reality and their personal life 
meaning. There was now a sense of being able, once again, to achieve goals related to 
exercise, activity, work and social participation. Sarah was able to go skiing and enjoy the 
theatre with friends: 
The skiing was for three days… it was a real win cause I thought I wouldn’t 
do it so, as far as I was concerned, if I could go that was great… 
We were at the theatre…there's two big flights of stairs…I felt so proud of 
myself. I got to the seat… and thought, wow, that's good. I was okay and I 
didn't make anyone stop.  
Anna was “going out and seeing my friends a lot more…I’ll initiate that, whereas I didn’t 
before”. She felt confident to shop on her own, “I find different ways around it now”, and 
consider changing her job: 
That little bit more confidence… I’m looking at wanting to change my work… 
maybe I should do something I love… I’m getting to do a lot more of what I 
like. …I do feel a lot more energetic…I feel a little bit more balanced.  
Secondly, they demonstrated that they had retained their agency and regained a sense of 
autonomy and control in their life through their successful self-management and self-
advocacy. In being independent researchers of their condition and managing their illness 
over time, they developed competence and knowledge which raised their self-efficacy by 
giving them confidence in their ability to manage problems that might arise in the future. 
They understood their bodies well and were able to distinguish between minor issues which 
they could manage themselves and more serious matters that required medical attention. 
While they remained diligent in attending regular medical check-ups there was less need for 
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medical attention between reviews. Mia had mastered managing her symptoms and was able 
to avoid a hospital admission: 
I know the symptoms, I know my body, I know what I have to do… I used a 
nebulizer…and prednisone and antibiotics.  A little bit more puffing and 
looking after myself here at home… I didn't end up in the hospital… I think its 
practice…  So that was good. 
Anna showed how her confidence had grown over time: 
 I have a bit of sternum pain, but then I think about what I’ve been doing in 
the last week and, is it really my lungs, or is it just muscular around that 
area? So just as time’s gone by, not to automatically think, okay it’s my 
lungs…beforehand I would have been a lot more alarmed… Knowing that it’s 
not something huge or major… As the time’s gone, that’s trying to just keep 
things in perspective… I got that sense of now, looking out for myself as well 
and knowing I can rely on myself.   
Thirdly, resilient women had reconstructed normality in a personally meaningful way and 
restored their sense of self, balancing the negative impacts of their illness. They did this 
through their personal agency in self-managing their illness within their individual social 
contexts. Gaining a sense of control and independence contributed to feelings of normality, 
coherence and being oneself again. Anna no longer relied on her family for practical support: 
I see them weekly or fortnightly but it’s nowhere near as often…Mum used to 
help out with the cleaning, I got a cleaning lady so she doesn’t do that 
anymore… I feel like I’ve taken back that independence as well…When I do 
see them it’s for family things, not because I need them to do something for 
me…Doing a lot more on my own, which makes me feel like that’s me again.  
There was a feeling of mental and emotional stability in contrast to the instability they 
experienced at diagnosis. Some further enriched their sense of self and enhanced their 
resilience through the personal growth they experienced in liminality. Aiko, Anna and Eva 
demonstrated spiritual growth and transformation and the peace, calm and acceptance that 
flowed from this. Accepting their illness enabled them to remove their focus from the illness 
itself and, in conjunction with successful self-management, ‘move on’ from adversity to 
direct their attention to possibilities for their life and outwards towards others, engendering 
empathy and a motivation to altruism. Ursula “just carried on with living… I just accept 
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it…I don’t think of the future with LAM, I just think of the future with me”. Eva revealed 
how she felt transformed by her illness: 
It's (having LAM) actually quite empowering too… because that's what I think 
really started this process of me accepting who I am and what I can do and 
what I can't do. In finding my own limits I became a lot happier 
person…stopping focusing on myself completely and actually focusing on 
helping others.  
 Sarah’s reflection illustrates how she had integrated her illness into her life over time: 
 I think it takes a long time to process and to get comfortable with the whole 
concept and to understand…. I try and most days forget about it… Even if I 
get breathless, I don't think about it directly. I think I've just accepted that 
that's where I'm at… It is just part of life now and you take it on as part of 
your person… it's not overwhelming… I think in perspective, it's probably 
because it's managed to be staying relatively stable where it is…Where it 
seems to be hovering, for now, allows me to do most of the things that I want 
to do… I really feel I got a large part of me back. 
Anna demonstrated how her resilience developed through reflection, personal agency and 
her everyday life experiences of social connectedness eleven years after her diagnosis. In 
the two years between her second and third interviews the anxiety and fatigue she had been 
experiencing had settled and she had remained physically stable. At her third interview she 
identified that this was a period in which “I’ve built up my resilience”. She attributed her 
resilience to her young age, her personal agency and the passage of time which opened a 
space in which she could reflect on her experience to view it in a more positive light. While 
she acknowledged the role of sirolimus in improving her quality of life, it was her own 
agency in successfully dealing with her anxiety and reconnecting with her social world that 
she felt had had a greater impact on developing her resilience: 
 As much as it’s a bit of a bitter twist, to get this thing when you’re younger 
and I can’t have children… it’s a good thing for me because I’ve built up my 
resilience… I think that sirolimus has given me my quality of life… but it’s 
also to do with, I think, having hit that anxiety wall…and to deal with that and 
have that reflection, reassessment… getting out again and putting myself back 
connected with the world…Not thinking, oh I can’t do this because I have 
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LAM… (I’m) a lot more independent. I’m a lot happier. I think I’m just a lot 
more peaceful…Just okay with me.  
4.9.2 Resilience and illness progression  
Resilience was evident not only in the positive improvements the participants achieved but 
also through difficult physical and social turning points as they experienced illness 
progression. Margaret’s story illustrates her resilience at the first significant turning point 
after her diagnosis when she was forced to stop work due to the progress of her illness. She 
demonstrated her decision-making and personal agency at this time and how her personal 
life meaning and social context influenced her ability to adapt to her changed situation.  
In narrating her life story Margaret revealed two significant aspects of her life meaning. 
Firstly, she regarded herself as a “mother hen”, reflecting her primary life goal of being a 
mother, her love of children and animals, and her sense of purpose in helping others:  
I've always had it more with children and animals… because they can't defend 
themselves…  I always stood up for my friends.  If someone hurt them or 
insulted them they had me to deal with…I’m mother hen. 
Secondly, in telling the story of a conflict with a teacher when she was at school, she 
identified herself as independent and a “fighter”. “If I thought something wasn’t right I 
would speak my mind…I do not stand back and let people walk over me…she had a fighter 
on her hands”. Throughout her illness, Margaret’s attitudes and actions consistently 
reflected these meanings. 
 LAM had begun to impact more seriously on Margaret eighteen months after her diagnosis 
when her lung capacity had dropped to 60%. Although she did not yet need to use oxygen 
therapy, she was forced to finish work. Stopping work represented significant loss. She lost 
her social world at work, her identity as a valued, expert worker, her main daily activity, 
and her financial independence. As a single woman living on her own, the financial impact 
of stopping work was considerable. Margaret could no longer afford to stay in her apartment 
and was forced to go on to a disability pension and to apply urgently for Department of 
Housing accommodation. A sense of powerlessness accompanied these losses: 
The hard thing was when I had to stop work cause I was doing 80 hours a 
week…my breathing would go because an employment agency is very fast 
paced… I just couldn’t do that anymore and that was getting frustrating… I 
was raised to be able to take care of myself… so I was very much, I’m going 
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to do this and no one’s going to stop me, and then of course my body’s 
stopping me. 
Margaret’s “fighter” and “mother hen” aspects of self and her past experience of 
successfully managing her asthma over time countered the disruptions and reduced choices 
now available to her. She demonstrated agency and maintained a sense of continuity in her 
life by continuing to live alone and manage her illness independently even as her health 
deteriorated:  
 I like living by myself cause I don’t have anyone saying, Are you ok? Do you 
need anything? Cause it’s like, No I’m fine, if I need anything I’ll get it… I 
hate having to rely on people. 
Margaret had viewed herself as a competent person at work and preserved this identity by 
presenting herself as expert in coping with LAM. As soon as she became breathless and 
anxious she would calm herself by reading, drawing, listening to music, or meditating. 
These strategies also relieved the boredom she felt being at home after she stopped work. 
Her optimism was evident in her positive attitude and refusal to take on a ‘sick’ identity or 
regard herself as a victim:  
It's easier for me because I have the disease.  I'm living with it.  I understand 
how to cope with it… I'll have a day and I'll just cry and cry and cry.  But it's 
a good release because it just gets all that stress out …I’d rather be happy… 
I'll get the home care for cleaning because I can't do that. Yes, you need that 
help, that assistance.  But for your own sanity and your own state of mind… 
you have to stop looking at yourself as a victim… That's just self-pity.  
 Margaret chose to direct her mothering instincts to animals. She became “mother hen” to 
two small pet dogs and took on the work of caring for dog rescue puppies until they were 
found a home. It was a role where she was in control and gained esteem through her expertise 
in caring for the dogs. It was consistent with her goal of being a mother and gave continuity 
to her life. 
Margaret showed resilience in adapting to this next stage of her illness through her positive, 
independent attitude, her humour, her self-management strategies, and redirecting her 
energies in a positive and creative way towards her hobbies and her pets. Margaret’s story 
will be explored further through later turning points in Chapter 6, Living with Advanced 
LAM. 
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4.10 Summary 
This chapter has presented the participants’ experiences of learning to live with LAM in 
their everyday lives after diagnosis at the mild to moderate stage of their illness. It was a 
period of transition in which they adapted and integrated their illness into their lives over 
time and built their resilience. Adaptation was a dynamic process of learning to manage 
their illness physically, and through their interactions within their social world of 
relationships and responsibilities, and their personal world of emotions, self and identity.  
Each participant’s personal life meaning motivated and directed their actions to adapt to 
their illness and achieve wellness and normality. In particular, the women were motivated 
by their prior health and fitness, their relationships, and a desire to fulfil their 
responsibilities, and participate in family, work, and social life. In integrating their illness 
into their life the participants accepted their situation and reframed their expectations and 
goals so that the meaning of living with their new limitations integrated with their life 
meaning.  
As part of their life meaning, the women held core self-efficacy beliefs, derived from their 
previous life experiences, when they were diagnosed. Those who had successfully coped 
with adversity or illness in the past had high levels of self-efficacy which enabled them to 
more readily accept and adapt to their limitations. Lower self-efficacy beliefs posed a barrier 
to adaptation as those participants felt less confident in managing the challenges of living 
with their illness and perceived themselves as lacking agency.   
Most participants actively took responsibility for their health and developed knowledge, 
skills and expertise as they learned to manage their illness. The rarity of LAM meant that a 
number of participants also developed enhanced skills of self-advocacy. The women 
engaged in seeking knowledge of LAM and became independent researchers. Over time 
they came to know their changed bodies well and learned through experience to manage 
their breathlessness. Fatigue was more difficult to manage and was not addressed by their 
physicians.  
The emotional and social impact of LAM was more difficult for the participants to manage 
than their physical symptoms. It was hard to elicit emotional support from others when 
externally most appeared well and healthy. The women were in a paradoxical situation of 
being both providers of care and recipients of support and this generated complex, 
paradoxical emotions. Their relationships and responsibilities were a positive source of 
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meaning, purpose and motivation to manage their illness effectively and live well, and they 
appreciated the support they received. However, the disrupted equilibrium they experienced, 
in being unable to fulfil their roles in the usual way and needing extra support, threatened 
their identity and created negative feelings of vulnerability, guilt, and being a burden.  
Participants who felt able to communicate openly and perceived empathic emotional support 
from their partners were able to resolve negative emotions. Younger participants indicated 
that they received limited and often conflicting advice from their physicians on their sexual 
health and contraception and these were significant areas of concern and confusion. While 
the majority of women were supported in their workplaces when they advocated for flexible 
working arrangements, receiving support engendered similar conflicting feelings. Two 
women encountered stigma and a lack of support from their managers. 
The women managed their emotions when they accepted their need to adjust their 
expectations and goals to accommodate their illness and focus on what was possible, 
including reducing their work hours or changing roles. The independent strategies they 
employed to care for their health also helped to balance their emotions. These variously 
improved their breathing, mood and energy levels. Being able to effectively manage their 
symptoms over time contributed to physical stability, strengthened their self-efficacy and 
engendered positive feelings of stability, autonomy, control and wellbeing. Sirolimus 
medication was an important factor for many participants in achieving physical stability and 
improved quality of life and subsequently positive emotions and a sense of hope. Engaging 
home services reduced the need for support from partners and family and associated feelings 
of guilt and dependency, and increased their sense of autonomy. Similarly, experiencing 
social connectedness created positive feelings of belonging, normality, and self-worth.  
 Liminality was, for some participants, a significant inner process of reconstructing their 
disrupted sense of self and finding meaning through personal and spiritual growth. The 
women who experienced this were able to accept their situation and felt a calmness and 
peace which allowed them to live with contentment in the present. They felt a connectedness 
to others and found new meaning and purpose which they expressed in altruistic activities 
such as volunteering work and supporting other women with LAM. These liminal 
experiences engendered positive feelings and emotional stability and facilitated their 
adaptation.  
The participants lived with their illness in interacting environments of constant change. For 
most of the participants these were the daily fluctuations of ordinary life punctuated by 
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temporary isolated disruptive events related to exacerbations of their illness or social 
situation. Others experienced new social or physical turning points which initiated new 
transitions and new experiences of liminality to generate new understandings.   
The participants’ ability to alter their expectations and goals and act to achieve these as they 
managed their symptoms, emotions and relationships and responsibilities was a 
demonstration of agency. This finding is consistent with Bandura’s (2001) social cognitive 
theory. Bandura (2001, p.2) defined agency as one’s ability “to intentionally make things 
happen by one’s actions”. He theorised that agency was characterised by core features, 
including intention, self-regulation, and self-reflectiveness on one’s abilities and life 
meaning, purpose and goals. As this current study demonstrates, Bandura viewed agency as 
functioning dynamically within sociostructural contexts as thought processes, emotions, 
biological events, behaviours and environments interact and influence one another. Further, 
he saw agentic action as the means by which people expand knowledge and competencies 
and adapt to limitation and a variety of environments. According to social cognitive theory, 
self-efficacy, a person’s belief in their ability to exercise control over their own behaviour 
and environmental events, is the core of human agency. 
The participants built their resilience through the process of adapting to their illness. 
Resilience represented the meaning, knowledge, skills, and positive beliefs they developed 
through this learning process and other life experiences. It enabled them to move forward 
with their life even while living with the uncertain, incurable and progressive nature of 
LAM. The women demonstrated their resilience in the mental and emotional stability they 
achieved through successfully managing their physical symptoms and limitations, emotions, 
and relationships and responsibilities. They felt a sense of wellness and control, and were 
able to reconstruct their sense of self and normality in a meaningful way. Resilience gave 
them the ability to deal with turning points of disruptive change as they occurred.  
4.11 Conclusion 
This chapter has presented the participants’ experiences from diagnosis to the moderate 
stage of their illness as they learned to live with LAM in their everyday lives in a period of 
transition. The women demonstrated that this was a multidimensional process of adaptation 
which encompassed learning to live with their altered bodies and manage their emotions, 
relationships and responsibilities in the context of constant change, in the fluctuations of 
daily life and more significant changes related to their illness or social situation. As the 
women accomplished this, they restored their sense of self, integrated their illness into their 
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lives in meaningful way, and built resilience. They showed this in their ability to experience 
wellness, and a sense of autonomy, competence, and coherence while living with the 
limitations of their incurable, progressive illness.  
In adapting and learning to live with LAM, the participants needed to develop 
communication skills in their encounters with healthcare professionals in healthcare 
settings. The following chapter focuses on their experiences of interacting with healthcare 
professionals at their regular reviews with their physicians and during hospital admissions, 
and how these were influenced by rarity of LAM.   
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Chapter 5 
INTERACTING WITH HEALTHCARE PROFESSIONALS 
 
5.1 Introduction 
The previous chapter presented the participants experiences as they learned to live with 
LAM in their everyday lives following diagnosis. As they adapted to their illness they 
developed knowledge and competence through their independent research and self-
management. They brought their expertise to their encounters with healthcare professionals 
who frequently lacked knowledge of LAM. This chapter presents the participants’ 
experiences of interacting with healthcare professionals, as patients in the hospital setting 
and at their periodic reviews with their physicians, and how their interactions were affected 
by the knowledge and attitudes of both parties, and the rarity of LAM.  
The participants were admitted to hospital when their health status changed. This occurred 
for isolated surgical procedures for particular issues, periodic events such as pneumothorax 
or chest infections over the course of their illness, or critical events such as respiratory 
failure or receiving a lung transplant. The most common reason for the participants being in 
hospital was for a surgical pleurodesis [n=7] to treat a chylothorax [n=3] or pneumothorax 
[n=4]. Of these, two participants had also had a previous nephrectomy (Veronica) and partial 
nephrectomy (Julie) for renal angiomyolipomas. Ruth had multiple embolisations for her 
renal angiomyolipomas. Mia was hospitalised periodically for chest infections. The 
participants were also admitted for procedures unrelated to LAM, including 
cholecystectomy (Helen), removal of ovarian haematoma (Clare), and appendicectomy 
(Anna). They were in hospital for varying periods from overnight to six weeks, with the 
exception of Clare whose prolonged hospital stay for persistent chylothorax in both lungs 
lasted for five months.  
While Clare was not the only participant to experience a hospital admission, her hospital 
stay was the longest and she experienced a prolonged period of contact with healthcare 
professionals in this setting. It constituted a critical event which was not only physically 
disruptive but also brought about significant social and emotional change for Clare. Clare’s 
story is presented to provide insight into the hospital experience as an aspect of living with 
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LAM, and illuminate how the rarity of LAM affected her experience and how she developed 
resilience in dealing with the particular issues she faced in this context. This is consistent 
with the life history approach of “intensity sampling” to give a deeper understanding of 
specific aspects of experience (Plummer 2001, p. 133).  No literature has explored the 
experiences of women living with LAM or other rare diseases in the hospital environment 
or how people show resilience in this setting.  
Figure 5.1 summarises the themes related to the participants’ experiences of interacting with 
healthcare professionals. Firstly, the participants revealed the impact of being a patient in 
hospital with a rare disease and how they responded in this situation. Secondly, Clare’s long 
hospitalisation demonstrated how she developed resilience and experienced liminality in 
this context. Thirdly, the participants’ interactions with healthcare professionals are 
explored in relation to the power balance that existed between them and how it was 
influenced by the rarity of LAM and shifted as knowledge and attitudes changed. Table 3.3, 
Appendix 3, shows the medical and surgical treatments the participants received. 
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5.2 Being a patient with a rare disease 
Being a patient with a rare disease created feelings of isolation and vulnerability as the 
participants interacted with healthcare professionals in the hospital setting. The healthcare 
professionals caring for them frequently knew little about LAM and were unable to provide 
adequate information and support. There are only two medical centres of expertise in LAM 
in Australia and women living a distance from these were isolated and relied on their 
physicians to communicate with LAM experts for up to date management. When they were 
in hospital the participants found they needed to be alert and vigilant, and take on the role 
of educating the healthcare professionals. It was a stressful experience which required effort, 
and two participants emphasised this in their use of war metaphors. Jess referred to being in 
hospital as “a battle for survival” and Clare as “going to war”.  
5.2.1 Feeling isolated and vulnerable 
Entering the hospital setting with a rare disease was an isolating experience for the 
participants. Their outward appearance of good health did not correlate with the expected 
presentation of a person with chronic respiratory disease. As Jess said: 
 (The doctor) was obviously really confused to see me, because I think looking 
at the pictures and such an enormous mass (her abdominal 
lymphangioleiomyoma), they were expecting probably somebody… who could 
barely stand, who was really emaciated, obviously sick, but when he saw me, I 
looked pretty normal.    
In this context the women looked out of place and felt their problems were discounted. They 
found they were ignored and left to look after themselves. Veronica felt she “was just really 
left to my own devices because I never complained.” Ruth said:  
You have to look after yourself in hospital…You feel quite isolated being 
stuck away…You spend a lot of time alone. 
Helen felt she was treated impersonally and as an object of curiosity: 
 The oxygen… was freaking them out a bit I think and they didn't know 
anything about LAM, so in between I had to keep explaining and then I just 
started taking leaflets every time I went.  I just said, read that… Then they 
started whispering about it and I could hear, this lady's got some really weird, 
rare disease. 
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It was obvious to the participants that the healthcare professionals who were caring for them 
knew little about LAM when they seemed excessively worried and sought information from 
non-medical internet sources such as Wikipedia. Ruth “had these teams of people coming 
around who didn't have a clue about LAM and had Wikipedia… generally there's great 
ignorance”. In addition to creating a sense of isolation this made the women feel vulnerable 
to receiving wrong or inadequate treatment. Mia “hoped that they would have control 
because you're in their hands… You feel, oh no, I don't trust (them)…They literally don't 
know”. They felt unsafe when they were uncertain if healthcare professionals understood 
the significance of their oxygen saturations and lung function tests, or were able to manage 
their care appropriately. When it was possible the women preferred to always attend the 
same hospital where a LAM expert was available. Mia chose “never go anywhere else 
because I know they have no idea what to do with me”. 
5.2.2. Being vigilant  
The participants felt particularly vulnerable on general surgical wards where nursing staff 
could be unfamiliar with LAM-related issues and how to manage oxygen therapy and pleural 
drains. The women felt a need to be vigilant in monitoring the care provided to them. When 
Jess was admitted for treatment of her chylothorax she realised that the nurses caring for her 
did not understand the implications of the amounts of drainage they were observing in her 
drains. She felt safer with nurses who demonstrated competence and confidence: 
The nurses…were always congratulating me, isn't it good, another two litres 
today.  I was really afraid and hated to hear how much was draining…they 
obviously had absolutely no idea about what the thing (chylothorax) was and 
some of them looked quite intimidated… from then on I knew it was going to 
be a battle for survival at this hospital.  They really didn't know what to do… 
There were…nurses who were really great…The difference wasn't really just that they 
had a nicer manner… it was that I actually felt safe with them.  I felt like they weren't 
going to kill me. That they knew how to use all the equipment…I actually think when 
you're in hospital - you know everybody gets so worried about do they have the best 
surgeon but… I think probably the quality of the nursing and the recovery is much 
more important.  
Helen felt a need to monitor her own oxygen saturations, explain her condition to nursing 
staff and advise them how to manage her oxygen therapy: 
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 My sats were really, really bad and I was checking all the time on the 
monitor… I said, can't you just put me back on nasal prongs?  The minute 
they put me back on nasal prongs my sats went right back up again… They 
were taking my blood pressure at the same time as taking my (sats)… They 
were all inaccurate, all the readings, because when I started checking them 
myself they were actually normal for me…It's that frustration that people 
didn't understand what was wrong with me and I had to explain to them. 
5.2.3 Educating the professionals  
The participants found themselves educating the healthcare professionals who were caring 
for them. It was a burden to be always having to explain their condition. Jess felt “it's awful 
to be an interesting patient, because I'd rather be just quickly diagnosed and treated and 
out of there”. Anna wanted to be “a patient like any other patient”.  
Some women took brochures provided by the LAM peer support organisation to hospital 
and distributed them to staff to raise awareness of their condition. Veronica “photocopied, 
from the internet, what it was, and up to date information, and I gave it to them… There were 
middle aged doctors that didn’t know”. They also made themselves available to be 
interviewed and examined by medical students and junior medical staff for education. 
Margaret said: 
I don't mind taking time to explain it… I tell them to bring the trainees in and 
ask me 5000 questions…I give them all pamphlets…I'll say, do you want to 
check the lungs?…I'm sure there won't be a cure in my lifetime. But if there's 
something I've contributed to that maybe will help…I'm more than happy to 
get poked and prodded. 
5.3 Being resilient during a long hospital stay 
Clare’s story revealed her resilience and experiences of liminality over the course of her 
prolonged five month hospital stay. Clare was admitted to a local hospital for persistent 
significant collections of chyle (effusions) in both lungs two months after her diagnosis. She 
was later transferred to a larger hospital interstate. Clare’s doctors had not encountered a 
case such as Clare’s before and they struggled over the course of her admission to find an 
effective treatment for her problem. Clare underwent various procedures and surgery 
(multiple drain insertions, lymphangiograms, pleurectomy and pleurodesis). She also 
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received all her nutrition via an intravenous infusion (total parenteral nutrition, TPN) for 
104 days to reduce dietary fat and the formation of the chyle which was leaking into her 
lungs. None of these measures were successful. Over the course of her admission Clare had 
multiple medical emergency calls (Metcalls) for low blood pressure, low oxygen 
saturations, and breathing difficulties. She was admitted to ICU (intensive care unit) four 
times.  
Clare’s experience was characterised by uncertainty and isolation. Not only did she feel 
isolated by her rare condition in the hospital setting but she was also geographically isolated 
from her partner, family and friends in an interstate hospital more than five hours drive from 
her home. The complexity and rarity of Clare’s particular issue added a further layer of 
uncertainty to the vulnerability felt by other women with LAM when they were in hospital. 
She was uncertain as to the outcome of her situation and her future and her doctors had no 
experience with her rare problem and did not know how best to manage and resolve it: 
The transplant team I was under… said Clare, honestly, we don’t know what 
to do. We’ve never seen a case like this…we’re scratching our heads, we 
don’t know how to stop this.  
Clare needed to be resilient to endure her unusually long hospitalisation. Throughout her 
hospital stay she was far removed from normality due to the acute and unpredictable nature 
of her medical problem and her frequent Metcalls and admissions to ICU. She was 
constantly aware of her illness. In this context Clare’s resilience enabled her to endure the 
instability and uncertainty of her situation.  
In her life story, Clare identified that her personal traits and past experiences, as aspects of 
her life meaning, were resources which contributed to her resilience. Her inquisitive nature 
stimulated her to research information on LAM and possible solutions to her problem. 
Although she had not previously experienced adversity or illness, she had travelled 
extensively and worked in a variety of jobs and locations before her diagnosis. These 
experiences had developed her resourcefulness, flexibility and self-efficacy. Clare’s 
resilience was evident in her positive attitude, her persistence, and her actions to take 
responsibility for her physical and emotional health. Being supported by family, nurses, 
other patients and women with LAM also contributed to her resilience.  
5.3.1 Staying positive and persisting 
Clare likened her situation to an experience she once had of skiing through an unknown 
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landscape. Her metaphor illustrated her persistence and determination to “keep going” in 
spite of the uncertainty she faced: 
Some stages you get to some spots in your life - you don’t have any option but 
to keep going because you’re in the middle of nowhere…I just wanted to keep 
going.  
In her difficult situation Clare cultivated positivity to maintain her hope that her problem 
would resolve and she would be discharged home and be well. Her young age motivated her 
to return to her previous good health. She was also motivated to manage her emotions to 
protect her parents from additional worry in the context of her father being seriously ill at 
the same time. She maintained a positive demeanour with the staff and allowed herself to 
cry only in private:  
I just had to deal with it…I think I was so positive through the whole ordeal to 
some extent, and I didn’t really cry much at all, I just thought, take each day 
as it comes…you try to be positive to the staff, but when they’d probably nip 
away I might have a bit of a sob. 
5.3.2 Being supported  
 Clare was supported through her ordeal by the relationships she established with the ward 
staff, other patients, and two women with LAM. Over such a long period of time the hospital 
ward became her ‘home’ and being cared for consistently by familiar and friendly staff 
assisted her to cope. In contrast, her ICU experience was one to be endured. For Clare, being 
in ICU, with additional equipment and monitoring, signified illness and a move backwards 
from going home and wellness. While she appreciated that the staff did “amazing things” 
there was not the consistency and familiarity with the staff and she did not receive emotional 
support from them. This contrasts with Veronica’s experience in ICU after her surgical 
pleurodesis. Veronica was focused on her physical safety and felt “the intensive care 
nurses… did their job well. You were always watched…They’d come in and look after you”. 
The difference here was that Clare needed a higher level of emotional support to deal with 
the instability and length of her hospital stay. She felt this was better provided by ward 
nurses who had formed a rapport with her over time and knew her as a person:  
When I was ICU… that was a really hard time when I was on the high flow 
and connected to everything. I couldn't do anything…ICU's different because 
it's a bit busier. I think I hadn’t really formed a relationship with the staff as 
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much because they would always swap; you'd have a different staff every 
shift... So I found that a little bit hard, because you don’t get the rapport with 
the staff as much. 
While Clare’s family and partner were unable to be with her consistently they provided 
moral support. In particular, Clare regarded her partner as “overwhelmingly supportive …my 
rock”. Clare also received moral support from another patient whose advice to stay strong 
became a guiding mantra for her throughout her hospitalisation:  
I think the biggest thing I got told by that lady  was keep strong; you've got to 
be strong - that really rings true because you feel a bit like, sometimes, you're 
going to war…She really kept me determined to be a bit tougher.  
Clare had made contact with the peer support organisation and was particularly supported 
by two other women with LAM. Firstly, they instilled hope and symbolised the possibility 
of wellness while living with LAM through their positive attitude and successful 
management of their own LAM.  Secondly, they visited her frequently, were a source of 
information and, in the absence of any known effective treatment, played an active role in 
researching possible solutions to resolve her persistent effusions. Clare was inspired to be 
positive by one of the women in particular: 
She was just so positive. She was not down about being sick. She was improving. 
Her lung functions had improved…She did a bit of meditation and just had her 
lifestyle in a good shape; so I'm like right, I'm jumping on her back and I'm 
going to do everything she's doing… It was good because she wasn't whingeing 
about it. She wasn't moping, going oh, I'm going to die… she was strong… I'd 
ring up and ask her all the questions.  
5.3.3 Taking responsibility 
Clare took responsibility for her emotional and physical health during her admission. 
Although confined in hospital, she set goals, remained vigilant in monitoring her body and 
the care being given to her, managed her emotions, actively participated in researching 
treatment options, advocated for herself, and collaborated with her physicians in clinical 
decision-making. While it was an added burden to take on the responsibility of finding her 
own solution and oversee the care given to her, it empowered her, gave her a sense of 
control, and raised her self-efficacy and self-esteem. In turn, perceiving herself as having 
agency in influencing the management of her health increased her resilience. 
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Clare had realised when she was diagnosed that there was no information or help available 
for women with LAM. She determined there was a need to produce brochures that would 
provide information for newly diagnosed women and healthcare professionals and she set a 
goal to raise money for this purpose. She had started organising a large fundraising event 
and continued to do so during her hospital admission although she was unable to attend the 
event herself.  She also determined that she would need to independently research LAM 
herself and, as her effusions persisted, search for alternate options for treatment that could 
resolve her problem. Setting these goals gave Clare a sense of purpose and a clear focus 
which helped her to cope by keeping her occupied and feeling useful:   
I was more clued up… I was like right, can we just perhaps do this this 
way?… It probably made me more determined to find out even more. I think 
my way of coping was just to find out a lot… to put all my focus on that… It 
gave me a bit of drive… They really didn't know much either… I'm pretty 
inquisitive. I like to ask lots of questions, so I was always wanting to know 
how this worked or that worked…I did feel quite involved with it and…that 
made me feel a bit worthwhile in what I was doing. 
Clare educated herself, accessing the internet from her hospital bed, searching for 
information about LAM and, with the assistance of her LAM friends, researching medical 
articles for possible effective treatments for her persistent effusions. They also initiated 
communication with other LAM experts overseas:  
They’re just like we don’t know how to stop this. So then we looked 
further…We came up with a whole list of possibilities of surgeries…So at this 
stage - because we didn’t have any options - we presented this to the surgeon. 
As she acquired knowledge Clare also educated healthcare professionals about LAM. She 
made herself available to groups of medical students for examination and to answer their 
questions.  
5.3.3.1. Advocating and collaborating  
Clare advocated for herself in communicating with her medical teams. Firstly, she advocated 
to be transferred interstate to the hospital which was a centre of LAM expertise where she 
had greater confidence that she would be managed according to latest research. Secondly, 
during her long admission, in the context of her physicians struggling to find a solution to 
her problem, the knowledge she gained through her research empowered her to voice her 
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opinions. In this way she collaborated closely with her medical team in making decisions 
concerning her care. She advocated to restart sirolimus medication when all other treatments 
had failed and then to increase the initial dose which she felt, from her research, was 
inadequate. After receiving it the effusions gradually resolved and, although it was uncertain 
why, Clare and her physician believed it contributed to the positive outcome:  
Sometimes in hospital I was on it (sirolimus), but they didn't want me on it very 
often because it lowers your immune system… even though I was begging them 
to put me back on it… my thought was, after lots of research, that (sirolimus) 
will help… They only put me on one milligram every second day. I was like it's 
(that dose) not going to help… towards the very end I was on it. Anyway, no-
one really knows why the chyle effusion stopped, but I think it's helped… (My 
doctor) believes… that the sirolimus helped.  
Clare was so involved with the clinical decision-making aspect of her medical care that 
she thought of herself as part of the medical team and this was reflected in her language: 
Sometimes we aspirated the tube. 
We tried Fentanyl as well. 
It just kept reducing the fluid. Then this one got down to 50 mls, so we pulled the 
plug. 
We did a laparotomy. 
5.3.4 Turning points and liminality 
Clare’s long hospitalisation and the immediate period after discharge was an experience of 
liminality and multiple paradoxes. The unreal space of the hospital became ‘home’ to her 
yet was not her home. Her status was ambiguous - she was a patient yet, in researching for 
solutions to her confounding medical problem, at the same time thought of herself as part 
of the medical team. She was ‘sick’ but worked to organise a fundraising event for LAM 
research at which she could be present only in a technological space through Skype. She 
was present but not present. Her physical condition was unstable and she shifted 
unpredictably between the spaces of the ward and intensive care. Her feelings of isolation 
and uncertainty were indicative of her liminality. 
Clare’s final stay in ICU was a turning point. Believing she was improving and would be 
discharged soon, her ICU admission was regressive and Clare felt she had lost hope when 
time seemed to have lengthened with no perceivable end to her problem. It was her “lowest 
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point” and difficult to endure. Paradoxically, however, it was also a positive turning point 
in shifting her perspective by providing the impetus for her to set a new goal and plan of 
action to renew her hope and remain resilient: 
 I’d thought I was getting better and I was going to get out. It just dragged on 
for such a long time. I just sobbed because I was hooked up to everything…It 
was just like I just want to get out (of ICU). I sobbed in front of my parents as 
well. That was the first time they'd really seen me have a good cry, because I'd 
just had enough…I was begging to go back to the ward… I just couldn't bear 
it. I knew that I was just not improving there. 
 
Clare decided she was going to recover by establishing a firm time frame for going home. 
She supported her goal through her personal spirituality and consciously renewing her 
positive attitude. She was supported by her parents and nurses from the ward who visited 
her in ICU. Her agency was evident in her actions of visiting the hospital chapel to “pray 
and wish” for her recovery, starting a journal to record what she was grateful for each day, 
and surrounding herself with positive affirmations. These actions provided a sense of 
control and balanced the negativity, uncertainty and powerlessness of her physical situation. 
Mentally and spiritually choosing hope was sustaining and contributed to her resilience. In 
turn, being resilient and continuing to cope maintained her hope for a positive outcome: 
So after that instance I was, right, I'm going home; so everything changed… I 
told everyone I'm marching out in March… I've decided… I've just had enough. 
I don’t want to be here anymore… Because you're in there for such a long time, 
and it's hard to remain really positive. So I started a little diary up. Whether it's 
the cleaner giving you a laugh… or someone making some joke. I think that's a 
good thing to do because… you don’t want to be negative while you're there 
because it doesn’t help… I think definitely it helped to believe that you could 
get better… I have this belief now that you might get worse if you don’t change 
that belief.  
After her ICU admission and treatment with sirolimus Clare’s effusions gradually reduced, 
her drains were removed and she was discharged home in the time frame she had set for 
herself. While the sirolimus treatment seemed to have been the likely reason for the 
resolution of her problem, her positive attitude and actions sustained hope and resilience in 
the final stages of her ordeal. 
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Clare’s discharge and passage from hospital was a turning point which initiated a new 
transition. She had experienced a separation from normality to illness and was now at a 
threshold where she had left the hospital world but had yet to integrate her illness to a new 
wellness. Positively, her discharge represented physical recovery and stability. However, 
paradoxically, it simultaneously shifted and intensified her liminality to an emotional and 
social level. She was no longer a patient yet not her “usual self” either. She felt like she was 
returning from “war” and had not adjusted to life outside the hospital. She lacked 
confidence and felt “wilted”. Her relationship with her partner was confused by vestiges of 
patient /carer roles creating tension and eventually a breakdown of the relationship,    “that 
patient-carer relationship, it has a big impact on you”. This was a significant social turning 
point which Clare found more difficult than her diagnosis. “When he left I probably got 
tearier than what I did when I found out I had LAM”. She felt marginalised among women 
her age by her inability to have children. She returned to live with her parents and felt 
stripped of relationship, work, and her own home. Clare identified her liminality at this time 
as being in “limbo”.  
 It is hard because lots of friends are having their babies. You think this is just 
my life… when I get older I won't have that extra support around… My job's 
finished… it was so active, not having that either. So I'm in a bit of a limbo 
patch at the moment.  
Although Clare experienced uncomfortable feelings in her liminality it was also a reflective 
period to ponder a meaning for her life going forward. As other participants had 
experienced, her liminality was a time of spiritual and personal growth. She felt a new sense 
of altruism and empathy for others, a desire to offer support to other women with LAM, and 
an interest in exploring other spiritually based modes of healing: 
 Before I was sick…I didn’t have a full understanding; whereas now I know 
…You see how vital having a good belief system is as well - that it affects 
you…like I said, I'm in that limbo stage now; what am I going to do? Hopefully, 
I'd like to - down the track - do something that I’m proud of, that will make a 
difference... I speak to other women that are diagnosed. I found that really 
rewarding…I'm quite open to different spiritual things. Probably more so after 
(my experience)… it just opens your eyes up to life itself… just open to other 
ways that people can maybe be healed…there's potential that you can help your 
body a little bit more, whether it's just mind over matter or just feeling good 
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inside yourself. 
Clare demonstrated a number of factors that promoted her resilience. Her motivation and 
personal resources of curiosity, flexibility, resourcefulness, self-efficacy and a positive 
attitude stimulated her actions to take responsibility for her health. She retained agency even 
in the context of her unstable physical condition and, in the process, gained knowledge and 
skills and reinforced her self-beliefs. In addition, she maintained hope, found meaning and 
purpose, and felt positive emotions in her agency, spirituality, gratitude, and connectedness 
with others. Supporting these findings, Kashdan and Rottenberg (2010) proposed that 
curiosity motivates a person to be engaged and find meaning in their actions when in 
situations of complexity and uncertainty. They suggested, furthermore, that this enhances a 
person’s psychological flexibility to promote resilience and the ability to adapt to changing 
demands. Emmons and McCulloch (2003) found, in a study of gratitude and wellbeing, that 
gratitude facilitates coping with stress and adversity and benefits emotional health by 
increasing positive emotions, optimism and a sense of connectedness to others. Tang and 
Anderson (1999), in two qualitative studies of women living with diabetes, reported that 
when their agency was diminished by illness the women reclaimed it by relying on 
themselves, understanding their bodies and taking responsibility for self-care. 
5.4 Shifting the power balance 
The participants’ narratives revealed a shifting power balance in their interactions with 
healthcare professionals. Power related to the differing abilities of both the participants and 
their physicians to influence and control behaviour and health outcomes affecting the 
participants. The women’s stories demonstrated a relationship between knowledge, power, 
attitude, and the rarity of their condition. The power balance between the participants and 
their physicians shifted with changes in knowledge and attitude. 
In the previous chapter, the participants showed that they had increased their power 
following diagnosis in a number of ways. Firstly, in living with a rare disease, they had 
developed knowledge, skills and expertise in managing LAM through their own experience 
of living with it, their independent information gathering, their ability to advocate for 
themselves, and their collaboration with medical researchers. Secondly they had shown 
agency in engaging in these activities and increased their self-efficacy beliefs. Thirdly, they 
possessed subjective knowledge of their own needs and preferences. These factors enabled 
them to collaborate with their physicians and influence decision-making concerning their 
own health outcomes. They took responsibility for monitoring their health, including their 
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oxygen saturation levels, lung function results and sirolimus levels, and wished to have 
adequate time to discuss these with their physicians. 
Physicians’ power lay in their biomedical knowledge and designated authority within the 
healthcare system. While LAM experts possessed expert knowledge of LAM, many 
physicians the participants encountered lacked this knowledge. In contrast, the participants 
had increased their own knowledge. The resulting difference in knowledge levels shifted 
the power balance between the participants and their physicians. However, physicians 
retained greater power in interactions with the women through their control of prescribing 
treatments, ordering investigations, and following up results. In this context many 
participants felt they needed to advocate for themselves in order to receive optimal 
treatment.  
5.4.1 Advocating for their health 
The participants advocated for where to be treated, appropriate investigations and 
management, full explanation of results, improved communication between physicians, and 
access to sirolimus therapy. In advocating for themselves they further increased their own 
power and shifted the power balance to improve their health.  
Not all participants engaged in self-advocacy. Their ability to self-advocate correlated with 
their self-efficacy and cultural beliefs, past experience, language barriers, and health status. 
Helen identified herself as “an advocate for my own health”. She was young, university 
educated, confident, and experienced in advocating for clients in her work. She was not 
afraid to speak up for herself and advocated for information, investigations, and inclusion 
in discussion. She also actively promoted better communication between different 
physicians to improve equity in treatment for women with LAM regardless of where they 
lived. “The biggest things are lack of communication between my state and the rest of 
Australia. I'm determined to get that changed.” Similarly, Jess, Julie, Mia and Ruth were 
experienced communicators in their work and Patricia had a long history of dealing with 
healthcare professionals as a result of her son’s disability. They did not hesitate to advocate 
for appropriate treatment and investigations.  
Veronica and Aiko, while highly competent in their work, did not feel as confident in their 
dealings with healthcare professionals and accepted the medical advice given. Aiko, who 
was Asian, was not confident to discuss her issues in English. “Whenever I have the check-
up…I have to go by myself. I have to be careful about if I misunderstand the English.”    
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Veronica, who regarded herself as timid and “not a strong character”, had lower self-
efficacy: 
Whatever they did I accepted because I presumed they knew more than I did.  
Some people are like that, more accepting. Other people are challenging…and 
ask lots of questions and things.  I didn’t because I didn’t know what was wrong 
with me. 
Margaret, at the late stage of her illness at the time of interview, was too unwell to engage 
in collaborative decision-making. 
When advocating for themselves, the participants revealed that physicians who lacked 
knowledge of LAM were less accepting of their expertise and tended to exert their power in 
paternalistic-style interactions. This was the case for Jess and Mia when, familiar with the 
management they needed, they advised hospital doctors how they should be treated. Jess 
“had… the worse registrar and intern…who just couldn't believe anything that I told 
them…They didn't know anything about LAM but they couldn't believe that I did”. Mia 
understood the treatment regime when she was admitted for her chest infections. She 
communicated this but found it uncomfortable to be issuing instructions to doctors: 
Every time I'm in the emergency room, most doctors have no idea what LAM is, 
no nurses know what LAM is…Just having to explain over and over again to 
everyone just to get a prescription for the antibiotics, it took 30 minutes trying 
to persuade a doctor to give me one.  I think that lack of awareness obviously 
has an impact… I feel really strange telling the doctor what to do with me. 
Similarly, when supporting another woman with LAM in hospital, Louise felt “they (the 
doctors) wouldn’t listen to us… (they were) patronising, you know… there’s a sort of a 
hierarchy that I was very unaware of to start with”.  Eva said: 
What my friend’s (who is a doctor) presence meant is that we could actually 
connect to all the surgeons more, because we had no respect from those, being 
just patients. So whatever we suggested was just a layman's view of things, and 
dismissed pretty much instantly…some of the doctors are so arrogant…If I've 
got the disease, at least listen to me, hear me out. 
Helen and Julie were geographically isolated interstate from the two centres of LAM 
expertise. They felt disadvantaged when their physicians did not initiate appropriate 
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investigations or explain results of tests adequately, did not know the therapeutic levels of 
sirolimus, and gave conflicting information. Helen said: 
I'm at a disadvantage.  I'm the worst in this state…I don't know anything… I 
don't know if I should be having pneumonia shots… I've got all these questions 
and… I can't fly (to see doctors interstate). 
Julie was concerned, having been treated for a renal angiomyolipoma in the past that more 
may have developed. Her doctor did not initiate an investigation and his response to Julie’s 
request for a scan to detect if any were present suggested that he did not take her seriously 
and agreed to her suggestion only to relieve her anxiety:  
 When I saw… (my doctor) I said to him, do you think I should have a kidney 
scan?  This can be part of it.  I said, I'd hate to miss something… because they 
could burst too...  He said, oh yeah, if it makes you feel better.  
Julie was frustrated that her physician was unable to explain her sirolimus levels to her: 
I check my sirolimus (level)… (my doctor) doesn’t really know that much about 
it.  All the doctors don't… The doctors just tell me what it (my sirolimus level) 
is because they don't know what it's meant to be.  So they just go, there's your 
level.  
Helen was unable to interact collaboratively with her physicians who were not LAM experts. 
Their interactions were characterised by a paternalistic style of communication, and, at 
times, Helen felt she needed to assert herself over issues.  The frustration and stress she 
experienced as a result exacerbated the disruption and uncertainty she felt in being recently 
diagnosed with advanced disease. Helen perceived a lack of communication between her 
physicians and LAM experts and found they had set opinions about stopping her sirolimus 
and seemed unable to assess if her sirolimus levels were therapeutic. She felt she had to tell 
them what to do and argue against their treatment options:  
Initially I was only put on one milligram (of sirolimus) and I had to fight and 
fight and fight and I've only just gone on to two milligrams… The two males 
(physicians) have this very set opinion about sirolimus… I tell them what to do. 
So when I came off sirolimus (for my gall bladder surgery) … they said look, 
we don't think we're going to put you back on it and I said well, you are… I had 
to do this whole presentation to him about why I wanted to go back on 
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sirolimus… In my situation with two young kids… I can't take that risk of 
deteriorating. I stabilised for a year on it. 
In addition, Helen felt she was not informed of additional aspects of managing her health, 
for example monitoring her bone density and having annual flu vaccination. She was 
frustrated by medical time pressures and her allocated appointment time being inadequate 
to ask questions: 
I didn't really feel like he was doing much for me... I was telling him 
everything… I was asking about vitamins and bone density and all that I’d 
learned from the other women and he wasn't really saying anything about 
it…He's very much time checking and I had all these questions … He never 
really even gave me my full results of the evaluation... He hadn't read them 
obviously… My trough levels, what are they meant to be?  I don't know…You 
(the doctor) could not speak to (the other doctor)…interstate and ask?...I’m sick 
of this whole bureaucracy around physicians not talking to each other.   
Vidu was satisfied with paternalistic-style interactions. She felt this suited her negative 
disposition and was culturally appropriate in the case of her South Asian Buddhist specialist 
who, she felt, knew her well as a person (see Chapter 3, Being Diagnosed, p.68).  
Jess’s story of her interaction with a physician in attempting to access sirolimus therapy 
revealed shifts in the power balance. Sirolimus is a product of research funded 
internationally by women with LAM. However, although the participants were partners in 
research, their physicians controlled access to sirolimus through their authority to prescribe 
and organise the additional approval and funding required for its use. From her own research 
Jess knew that sirolimus was a possible treatment for the abdominal lymphangioleiomyoma 
which was making her bloated and causing her distress. She advocated her physician for 
access to the treatment over a prolonged period of 18 months. She felt she wasn’t listened 
to and that her concerns were dismissed: 
I really began this whole campaign with… (my doctor) to try and get this drug 
which I'd read about on the internet… But… (the doctor) never got it.  He was 
very dismissive… every time I went down there I was always trying to make him 
understand how desperate I was to get rid of this abdominal mass and how 
much it affected my life… He never listened. 
Jess was finally approved for sirolimus but when she was about to start treatment approval 
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was withdrawn and she was offered a course of radiotherapy and doxycycline instead, 
neither of which resolved her problem. The reason for withdrawal was not clearly 
communicated to her and, being aware of another patient at the same hospital who had 
received sirolimus, she could not understand why she was denied the therapy. After further 
enquiries Jess sought the opinion of another physician at the hospital, also a LAM expert, 
who, in a reasonable time frame, organised sirolimus for her. It was an effective treatment. 
Her abdominal symptoms resolved over twelve months and she had a 60% improvement in 
her lung function. She could not understand the reason for conflicting opinions: 
The huge crisis was that my partner was looking on PubMed as we both often 
did.  He saw that… (my doctor) had published this article about giving 
sirolimus to one of the patients. So I emailed him and I asked why he hadn't 
given it to me, because I'd been going on about it for so long… He sent this… 
letter to me and it said… you can't be on sirolimus. It's not available. You 
cannot take it for this purpose… I couldn't believe that this had happened.  If 
he had explained it to me and said that this other patient met our criteria 
better… but he'd always told me that you just can't have it… I find it odd that 
you can go to the same hospital and get different treatment depending on who 
you see.  He was saying to me, you can't get it…when, really, he could've just 
referred me to… (the other doctor).   
Jess’s interaction with the first physician she consulted was paternalistic. It revealed how 
poor communication shifted the power balance, and affected Jess’s quality of life and 
clinical outcome. The physician’s failure to listen to Jess’s perspective and communicate 
the reasons for the initial delay in approval for sirolimus and its subsequent withdrawal 
diminished Jess’s power by limiting the effectiveness of her advocacy and diminishing her 
sense of control when she was unable to influence decisions concerning her health. 
Furthermore, it created additional uncertainty and reduced her quality of life when her 
problem remained unresolved.  
5.4.2 Being a ‘good’ patient 
The participants understood that their physicians controlled access to treatment. In this 
context, they retained respect for medical authority and reported a need to modify their own 
advocacy behaviour. They exercised diplomacy in their interactions with their physicians 
and other healthcare professionals in order to maintain friendly relations, ensure ongoing 
care and access to treatment, and be perceived as a ‘good’ patient. After Jess was finally 
 
 
147 
 
prescribed sirolimus, she feared having her treatment withdrawn, “I wouldn't want to 
complain because I don't want them to stop my drugs… I don't want to be a difficult patient”. 
Aiko didn’t want to be seen to be “rock(ing) the boat” if she sought a second opinion. Ruth 
observed the conflict between self-advocacy and the need to temper advocacy with 
diplomacy: 
You need to be your own advocate… and so often it's hard and you don't want 
to upset anybody by speaking out in a way that might be thought of as rude 
when you're in their hands. 
Clare judged that making suggestions to nursing and medical staff were best done tactfully 
so as not to usurp her role as a patient:  
I had a very good relationship with all the specialists at the hospital, because 
they’d let me have a bit of a say and investigate and find papers…as long as I 
was tactful and just said, look, this is what we’ve found…it had to be from a 
substantial hospital…from a recognised specialist.  
This was particularly the case when healthcare professionals who had no knowledge of 
LAM or her case were caring for her. Clare described how she had to provide instructions 
as to her management in a sensitive manner when she was having difficulty breathing and 
becoming distressed. An on call nurse who was unfamiliar with Clare’s case interpreted her 
distress as anxiety and tried to calm her. Clare, however, knew that her symptoms were due 
to a blockage in her drain and had to advocate for herself and give instructions to the nurse 
even while she was distressed:  
A lot of the times my sats (oxygen saturation) would still read not too bad, even 
though I was gasping… I remember being a bit frustrated because I might have 
an on call nurse who was not normally on the ward…You've just got anxiety, 
love… you'll be fine, just calm down… and I'd already known - because I'd had 
a couple during the week - that it was a clog (blockage in her drain), but you've 
got to be a bit diplomatic. You don’t want to go well, I know. You've got say 
well, this happened the other day, I think this is what it could be.  
Helen, in contrast, was less concerned with diplomacy and being a ‘good’ patient. She was 
focused on resolving her issues and more forthright in her advocacy when dealing with her 
physicians who were not LAM experts. Having advanced disease, she felt pressed to put 
forward her own case in the absence of expert care and other advocates. This can be seen in 
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her interaction with a psychiatrist consulted when she was feeling anxious about the 
possibility of receiving a transplant: 
He was going, you seem quite anxious… how would you feel about anti-anxiety 
drugs? I said… there's no way I'm going on any medication. He goes, what 
about compliance with drugs with the lung transplant team? You've got to be 
compliant… I said, firstly, I've initiated this meeting with you. Secondly, I know 
what I need for myself and I will be compliant… I am dedicated but I'm not 
going on any more medication than I need to be…I'm an advocate for my own 
health. I'm on trial drugs so I'll be saying what I feel I need.  
5.4.3 Collaborating with LAM experts  
At interview, sixteen of the 19 participants had come under the care of LAM experts who 
reviewed them every six months. Of these, four women travelled or had relocated to be 
managed by a LAM expert. Julie arranged a government subsidy to travel interstate annually 
to be reviewed by one. In between these visits she consulted a general respiratory physician. 
Three participants were not under the care of LAM experts. Margaret was now too sick to 
travel to see her LAM physician and was managed by a local respiratory physician. Deb and 
Helen lived long distances from LAM centres of expertise and Helen was unable to fly. Deb 
was reviewed by a general respiratory physician. At the second interview, Helen was being 
seen by a team of respiratory physicians, one of whom had recently moved to her city and 
had an interest in LAM. She was hopeful that her assessments and treatment would now be 
more focused. 
The participants’ stories showed that power shifted to be more mutually shared when their 
physicians accepted their expertise and collaborated with them in decision-making. This was 
dependent on the attitude of the physicians, as demonstrated by Jess’s story, and, although 
not uniformly the case, was more likely to occur with LAM experts. The participants 
generally experienced a high level of collaboration and satisfaction when they were cared 
for by LAM experts. LAM experts were cognisant of latest research and were able to arrange 
sirolimus therapy where appropriate and monitor drug levels. Their care was focused and 
their knowledge and expertise engendered positive feelings of confidence and trust.  There 
was no need to continually explain their disease. In Aiko’s opinion:  
That supportive system available here… is good. I don't need to explain 
everything every time I open up my mouth…It seems like he's under control with 
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my disease…I feel more positive…I really feel very confident… They are all 
caring. Keep eye on me.  
The women felt their issues were understood and their own expertise accepted. Clare’s story 
showed that being able to influence clinical decision-making and her health outcomes 
increased her self-efficacy and sense of control and, in turn, enhanced her resilience during 
her long hospital stay.  They received appropriate assessments and investigations and these 
physicians were prepared to explain results and discuss treatment options collaboratively. 
Sarah said: 
(In my altitude study) they said I actually didn’t need the oxygen any more (to 
fly). Then I got nervous and said, well I’d still like it please, and my doctor said, 
well you don’t really need it… We had a bit of negotiation about that, so I had 
it as emergency oxygen in case. 
The participants found that LAM experts were accessible and would respond to email 
questions. Ruth was “able to ask about anything and… (my doctor’s) wonderful about 
answering questions.” They would also contact hospital staff to advise on appropriate care 
when a woman alerted them she was in hospital. As Mia said:  
I'm so reliant on… (my specialist) because I feel that I can trust being in his 
hands.  Like for instance when I'm in the emergency room I always SMS and 
tell him and then he finds a way to get there, to call and to give instructions on 
what to do with me because it's always like that… because they don't know.  
5.4.4 Being known as a person 
The participants considered that knowing each woman as a person was an important aspect 
of communication and collaborative care in order to understand their individual priorities 
when deciding on treatments. Aiko appreciated that her physician “will talk to the patient”. 
Some women, such as Veronica, preferred a gentle positive approach while others, such as 
Jess, liked “frank talking”. Jess felt that knowing a person as an individual allowed the 
physician to “work out what kinds of conversations people want to have.” She said: 
I think doctors probably don't need to understand much about the personality 
of the patient in a way, because they're thinking more about the symptoms.  But, 
the doctors who do - my GP (local doctor) or(my physician) - are always, I 
think, better at conveying information and also receiving information…to even 
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know what your priorities are.  
Underlying knowledge of the person was an attitude of empathy and a willingness to listen. 
Helen felt a sense of relief and hope from her communication with her new physician who 
had an interest in LAM and demonstrated these qualities: 
I just felt for the first time some hope that someone was listening to me and 
taking it seriously…He spent ages with me…I think he is just really empathetic 
and even though he's busy and he's a top specialist…he was interested.  
Jess’s story of how she accessed sirolimus illustrated the impact of a physician’s ability to 
listen and know her as a person. The first physician Jess consulted did not take her 
perspective into account and failed to elicit knowledge of her as a person. According to Jess, 
the physician lacked empathy and did not listen to her, and consequently did not understand 
that her priority was the resolution of her abdominal lymphangioleiomyoma which had 
markedly reduced her quality of life. The physician focused instead on her lung disease. 
Clinically her abdominal mass remained a problem and her quality of life had not improved. 
In contrast, the second LAM expert Jess consulted listened to her viewpoint, gained 
knowledge of her as a person, understood her priority, focused on its resolution and 
facilitated appropriate treatment. Her quality of life increased significantly and she achieved 
an excellent clinical outcome when her lymphangioleiomyoma resolved and her lung 
function improved.  
A physician’s ability to communicate skilfully and discuss how to live life well within the 
parameters of their chronic illness was important to the participants when there was no cure 
and, for some, no treatment options other than oxygen therapy. Aiko’s LAM expert offered 
hope by considering how she could live fully without a transplant as her disease progressed. 
Aiko said: 
He said, better to be living with your own organs… So we will probably focus 
on how we're going to make you a little bit more normal life than bedridden. 
You can still enjoy your life… without transplantation, which is a very, very 
clear focus.  
The participants revealed that time was a desirable but limited resource in knowing a woman 
and her priorities. While they generally had a good rapport with their LAM specialists they 
were aware of their busy schedules, and their allocated appointment times were often 
inadequate to discuss issues more fully or bring up minor, but nevertheless concerning, 
 
 
151 
 
matters. Ruth reported there was “usually not time for chatting”. The limited time of 
medical appointments was constraining and could inhibit discussion, collaboration or 
understanding a woman fully. Aiko felt that: 
Sometimes doctors and patient don’t talk too much… consultation time is, that’s 
that, and we will see you six months’ time. Not enough to get to know each 
other…Doctors are sometimes very blunt.  Just fact is fact…I don’t think they’ve 
got the time to discuss.   
The participants’ experiences have demonstrated that the power balance in their interactions 
with their physicians related to the ability of each to influence and control behaviour and 
health outcomes affecting the participants. The power balance shifted in relation to 
knowledge and attitudes. The rarity of LAM meant that the participants increased their 
knowledge and power but many physicians lacked knowledge. Physicians’ power, however, 
tended to remain constant while the participants’ power shifted in response to the attitudes 
of their physicians. Physicians who lacked knowledge of LAM retained power in their 
authority to control treatment and investigations. Although the participants increased their 
power as their knowledge and expertise increased, they concealed it by modifying their 
advocacy behaviour so as not to challenge the authority of their physicians. The participants’ 
power was reduced when physicians exercised their power with a paternalistic attitude and 
communication style. The women were most empowered and more satisfied when their 
physicians shared power, accepted their knowledge and expertise, listened to know their 
priorities, and were willing to collaboratively share decision-making.  
5.5 Summary 
The rarity of LAM had a significant impact on the participants’ experiences in their 
interactions with healthcare professionals. It was associated with a notable increase in their 
illness burden when healthcare professionals lacked knowledge, and did not communicate 
clearly or provide adequate information or support. When they were in hospital these factors 
generated feelings of isolation and vulnerability. In this context the women demonstrated 
agency by taking responsibility for their health and outcomes through vigilance, self-
advocacy, and taking on the role of educating healthcare professionals. Having expert 
knowledge was empowering for the participants in the health care setting. It facilitated 
meaningful communication with healthcare professionals to narrow the power differential 
between medical authority and their position as vulnerable patients.  
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A prolonged length of stay in hospital, as demonstrated by Clare’s experience, exacerbated 
these effects and generated a greater need for resilience and emotional support than in a 
short hospital stay. Clare showed that her personal attributes, positive attitude and agency 
in researching, gaining knowledge, and advocating for herself, as well as being supported 
by others, enabled her to be resilient. Her inclusion in collaborative decision-making in 
hospital reduced her feelings of isolation, vulnerability and uncertainty and increased her 
self-efficacy and sense of control. In addition to these factors, Clare revealed that the 
personal growth and spirituality she developed through periods of liminality during and 
immediately after her long hospital stay contributed to her resilience.  
The participants approached their interactions with healthcare professionals with knowledge 
they had acquired of their disease through their own research and illness experience, and 
communication skills gained from past life experience. This had the effect of reducing the 
power difference between them and their physicians. However, adopting the role of expert 
in their self-advocacy efforts with their physicians challenged traditional patient/physician 
roles. Budych et al. (2012), in an exploratory study of the experiences of patient-physician 
interaction in rare diseases, found this to be the case and identified four patterns of 
patient/physician interaction: paternalistic where the physician directed decision-making; 
collaborative involving equal information exchange and mutual decision-making; patient-
directed where the physician lacked expertise and was educated by the patient; and 
confrontational involving conflict.  
At diagnosis, interactions for the majority of women were directed by their physicians due 
to the women’s lack of knowledge at that stage. As they acquired knowledge and developed 
their own expertise, the majority of participants participated actively in their health care and 
adopted a collaborative style of interaction with their physicians. Julie and Helen 
experienced different patterns of interaction with different physicians. This generally 
corresponded to the physician’s level of knowledge and their willingness to acknowledge a 
woman’s expertise. Collaborative interactions were more likely when a woman’s physician 
was a LAM expert. In the process of collaborating the participants enhanced their own 
communication skills and gained a greater sense of partnership with their physicians and 
control in influencing their own health outcomes.  
Interactions with physicians who lacked expert knowledge of LAM were patient-driven in 
the case of Helen who was isolated from centres of expertise, and Clare during her admission 
for a gynaecological procedure.  At times the women needed to be assertive in these 
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interactions and rejected medical advice on the basis of their own knowledge. Brashers 
(2000, p.387) termed this “mindful nonadherence”. Helen, for example, explicitly identified 
herself as her own health advocate and demonstrated assertiveness in advocating for expert 
medical care, variation in her sirolimus dose, and discussion of medical investigations and 
issues of concern such as contraception. She rejected proposals for antidepressant treatment 
and the inducement of early menopause for the purpose of contraception.  
Some participants were satisfied with physician-directed interactions. These included 
women with mild disease; those who coped by avoidance; women who were not confident 
in voicing an opinion or for whom language was a barrier; and women at the late stage of 
the illness who were too unwell to engage in collaborative interactions. Other issues of 
communication included misunderstanding due to looking healthier than the expected 
clinical picture of a person with degenerative lung disease in the case of Jess, and conflicting 
medical opinions, as experienced by Helen in relation to contraception. Budych et al. (2012) 
similarly found that interactions were influenced by a person’s health status and that 
conflicts could arise when there was medical uncertainty due to a person’s appearance not 
corresponding with the typical clinical picture. A number of women voiced the opinion that 
the limited time allocated to medical consultations constrained communication, even in 
collaborative interactions. This aligns with the findings of A.E. Beisecker and T.D. 
Beisecker (1990) who, in a study of rehabilitation patients’ information-seeking behaviours, 
demonstrated that a longer interaction time of greater than 19 minutes with their physician 
was necessary for a patient to engage in communication behaviour such as asking questions 
in order to gain information and participate in decision-making. 
According to Foucault (1977, p. 27) “power and knowledge directly imply one another”. 
The participants showed that power and knowledge were directly related, and also that their 
ability to exercise their power depended on how their knowledge was received by their 
physicians and the physicians’ attitudes to sharing decision-making. Physicians retained 
greater power in interactions with the participants due to their control of prescribing 
treatment and investigations. The majority of physicians lacking expertise in LAM did not 
accept the knowledge of participants. The participants, recognising the power imbalance, 
modified their own behaviour so that they could receive optimal treatment. While the 
majority of participants advocated for themselves, they attempted to communicate in ways 
that were acceptable to physicians and did not challenge their authority. The exception was 
Helen who, with advanced disease, felt a more urgent need to advocate strongly and 
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challenge her physicians in order to have her needs met.  
The value of patient knowledge/expertise in partnership with healthcare professionals has 
been recognised in reducing symptom severity, and improving confidence, resourcefulness, 
self-efficacy, and sense of control for patients with chronic illness (Department of Health 
UK 2001). As a consequence, expert patient programmes have been introduced in the UK 
(Shaw & Baker 2004), and in Australia as the Sharing Health Care Initiative (Department 
of Health 2005). However, as this current study has found, patient expertise is not always 
accepted by physicians. Similarly, Thorne et al. (2000), in a study of the experiences of 
people living with Type 1 diabetes and environmental sensitivities, found that healthcare 
professionals’ attitudes influenced interactions with healthcare professionals. They reported 
that healthcare professionals held on to the role of expert, and controlled information and 
who qualified for health services. Likewise, Henwood et al. (2003), in a study of the 
information practices of midlife women seeking to know about hormone replacement 
therapy for the relief of menopausal symptoms, found that shared decision-making was 
constrained by some participants’ choice to leave decision-making to their physician who 
they trusted, others not disclosing their own knowledge for fear of challenging the authority 
of their physician, and physicians’ reluctance to engage in collaboration and consequent 
dismissal of the women’s views. Shaw & Baker (2004) suggested that physicians reject 
patient expertise because they associate it with demanding, unreasonable and time-
consuming behaviour even though it leads to improved outcomes. The findings of this 
current study suggest that improving patient-physician interactions is complex and requires 
a shift of medical cultural attitudes. This was similarly proposed by Tattersall (2002) in 
discussion of chronic disease management. Likewise, Ellis-Hill et al. (2008) and Tang and 
Anderson (1999) called for healthcare professionals to be reflexive of and address power 
differentials inherent in their encounters with patients.  
Physicians having expert knowledge of LAM did not alone provide the best outcomes for 
the participants. When they supplemented their expert knowledge with subjective 
knowledge of each woman as a person, taking into account her individual perspective, care 
was focused. This achieved higher levels of satisfaction for the participants and 
improvement in their illness management. Communication skills of empathy and an ability 
to listen enabled healthcare professionals to elicit this subjective knowledge while time 
constraints could hinder the process.  
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5.6 Conclusion 
This chapter has presented the participants’ experiences of interacting with healthcare 
professionals, as patients in the hospital setting and at their periodic reviews with their 
physicians, and how their interactions were affected by the knowledge and attitudes of both 
parties, and the rarity of LAM. The participants demonstrated that being a patient with a 
rare disease in the hospital setting created feelings of vulnerability and isolation when 
healthcare professionals lacked awareness and knowledge of LAM. In this context the 
participants were vigilant in monitoring their care and educating the healthcare 
professionals. Being in hospital for an extended period created a need for resilience. Clare’s 
personal qualities and spirituality, maintaining hope and a positive attitude, taking an active 
role in increasing her own knowledge and educating healthcare professionals, advocating 
and collaborating with healthcare professionals, and being supported by nurses, family and 
other women with LAM contributed to her resilience. Being an active participant in her care 
was empowering and created meaning by giving her a sense of purpose and enhancing her 
positive self-beliefs.  
A power balance existed between the participants and their physicians. This represented 
their differing abilities to influence the health outcomes of the participants. The power 
balance shifted in relation to knowledge and attitudes. While the participants increased their 
power through their own increased knowledge and self-advocacy efforts, physicians 
retained greater power due to their authority to control investigations and treatments. The 
ability of the participants to collaboratively share in decision-making concerning their care 
depended on the attitude of their physician. The women modified their own behaviour so as 
not to usurp medical authority or jeopardise their care. The exception was Helen who, with 
advanced disease, felt a more pressing need to exert her own power. The women’s 
experiences demonstrated that their satisfaction and management of their illness were most 
improved when power was more equally balanced. This was the case when both they and 
their physicians acquired expert knowledge, physicians took time to listen to the participants 
and gain subjective knowledge, and when power was mutually shared and physicians and 
participants collaborated in decision-making. 
The following chapter will explore the participants’ experiences of living with LAM as their 
illness progressed to the advanced and late stage, including their experiences of living with 
oxygen therapy, respiratory failure, and receiving a lung transplant. Their hospital 
experiences and interactions with healthcare professionals at that stage are considered in 
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that chapter.  
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Chapter 6 
LIVING WITH ADVANCED LAM - EXPERIENCES OF 
OXYGEN THERAPY, RESPIRATORY FAILURE AND 
LUNG TRANSPLANT 
 
6.1 Introduction 
The previous chapter presented the participants’ experiences of interacting with health care 
professionals in the hospital setting and at their regular reviews with their physicians. This 
chapter explores the experiences of the participants who were living with advanced LAM. 
Their illness had progressed to the stage where they had lost a significant amount of their 
lung function and now required oxygen therapy for exercise or other activities, either 
intermittently when they required or continuously. The need to commence oxygen therapy 
was a turning point of disruptive change. Seven participants described how having to use 
oxygen affected them and how they adapted and learned to live with it.  
Margaret, Patricia and Vidu reached the late stage of advanced LAM. Margaret had 
advanced disease in both her lungs and her kidneys and was not suitable for a lung 
transplant. She had been hospitalised for life threatening respiratory failure. Patricia and 
Vidu received lung transplants. These participants revealed the impact of advanced disease 
on their lives, how they faced their mortality, their resilience, and their experiences of 
liminality at these major turning points and times of transition.  
Figure 6.1 provides a visual summary of the themes of this chapter related to the progressive 
stages of living with advanced LAM. Firstly, the participants revealed the meaning of 
oxygen as a therapy of paradox, with both positive benefits and negative limitations, and the 
issues they faced in accessing their oxygen supplies. Secondly, the participants’ experiences 
of living with late stage LAM are presented in relation to their everyday lives and at turning 
points of being hospitalised for respiratory failure and listed for transplant. Thirdly, the 
women who received a transplant experienced a period of transition as they adapted to living 
with their new lungs. Fourthly, the participants revealed how they felt transformed by their 
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experiences of living with late stage LAM and receiving a transplant. Through each turning 
point the women demonstrated how they developed the resilience which enabled them to 
live with their struggle and suffering.  
 
 
159 
 
 
 
 
160 
 
6.2 Oxygen – a therapy of paradox 
Commencing oxygen therapy was a critical turning point which marked significant 
progression of their disease and added a new dimension of disruption to the participants’ 
lives.  The majority of participants using oxygen were initially prescribed it intermittently, 
using it at night and when needed during the day to support exercise and activity. Over time 
they progressed to continuous oxygen use as their illness advanced. Five women in the study 
were using oxygen at the time of the interviews, Helen and Margaret continuously, and 
Irena, Aiko and Sarah intermittently. Helen, whose disease had progressed rapidly, required 
continuous oxygen therapy from when she was first diagnosed. Patricia and Vidu, who had 
received lung transplants, had used oxygen continuously in the twelve months prior to their 
transplants. Clare had used oxygen both intermittently and continuously over a period of six 
months while hospitalised and in the immediate period after her discharge but now no longer 
required it. Sarah was the only participant who used oxygen voluntarily even though her 
LAM was not at the advanced stage.   
Oxygen therapy held paradoxical meanings for the participants according to their stage of 
illness and their own particular context and life meaning. Positive meanings were associated 
with having some element of choice regarding when to use their oxygen, being able to 
conceal it from others, and using it to independently engage in activities. Negative meanings 
were associated with the physical presence and visibility of the oxygen equipment and a loss 
of freedom when they needed to use oxygen for mobility and all activity. The experiences 
of seven of the women who had used or were currently living with oxygen therapy illustrate 
these meanings and how shifts in perception influenced their resilience.  
Intermittent oxygen therapy was less disruptive for the participants who commenced it some 
years after diagnosis. In this context their disease had progressed slowly allowing them time 
to adjust to living with breathlessness and certain limitations. Irena commenced intermittent 
therapy five years after diagnosis, Aiko eleven years and Vidu nine years. According to 
Aiko: 
I’m not worrying about handling the portable oxygen, because my life for 11 
years has been limited.  So having the portable oxygen 24/7 may not make much 
of a difference.  
Intermittent oxygen was a supportive therapy for the women. It improved their sleep, 
facilitated exercise and activity, and gave them the ability to undertake air travel. This was 
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particularly important for Vidu in maintaining the close social connection with her family 
overseas who were her primary source of support. Additionally, intermittent oxygen therapy 
allowed the women some sense of control through having the freedom to choose when they 
would use it outside their home. They were then able to conceal their oxygen use from public 
view and avoid stigma and discussion around their condition. This had the positive effect of 
achieving a level of normality. While being able to choose when to use their oxygen made 
it easier for the women to tolerate it, it also meant that the manner in which they used it, due 
to misunderstandings, did not always provide them with the greatest physical benefit. Irena 
and Vidu used their oxygen after rather than during activity, negating its supportive benefit. 
Irena said: 
I don't use it as often as I should… As soon as I get back from mum - I don't 
take it there with me, it's just a hindrance rather than a help,… I'll have a bite 
to eat, clean up… Then I might just sit down and just get the wind get back into 
me…That's when I'll put it on because when I'm active it bothers me.  
Patricia was uncertain if it was legal to use oxygen while driving and waited until she felt 
very fatigued before stopping the car to use some oxygen:    
 I wasn't sure whether it was legal to drive with it or not…I did, on a few 
occasions, drive with it, but then I always made sure I had rest periods, 
because… I got fatigued very easily … I had to have rest periods to stop and 
close my eyes, have some oxygen and go. 
Clare thought oxygen was addictive: 
 I think the other thing with oxygen is the more you have it, the more reliant you 
get on it as well. So you try and limit it a bit.  
Irena and Vidu had both adopted a strategy of avoiding anything related to LAM when they 
were diagnosed and applied this strategy to their intermittent oxygen use. They avoided 
using their oxygen where possible, kept it hidden, and avoided discussion with others. For 
both women, this was consistent with how they viewed themselves. Irena felt she was 
capable of coping without oxygen, while Vidu saw herself as prone to negative thoughts.  
Irena found using oxygen uncomfortable and the cylinders were heavy so she did not 
perceive it to be beneficial. She also had a strong sense of self-efficacy and autonomy. Her 
life experience reinforced her view of herself as strong, and a “doer… (who) can get things 
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done” on her own. She had adapted to living with breathlessness in the five years since her 
diagnosis and was confident in deciding independently to continue to manage by pacing 
herself as she had become expert in doing. “I know that I can walk up to a certain amount, 
then I stop, then I keep walking.  I pace myself and I think I can cope.” Irena presented 
herself as one who met adversity in a positive way, “always smiling, that’s how I’d like to 
see myself”. Keeping LAM backgrounded through avoidance helped her to remain 
optimistic:  
I've always been like this - even before the LAM, if anything affected me I dealt 
with it on my own.  I didn’t necessarily talk too much about it, because for me 
talking about it, you just live it all the time and relive it.  I just think well, if I 
can handle it - and I've been pretty good.   
Over time this was likely to be a negative strategy as her medical record showed that her 
oxygen saturation dropped to only 80% on her six minute walk test, indicating that she was 
placing stress on vital organs by not using her oxygen when active. Avoidance also meant 
losing fitness because she also avoided exercise. Although it assisted Irena to cope 
psychologically and adjust to her illness, avoidance was not likely to be beneficial over the 
course of her illness. 
Vidu saw herself as “a bit of a weak person…if I think I will be negative, I will get negative 
thoughts.” She hid her oxygen even from her family to avoid negative thoughts and being 
identified as a sick person. She didn’t want to be treated as an invalid and denied the 
opportunity to do anything for herself which would further limit her freedom, control and 
independence, already restricted by her disease: 
I just didn’t want to see them see me with oxygen...I didn’t want to listen to any 
stories. I just wanted to avoid things like, my god what’s wrong …I didn’t want 
to talk about it…She (my husband’s sister) treated me like she didn’t want me 
to stand even…I felt bad. I thought at that time, good I didn’t tell my friends. 
In avoiding using their oxygen Irena and Vidu did not adapt to it. They had not accepted 
and integrated their oxygen as a part of everyday life nor developed the knowledge and skills 
to manage it effectively. Vidu’s story later in the chapter will reveal the effect of avoidance 
on her resilience and ability to manage her illness when she progressed to late stage prior to 
transplant. 
Intermittent oxygen therapy was less disruptive because the participants retained control 
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over its use. However, this meant that they did not always adhere to it due to 
misunderstandings about its use, inconvenience, discomfort, and to avoid making their 
illness visible and consequently avoid stigma and a sick identity. 
Becoming less well and progressing to continuous oxygen therapy caused a high level of 
disruption to the participants’ lives. They could no longer avoid using their oxygen. To 
maintain their mobility while living with advanced disease, they would now need to learn 
to live with their oxygen and use it for the rest of their lives or until transplant. Continuous 
oxygen therapy was a paradox in that it disrupted their lives but, at the same time, enabled 
them to remain active.  
 6.2.1 Disruption - the negative meaning of oxygen 
The negative meanings of continuous oxygen were associated with its disruptive effect on 
the participants’ lives. The women experienced additional losses and limitations due to both 
the physical and visible presence of oxygen equipment, and their advanced lung disease. 
Using continuous oxygen therapy felt like a burden and, being visible to others, created 
feelings of being stigmatised. It was a new period of transition and adjustment.  
6.2.1.1. Losses and limitations   
Physically, continuous oxygen therapy indicated to the participants that they had lost a 
significant amount of lung function. The women found their activities and ability to access 
certain spaces, already restricted by their breathlessness, were further limited by their 
oxygen. At home, oxygen cylinders and the concentrator took up space and the women’s 
freedom and range of movement was limited by the length of their oxygen tubing. Helen 
had high functional mobility and was able to walk about independently with her oxygen. 
Margaret, however, whose disease was further advanced, was functionally very limited and 
needed to use a motorised scooter to get about. She could not access other social spaces such 
as movie cinemas and cafes with steps. Camping and going to beaches and swimming pools 
were logistically difficult to manage. Margaret “loved the beach… I can’t go to the beaches 
the way I used to, I need the oxygen which I can’t have around the sand.” Going out meant 
having to carry oxygen cylinders, tubing and spare batteries and the women needed to plan 
their outings to ensure an adequate supply of oxygen. Helen expressed her loss: 
We loved camping, and now we can't do it. I just got rid of all my exercise 
equipment… I don't want it as a reminder of what I can't do…We'll replace it 
by oxygen concentrators and tubing and batteries.  
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The women’s physical losses and limitations generated social losses. Margaret and Helen 
had lost most of their friends who they felt did not understand their situation and found it 
too hard to accommodate them in social arrangements. Margaret said: 
That’s the hard thing too, your social life. I mean I’ve lost basically 95% of my 
friends because it’s too hard for them to want to keep in contact…. I was 
devastated because I’ve always done everything I can to help my friends.  
The two women felt the visible and constant presence of their continuous oxygen impinged 
on their identity and sense of self.   Helen had always viewed herself as a fit and active 
person. The limitations posed by her advanced disease and oxygen therapy meant she was 
unable to engage in her fitness activities in the usual way. She experienced an altered sense 
of self:  
I just cried because I just wanted to be able to go to boot camp, I feel terrible 
about my weight and people just don't get how I can't do that. I feel like saying, 
imagine… how you'd feel in yourself if that's your whole thing you really love 
doing, and for me that's what it was, doing my exercise. I loved it, it was my de-
stressor. 
The visibility of their oxygen tubing threatened their female identity by making them feel 
less attractive. Margaret felt rejected by potential partners:  
Now no one really wants to go out with me cause the first thing they see is the 
nasal prongs and like something’s wrong with me cause as soon as you’ve got 
nasal prongs you’ve got no brains...   
Helen worried about what her partner thought of her when he looked at her with oxygen 
tubing and felt that oxygen and breathlessness intruded on intimate moments:  
You feel terrible about yourself… I hate looking at myself in the mirror especially 
when I've got oxygen on…You’ve got this tube attached to you…I’m half the time 
thinking, oh god, what’s he thinking about when he looks at me?     
6.2.1.2 The burden of oxygen therapy 
The women felt that their oxygen was a physical and economic burden. Physically, oxygen 
cylinders were literally and metaphorically a heavy weight. Oxygen was a financial burden 
although it was medically necessary. It was not funded equally in all Australian states and 
the participants reported different levels of government subsidy. Some states subsidised all 
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oxygen equipment including a large concentrator, while others, as in Margaret’s case, 
provided oxygen cylinders only for a fee. Margaret was a single woman on a disability 
pension. She reported that she was paying $400 a month (almost one fortnight’s payment of 
her pension) for her oxygen cylinders. Helen and her partner had to undergo expensive 
kitchen renovations to change from gas to electricity.  
The women did not receive funding for portable oxygen concentrators which facilitated their 
ability to participate in exercise and activity and, in turn, social engagement. They reported 
that they could not afford portable concentrators which cost between six and seven thousand 
dollars. Margaret and Vidu’s parents paid for their portable oxygen concentrators while 
Helen’s mother paid for a large stationary concentrator for home. This in itself created a 
feeling of being a burden to family. The women would have preferred to use liquid oxygen 
which was light and convenient but this was not available. As Helen said: 
 In the UK they have liquid oxygen so you have a big tank and you fill it up 
yourself and they're much lighter and it's a much better system.  I don't know 
why they don't have it here. 
The burden the women felt was increased by the inadequacy of the criteria used to assess 
their oxygen requirements as younger people.  Margaret and Helen reported that their 
oxygen needs were assessed on the basis of spot checks of their oxygen saturation levels at 
rest and did not take into account their function and activity level. According to Margaret, 
her oxygen saturation at rest was not low enough to ensure funding for her oxygen even 
though functionally she clearly demonstrated she needed it to manage activities of daily 
living. Helen was a young mother of two preschool aged children and working two days a 
week. Her assessed requirements for oxygen did not take into account her exercise and 
activities at home, work and caring for her children and were inadequate to meet her 
requirements. It was only when she assertively advocated for herself that she was able to 
access the extra oxygen she needed: 
 They take your sats (oxygen saturation level), oh your sats are really good, and 
they say, you can have three bottles of oxygen for the week and I'm like, that's 
not going to work for me… I'm 40, I've got two young kids, I work two days, I 
need oxygen to survive… I said I need another bottle of oxygen.  She goes, well 
you can't have it… I said well, you know, forget it, I'm just going to phone the 
oxygen company… and just say I need more oxygen, I've run out, and I said, I'll 
just get my specialist involved, and they're like, no, no, no, don't do anything… 
 
 
166 
 
later she goes, you can have your six bottles.  
Helen displayed resilience in organising her oxygen supply. As an articulate, well-educated, 
professional woman, her self-efficacy was evident in her belief in her own ability to solve 
her problems and reach her goal of obtaining adequate supplies of oxygen. She showed self-
determination in deciding her oxygen requirements, and self-reliance and self-advocacy in 
being able to voice her needs and negotiate the bureaucracy of the supply system. While the 
necessity of relying on her own abilities so early in her illness was a psychological burden 
compounding the physical burden of her illness and the therapy itself, it also enhanced her 
sense of autonomy, control, and confidence in her capacity to manage any ongoing health 
issues. 
Helen was the only participant to be living with oxygen therapy while caring for young 
children. Her illness and oxygen therapy added layers of complexity and challenge to her 
already demanding role of mothering two preschool aged children while also working. 
Helen was still adjusting to having a new baby when she was diagnosed. She left hospital 
experiencing the emotional disruption and loss of being forced to wean her daughter and 
accommodate oxygen equipment. At the time of our interviews her children were three years 
and sixteen months old respectively. The fatigue associated with Helen’s illness meant that 
she lacked the energy to manage her two active children and this was exacerbated by nightly 
disrupted sleep due to her children’s frequent waking. She was perpetually exhausted. 
“Some days at the end I'm exhausted…I just totally give up, I literally have not one ounce 
of energy in my body to even make dinner”. It was a difficult cycle to break and increased 
her sense of struggle and burden. 
Oxygen interfered with Helen’s ability to lift her children and participate in and enjoy 
activities with them. At home it was difficult for her to move quickly enough to prevent falls 
and break up fights between the children. Attending medical appointments with two children 
was not possible on her own. Pushing a stroller affected her breathing, making even going 
for a walk with her children too hard. She expressed the burden of her oxygen: 
I get really bad shoulders from lugging the oxygen around all the time, 
especially if I've got Emma (pseudonym) in one hand and the oxygen in the 
other. It really hurts. It's really heavy because I'm carrying 15 kilos.  
The children also restricted Helen’s ability to manage her health. They played with her 
oxygen tubing and the settings on her concentrator causing her oxygen saturation levels to 
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drop. Although she had a treadmill it was difficult to exercise independently at home when 
the children were around and she rarely used it. Constantly supervising her children around 
her equipment added to the burden of her oxygen: 
People are always treading on my oxygen… they're always switching my 
concentrator on and off… or they're changing the setting…The other night… I 
was thinking, I just really don't feel like my breathing is brilliant… I just felt 
awful. Then I suddenly thought, my God, I hope my oxygen's up because 
Emma's been fiddling with the dial…. it had been basically turned down to zero. 
So I had no oxygen for nine hours and I've been running around. 
Helen’s illness and periods of hospitalisation disrupted her children, particularly “affecting 
(my son) badly”. He resisted going to day care after Helen had been in hospital and displayed 
aggressive behaviour towards other children while there. At home he had nightmares, “gets 
very angry at me…or just panics”. Helen felt frustrated and isolated when she searched but 
found no resources to assist her in explaining her illness, oxygen therapy and hospitalisation 
to her young children. She knew of no other women in her position, either locally or 
nationally, with whom to share her experiences. In this context, she found online 
communication with women overseas was a vital source of social support.  
Helen experienced a spectrum of emotions in her mothering role. She loved her children and 
was grateful that she had them before she was diagnosed. At the same time she felt guilty 
and frustrated at the restrictions her breathing and oxygen imposed on her ability to interact 
with her children. “I feel like I'm not doing enough for the kids because I'm limited to what 
I can do now because of the oxygen.” She felt “sometimes like a bit of a failure or I’m not 
doing a good enough job” as a mother. Uncertainty and fear as to whether she would be 
alive to see her children grow up was a constant presence:  
You just think I don’t know what's going to happen tomorrow…I'm stressing 
about the transplant now…What happens if I don’t make it? What happens if I 
have rejection? I want to know the figures about life expectancy after 
transplant... I just need to know because I've got the kids and I want to see them 
get up to their 20s. 
6.2.1.3 Feeling stigmatised  
The participants experienced stigma in public spaces, commonly in relation to their use of 
a disability parking scheme which allowed them to park their car in specially designated 
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parking spots that were closer to facilities and shopping centre entrances in order to avoid 
walking long distances and becoming breathless. Although they were wearing oxygen, their 
appearance of being young and otherwise well meant that other people assumed they were 
misusing the disabled parking spot and they frequently experienced disparaging looks or 
verbal abuse, chiefly from other disabled or elderly people. Helen described the stigma she 
received and how she responded: 
I think it's because I've got the kids and I don't look sick…I get it all the time… 
This woman started screaming from her ute, what are you doing parking in the 
disabled bay? We need that…so I just got my leaflet and said, you know what 
lady, I'd love to swap lives with you. Read this and educate yourself before you 
start making judgments… Sometimes I feel I have to actually make myself worse 
than I am, especially when I'm shopping. 
Patricia, Helen and Aiko were excluded from yoga classes because of their oxygen. Patricia 
said, “I used to do yoga, even with my oxygen, until the person that was taking the class 
said to me one day, I think you should give it up”. Margaret felt that she attracted unwanted 
stares, looks of pity and people deliberately crossing her path: 
Being in the scooter… going along the aisles (of the supermarket) and… it was 
so blatant… this woman kept staring …. Some look at me with pity…. A lot of 
them do it out spite, especially to walk in front of me.  Because I'm young and 
on oxygen in a scooter I must have done something to myself to be like this. 
 
The participants responded to stigma in a number of ways - “fighting” back verbally 
(Margaret), ignoring (Patricia, Helen, Margaret), handing out information brochures about 
LAM to raise awareness (Helen), giving up the parking space (Patricia), parking further 
away (Irena) or exaggerating symptoms of breathlessness to avoid stigma (Helen). Irena 
even pretended to limp to be visible and appear acceptable.  Margaret could ignore stigma 
when she felt well but retorted angrily when she felt unwell:  
I wasn’t feeling well, I hadn’t slept, and then things get on top of me a lot 
easier…She goes, what the bloody hell do you think you’re doing parking in a 
disability spot?… I just turned around and said…Would you like to see my*** 
(swearing) lungs?... cause I can’t*** (swearing) breathe. 
 
 
169 
 
Helen felt that her manager made assumptions about her work performance because of her 
oxygen. The stigma she experienced was more subtle and took the form of inflexible work 
practices, being overlooked for positions, and being made to feel ignored, isolated and 
ostracised. She was denied the flexibility to work from home so that her oxygen could be 
more easily accommodated, and felt that her opinions and skills were discounted. In contrast 
to her ability to advocate for herself in other situations, Helen felt restricted in what she 
could say, fearful of losing her job in the context of needing the income and accumulated 
benefits it provided. She also enjoyed her work, “it keeps me going”:  
I'm on quite a good wage if I was working full time but that's now not happening 
…I have to stay there because of the benefits…I'm scared about leave…I'm 
never consulted about anything…I kept coming up with ideas, they were just 
like oh no… that wouldn't work… I thought I just want to resign from this, I 
can't do this anymore. It's just too hard. I'm not being respected as an 
experienced worker, I'm being devalued. I'm basically just seen as nothing, just 
like a cleaner. That's how I was feeling… normally I would change jobs, I 
wouldn't stay in a team like that.  
6.2.2 Enabling - the positive meaning of oxygen 
The participants were able to perceive positive meanings for their continuous oxygen as 
they accepted it as part of their everyday life, adapted to it and learned to manage it. In a 
positive sense, oxygen enabled them to not only survive, but also participate in everyday 
life at this advanced stage of their illness. Being able to engage in exercise, work, and social 
activities allowed them to preserve a sense of normality and control. 
6.2.2.1. Staying alive 
Staying alive was the enduring meaning of oxygen for the participants at the late stage of 
their illness. Margaret’s lung function was severely impaired and she had experienced 
respiratory failure. Her life depended on her oxygen. Initially she had felt self-conscious 
about it but, over time, so intimately attached to it in all that she did, she embodied it. “(The 
oxygen) is just me…I need it to breathe.”  She accepted it and it became a silent extension 
of herself. In sustaining life, oxygen was a therapy of hope for quality of life, for Patricia, 
Vidu and Helen until transplant or, in Margaret’s case, until the end of her life.  
6.2.2.2 Preserving normality 
Rather than focusing on the limitations of oxygen therapy, Patricia concentrated on the 
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possibilities for activity that oxygen enabled and put these into action. Throughout the 
course of her illness Patricia had adopted a pragmatic attitude. She had demonstrated her 
resilience in capably managing her own health and her intellectually disabled son’s complex 
medical and social needs for five years while using intermittent oxygen therapy, as well as 
working part time. Seeing her oxygen as enabling allowed her to fulfil her responsibilities, 
continue to exercise, and remain socially connected. In turn this provided a sense of 
normality, maintained her stamina and positive mood, and preserved her identity. She 
continued walking, swimming, going to the gym every day (walking on the treadmill, doing 
light weights), ten pin bowling, yoga and bike riding using oxygen: 
I walked and I went to gym every day and just got on the treadmill, I had my 
oxygen and I did light weights - I still ten pin bowled… I started riding with my 
oxygen on my bike…I swam…  
I went on a cruise with my mother-in-law… and I took about six bottles of 
oxygen in a shopping trolley and I went through every last bit …I got around - 
I had my oxygen in my backpack…I got off every day…I walked around the 
town. 
Oxygen also enabled Patricia to participate in caring for her father when he was seriously 
ill and she applied humour to attending to her father’s needs even while her own breathing 
was compromised: 
When Dad was first sick, I remember looking after him one day… I said to him, 
now, Dad, just stay there, don't move… the top half of his bottom was nearly 
over the bed, and I said to him, Dad…you and I will have to take a puff each of 
the oxygen to get you back up…I got him on the bed. I managed to. 
6.2.2.3 Feeling liberated  
Sarah’s story illustrated her creative thinking and ability to see possibilities for using 
oxygen. Oxygen was liberating for Sarah. Although she did not medically need to use it, 
and because she had the financial resources available to privately purchase an oxygen 
concentrator, Sarah uniquely advocated for an oxygen prescription in order to be able to 
exercise more intensely on her treadmill at home and maintain her identity as a fit and active 
person in order to be a role model for her daughters. “I didn’t want it (LAM) to define me”. 
For Sarah, oxygen positively meant empowerment and liberation in taking control of her 
exercise and walking at a faster rate:  
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I said to him (my husband), I want to get an oxygen concentrator at home and 
a treadmill and I want to walk with oxygen. He really didn’t like the idea at 
all…I said, no, I need to move and I’m not able to move fast enough on my own 
steam… I feel frustrated that I can’t go and it’s really annoying me, and I don’t 
want my kids to ever think that I’m not a very active person. I want them to see 
that because that’s who I always was…In the end I got it… I just thought it was 
very liberating …if I can do what I want, then why wouldn’t I? 
The participants demonstrated that oxygen therapy was a paradox, in both disrupting their 
lives and enabling them to be active. Negatively, they experienced a loss of freedom and 
friendships as their oxygen equipment and advanced disease restricted their movement and 
access to social spaces. Oxygen therapy was a physical and economic burden. Its visibility 
threatened their identity and created feelings of being stigmatised in public spaces and 
workplaces. Positively, oxygen therapy enabled the women to stay alive and participate in 
exercise, work, and social activity, in turn allowing them to preserve a sense of normality 
and control. 
6.2.3 Turning points and shifting perceptions 
Vidu and Helen demonstrated how their perceptions of their oxygen therapy shifted and 
influenced their resilience. Vidu experienced a turning point when she changed from 
intermittent to continuous oxygen in the year before her transplant, ten years after her 
diagnosis. This represented significant illness progression and negative change. With the 
constant presence of oxygen, and experiencing increasing breathlessness and periods of 
anxiety and panic, she was no longer able to avoid her illness but continued to avoid showing 
people her oxygen. However, to maintain this strategy, she now had to confine herself to 
her home and avoid face to face social interactions. Avoidance now meant social isolation 
rather than normality.  
Vidu demonstrated a lower level of resilience at this transition. While avoidance had been 
an effective means of coping earlier in her illness, it was now an isolating strategy. 
Additionally, in relying heavily on her family for support, Vidu had not developed personal 
resources to assist her in adjusting to the change. She entered a liminal phase of feeling 
trapped and socially marginalised. She was uncertain if she would survive. She used 
metaphors of chains and death to demonstrate her loss of freedom and feelings of being 
imprisoned by her breathlessness and oxygen. She felt she was giving up on life and had 
thoughts of dying. Her perception was one of suffering and, with limited resilience, she 
 
 
172 
 
struggled to endure: 
I couldn't breathe then, I was so tired… I was a bit isolated… I didn't go 
anywhere, I was just chained inside… I didn't want to go, because I can't… I 
just didn’t want them (her neighbours) to see me with oxygen…Sometimes I was 
scared…I just thought why should we suffer like this? It’s better if I die now.  
Helen showed how her agency and self-advocacy shifted her perception to enable her to 
view her oxygen as having positive benefits. Helen had entered a liminal phase when she 
was diagnosed due to the early rapid progression of her disease and the uncertainty of not 
knowing how quickly she would need a transplant. Although sirolimus medication had 
stabilised her physically she still felt emotional and mental disruption due to her inability to 
access adequate social support. Helen’s agency was apparent in her determination of her 
need for additional support and her advocacy in independently organising affordable home 
services:  
The company that does my oxygen prescription, I had a big meltdown with 
them…I just said, there's no services and you don't help me at all really…So 
they got a healthcare assessment…It was a bit tricky because I didn't really fit 
the criteria… I said I can do it (housework) on oxygen but off oxygen I couldn't. 
So I think that's how I got through the system. So then they started home care 
services. 
Accessing home help was a significant positive turning point which shifted Helen’s 
perception of her oxygen as a burden to one of seeing it as enabling. Helen’s first narrative 
was focused on a negative view of her life on oxygen as one of struggle and heavy burden. 
Her second narrative, in contrast, had a positive focus of moving beyond coping to adapting 
to her situation. In doing so the intensity of Helen’s liminality was lessened. Home help 
restored Helen’s energy, gave her time to herself and enhanced her optimism and resilience. 
She still lived with uncertainty but, with the additional social support, she felt greater 
emotional and mental stability and could now see possibilities for her life. She took control 
and decided independently to return to exercise at the gym:  
I've got a really wonderful woman that comes in…(She) now comes to (the 
kids’) swimming lessons…So I’m achieving that and that’s something I never 
thought was going to happen - to give my kids the opportunity…Then she does 
an hour’s cleaning. She's babysat a couple of times so my partner and I've 
actually got out…I now have a bit more energy so I can do a bit of cooking...  
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I just decided…I was feeling just so depressed because I wasn't exercising - 
because I love exercising. So I just thought I'm just going to phone my own 
gym…I just said, These are my worries, I am on oxygen, I really hope you can 
look beyond that. I'm responsible for my own oxygen. 
By exercising at the gym Helen regained a vital aspect of her identity and, although she 
could not exercise in the same way as before her diagnosis, exercise elevated her mood, 
improved her self-image, and gave her a sense of achievement and normality. The benefits 
Helen was feeling flowed on to her family so that family interactions were also more 
positive: 
I just felt so normal…even though I've got the oxygen I just feel really 
normal…I've built it up (riding her bike) from four minutes right up to eighteen  
now. I just check my oxygen…I just feel so good. It just makes me feel happy 
and I feel really like I’ve achieved something… 
I went to the gym and then I said to my partner, let's go for a walk. That was 
something we always used to do all the time with the kids. It was just lovely… 
my partner and I actually talked normally without arguing. It was just a little 
bit of normality without focusing on LAM. 
Helen’s actions in organising her oxygen supplies, mobilising home services, and managing 
her health increased her self-efficacy and feelings of autonomy and competence. In adapting 
to her illness, Helen demonstrated resilience in her acceptance of both “good days” and 
“bad days” in her life with LAM and her confidence that she had developed strategies for 
managing the “bad days” and moving on from them: 
 I have good days all the time…I think it's just time goes by and you just get 
more used to adapting. I'm not going to let this thing beat me… I think you're 
always going to have bad days… I just Facebook or talk to… (my friend with 
LAM)…Then… I think it's not worth doing that for more than two days… it's 
just not worth it for your own health and everything. So I just can pull myself 
(up) - luckily I know, and I just go to the gym. 
Helen and Vidu demonstrated the connection between resilience, coping style and 
perceptions of illness or wellness. Vidu’s avoidance style of coping, lack of experience in 
learning to manage her illness, and lower resilience prevented her from seeing the positive 
effects of her oxygen and she associated it with illness, restriction and isolation. Helen’s 
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resilience increased as her perspective shifted to view her oxygen as enabling possibilities 
of experiencing wellness when she mobilised adequate social support.   
6.3 Living a liminal existence – respiratory failure and waiting for a 
transplant 
The late stage of LAM marked the progression of the participants’ illness to respiratory 
failure or lung transplant. At this stage the women experienced a marked decline in their 
function and mobility, persistent breathlessness, anxiety, and needed to use oxygen 
continuously.  Only three participants reached this stage. Margaret experienced respiratory 
failure and Patricia and Vidu each received a lung transplant. Respiratory failure, being 
listed for transplant, and receiving a transplant were major turning points when the women 
tangibly faced mortality. Their stories revealed their struggle and suffering, resilience, and 
experiences of liminality and personal transformation. While there were commonalities in 
the women’s experiences they were, at the same time, very individual according to each 
woman’s own physical condition, existing resilience, personal resources, social context and 
coping style. Spirituality and social support were significant factors which enabled them to 
be resilient and live with their suffering. 
The late stage of LAM was a transition to new life after transplant or end of life from 
respiratory failure. It was a liminal period in which the participants moved from a relatively 
stable physical state to one of instability. Turning points marked entry to this transition. For 
Margaret, two life threatening hospital admissions for respiratory failure and a complicated 
pneumothorax were critical events that indicated severe disease and forced her to evaluate 
her life as she faced the very real possibility of her own death. Being listed for transplant 
intensified the liminality associated with Vidu’s oxygen therapy. It was a turning point 
which ushered in a heightened period of uncertainty and waiting. At this stage of their 
illness, life was precarious as the women hovered between life and death. It was a shadow 
existence at the margins of physical and social life. Their life was characterised by struggle 
and a shrinking social world as their ability to interact socially became more limited. They 
struggled to carry out the simplest of tasks. Illness dominated the foreground of their 
consciousness as they became acutely aware of their breathing. Struggling to breathe was 
frightening and they experienced episodes of anxiety and panic.  
Liminality at this stage was a time of struggle and suffering. There was, however, a marked 
difference in the women’s perceived levels of suffering which corresponded to their 
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individual levels of resilience. Patricia and Margaret had demonstrated high levels of 
resilience throughout their illness while Vidu had a low level of resilience due to her usual 
practice of avoidance. Patricia only alluded to her struggle and did not convey a sense of 
suffering. Margaret relayed her struggle and suffering but emphasised her positive 
perspective and ability to cope with her situation. In contrast, Vidu conveyed the deepest 
sense of suffering and difficulty in enduring. 
Being listed for transplant increased Vidu’s suffering by adding a further dimension of 
heightened negativity, uncertainty and waiting to the liminality she felt in using oxygen 
continuously. Her blood group was rare and the possibility of finding donor lungs was even 
more uncertain for her. She felt that dying would end her suffering. Vidu used her strategy 
of avoidance to cope with this stage. Although she was unable to avoid her own suffering 
she avoided discussing the severity of her condition to limit her negative thoughts and lessen 
her family’s worry:  
I didn’t want to show them (her husband, daughter, parents) that I am suffering 
like this…I was avoiding that. I didn’t want to discuss it because I knew…if I 
don’t get a lung then they would be upset…I thought actually it’s better if while 
I was sleeping if that (dying) happens…so that no one will feel it. Even I will 
not suffer.  
6.3.1 Being in hospital  
Margaret’s life threatening hospital admissions were both turning points and a paradox. At 
these turning points Margaret’s life was threatened by her deteriorating physical condition. 
However, paradoxically, her hospital experience represented success in surviving a life 
threatening situation and was also socially positive. She felt less isolated and part of the 
hospital community through her interactions with other patients and nursing staff. These 
interactions maintained some continuity of her sense of self and balanced the impact of her 
physical decline.  
Margaret demonstrated resilience in response to the disruption of her physical deterioration 
and being in hospital by choosing an attitude that was consistent with her personal identity. 
She gained a sense of control by presenting herself as a “fighter”, and a sense of purpose 
and feelings of self-worth by being an expert and “mother hen” to other patients and nursing 
staff. Her “fighter” self was apparent as she told of her stubbornness and attempt to continue 
to self-manage her breathlessness when the ambulance arrived to transport her to hospital, 
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even though she “could hardly breathe and talk…and was just grey and…completely blue 
on the lips”. 
Margaret presented herself as an expert in managing anxiety and breathlessness by advising 
other patients experiencing these problems how to manage them. Her medical notes record 
that in fact Margaret was not able to manage her symptoms as usual. Anxiety triggered 
multiple medical emergency calls for respiratory distress and she required medication to 
settle. She did not mention that anxiety had been a problem for her in hospital. This omission 
was interpreted as her attempt to maintain a positive attitude and reinforce her identity and 
ability to cope with adversity by choosing to present this aspect of herself in her narration:  
When I was in hospital this time there was a lady across from me… she was 
having problems breathing and I know what it feels like to have the panic 
attacks…I said, Breathe in when I breathe in, and breathe out when I breathe 
out, Mary… I could see her starting to relax cause her panic was going from 
her face… within five minutes she was fine. 
In her relations with nursing staff Margaret presented herself as an expert, a fun, positive 
person, and a “mother hen” by providing brochures and education about LAM, enjoying 
humorous banter with the nurses and striving to “help” them by making few demands on 
their time herself and by keeping an eye on the other patients:  
Three o’clock in the morning… they’re (the nurses) having their coffee break 
and we were talking so I got to know them really well…I had to laugh because 
one came in and… he goes, I’ve got you tonight, and I went, Oh you poor bugger 
(laugh) and he goes, No we fight over who gets you… because when you buzz 
you’ve actually got something wrong or you’re helping someone else.  
Vidu was hospitalised for a pneumothorax two months after she was listed for transplant. 
In contrast to Margaret who was active in the hospital context despite her physical condition, 
Vidu emphasised the suffering she was experiencing at that time. Vidu had not developed 
strategies to manage her symptoms and had a correspondingly lower level of self-efficacy 
and resilience. She took a more passive role of depending on her family and nursing staff to 
assist her in even basic activities and managing her anxiety. She was highly anxious, 
“always asking for oxygen… (and) couldn’t go to the toilet alone.” Members of her 
healthcare team recorded her high level of anxiety. Nurses documented that she was 
“agitated and anxious, SpO2 (oxygen saturation) 82%, requiring assistance with ADLs 
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(activities of daily living)”, and the psychiatry team that she “experiences panic symptoms 
- has become increasingly dependent on family for perceived safety.” Vidu said: 
I wanted someone so I was just insisting whether I could keep someone (from 
my family) because I know the nurses are really busy and I can’t depend on 
them… I was so panicked then. I thought I will die.  
6.3.2 Living on the margin   
Margaret’s narratives described her struggle to manage everyday life as a single woman 
living alone with severe disease. She was living a marginal existence physically, socially 
and financially. At home, following her discharge from hospital, Margaret struggled to 
manage activities of daily living. Physically, she was experiencing persistent pain due to her 
lung disease and kidney growths and was only able to move about indoors using her scooter. 
Her breathlessness interfered with her ability to shop, prepare meals and eat and drink. She 
gave a vivid description of the difficulty she had in making simply a salad and a cup of 
coffee.  
When dad was here… I don't think he realised how bad I was until he saw me 
when I came out of hospital… I was just cutting up vegetables for a salad…I 
had sweat, like a tap on my head.  Sweat was just coming off me and I was 
fighting to breathe.  He goes, you're going grey.  He goes, stop, go on your 
nebuliser, and he finished it.  He didn't realise the energy it takes for me…even 
to make a cup of coffee…and I'm out of breath… 
…Every winter I have lung infections for longer.  They're more severe.  I have 
to drive my scooter into the bathroom… I drove straight in, turned the seat 
sideways, and to lift my bottom from there onto the toilet I was fighting to 
breathe.   
The metaphor of “fighting” illustrated this struggle that was part of her daily life. She 
referred to “fighting to breathe” and February as the “killer month”. Her “fighter” identity 
responded to the struggle, “fighting” not only to breathe but also to maintain some level of 
independence and continue to live alone in her own home: 
 I hate having to rely on people… I'm so bloody stubborn and so independent.  
6.3.2.1 Living with hardship  
Margaret was disadvantaged financially, and suffered economic hardship. The cost of 
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additional medications stretched her budget to the limit. She could not afford fresh fruit and 
vegetables, or high energy supplements that may have been useful for her to ensure an 
adequate nutritional intake. Social support was crucial for Margaret’s resilience at home at 
this stage. She depended on the practical and financial support of her mother in helping to 
pay for her medications and providing home cooked meals for her. Her financial worries 
were one of the main sources of stress for her at this stage and further exacerbated her 
physical symptoms:  
 Usually I'll be spending about maybe $90 or so a month (on medicine) - that's 
when I'm healthy.  When I'm not healthy then you've got the antibiotics and 
everything else.  I get, like, $500 a fortnight.  That's food, electricity, 
medicine… I can't afford fruit and vegetables…they cost a fortune…That 
stresses me like you would not believe…and when I stress about that my body 
tenses and then my breathing goes.  
6.3.2.2 Living in a shrinking social world  
Margaret’s social world was shrinking. Breathlessness, pain, immobility, and her inability 
to afford to continue running her car meant social isolation. The most difficult aspect of her 
illness to deal with was “not being able to get around by myself that much…and not having 
anybody in my life”. She was unable to continue with her dog rescue work and lost her social 
interaction with visiting potential owners and the puppies. Her identity and sense of self 
were threatened by the loss of this mothering role and sense of expertise and 
accomplishment she gained through that work:  
I cried. God, I cried (when I gave up dog rescue)… not just because I was giving 
them a chance at life. but seeing the people when they came to pick them up… 
I still miss my dog rescue… with children or animals, I have the patience of a 
saint … I had (one dog) trained in a week. 
Although she still lived alone, growing dependency altered Margaret’s regular social 
relationships. Her family and close friends continued to support her but, for Margaret, her 
relationship with her mother and her friendships were becoming overlaid with a sense of 
being a “burden” causing her to lose reciprocity in her relationships.  Margaret was 
particularly concerned about the toll her illness was taking on her mother. Her “mother hen” 
identity was evident as she attempted to balance the relationship by reversing the 
mother/daughter roles and taking on a mothering role herself, protectively limiting the 
amount of time her mother spent with her. Dependency was also balanced by continuing to 
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provide care for her dogs.  
 I get down because I feel like I'm a burden.  Mum's 67 this year so I don't want 
her to do too much for me…I said, live your life… I have to, she’s the one who 
has to drop the apron string, not me (laugh), you know it’s the other way 
around.  
Vidu was similarly socially isolated by her illness and depended on her family for practical 
and financial support. She rarely went out during the day due to breathlessness and fatigue 
and, by choice, to avoid revealing her oxygen use. She washed herself by a sponge bath. 
Her husband showered her on weekends and attended to shopping and other chores. Vidu 
was less physically impaired than Margaret and was able to walk slowly and cook at home. 
She also had more financial resources at her disposal. Her husband was working and so she 
was able to afford a cleaner, running a car, and adequate supplies of fresh food. Being able 
to drive a car with her oxygen if she chose gave her greater mobility than Margaret. 
Although Margaret was the most socially isolated by her illness and her circumstances she 
demonstrated greater resilience than Vidu who isolated herself further by her avoidance 
strategy. 
6.3.3 Living with struggle and suffering 
The women drew on their personal and social resources to live with the struggle and 
suffering associated with this liminal late stage of the illness. The accumulated knowledge 
and skills they had gained over the course of their life and through their illness experience 
contributed to Margaret and Patricia’s resilience. Vidu struggled to endure her suffering but 
a social turning point shifted her perspective to enable her to endure until she received her 
transplant. Each of the women experienced spiritual and personal growth and were 
supported by their family and close friends. Family relationships, and, in Margaret’s case 
her pets, continued to give their lives meaning and a sense of purpose. These were a source 
of hope and crucial elements in living with their suffering.  
6.3.3.1 Coping and persisting - Patricia 
Patricia’s resilience was evident in her ability to persist through her struggle with 
breathlessness. She did not perceive herself as suffering. Patricia continued to present 
herself in her narrative as managing her health at the late stage of her illness, the year before 
her transplant, in the same pragmatic way she had since her diagnosis. She emphasised her 
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positive perception of herself as independent, persisting and coping in spite of her severe 
disease. Her younger son, husband and close friends provided social support in this period. 
“I just tried to hang onto what I had, and my friends were quite supportive.”  Her regular 
exercise and spirituality were instrumental in supporting her resilience and ability to cope 
while waiting for transplant:  
 I needed oxygen more and more - I couldn't bike ride. The dog was 15, had hip 
dysplasia…Him and I struggled round the block every night - we walked…I 
struggled with the breathing, and had the oxygen tank…everybody knew me as 
the lady with the limpy dog and the oxygen…  
I became very spiritual…I bought a lot of angels … I went into the Catholic 
Church…and lit some candles … I think it helps with coping…I meditated… it's 
a stillness, a quietness, a calmness.  
She remained hopeful by choosing to avoid thoughts of death and the possible consequences 
of a transplant: 
 You don't think about it (dying), because if you think about it, it just makes it 
worse… I think keeping active and walking and going to the gym - just keeping 
yourself busy, and then resting when you need to. I still had to cook and all of 
that for myself…. It's just a matter of do it, you know… The outcome is going 
to happen, whatever. I was lucky. I was blessed to get a transplant. 
6.3.3.2 Feeling transformed by compassion – Vidu 
While her suffering continued until her transplant, Vidu simultaneously experienced a 
turning point of positive transformation as a result of compassion extended to her by her 
family, doctors, nurses and other patients. Vidu’s South Asian chest specialist encouraged 
her Buddhist spirituality. He “meditates a lot…he was always telling me, just meditate, be 
positive.” Similarly her father gave her “moral support” by reminding her of their Buddhist 
beliefs, “he was just telling me to do good things, be kind to people, help whenever you 
can…then it will be easier for you to cope…think positively.” Her husband “was 
praying…he was encouraging me.”  
In hospital, her doctors and nurses provided compassionate care and offered positive 
messages and prayers. One nurse “was telling me I’m always praying for you. You will get 
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a lung as soon as possible. If you get a lung, don’t worry…Even the doctor… he said don’t 
worry…we’re praying for you.” Vidu met other patients who had received lung transplants. 
She saw they were “so active and doing this and that.” They gave her a belief that she 
would be well after a transplant. “Don’t worry, if you get a lung you don’t have to suffer 
like this. You are going to get a lung. Think positively.”  
The compassion offered to Vidu had the powerful effect of transforming her negative 
feelings of giving up life and wishing for death into positive feelings of happiness, a renewal 
of her will to live, hope to receive a transplant, and an outward turning to others through her 
desire to extend loving kindness to all: 
 It gave me hope when I saw these transplanted people and when they were 
talking about the good side of it. I got positiveness and I was just thinking that 
I wanted my life back. I wanted to fight for it… I think at that stage I was giving 
up everything… So when someone said that they prayed for me… I felt that I 
had to live. I can do a lot more for other people if I live not just to waste my life 
like this… I was just happy about people because they are praying for me.   
Compassion enhanced Vidu’s resilience. While she remained in a negative situation, 
positively she had been transformed mentally and spiritually. Through her practice of loving 
kindness meditation, she was paradoxically elevated from her physical reality to a spiritual 
plane of calm and detachment which enabled her to endure her physical suffering: 
To calm myself down… I always sent loving kindness to other people, at first to 
myself and then to others…I forgot about my breathing …I didn’t get angry… 
It's really a calm feeling and you feel good about yourself and others… you are 
not getting attached to everything… 
I was so happy now, I just wanted to go - I was waiting - I was looking forward 
to it…I was not scared about the transplant because at that stage I knew that 
this was the last option for me. If not there’s no point in living like this…There’s 
no point in suffering like this.  
6.3.3.3. Facing death and living with hope – Margaret 
Facing the end of her life was a major issue confronting Margaret. She introduced the subject 
of death early in her first interview with “I was in high dependency cause I flat lined three 
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times”, and reflected again on her mortality at the beginning of her second interview. She 
could not hope for a transplant and lived with uncertainty as to how much time she had left. 
While death occupied a prominent position in Margaret’s consciousness after her life 
threatening hospital admissions, at the same time she vigorously continued to be engaged 
with life and have hope for the future. 
Margaret discussed the end of her life openly and frankly. She had reflected on this stage of 
her life and confronted death philosophically and practically. Her personal spiritual belief 
in reincarnation, a core aspect of her personal life meaning, supported her and enabled her 
to remain resilient by adding meaning to her life and death and providing a sense of hope. 
She distinguished between the existential fear of death and the emotion of feeling scared 
and anxious when unable to breathe. She was not afraid of death, believing in time as 
infinite, with “no beginning…no end”, and offering “continual, continual learning”. 
Margaret believed her death held a purpose and meaning of new life and learning: 
I’ve still got a lot more to learn so I think I’ll be reincarnated…I’ve got no fear. 
I mean, when you can’t breathe, yeah, you get scared. But that’s an emotion. 
Practically, death would represent an end to Margaret’s physical suffering. She had 
developed a deeper knowledge of her body over the course of living with LAM and she felt 
that she would know when death was at hand. Her positive experience of the care she had 
received during her recent hospital admissions made her believe that she would be kept 
comfortable and allowed to die peacefully: 
When it’s time for me to say goodnight my body will let me know…I’ll be happy 
because I'll be in so much pain or in so much strife trying to just draw breath 
that it'll be like a godsend.  No more pain.  No more sweating, literally sweating 
taking a breath…What’s there to be scared of?…You go to sleep peacefully, 
especially in hospital…with morphine. 
Margaret also saw death as a release for her family of the burden of caring for her and her 
own sense of being a burden: 
I don't want to be a burden on them.  When I was in hospital I did feel like a 
burden…That's why I was, like, if I'd just gone they wouldn't have to worry 
about anything. 
She demonstrated her agency by acting to relieve her family of decision-making regarding 
her end of life issues. She had discussed with them at what point she no longer wished to be 
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kept alive with medical treatment and had made notes about her preferred funeral 
arrangements. Caring for her family in a way that was consistent with her identity as a 
competent, organised person and “mother hen” gave her a sense of control and mediated 
her feelings of being a burden:  
I was just doing notes of what I really want… so then mum can just have this 
thing and go, okay, that's what she wants… I just like being prepared.  It's the 
PA in me…They all know if I get to a certain way with my health and I can't 
talk for myself, I've told them at which point basically to pull the plug…Non-
responsive, less than a 40 per cent chance of recovery… why put the family 
through it?   
Although she was living in a seemingly hope-less situation with no hope of either a cure for 
her condition or of receiving a lung transplant, Margaret maintained a sense of hope and 
purpose for the present as well as the future. Hope lay in her ability to imagine possibilities 
for her life. She believed it was possible to experience wellness and enjoyment in simple 
pleasures and her relationships with her family, close friends and pets. Furthermore, she 
believed it was possible for her to realise her chosen role of “mother hen” by helping others. 
Margaret acknowledged the anxiety and sadness she felt but demonstrated hope in her 
positive attitude, her optimism and her independent choices: 
 I think with any disease… out of some really bad adversity whether it be this, 
whether it be cancer, whether it be you have to have a limb amputated… there’s 
a future. There’s still, you wake up in the morning and you get sloppy kisses 
from your dogs.  It's so nice.  
Realistically Margaret approached the physical future with “six month plans because I never 
know” but hoped “to make it to… (her) 50th”, four years away. Hope was present in her 
setting herself a goal for six months “to be as healthy as possible…and enjoy myself…I have 
my really good days”.  
6.4 Receiving a transplant 
Patricia and Vidu’s experiences of transplant aligned with their previous illness experience. 
Patricia remained grounded and practical. When she received the phone call to go to the 
hospital she did not think about possible outcomes and pragmatically took the attitude that 
“you just automatically do what you’ve got to do.” Vidu felt shocked to receive her call. 
She was thrust into unreality, experiencing a sense of disembodiment - “I knew at that 
 
 
184 
 
moment I was not the real me”. She shifted between a state of “fear” and being “not that 
scared”. She tried to hold on to some sense of reality by reverting to her mothering role, 
preparing breakfast for her daughter before she left for the hospital.  
Receiving a transplant was a positive turning point in the women’s lives which initiated a 
change in state from suffering and limitation to renewal and wellness. The immediate 
postoperative period after transplant constituted a time of transition in which the women 
adapted to living with their new lungs and learned their medication regime and caring for 
their health after transplant.  
Patricia’s resilience and preoperative fitness facilitated a smooth postoperative recovery. 
She progressed well with no complications and had no difficulty relinquishing her oxygen 
after her surgery. She had regarded it as an aid only to her survival and activity 
preoperatively and had not embodied it. As she had accepted her need for oxygen then, 
postoperatively she accepted that she now no longer needed it. “I didn’t have it.”  
Her sense of humour helped her to remain resilient in the postoperative period. She had 
viewed her illness experience through a humorous lens and she was able to see humour in 
the postoperative hallucinations she experienced due to her medication: 
When I was in the ward after I had been in intensive care, I had really ruthless 
legs, and the drugs were sending me high… I'm sure I saw the pilot out there 
and the helicopter.  I thought it was coming to take me, and I was struggling to 
get out of bed… The staff were telling me to keep my legs to myself in intensive 
care, and I said, I can't help it, they've got a mind of their own.  
Embodying her new lungs was a more gradual process for Vidu. During the postoperative 
transition she experienced nausea, vomiting, bowel problems, chyle leaks and feelings of 
depression related to new medications as her body adjusted to profound physical change. 
Vidu also found it difficult to wean from her oxygen therapy and become used to the 
freedom of breathing only air. She had embodied oxygen therapy during her period of 
suffering. Although it was itself a metaphor for feeling “chained” and lost freedom, it was 
also paradoxically a metaphor for life as survival. At a time when feelings of illness were 
part of her transition experience, it was therefore difficult for her to release the oxygen and 
its powerful meaning of survival. “It took some time for me to get rid of oxygen.” As she 
moved through the transition period and wellness became her dominant experience, she was 
able to integrate and embody her new lungs, let go of oxygen for survival, and experience 
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the full positive transformation of transplant and its meaning of life as possibility, renewal, 
hope and the future. 
6.5 Feeling transformed 
The three women all felt transformed through their experience of liminality at the late stage 
of LAM. All experienced personal growth, a deepened spirituality and feelings of empathy 
and being open to other people and new experiences. Facing death made them less fearful 
of the end of life and enabled them to accept their human condition of impermanence and 
live calmly and contentedly in the present in whatever time they had. For Vidu and Patricia, 
personal growth was also associated with adaptation to a new stable state and moving on 
with life after transplant. Margaret, in contrast, remained in an unstable state of late stage 
disease where her illness was foregrounded. Her personal growth enhanced her resilience 
and enabled her to continue living with struggle with positivity and hope. The transformative 
growth and learning that took place in late stage liminality became part of each woman’s 
personal life meaning and strengthened her resilience as a personal resource to be mobilised 
at future turning points. 
6.5.1 A transformation of learning and growth 
Margaret felt that her experience of living with LAM had been an opportunity for personal 
growth. As her disease had progressed and her physical and social world shrank, her inner 
world had expanded, providing space and time for learning and growth.  Through this lens, 
Margaret saw LAM as a “blessing in disguise” which broadened her perspectives as she 
“learned” to slow down in attitude as well as physically, be calmer and “don’t… sweat the 
big stuff anymore”. She felt that her awareness of others grew as LAM “opened… (her) 
eyes more” to “prejudice, not just me, people towards other people” and so develop her 
sense of empathy and tolerance for others consistent with her “mother hen” identity:  
I've become calmer.  Don't stress as much…I truly believe I was given this as a 
learning curve for some reason…maybe to calm me down.  Maybe to make me 
sit back and not rush through life…Don't take things too seriously.  Let go.  
Don't worry what other people think or say. 
Margaret believed her life with LAM held purpose. “I’ve always believed you’re here for a 
reason. I believe I’ve got this disease cause I can handle it”. She hoped to contribute to the 
understanding of LAM by sharing her experience of living with her illness with healthcare 
professionals and helping other women live with LAM by showing them “they’re not alone 
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if they have this disease” :  
LAM is not something that’s well known so if there were doctors or nurses that 
you said… I’ll bring a LAM patient along and you can ask questions, I’ll be 
there… Show them the positive…take out the negative. 
6.5.2 Moving on with life after transplant 
Vidu and Patricia were renewed physically and socially by their transplants. Through the 
transition after surgery they adapted to their new stable state. Each woman regarded her 
transplant as a gift and took responsibility for caring for her health. 
Patricia was transformed physically and psychologically from the “lady with the limpy dog” 
to a “social butterfly”. The butterfly metaphor represents her metamorphosis from the 
“struggle” of slow, limited mobility and breathlessness to “freedom” of movement, 
exercising and socialising, unimpeded by illness, oxygen cylinders and tubing. She regarded 
her transplant as a “gift” that “you want to make sure you make the most of.” Physically, 
“having a transplant has allowed me to go back to living how I used to live… being really 
active.” Patricia, in valuing her transplant, desired to live life fully. She enjoyed her social 
life, resumed activities she had enjoyed before transplant, learned new ones and participated 
in sporting competitions:  
We’ve had our transplants and we’re moving on…When you have had these 
things, you don't want to be staying at home sitting in a chair. I think you want 
to be out. I'm a social butterfly… now I just want to do what I want to do… I'm 
going to go and learn to play racquetball…, when you've had no complications 
and the drugs are working well… you have to keep your side of the bargain, 
and do the right things by yourself.   
Receiving a transplant changed Patricia as a person. She felt she had “become more open 
to things, more open to suggestions… more patient.” Patricia maintained a pragmatic 
attitude towards her future. She understood that a long life was not guaranteed after her lung 
transplant. Her hope was directed towards wellness in the present by focusing on being as 
active and engaged with life as she could: 
You've got to look at it this way, I've had three and a half years, and each one 
is a bonus, isn't it?…The expectation can't be there, because nobody knows 
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when their time is to go… I think you've got to say, you're blessed to have what 
you've got… lucky enough to get a transplant.  
Vidu’s transplant extended the transformation she had experienced prior to her surgery. 
Her negativity was replaced by a positive attitude, happiness, a sense of hope and looking 
toward the future. She experienced a renewal of her social relationships, particularly with 
her husband and daughter, and no longer felt a need for the support of her parents. At the 
time of her interviews she felt she had lived “well” in the eleven months since her transplant 
and she appreciated the new quality of her life. She had let go of her fear of dying and could 
live positively in the present. She now saw life as the possibility of action, enjoyment and 
satisfaction. She felt a sense of gratitude and a strong imperative to help other people. She 
acted to organise voluntary work at a retirement village and this was a source of satisfaction. 
She was undertaking a business course and had made plans to seek part time work in 
addition to her work as a volunteer. She exercised by walking and had taken up yoga. There 
seemed almost to be a sense of urgency not to “waste” any more time at home but to “do 
what I want to do”. After coming so close to death time was more precious now. Vidu could 
now foresee a future and had a goal of travelling with her husband: 
Now I go for walks and I do everything…I’m really grateful…I don’t mind 
dying tomorrow even because I suffered a lot…At least this 11 months I spent 
well…I’m trying to find voluntary work because I just want to help people…I 
feel like I have to do something… I don’t want to waste my time… I feel really 
happy… Everything has changed, the way that I think… now I try to think the 
good side of it. Earlier it was the other way, mainly because of the illness.  
The late stage of advanced LAM was a transition to transplant or death from respiratory 
failure. The participants experienced it as a liminal existence of instability, uncertainty, 
struggle and suffering in which they confronted their own mortality and experienced 
personal growth and transformation. They found meaning in their spirituality and close 
relationships and retained agency in their active efforts to manage the effects of their illness. 
This contributed to their resilience and enabled them to live with struggle and suffering.    
6.6 Summary 
The participants who were living with advanced LAM experienced two levels of illness at 
this stage. Commencing oxygen therapy marked the first stage of advanced illness while 
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periods of respiratory failure and being listed for a lung transplant signified the second later 
stage of severe disease and disabling breathlessness. Most participants used oxygen 
intermittently initially and progressed to continuous use as their lung function deteriorated. 
Oxygen therapy represented a paradox as it held both negative and positive meanings for 
the participants. Negative meanings were associated with the visibility and physical 
presence of the oxygen equipment and the effects of advanced disease. Oxygen therapy 
added a new dimension of disruption to everyday life and the participants who needed to 
use oxygen continuously experienced losses and limitations, threat to their identity, physical 
and economic burden, and stigma.  
Intermittent oxygen therapy was less disruptive as the participants could choose when they 
used it. This allowed the women who had earlier coped by avoiding their illness to avoid 
using their oxygen where possible and hide it from others to avoid its negative effects. The 
participants demonstrated misunderstandings about how they should use their oxygen to 
gain benefit from it, including using it after, rather than during activities and while driving, 
and believing they might become addicted if they used it frequently. 
Helen and Margaret revealed that the measures applied to assess their oxygen requirements 
did not take into account their function and activity levels. Helen had to advocate strongly 
for herself in order to receive adequate supplies of oxygen. It was difficult for the women 
to access the lighter, portable means of oxygen delivery which they favoured. Portable 
oxygen concentrators, which would facilitate their ability to improve their health and quality 
of life through participation in exercise, work, and social activities, were expensive and not 
subsidised. Liquid oxygen which was lighter, more affordable and suited to exercise and 
activity was not available in Australia. There were also no educational resources available 
to support mothers using oxygen therapy and caring for young children. 
The participants’ view of their oxygen shifted as they accepted it, adapted to it and learned 
to manage it. They were then able to perceive it positively as helping them to survive at the 
late stage, and enabling them to be active. Although Sarah did not medically require oxygen, 
she regarded it as liberating and used it creatively to allow her to exercise more intensely, 
and retain her identity as a fit and active person. Accessing social support in the form of 
affordable home services shifted Helen’s perception of her life with oxygen as struggle and 
burden to a more positive view of seeing her oxygen as enabling possibilities for exercise 
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and activity which aligned with her sense of self. Her mood, self-image and family 
relationships improved and she felt a greater sense of control and normality.  
The participants strove for normality even while living with advanced disease. This 
contrasts with Pollock BarZiv’s (2005) study of lung transplant experiences of women with 
LAM who adopted a ‘sick role’ when using supplemental oxygen. In common with this 
current study, Kelly and Madden (2014), in a critical interpretative synthesis of 42 studies 
of respiratory patients’ perceptions of their oxygen therapy, reported that patients perceived 
their oxygen both positively and negatively. Likewise, Adams (2008), in a study of five 
rural patients’ perceptions of oxygen therapy, found the patients adapted to their oxygen, 
accepting that it was both restrictive and enabled greater independence. Kelly and Madden 
(2014) were unable to elucidate why some patients adapted better than others. This study 
has found that participants with more advanced disease were able to perceive greater 
benefits in their continuous oxygen therapy and adapted to it more readily. This was also 
the case for resilient participants who had an optimistic disposition, higher self-efficacy 
beliefs, and a strong sense of self and purpose.  
The participants using oxygen intermittently had more difficulty adhering to their oxygen. 
Similarly, Katsenos and Constantopoulos (2011), in a review of patient compliance with 
long term oxygen therapy in COPD, reported that poor adherence was associated with 
misunderstandings about oxygen use, perceptions of limitation, bulky and heavy equipment, 
discomfort, fear of addiction, lack of support, and stigma. According to Goffman (1963), 
stigma relates to an individual’s undesirable attributes or appearing different to what is 
expected. The stigma which the participants of this current study experienced related to their 
appearance as young, well-looking women who, although using oxygen, did not fit the 
expected appearance of a person with a disability. Carel (2013b), as a young woman living 
with LAM, also reported experiencing stigma when using oxygen.  
The participants were highly motivated to engage in exercise and preferred lightweight 
portable oxygen concentrators to facilitate their physical activity. Encouraging exercise is 
important for people with respiratory conditions as, according to Watz et al. (2014), in an 
official European Respiratory Society Statement on physical activity in COPD, regular 
physical activity reduces decline in lung function and hospital admissions. Furthermore, Dal 
Negro and Hodder (2012) have argued that lightweight, portable oxygen promotes exercise, 
mobility, social interaction and quality of life for people requiring long term oxygen. 
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Funding policy in Australia is influenced by research into the older COPD population. 
Casaburi et al. (2012), for example, in a study of 22 patients with advanced COPD, found 
that activity levels did not increase when lightweight oxygen devices were used over a six 
month period. The lack of funding for portable concentrators does not take account of 
younger, active people’s need for affordable, lighter, portable devices.  
The participants reported differences in funding for their oxygen. Similarly, Serginson et al. 
(2009), in a retrospective observational study of domiciliary oxygen therapy in Australia, 
found that funding varied across states and access to portable oxygen was inequitable. They 
recommended a national oxygen register to enable a more equitable supply of oxygen 
equipment. Five years later, the Thoracic Society of Australia and New Zealand, in the 
clinical practice guideline for adult domiciliary oxygen therapy, was still calling for this 
policy change (McDonald et al. 2014). This document also stated that the spot checks of 
oxygen saturation, which Margaret and Helen reported, are not a suitable means of assessing 
ongoing oxygen needs. 
At the late stage of their illness, the impact on each participant’s life was more severe as 
they contended with persistent breathlessness, and increasing impairment of their function 
and mobility. Their physical condition was unstable and they underwent periods of 
hospitalisation. Respiratory failure and being listed for transplant were turning points which 
initiated a persistent liminality of uncertainty, waiting, and living on the margin physically 
and socially. Struggle, anxiety and suffering were significant aspects of their experience at 
this time of transition to either death or transplant. As the women reflected on their mortality, 
they experienced a deepened spirituality, personal growth and transformation. Receiving a 
transplant was the turning point which signified Patricia and Vidu’s passage from the 
transition of late stage to stability and wellness as they adapted to living with their new 
lungs.  
Margaret’s experience of economic hardship at late stage is reflected in Essue et al.’s (2011) 
cross-sectional study of 218 patients with COPD attending a Respiratory Ambulatory Care 
Service in Australia. The authors reported that 78% of the respondents could not afford basic 
living costs due to their health care expenses. The cost of medications, medical 
consultations, home oxygen, transport and their inability to access adequate social support 
contributed to their economic stress. Essue et al. (2011) argued changes in public policy are 
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required to address these factors and reduce economic hardship for people living with 
chronic illness. 
The participants demonstrated resilience in their ability to accept their situation, adapt to 
life with continuous oxygen therapy, and live with struggle and suffering. They revealed 
that personal traits of optimism, humour, and flexibility; self-esteem and self-efficacy 
beliefs; knowledge, skills and competence acquired from past experiences; and having a 
sense of hope and purpose were factors which contributed to their resilience. For the women 
at late stage, finding meaning in their life and spirituality, experiencing connectedness with 
others, and receiving practical and moral support from family and close friends were 
particularly important in assisting them to live with their suffering and remain resilient. The 
participants showed, by setting goals and influencing their situation through their attitude 
and actions, that it was possible to retain a sense of agency and autonomy despite their 
difficult circumstances and physical limitations. 
The levels of disruption and suffering which the participants perceived corresponded to their 
individual levels of resilience. Higher levels of resilience were associated with lower 
perceived levels of suffering and vice versa. Patricia showed that continuing to exercise as 
she was able throughout her illness elevated her resilience. It was protective for her at late 
stage, enabling her to cope effectively, perceive less suffering, and make a smooth transition 
through recovery after transplant. Vidu’s avoidance was associated with her lower level of 
resilience and greater suffering at the late stage of her illness.  
6.7 Conclusion 
This chapter has presented the participants’ experiences of living with advanced LAM 
through the turning points of commencing oxygen therapy, experiencing respiratory failure, 
and receiving a lung transplant. Oxygen therapy was a paradox, in both disrupting the 
participants’ lives and enabling them to be active. Negatively, the women felt continuous 
oxygen therapy was a burden. The visibility of oxygen equipment threatened their identity 
and engendered feelings of being stigmatised. The women identified problems related to 
public policy which increased their sense of burden, including inequities in oxygen funding 
between states, lack of funding for lighter portable oxygen concentrators, assessment criteria 
for oxygen supplies that did not take their function and activity into account, and a lack of 
educational resources to support mothers with young children. Positively oxygen therapy 
enabled the women to stay alive and participate in exercise, work and social activities. 
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Accepting and learning to manage their oxygen while receiving adequate social support 
allowed the participants to perceive its benefits.  
The participants demonstrated resilience in their experiences of living with advanced LAM. 
The women who had developed positive self-beliefs, knowledge and skills throughout their 
lives and in the course of learning to live with their illness had become resilient and they 
drew on this as a resource at the advanced stage of their illness. Their resilience influenced 
their ability to accept their oxygen therapy and adapt to it, and their perceptions of their 
ability to cope with persistent breathlessness and disabling limitations at late stage.  
The participants continued to build their resilience as a dynamic process. Mobilising 
affordable home services, continuing to manage their illness effectively, and participating 
in work and social life while living with oxygen therapy increased the women’s self-efficacy 
and positive feelings of autonomy and competence. Experiences of spirituality and personal 
growth, connecting socially with others, choosing to maintain hope and a positive attitude, 
and receiving compassionate support were sources of meaning and purpose and positive 
feelings which enhanced their resilience at late stage. As an outcome, resilience improved 
the participants’ ability to manage their health, and enabled them to experience wellness 
while living with the effects of advanced disease. 
These last four chapters have revealed two interrelated concepts weaving through the 
collective life history, an overarching narrative of resilience, and the influence of the rarity 
of LAM on the women’s experiences. The narrative of resilience encompasses the turning 
points the participants experienced in living with LAM, beginning with the disruptive life 
change of their diagnosis and its impact on their expected life plans, sense of self and how 
they related to the world; the transition period and process of adaptation in which they 
learned to live with change, integrate their illness into their lives, and restore a sense of self, 
coherence and purpose; and the influence of the rarity of LAM on their resilience narrative.  
The following chapter will discuss the findings of the thesis in relation to resilience in the 
context of a rare condition and in the light of existing literature and theories.  
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Chapter 7 
DISCUSSION 
  
7.1 Introduction 
The previous four chapters presented a life history of women living with LAM to provide 
an understanding of their experiences from the onset of symptoms to the late stage of their 
illness. The participants showed that they lived with LAM in a context of constant change, 
from the day to day fluctuations of everyday life to turning points of significant change 
related to their illness or social world. In their narratives the women revealed diagnosis, a 
long hospital admission, commencing oxygen therapy, experiencing respiratory failure, and 
receiving a transplant as turning points when they experienced significant life disruption.  
While each participant’s life was unique, the women demonstrated resilience as an 
overarching theme in their experiences of living with LAM.  Analysis revealed that 
resilience was the complex learning that evolved over the course of each woman’s life 
through adaptation to situations of change and adversity, and as a process of everyday life. 
As a learning outcome, it enabled them to experience wellness while living with the 
uncertainty and limitations of their rare, incurable condition, and, for those whose illness 
advanced, cope with the progressive deterioration in their health. Resilience learning was 
multidimensional and involved the growth of meaning, knowledge and competence. It was 
a dynamic process influenced by changes in their health status and social contexts and the 
rarity of their illness. As it accumulated through life it formed a resource that could be drawn 
on as new turning points occurred.  
Resilience has been described as a complex concept that is more easily recognised than 
defined (Butler 1997). Within a large body of literature examining resilience in varying 
populations (children, adolescents, the elderly, the chronically ill, minority groups, 
communities) and contexts (loss, trauma, poverty, life span, organisations, social systems, 
ecosystems), there is no agreed definition of the concept (Haase & Peterson 2013).  
Additionally, there is a limited range of literature exploring resilience in chronic illness 
(Edward 2013). While many studies use the terms resilience and resiliency interchangeably, 
Luthar et al. (2000, p.546) distinguished between ego-resiliency as a “personality 
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characteristic of the individual” and resilience as “a dynamic developmental process”. This 
latter description of resilience applied to the participants’ experiences of living with LAM 
and resilience is the term used in this thesis.  
The participants’ experiences highlighted that resilience and learning were interrelated as 
they adapted to their illness. Adaptation was a response to specific turning points during a 
period of transition. It was a way of dealing constructively with change and incorporated 
problem-focused learning and self-learning. In adaptation the participants’ learning was 
focused on problems related to their illness. It was a process of acquiring knowledge and 
skills to manage their symptoms, relationships, responsibilities, emotions and identity in 
their individual contexts, and communicate with healthcare professionals in healthcare 
settings. The rarity of LAM stimulated the participants to develop increased knowledge and 
enhanced communication skills through their need for self-reliance in seeking information, 
and self-advocacy in accessing expert management and treatment. Self-learning developed 
in the state of liminality as they reflected on their existence, created meaning, and 
reconstructed their sense of self through their experiences of spirituality and personal 
growth. Everyday life was a process of resilience learning by increasing their competence 
and self-efficacy as they dealt with minor disruptions and the fluctuations of daily life, and 
by generating meaning and positive emotions in their incidental experiences of social 
connectedness and enjoyable activities. 
Resilience as a learning outcome was the meaning, knowledge and competence the 
participants gained through these processes, allowing them to integrate their illness into their 
life. Knowledge and competence in self-managing their illness, in a practical sense, enabled 
them to participate in family, work and social life, and was a source of meaning in 
facilitating connectedness with others and generating positive self-beliefs. Finding meaning 
in their new reality involved perceiving life having value and purpose, and a sense of 
autonomy and self-efficacy in being able to independently determine life goals, make 
decisions, adopt attitudes and behaviours, and act to meet their goals. Change became less 
disruptive and they were able to experience a sense of coherence and wellness.  
Women whose illness progressed to late stage drew on resilience they had accumulated 
through life as a resource. Resilience was also an ongoing process as they created meaning 
in their experiences of spirituality and personal growth. This learning enabled them to live 
with struggle and suffering while waiting for transplant or until end of life. 
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Previous research has associated resilience with adaptation. According to Luthar et al. 
(2000) and Cicchetti (2010), resilience is a process or capability which enables a person to 
cope successfully with or adapt positively to adversity. Zautra et al. (2010), in contrast, 
suggested that resilience is an outcome of successfully adapting to adversity. Common 
factors and characteristics of resilience identified in the literature (see Table 7.1) included 
active engagement, motivation, positive reappraisal (finding benefit in one’s situation and 
reframing issues), optimism, competence, self-efficacy, spirituality, growth, learning, and 
finding meaning.  Resilience was also regarded as occurring in the context of 
person/environment interactions over time or across the life span and was facilitated by a 
supportive social environment.  
This chapter will discuss the findings of the study in relation to resilience, the participants’ 
experiences of living with LAM as a rare disease, and the life history method. It will present 
a broad concept of resilience as both a learning process and outcome in the context of a rare, 
chronic illness. Discussion is guided by a model of resilience (Figure 7.1) constructed to 
provide a visual summary of resilience in the collective life course of the participants and 
their experiences over time. Horizontally, the model shows the turning points of their illness 
and social world across their life course. Vertically, it displays the learning processes and 
outcomes of adaptation and resilience that developed during periods of transition following 
turning points, the personal and social resources which influenced the process, and processes 
of everyday life which contributed to their resilience.  
The discussion focuses specifically on the following dimensions of resilience learning: 
turning points; transition; the process of adaptation, including problem-focused learning and 
self-learning; self-advocacy in the context of living with LAM as a rare disease; how 
avoidance coping influenced resilience learning; resilience as a dynamic process; living with 
struggle and suffering at late stage; and the significance of hope and meaning in the process 
of resilience. Following this discussion, the findings are discussed in relation to the 
interpretation of experience using life history and Gadamer’s (2004) hermeneutic 
philosophy. Finally, the findings of the study are summarised in relation to the specific aims 
of the study. 
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Table 7.1: Resilience factors and characteristics 
 
Resilience 
Factors 
Resilience 
Characteristics 
Resilience Literature 
Personal 
Resources 
Optimism
  
Trivedi et al. 2011; Sturgeon & Zautra 2010;  
Zautra et al. 2010 
Hardiness  Trivedi et al. 2011; Bonanno 2004; Kobasa et al. 1982 
Empathy Holaday & McPhearson 1997; Zautra et al. 2010; 
 Norman 2000 
Curiosity  Holaday & McPhearson 1997 
Flexibility Holaday & McPhearson 1997 
Sense of humour Holaday & McPhearson 1997; Norman 2000; Vaillant 2003 
Creativity Richardson 2002; Vaillant 2003; Simonton 2000 
Hope Butler 1997; Richardson 2002; Gillespie et al. 2007;  
Horton & Wallander 2001; Haase et al. 2014 
Social competence Holaday & McPhearson 1997 
Personal control Holaday & McPhearson 1997; Zautra et al. 2010 
Positive emotions Ong et al. 2006; Zautra et al. 2010; Cohn et al. 2009; 
 Sturgeon & Zautra 2010; Tugade et al. 2004 
Perseverence Allen et al. 2011 
Spirituality Trivedi et al. 2011; DeSantis et al. 2013; Richardson 2002;  
Nelson-Becker 2006; Hunter-Hernandez et al. 2015; 
 Haase et al. 2014 
Self-efficacy Trivedi et al. 2011; Holaday & McPhearson 1997;  
Zautra et al. 2010; Norman 2000 
Self-esteem Trivedi et al. 2011; Haase et al. 2014 
Social Resources Supportive social  
environment 
Haase et al. 2014; Kralik et al. 2006; Rabkin et al. 1993; 
 Wyman et al. 2000; Zautra et al. 2011; Henderson 1998 
Adaptive 
coping 
Active engagement Trivedi et al. 2011; DeSantis et al. 2013; Kralik et al. 2006;  
Schanke & Thorsen 2014; Zautra et al. 2010 
Person/environment  
interactions 
Egeland et al. 1993; Gillespie et al. 2007; Butler 1997; Ungar 
2011; Resnick 2011; Waller 2001; Edward & Warelow 2005; 
Polk 1997; Tusaie & Dyer 2004 
Dynamic Luthar et al. 2000; Gillespie et al. 2007; Cicchetti 2010;  
DeSantis et al. 2013 
Over time/life span Trivedi et al. 2011; Egeland et al. 1993; Gillespie et al. 2007; 
 Robertson & Cooper 2013 
Acceptance Sturgeon & Zautra 2010; Zautra et al. 2010; Nelson-Becker 
2006 
Growth Richardson 2002; Kralik et al. 2006; Sturgeon & Zautra 2010; 
 Nelson-Becker, 2006 
Learning Kralik et al, 2006; DeSantis et al, 2013;  
McAllister & McKinnon 2009 
Competence Norman, 2000; Gillespie et al, 2007; DeSantis et al, 2013; 
 Holaday & McPhearson 1997 
Motivation DeSantis et al. 2013; Gillespie et al. 2007; Richardson 2002;  
Resnick 2011; Norman 2000 
Positive reappraisal 
(finding benefits) 
Affleck & Tennan 1996; DeSantis et al. 2013; Kralik et al. 2006;  
Sturgeon & Zautra 2010 
Finding meaning Kralik et al. 2006; Sturgeon & Zautra 2010; Fife 2005 
Positive adaptation  
to adversity 
Luthar et al. 2000; Waller 2001; Gillespie et al. 2007;  
Herrman et al. 2011; Ciccheti 2010 
Altruism Norman 2000; Richardson 2002 
Wellness Carel 2013a; Zautra et al. 2011 
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7.2 Turning points 
In living with LAM, the participants experienced turning points as significant life changes 
related to their illness or social world. Turning points could signify either negative or 
positive change. The women revealed illness-related turning points as being diagnosed, a 
long hospital admission, commencing sirolimus therapy, starting intermittent oxygen 
therapy, advancing to continuous oxygen therapy, being listed for transplant, receiving a 
transplant, and experiencing respiratory failure.  
Fifteen participants, as fit and healthy women with no significant medical histories, 
experienced being diagnosed as a turning point of profound life disruption. Physically they 
experienced changes in their bodies which impacted on their expected life plans, their sense 
of self and their interactions in the world. They evaluated the meaning and significance of 
the changes they were experiencing through the lens of their personal life meaning which 
incorporated their values, beliefs, disposition, sense of self, past experiences, and future 
expectations. Their appraisal of their diagnosis as a disruption of their familiar world, 
personal meaning and sense of coherence reflected Bury’s (1982, p. 169) concept of chronic 
illness as a “biographical disruption” of “the structures of everyday life”, including a 
person’s assumptions, beliefs, behaviours, and sense of self.  The women’s feelings of 
shock, loss, uncertainty, isolation and shifting sense of self revealed their sense of 
disruption.  
The feelings of disruption expressed by the participants were also felt by other women 
diagnosed with LAM (Carel 2013b; Pollock-BarZiv 2005) and people with pulmonary 
fibrosis (Duck et al. 2015; Schoenheit et al. 2011; Swigris et al. 2005), pulmonary 
hypertension (Kingman et al. 2014) and women with scleroderma (Oksel & Gunduzoglu 
2014). The women in this current study described emotions of fear, sadness, grief and anger. 
These were similarly reported by Carel (2013b), Hoy (2016), and Pollock-BarZiv (2005) 
and people with pulmonary hypertension and pulmonary fibrosis (Armstrong et al. 2012; 
McDonough et al. 2011; Swigris et al. 2005). 
Bury’s (1982) concept of biographical disruption was not true for all participants. Four 
women experienced their diagnosis as less disruptive and were able to adjust more quickly 
to their illness due to the meaning they attributed to their situation, their life expectations, 
and the context of their diagnosis. Patricia interpreted her diagnosis as a continuation of her 
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experience of tuberous sclerosis, her son’s multiple medical issues, and her regular contact 
over many years with healthcare professionals and the healthcare system. Ruth felt her 
diagnosis was consistent with her expectation that she would develop cancer, and her own 
recent experience of breast cancer. Carol felt very little impact on her daily life or expected 
future. Ursula reconciled her diagnosis contextually by comparing her situation with that of 
a well-known young celebrity who died tragically and suddenly at the same time. These 
experiences are consistent with Williams’ (2000) argument that the onset of illness is not 
disruptive for all and that the level of disruption depends on the meaning a person attributes 
to their situation, their context, timing, purpose, and current expectations. A diagnosis of 
chronic illness might, for some individuals, represent “biographical continuity… 
reinforcement” or confirmation when their illness aligns with their past biographical 
experience (Williams 2000, p. 52).  
Patricia, Margaret and Eva who had respectively experienced illness, adversity and the 
disruption of civil war, were able to interpret their diagnosis in the context of these past 
experiences by perceiving their illness as a challenge they could manage rather than a threat. 
Similarly, Williams (1984) argued that people engage in a process of “narrative 
reconstruction” in which they interpret the meaning of their illness in the light of their past 
experiences in order to reaffirm a sense of purpose and future and “repair the rupture 
between body, self, and world”. Pound et al. (1998), in a study of older working class 
people’s experience of stroke, found that, although their stroke was a crisis, they perceived 
it as not an unusual event in their lives. Pound et al. (1998) theorised that their participants’ 
responses may have been mediated by their past experiences of hardship over the course of 
their long lives and the skills they may have developed over time to adapt to new 
circumstances and difficulties.  
The concept of resilience as lifelong learning proposed by this study provides an 
understanding of the mechanisms underlying the participants’ responses to their illness. 
Through their past experiences Patricia, Margaret and Eva had learned knowledge and skills 
in managing illness and difficult situations. This learning strengthened their self-efficacy 
beliefs and confidence in their ability to manage challenges in their lives. It constituted a 
resource of resilience which facilitated their initial adaptive response to their diagnosis of 
attempting to have their needs met by seeking the information, support and expert care they 
required to effectively manage their health. Resilience learning in the participants’ later 
experiences of living with LAM is discussed further below in relation to adaptation, living 
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with a rare disease, avoidance coping, the dynamic process of resilience, everyday life, 
living with struggle and suffering at late stage, and hope and meaning.   
7.3 Transition 
Turning points initiated a period of transition in which the women learned to live with 
change. Transition was complex and dynamic as they experienced variations through 
transition, physically with acute illness events, and subjectively with fluctuating day to day 
experiences of their illness in their individual changing social environments. This study 
identified three transitional experiences, adaptive coping, avoidance coping, and living with 
struggle and suffering.  
After the shock of diagnosis had settled, the majority of participants engaged in adaptive 
coping and the learning processes of adaptation. In contrast, Vidu’s experience 
demonstrated that avoidance coping was associated with her negative personal disposition 
and the availability of strong family support which, consistent with family and cultural 
values, encouraged her reliance on family to manage illness-related issues.  The late stage 
of the illness was a transition to transplant or end of life, marked by turning points of being 
listed for transplant and respiratory failure. At this stage women coped with struggle and 
suffering. 
Transition frameworks have been developed which relate to illness transitions (Chick and 
Meleis 2010; Kralik and van Loon 2010; Meleis et al. 2000; Schlossberg 1981; Schumacher 
1994). They generally include a critical event initiating significant disruptive change, 
personal and environmental factors influencing perception of change and the process of 
transition, and adaptation as an outcome of transition. In signifying adaptation as the 
outcome of passage through transition, current models do not account for the alternate 
transitional experiences observed in this current study. Kralik and van Loon (2010) 
suggested that studies of transition and chronic illness are limited by their short-term focus, 
and that longitudinal studies are needed to examine transition in relation to the passage of 
time. By examining the adaptive process across the illness trajectory, this study expands 
current knowledge of transition by differentiating between varying transitional responses, 
their effects over time, and their relationship to resilience. 
7.4 Adaptation – a process of resilience learning 
Adaptation, for the participants, was a process of learning to live with their illness, re-
establishing their sense of self, and building resilience over time as they developed 
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knowledge and skills in managing their illness and found meaning in their situation. It 
involved motivation, active engagement and learning processes of problem-focused and 
self-learning. Their personal resources of pre-illness health and fitness, social networks, 
work, self-efficacy beliefs and interests shaped their personal life meaning, motivated them 
and influenced their perceptions and decision-making as they engaged in the process of 
adaptation. Personal qualities of optimism, curiosity, flexibility, and spirituality were 
additional resources for some. They were motivated to restore coherence to their lives, 
regain their sense of autonomy and competence, fulfil their responsibilities and goals, and 
experience connectedness through participation in family, work and social life. (See 
summary of participants’ personal and social resources in Appendix 3, Table 3.1). These 
findings reflect Bury’s (1982) claim that the responses people make to chronic illness 
involve a search for meaning, a re-evaluation of self, and the mobilisation of cognitive, 
material and social resources. 
7.4.1 Problem-focused learning 
Learning involved thinking and problem-solving to manage their physical symptoms and 
the impact of these on their emotions, identity, relationships and responsibilities. The 
women demonstrated agency by intentionally acting to manage these illness-related 
concerns. They reframed their goals and expectations, found new ways of performing 
familiar tasks, and adopted management strategies and new roles to accommodate their 
illness and balance their emotions in meaningful ways. They learned to negotiate the 
healthcare system, source information and support, communicate with healthcare 
professionals, and self-advocate for treatments, services and flexibility in their workplaces. 
These processes produced knowledge and skills in managing their illness, and were sources 
of meaning by engendering positive feelings of confidence, autonomy and control to 
increase their self-efficacy and self-esteem. 
The participants’ social environments influenced their ability to build their resilience as they 
managed their physical and emotional health. The women mostly needed practical social 
support at turning points, especially diagnosis, and late stage, and during acute illness events 
and periods of hospitalisation. Their resilience was facilitated by support, such as affordable 
external home services, which encouraged their autonomy and agency, and having access 
to expert medical care, online LAM resources and communities, and supportive and flexible 
workplaces. At all stages of their illness, experiencing connectedness with others increased 
the women’s resilience by generating meaning in positive feelings of self-worth and 
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belonging. In this regard, Ong and Allaire (2005), in a study of the effect of social 
connectedness and positive emotions on cardiovascular function in older adults, found that 
social connectedness extended positive emotions and conferred biological resilience by 
buffering the effects of daily negative emotions.  
The participants expressed a need for emotional support and many relied on their own 
strategies to manage their emotions. These included exercise, meditation, yoga, creative 
pursuits such as art, and alternative therapies. Their ability to manage their emotions was 
enhanced by receiving empathic emotional support and communicating openly with their 
partners. This was difficult for some participants when their partners were themselves in 
need of emotional support. In limited appointment times the women did not receive 
emotional support from their physicians.  
The strategies adopted by the participants to improve their emotional wellbeing have been 
identified by other authors. Trivedi et al. (2011), in discussion of resilience in chronic 
illness, proposed that people who recover from the negative emotional impacts of chronic 
illness are resilient. They found that exercise improved emotional wellbeing through 
achieving lifestyle goals and resultant feelings of mastery and improved self-efficacy. 
Likewise, mindfulness meditation (Elias 2012), and yoga (Fulambarker et al. (2012) were 
reported to have positive effects on symptoms and quality of life for people with respiratory 
conditions.   
The participants’ actions to independently manage their illness can be referred to as self-
management. In a metasynthesis of studies of self-management in chronic illness, 
Schulman-Green et al. (2012, p.136) defined self-management as “a dynamic process in 
which individuals actively manage a chronic illness”. This study found, similar to 
Schulman-Green et al.’s (2012) findings, that self-management related to transition to 
integration of the illness into life, and was associated with knowledge acquisition, learning 
skills of illness management and communication with healthcare professionals, mobilising 
resources including social support, processing emotions, finding meaning, and personal 
growth. The findings of this current study extend the concept of self-management by 
demonstrating its association with resilience in the learning processes and outcomes which 
developed as the participants learned to manage their illness.  
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7.4.1.1 Living with a rare disease - self-advocacy and resilience 
This study illuminates how the rarity of LAM influenced the participants’ illness 
experiences. The participants experienced problems associated with the attitudes and limited 
knowledge and awareness of both healthcare professionals and members of the community, 
and the low numbers of women living with LAM in the Australian context. These factors 
relating to the rarity of LAM influenced the process of their diagnosis, their interactions 
with healthcare professionals in the healthcare system and their social relations in the 
community. In response, many participants engaged in self-advocacy to have their 
healthcare needs met and this contributed to their resilience. 
Medical professionals’ lack of knowledge of LAM was the main cause of the participants’ 
negative experiences of searching for a diagnosis, including delayed diagnosis, being 
misdiagnosed, and, for some, multiple medical consultations and investigations. These 
experiences reflected those of Carel (2013b), women with LAM in the US (Pollock-BarZiv 
et al. (2005), and other people with a variety of rare diseases (EURORDIS 2009; Feinberg 
et al. 2013; Garau 2016; Garrino et al. 2015; Gordon 2013; Molster 2016; Rare Diseases 
UK 2016; Rare Voices Australia 2013; Vitale 2005). Four women in this current study 
reported their symptoms being attributed to depression or psychosomatic causes. This was 
also the case for people with pulmonary hypertension (Armstrong et al. 2012) and 
pulmonary fibrosis (Duck et al. 2015). These experiences demonstrated the need to raise 
awareness among medical professionals of considering a diagnosis of rare disease when 
encountering difficult to diagnose symptoms. 
The majority of participants received their diagnosis alone and were given scant information 
and emotional support, exacerbating their feelings of uncertainty and isolation in being 
diagnosed with a rare, potentially life limiting illness. This was also reported by Carel 
(2013b) and other people with rare diseases (Collard et al. 2007; Duck et al. 2015; 
EURORDIS 2009; Garau 2016; Garrino et al. 2015; Gordon 2013; Jefferies & Clifford 
2009; Pollock-BarZiv 2005; Rare Diseases UK 2016; Rare Voices Australia 2013). The  
participants read and received from some physicians outdated information, sourced from 
unreliable internet sites such as Wikipedia, concerning survival rates of between one and 
ten years from onset of symptoms of LAM. This was similarly the case for Carel (2013b) 
and Hoy (2016) as recently as 2014. These negative experiences of being diagnosed indicate 
physicians’ lack of both knowledge and empathy and, as reported by Huyard (2009), their 
failure to meet the moral needs of their patients. 
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Participants who were isolated geographically or by their health status felt marginalised in 
the healthcare system. They experienced difficulties in accessing expert care, appropriate 
information, explanations, investigations and treatment, advice concerning social services, 
and adequate supplies of oxygen. This was compounded by poor communication between 
physicians and LAM experts, and other healthcare professionals. These findings were also 
reported for people living with other rare diseases by Rare Voices Australia (2013) and in 
the EURORDIS (2009) and Rare Diseases UK (2016) surveys. Molster et al. (2016), in a 
survey of 744 Australian adults living with various rare diseases on their healthcare 
experiences, found their respondents’ healthcare needs were not being met. These people 
felt their treatment was not holistic and there was a lack of communication between 
specialist physicians. Molster et al. (2016) suggested that integrated and coordinated care 
and diagnosis for people with rare diseases in Australia was constrained by the fragmented 
nature of the structures of the Australian healthcare system, and that there was a need for 
multidisciplinary centres of expertise in rare disease in Australia. Supporting this proposal, 
Garrino et al. (2015), in a qualitative study exploring the impact of a rare disease on patients’ 
lives, found that after diagnosis the rarity of the disease was not problematic for people who 
attended a multidisciplinary Regional Centre for Rare Diseases in Italy. These people 
reported satisfaction with their care, that their information needs were met, and that they 
were able to focus on adapting to living with their illness.  
Healthcare professionals’ lack of knowledge and awareness of their rare disease motivated 
the participants to be self-reliant in gathering information, and to engage in self-advocacy 
to have their healthcare needs met. The women demonstrated two levels of advocacy. At an 
individual level, they advocated physicians for expert medical management, investigations, 
information, and access to treatment, and individual community members socially and in 
the workplace to raise awareness of LAM and seek support for their needs.  At a collective 
level, in conjunction with the peer support group, they advocated in the community by 
fundraising to support LAM research, speaking publicly to raise awareness of LAM, and 
providing support to other women living with LAM.   
Self-advocacy was a problem-focused learning process which enhanced the women’s 
resilience by expanding their knowledge and communication skills to develop their 
expertise in self-management of their illness. Successful self-advocacy created meaning by 
increasing their self-efficacy and restoring a sense of autonomy, competence and control. 
Congruent with these findings, De Santis et al. (2013), in a study of resilience in the context 
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of HIV infection, found that the ability to master self-advocacy was an important aspect of 
mastering the disease, gaining a sense of control, and being resilient. Similarly, Hagan and 
Donovan (2013), in a concept analysis of self-advocacy among people with cancer, 
associated self-advocacy with learned communication, information-seeking and problem-
solving skills and a drive to resolve difficulties which reflected personal values, beliefs and 
goals. They reported improved self-concept, a sense of control, and adaptation as long term 
effects of self-advocacy. Likewise, Jonikas et al. (2013), in an investigation of patient self-
advocacy among those who received a peer-led mental illness self-management 
intervention, found that self-advocacy skills could be learned and when practised increased 
the participants’ hopefulness, quality of life and psychiatric symptoms.  
Ayme et al. (2008), in a medical essay on patient empowerment and rare diseases, claimed 
that people with a rare disease have been empowered by their advocacy. This was the case 
for the participants collectively through their collaboration with researchers, fundraising 
efforts, and participation in clinical trials. Individually, however, self-advocacy was more 
complex and could be constrained by the attitude of physicians and personal factors. While 
the women’s power to influence their health outcomes in their interactions with their 
physicians was strengthened by the expertise they developed over time, physicians retained 
greater power due to their authority to order investigations and prescribe treatments. The 
ease and effectiveness of the participants’ self-advocacy was dependent on the attitudes and 
willingness of their physicians to accept their knowledge and share decision-making. 
Physicians with expert knowledge of LAM were more willing to engage collaboratively 
with the participants while those lacking knowledge were less inclined to accept the 
women’s self-advocacy. 
This issue was accentuated in the acute hospital setting when the women experienced greater 
vulnerability during acute illness events. The women’s advocacy took the form of being 
vigilant in monitoring their care and educating the health professionals.  However, there was 
a wider power differential between themselves and their care providers in this context and, 
perceiving a need for diplomacy, they modified their self-advocacy when communicating 
and offering opinions. Consistent with these findings, Finn (2008, p.191), in an ethnographic 
study of empowerment in the alpha-1 antitrypsin rare disease community, reported that 
physicians remained in control and that empowerment for patients meant participating in 
managing their illness in a subordinate role to their physicians.  
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Participants of this current study who were assertive and persisted in their advocacy efforts 
had a high level of self-efficacy and were motivated by a sense of increased need and 
urgency. This was demonstrated by Helen who had been diagnosed with advanced disease, 
and Clare during her long hospital admission for persistent chylous effusions. Both Helen 
and Clare had become well-informed about their rare disease through their own research 
efforts. Advocating successfully to have their needs met gave the women a sense of 
satisfaction and control and enabled them to better manage their health. Similarly, Brashers  
(2000, p.386), in a study of AIDs activism and communication patterns between people with 
HIV/AIDs and healthcare professionals, found that both collective advocacy and self-
advocacy were associated with education about the illness, taking an 
assertive/confrontational stance toward healthcare, and “mindful nonadherence” to 
physicians’ orders.  
Individually, some participants reported that the lack of knowledge of LAM in the 
community and their general appearance of being healthy meant that, at times, they 
encountered a lack of understanding for their issues and felt stigmatised in their social 
networks, workplaces, and the general community. This was similarly reported by other 
women living with LAM in relation to using oxygen therapy in the community (Carel 
2013b; Pollock-BarZiz 2005). Yorke (2014), in a qualitative study of the impact of living 
with pulmonary hypertension, found that their participants’ feelings of being stigmatised 
was compounded by the invisible nature of the condition and others’ lack of knowledge of 
the disease.  
Collectively, in the Australian context, the very small number of women with LAM meant 
that there were few available to run the peer support organisation, fundraise and support 
other women. These roles took time and energy and, at times, involved the use of personal 
resources. While collective advocacy provided a sense of purpose and empowerment, it 
could also be a burden. Women who engaged in fundraising could feel a sense of guilt in 
asking friends and community members for donations when, due to the invisibility of LAM, 
they appeared healthy. No studies have reported on experiences of collective advocacy in 
the community for people with rare diseases. 
Not all participants engaged in self-advocacy. Hagan and Donovan (2013), in a study 
exploring ovarian cancer survivors’ experiences of self-advocacy, suggested that further 
research is needed to identify people who are unable to self-advocate. This study has 
distinguished personal factors which limited the ability of some participants to self-
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advocate. These included their disposition, self-efficacy beliefs, health status, competence 
in speaking English, and coping style. For example, women who had a negative disposition, 
less confidence, lower levels of self-efficacy, and who adopted an avoidance style of coping 
tended not to self-advocate and their interactions were directed by their physicians. This was 
also the case at late stage for women such as Margaret who struggled with breathlessness 
and limited mobility. She was unable to travel to see a LAM expert and so was isolated from 
expert care, and could not self-advocate or access potential treatments. 
This study has revealed the complexity of self-advocacy in the context of living with a rare 
disease and how engaging in self-advocacy helped build the participants’ resilience.  In a 
positive sense, the women’s resilience and sense of empowerment were enhanced when they 
were able to engage in collaborative relationships with their healthcare providers and share 
decision-making. Negatively, having to assume responsibility for research and educating 
healthcare professionals, and being forced to take an assertive stand in interactions could be 
a burden, particularly in the acute care setting. According to Huyard (2009), difficult rare 
disease experiences were caused by the failure of healthcare professionals to meet the moral 
needs of their patients rather the rarity of the disease itself. This current study found, in the 
Australian context, that the rarity of LAM did exert an influence on the participants’ difficult 
experiences through the knowledge, awareness, and attitudes of both healthcare 
professionals and community members. These affected the women’s experiences in the 
health system and their broader social relations.  
7.4.2 Self-learning in liminality 
For six participants, self-learning created meaning and reconstructed their sense of self 
through a process of reflecting on their existence in the transitional state of liminality. 
Although this was a state of negative feelings of instability and ambiguity, it was also a 
space in which they broadened their self-understanding through their experiences of positive 
personal growth and deepened spirituality. This learning assisted them in managing their 
emotions by producing feelings of calm, peace and contentment and a desire to live in the 
present, and created meaning in enhancing their feelings of self-worth and renewing their 
sense of self. While it was an inward process, personal growth simultaneously enabled them 
to look beyond themselves and feel a sense of connectedness with others which was a further 
source of meaning and purpose. Eva, for example, expressed this as empathy and altruism 
in her desire to become involved in volunteer work. Reed (1991) defined this process of 
expanding the self inwardly in reflection and outwardly by reaching out to others as self-
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transcendence, and recognised that, for people living with a life-threatening or terminal 
illness, it was associated with wellbeing. Similarly, Coward (2000) found that self-
transcendence was associated with finding meaning and improved quality of life for women 
with breast cancer. Not all participants of this current study experienced transition as a 
liminal period. Women with very mild disease, for example, who felt less disrupted by their 
diagnosis, adapted and passed through transition without experiencing a sense of existential 
threat.  
Liminality has been identified in other studies of chronic conditions, including the frail 
elderly (Nicholson et al. 2012), the disabled (Murphy et al. 1988), those living with AIDS 
dementia (Kelly 2008), HIV/AIDs (Bruce et al. 2014), chronic kidney disease (Molzahn et 
al. 2008), chronic pain (Jackson 2005), and cancer (Blows et al. 2012; Little et al. 1998). 
Sabo (2014), exploring the experience of caregivers of stem cell transplant recipients, 
associated liminality with transformation and creating meaning. Similarly, Little et al. 
(1998) found that meaning was constructed and reconstructed during sustained liminality. 
Most studies, however, associated liminality with negative feelings, including uncertainty, 
loss, disruption, fear, grief, and isolation. Kralik and van Loon (2010, p.29) described 
“limbo” as a commonly experienced phase of transition associated with suffering, isolation 
and powerlessness. This current study has increased understanding of both liminality and 
resilience by uncovering the meaning-making processes of liminality as mechanisms of 
resilience while living with chronic illness. 
7.4.3 Resilience as an outcome of adaptation 
Resilience was an outcome of the participants’ adaptive learning when they moved through 
transition and integrated the reality of their illness into their lives. It related to acceptance 
of their situation and the ability to experience wellness while living with their incurable 
progressive illness. Wellness was associated with positive feelings of normality, coherence 
and stability as they participated in social life and found meaning in their situation which 
aligned with their life meaning. For some participants this was enhanced by personal growth.  
The women had retained their agency in being able to determine and act to achieve their 
goals, and regained a sense of autonomy, competence and control through their self-
management and self-advocacy. The knowledge and skills which they acquired increased 
their self-efficacy, giving them confidence that they could manage day to day fluctuations 
in their health as they arose. Life was no longer dominated by their illness. It assumed a 
background position and there was a sense of being able to move on with everyday life.  
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Congruent with these findings, other studies of chronic illness have found that people with 
chronic illness can move from a focus on illness to one of wellness as they adapt to their 
illness. Paterson (2001), in a metasynthesis of qualitative research on chronic illness, found 
wellness in the foreground was associated with illness knowledge and skills, support, 
appreciation of life and close relationships, supporting others and spirituality. Whittemore 
and Dixon (2008), in a study exploring how adults with chronic illness integrate the illness 
experience into their life, additionally found managing emotions was an important aspect of 
moving from living an illness to living a life. Further, according to Ellis-Hill et al.’s (2008) 
life threads model, a person can manage their emotional responses to acquired disability and 
move on with life by recreating a positive sense of self. 
According to Carel (2013a), resilience for people living with illness correlated with personal 
growth, living in the present, and experiencing wellbeing. Haase et al. (2014), in discussion 
of a Resilience in Illness Model, associated resilience with confidence/mastery, self-
transcendence and self-esteem. The experiences of the participants of this current study of 
moving on with life contrast with Belkin et al.’s (2014, p.3) finding that the “primary 
psychological experience” of living with LAM was one of “getting stuck with LAM”. 
7.5 Avoidance coping 
Avoidance coping was an outcome of transition which enabled adjustment and a sense of 
control and normality while a participant’s illness remained relatively stable. However, it 
was associated with lowered resilience as their illness progressed. Vidu demonstrated that, 
in coping by avoidance, she had not engaged in the learning processes of adaptation. The 
strong social support she received from her family limited her resilience through her over 
reliance on them. She did not develop the knowledge and skills of self-management nor the 
personal resources of competence, confidence and self-efficacy associated with adaptive 
learning. Subsequently, she lacked the resilience to sustain her coping as her illness 
advanced. Vidu’s perception was one of illness and she felt restricted and isolated by her 
need for continuous oxygen therapy.  At the late stage, in the months before her transplant, 
she perceived her situation to be one of profound suffering which she struggled to endure. 
Congruent with these findings, Stanton et al. (2001) asserted that coping by avoidance 
temporarily reduces the effects of severe stress but, in the long term, is associated with poor 
psychological adjustment and impaired coping, and that adjustment is impeded by support 
that results in dependence and lack of control. Vidu’s situation revealed that social support 
which encourages autonomy and agency is more effective in building resilience than support 
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which fosters dependency. This finding is supported by Weinstein et al.’s (2012) claim that 
environments that support people’s need for autonomy, competence and relatedness 
facilitate their ability to adapt to new situations and challenges. Similarly, Sturgeon and 
Zautra (2010), in a study of resilience in chronic pain, reported that resilience develops in 
environments that reward efforts to achieve growth and recovery. 
7.6 The dynamic process of resilience  
The participants adapted to their illness and built resilience as a dynamic process shaped by 
changing environments and individual perceptions of illness or wellness over time. 
Although LAM as a disease process followed a linear trajectory from the initial onset of 
symptoms to progressive breathlessness and loss of lung function requiring oxygen therapy 
and, at the late stage, transplantation or eventual respiratory failure, the women experienced 
the illness differently. The women’s physical manifestations and progress of LAM varied 
from minimal and stable symptoms to rapidly progressing disease with marked impact on 
daily life, and disease which advanced over time to the late stage. Likewise, the process of 
adaptation and building resilience was a continuous and fluctuating process over their life 
course which developed individually both temporally and experientially for the women. It 
was influenced by their personal life meaning, social context, and past experiences. Some 
adapted more quickly, others experienced a longer period of adjustment. Resilience learning 
that accumulated through life influenced their perceptions of their situation and facilitated 
their ability to adapt and deal constructively with their individual level of change and 
experience a sense of wellbeing. 
Changes in the participants’ health or social situation could constitute turning points and 
shift their perceptions either positively or negatively. Some participants felt their wellness 
and resilience was diminished when they encountered new disruptions which they felt they 
did not have the resources to deal with. This initiated new periods of transition and 
adaptation. For example, losing a valuable work role created emotional and physical 
disruption for Louise and shifted her perspective negatively. Conversely, wellness and 
resilience increased when they perceived changes as positive. This was the case for Aiko 
who found meaning in a renewed will to live, sense of purpose, and connectedness with her 
family after the birth of her grandson. Similarly, organising affordable home services 
renewed Helen’s sense of autonomy and shifted her perception of her oxygen therapy from 
being restrictive to enabling her to engage in enjoyable activities and quality social 
interactions with her family. 
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Eight participants experienced commencing sirolimus therapy as a positive turning point. It 
stabilised their lung function and resolved other issues, including chylothorax and 
lymphangioleiomyomas, giving the women physical stability and improved function. Their 
resilience increased and quality of life improved as they found meaning in their renewed 
capacity to participate in social life, sustain hope for a longer life, and to achieve goals.  
Resilience could fluctuate with shifting perceptions of wellness and illness in everyday life. 
Jess, for example, although managing her illness competently, and physically stable on 
sirolimus, was socially isolated and experienced persistent fatigue which foregrounded her 
illness so that she primarily viewed herself as a sick person lacking agency. This perception 
limited her self-efficacy beliefs and resilience. When exercising her dominant perspective 
was one of wellness. When she felt the effects of fatigue it shifted to illness. 
Resilience could develop at any stage. This was demonstrated by Vidu when, at the late 
stage of her illness, she received compassionate support from healthcare professionals and 
other patients during a hospital admission. This turning point enabled her to find a positive 
meaning in her situation and shifted her perception of her suffering. Perceiving empathy 
lessened her distress, enabled her to view her life as having value and purpose, and 
motivated her to reach beyond herself and connect with others by practising loving kindness 
meditation.  This spiritual practice reduced her anxiety, enabled her to better manage her 
breathlessness and, in being freely chosen, gave her a sense of autonomy, balancing her 
dependency on others. Her positive feelings of hope and self-worth increased her resilience 
and enabled her to endure her suffering. Vidu’s experience is consistent with Gillespie et 
al.’s (2007) assertion that resilience can be developed at any stage. Likewise, Fredrickson 
et al. (2008) found that a loving kindness meditation intervention could induce a wide range 
of positive emotions to build personal resources of self-acceptance and feelings of 
competence in managing life situations.  
The participants’ experiences of changes in their health and social context showed that they 
were able to shift their perceptions to wellness and increase their resilience when they found 
meaning in their situation. This occurred when they felt a sense of purpose, gained a sense 
of autonomy and agency, and experienced connectedness with others. Their experiences of 
shifting perceptions of wellness and illness aligns with Paterson’s (2001) Shifting 
Perspectives Model of Chronic Illness which holds that illness changes, social situations and 
life events can shift perspective towards either illness or wellness. The findings of this 
current study extend Paterson’s model by linking it with resilience. Being able to cope with 
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or adapt to changed social circumstances and find positive meaning in them increased 
feelings of wellness and enhanced the participants’ resilience. Perceptions of illness and a 
loss of agency lowered their resilience.  
7.7 Resilience as a process of everyday life 
The participants built their resilience not only through the process of learning to manage 
their illness but also as a process of everyday life through their daily experiences of positive 
interactions and dealing with the fluctuations of day to day life. Resilience here was derived 
from their experiences of competence, meaning and positive emotions. They felt positive 
emotions in their daily incidental experiences of happiness, humour, work and social 
connectedness, as well as their chosen strategies of exercise, creativity, yoga, meditation, 
spirituality, and altruistic activities such as volunteer work, fundraising for research and 
supporting other women with LAM. These activities were a source of meaning by increasing 
beliefs of self-worth, self-efficacy and self-esteem, and life having value and purpose. 
Positive emotions counteracted their negative emotions and enhanced their feelings of 
wellbeing.  
Luthar et al. (2000) suggested that significant or severe adversity is a core condition of 
resilience, but the concept has since been expanded to include the notion that resilience 
develops also through everyday life disruptions (Allen et al. 2011; Richardson 2002). This 
study revealed that resilience accumulated throughout life in everyday experiences as well 
as through the process of adapting to negative change and adversity. Masten (2001, p.226) 
referred to the “ordinariness” of resilience, and Wyman et al. (2000, p.155) to “cumulative 
competence”, suggesting resilience and learning accumulate through life. 
7.8 Living with struggle and suffering 
The late stage of living with LAM was a significant turning point. Being listed for transplant 
and experiencing respiratory failure marked entry to a transition of a persistent state of 
liminality between life and death, characterised by struggle and suffering. Bruce et al. (2014, 
p. 37) referred to the uncertainty of living with a life-threatening illness as a “pervasive 
liminality”. This transition revealed resilience as a resource, a way of being, and an ongoing 
process.  
As a resource, resilience influenced the women’s perceptions of their situation, reflecting 
their degree of confidence in their ability to cope. Margaret and Patricia, for example, had 
high levels of resilience. By late stage they had developed a stable self-concept and a strong 
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sense of personal control and self-efficacy beliefs. They appraised their situation as one of 
struggle rather than suffering. This contrasted with Vidu who, with lower resilience, 
perceived herself as suffering. 
Resilience as a way of being was evident in their choice of attitude, ability to find meaning 
and purpose in their situation, sustain hope, and apply the self-management strategies they 
had learned over time. Their selection of strategies were meaningful in reflecting their sense 
of self and personal goals. For example, Patricia continued to exercise gently, Margaret 
persevered with living independently and managing her breathlessness by distracting herself 
with art activities, music and the companionship of her pets. Vidu practised loving kindness 
meditation to diminish her suffering. Margaret and Patricia had optimistic dispositions and 
chose to use humour to maintain a positive attitude. Maintaining a sense of social 
connectedness and finding meaning in ordinary experiences contributed to the women’s 
resilience.  
Margaret’s use of humour was an important strategy to sustain her positive emotions and 
balance her negative feelings of anxiety in her experience of respiratory failure. Expressing 
humour when interacting with nurses while in hospital, and emphasising the positive aspects 
of her experience as she narrated her life story was a strategy which Langston (1994) 
identified as “capitalizing”. He found it amplified positive effects and boosted self-esteem. 
Margaret also overestimated her personal control in managing her breathlessness in hospital, 
not acknowledging the multiple medical emergency calls made for her acute anxiety. Taylor 
and Armor (1996) termed this effect “positive illusions” and suggested that it was a way of 
actively restoring a sense of self during extreme adversity when self-beliefs are threatened. 
They further asserted that such illusions were contained as an individual gradually processed 
and integrated negative information. This was the case for Margaret who recognised and 
incorporated her possible mortality in later formulating an end of life plan. This action 
created meaning in being an expression of her agency, autonomy and control. Nelson-
Becker (2006) similarly found that terminally ill older adults valued independence through 
the process of dying. In experiencing both positive and negative emotions Margaret 
demonstrated the emotional complexity which Ong and Bergman (2004) and Ong et al. 
(2006) stated is characteristic of high resilience people who are able to experience and 
regulate both negative and positive emotions and maintain a boundary between them. 
Similarly, Tugade et al. (2004), Moskowitz (2010), and Bonanno (2004) found that people 
who demonstrate resilient traits and have built resilient resources throughout life are able to 
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use emotional knowledge to regulate their emotions and enhance coping efforts during 
negative experiences of adversity.  
Resilience continued to develop at late stage through the women’s experiences of 
spirituality. Spirituality was a source of meaning, purpose, and growth through their ongoing 
self-learning. This strengthened their self-efficacy, self-esteem and self-worth and generated 
positive emotions to assist them in balancing their anxiety. Spirituality additionally provided 
connectedness with a higher power which was a source of support, comfort and hope. The 
three women felt an expansion of their inner world and a connectedness to others through 
their spiritual practices and expanded feelings of empathy. This enabled them to transcend 
their limitations and live with their struggle and suffering. 
Spirituality has been recognised as a resilience factor more generally (De Santis et al. 2013; 
Kuhlman 2007; Richardson 2002) and for people living with terminal illness (Nelson-
Becker 2006; Vanistendael 2007). Fredrickson (2002) furthermore stated that spirituality 
contributes to positive emotions through finding positive meaning. Reader (2010) linked 
spirituality to liminality and learning. He referred to spiritual resilience as the capacity to 
remain in the uncertainty of liminality through openness and flexibility in order to develop 
the learning of self-understanding.  
7.9 Hope and resilience 
Hope was the participants’ ability to perceive meaning in their changing circumstances and 
encompassed their beliefs, perceptions of future possibilities, sense of purpose, and goals. 
Hope motivated and assisted the women in coping with an uncertain future. It was both a 
resource and a way of being resilient in the context of living with their incurable, progressive 
condition. 
Sarah saw hope as essential to successful adaptation and moving on with life. Eva, Irena and 
Margaret associated hope with meaning, and a peaceful and purposeful existence. Over her 
long period in hospital Clare’s resilience was evident as she sustained hope for the resolution 
of her chylothorax through her practice of positivity and gratitude. Women with children 
hoped to survive to see their children grow up. Medical research was a source of hope for a 
cure. The effectiveness of sirolimus treatment in stabilising lung function gave women hope 
for a longer life.  
Spirituality, social support and self-efficacy beliefs supported hopeful thinking at late stage. 
Patricia and Vidu sustained hope for a transplant. Margaret hoped for survival and quality 
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of life even though a transplant was not a possibility for her. She maintained a positive belief 
in her self-worth and ability to achieve her goals of health, quality of life, learning, and 
connecting with and helping others. Hope was, at the same time, realistic in her awareness 
of her mortality, planning for her end of life, and her faith in the possibility of a peaceful 
death. Similarly, in a study of families living with chronic illness, Mattingly (2010) found 
hope was a practice of creating meaning in the presence of suffering. Hickey (1986) and 
Borneman et al. (2014) found that hope can coexist with fear and uncertainty for people 
with cancer and that this is related to realistic awareness of their situation.  
Previous research supports the connection between hope and resilience. Gillespie (2007), in 
a concept analysis of resilience, identified hope as integral to resilience. Similarly, Ong et 
al (2006), in a study of daily stress and emotion in older adults, found that hope was an 
important source of resilience and reduced the intensity of stress. According to Snyder’s 
hope theory (2002), hope is a person’s perception of their ability to find pathways to their 
goals and be motivated by agency to use them. Further, supporting the connection between 
resilience and learning, Snyder (2002) asserted that hope is learned through life in social 
interaction and is an enduring way of thinking applied to particular situations. The 
participants highlighted the cumulative effect of hope and resilience through the mechanism 
of meaning. Having hope contributed to their resilience by being a source of meaning and 
motivation to cope with their illness, and hope was also facilitated through the process of 
finding meaning as an aspect of resilience learning.  
7.10 Meaning and resilience 
Through their experiences, the participants highlighted that meaning, learning and resilience 
were interrelated. Their personal life meaning motivated and directed their engagement with 
their illness and, in turn, resilience learning was a process of making meaning as they gained 
competence in self-management, developed spirituality and personal growth, and 
experienced social connectedness in everyday life. The positive self-beliefs, hope, and sense 
of life having value and purpose that were generated in these processes enabled them to 
integrate the reality of their illness into their life, re-establish a sense of self, experience 
wellness, and cope with illness progression and other life changes. 
Visser (2008), defined learning as interacting constructively with constantly changing 
environments throughout life. Visser (2008) and Land et al. (2014) argued that learning 
involves the creation of meaning and self through life experience and develops in the context 
not only of significant change but also through the fluctuations of everyday life. As the 
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participants’ experiences attested, learning, according to Visser (2008) and Patel and 
Yoskowitz (2005), has been associated with adaptive, health-related behaviours and reflects 
beliefs, values, emotions, context, and past knowledge and experiences in individual 
decision-making. This concept of learning identifies the connection between resilience and 
learning revealed by this study and encompasses the dynamic, developmental and 
transactional character of resilience as well as the meaning, knowledge and competencies 
associated with it.  
The participants were motivated by their relationships and their desire to experience 
autonomy, coherence, wellness, connectedness with others, and fulfil their responsibilities 
competently. They found meaning when they had learned to live with their illness and 
mastered managing it, and were again able to achieve goals and participate in work and 
social life. These findings are consistent with self-determination theory, articulated by Deci 
and Ryan (2000), which holds that people have a basic psychological need for autonomy, 
competence and relatedness. The participants demonstrated the view of Weinstein et al. 
(2012) that meaning was found when their goals and actions satisfied these needs.  
Resilience was multidimensional. The participants’ experiences revealed a constant 
interplay of meaning, agency, and interactions in their changing physical, emotional, 
spiritual, and social environments. Wong and Wong (2012) proposed that programs to build 
youth resilience should be comprehensive and meaning-centred to address the 
multidimensional nature of resilience. They identified dimensions of resilience as 
interactions with changing environments, behaviours, motivation, social relations, 
emotions, spirituality, and cognition. These dimensions were demonstrated by the 
participants of this current study and relate to meaning and learning. Likewise, Edwards 
(2013), in a review of chronic illness and resilience, distinguished biological, psychological, 
emotional, social and spiritual domains of resilience.  
This study has demonstrated that meaning developed across the course of the participants’ 
lives, shaped their perceptions, decision-making, and experiences throughout the course of 
their illness, and was integral to their learning, adaptation and resilience. Frankl (1984) 
claimed that a person’s main motivation in life was to find meaning and they did this by 
doing deeds, experiencing or creating something, encountering others, and in the attitude 
they chose to suffering. The participants similarly found meaning in their attitudes, agency, 
experiences, and interactions as they adapted to their illness.  Other authors agree that the 
formation of self and meaning involves agency through one’s choice of action and attitude 
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(Land et al. 2014; Murray Parkes 1971; Dewey 1916), and that a sense of agency is 
associated with resilience (Wong and Wong 2012).  
The participants demonstrated resilience as an outcome of their adaptive learning in their 
ability to experience positive feelings of wellness while living with their illness. The 
wellness they felt as they integrated their illness into life was associated with finding 
meaning that was congruent with their personal life meaning of self, values and beliefs. 
Wellness included functioning optimally within the limitations of their illness and feeling a 
sense of emotional wellbeing. Wellness, according to Lightsey (1996, p.591) is “a broad 
range of positive outcomes, including physical and psychological health”, with 
psychological health equivalent to subjective wellbeing.  
In considering the role of positive emotions and meaning in building resilience and 
wellbeing, it has been suggested that positive emotions precede experiencing life as 
meaningful. King et al. (2006) found a strong correlation between positive emotions and 
meaning in life and claimed that positive emotions predispose people to feeling life has 
meaning. Similarly, Ong et al. (2010, p.89) claimed that positive emotions are the primary 
mechanism by which everyday experiences build resilience by promoting “adaptive 
flexibility”. Using Fredrickson’s (1998) broaden-and-build theory of positive emotions, 
Tugade and Fredrickson (2007) proposed that the effects of incidental experiences of 
positive emotions accumulate over time to enhance wellbeing, build resilience and form a 
personal resource.  
In contrast, this study argues that the participants’ resilience, in the context of living with a 
rare, chronic illness, was closely related to the process of finding meaning, and they 
experienced wellness and positive emotions as an outcome of this process. This echoes 
Frankl’s (1966) assertion that happiness is an effect of meaning being fulfilled. The 
participants, for example, during liminal periods of uncertainty and shifting sense of self, 
felt positive emotions and greater emotional stability when they found meaning through 
their experiences of spirituality and personal growth. Similarly, Margaret’s strategy of 
“capitalizing” during her experience of respiratory failure might also be viewed as her effort 
to create meaning by expressing her optimism and competence as a reflection of her sense 
of self. In accordance with these findings, Park et al. (2008), in a study of meaning-making 
in cancer survivors, reported that the process of making meaning produced an outcome of 
psychological wellbeing.  
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Day to day experiences which built the participants’ resilience throughout their lives were 
a source of both positive emotions and meaning. While their experiences of happiness in 
daily life gave rise to positive emotions in a present sense, it was finding meaning in their 
experiences that made an enduring contribution to their construction of self, wellbeing and 
resilience throughout life. This finding is explained by a closer examination of wellbeing. 
King and Hicks (2012) distinguished between hedonic wellbeing as a subjective feeling state 
of pleasure or happiness, and eudaimonia as the experience of values and meaning in life. 
Reflecting the enduring quality of meaning, Baumeister et al. (2013, p.505) claimed that 
“happiness was largely present-orientated, whereas meaningfulness involves integrating 
past, present and future” and is related to acts that reflect the self and positively help others.  
It is conceivable that meaning and positive emotions may act synergistically to increase 
wellbeing and resilience, and the dominance of each may vary in different contexts at 
different stages of life. King et al.’s (2006) finding that positive emotions predicted 
meaning, for example, was based on research with university undergraduate students and 
meaning as related to personal goals. Finding meaning in a broader sense and experiencing 
eudaimonic wellbeing may be more important in building resilience in contexts such as the 
onset of chronic illness where a person’s life meaning has been disrupted by their diagnosis.  
Previous research related to older adults and chronic illness has connected learning with the 
cognitive and competency aspects of resilience. Lewis and Harrell (2012, p.348), in 
discussion of resilience in older adults, conceptualised resilience as “continued competence 
across the lifespan”. Optimism and positive emotions, associated with resilience, have been 
shown to be skills that can be learned through behavioural and cognitive interventions 
(Moskowitz, 2010; Seligman, 1991) and loving-kindness meditation interventions 
(Fredrickson et al. 2008). In relation to chronic illness, Kralik et al. (2006, p.199) stated that 
resilience was associated with knowledge and skills and could be strengthened by 
participatory action research as “a process of reflection, learning and action focused toward 
overcoming adversity”. Further, according to Rosenbaum (1990), skills and behaviours 
which influence a person’s ability to adopt and maintain health practices are learned and he 
referred to these as learned resourcefulness. Likewise, Trivedi et al. (2011, p.181) asserted 
that resilience is “an ability that can be fostered”. This study has presented a broader concept 
of resilience learning which, while inclusive of knowledge and competence as essential to 
illness management, identifies the creation of meaning as integral to building resilience in 
the context of chronic illness.  
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7.11 Interpreting the meaning of the experience of living with LAM 
through life history 
This life history study revealed the meaning of the participants’ experiences of living with 
LAM through levels of interpretation and the reconstruction of the temporal order of their 
experiences in the construction of the life history. Gadamer’s (2004) hermeneutic 
philosophy and the view that “human life is a process of narrative interpretation” 
(Widdershoven 1993, p.2) was reflected in the women’s life stories. On a personal level, the 
participants’ lives involved constant change which they interpreted against their personal 
life meaning. This background meaning of their personal, family, society and cultural values 
and understandings, consistent with Gadamer’s (2004) concept of “prejudice”, influenced 
how they interpreted their experiences and interactions and informed their perspectives and 
view of the world. Gadamer (2004) referred to a person’s perspective as their “horizon” and 
asserted that understanding is always the fusing of past and present horizons, a “fusion of 
horizons”. Similarly, meaning constantly evolved and shifted as the participants interpreted 
situations they were experiencing and fused their present perspectives/ horizons with their 
past perspectives. Engaging in the learning processes of adaptation enabled them to interpret 
their illness in a more positive light and integrate its meaning into their life meaning to build 
their resilience and move from an experience of disruption to one of wellness. Interpreting 
an experience negatively could lower their experience of wellbeing and resilience. 
The research process involved further levels of interpretation. The participants deepened 
their understanding of their experiences as they reflected on them and interpreted them in 
the telling of their life stories in the context of the interviews. Moreover, my own 
background/prejudices and the “standpoint” I took of openness and privileging the 
participants’ accounts (Frank 2000) influenced the conduct of the research, my 
interpretations of their told stories, and the presentation of the interpreted stories in the 
thesis.  
Constructing the collective life history of the participants concerned the issue of temporal 
order as well as interpretation. The order of the women’s stories as they told them was 
subjective rather than temporal and linear. The women ordered them according to the 
significance they placed on different experiences and events from their present perspective, 
and, in the context of the interviews, as a response to the main purpose of the research 
inquiry to uncover the meaning of living with LAM.  
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The collective life history was a co-created construction. It represented both the participants’ 
interpretation and telling of their experiences as they constructed their life stories in 
interaction with me in the interviews, and my interpretation and reconstruction of these told 
stories through the analysis undertaken. Constructing the collective life history in 
chronological order connected the women’s experiences and, in Mishler’s (1995, p. 96) 
words, “reconstructed the order of the told”. The presentation of the participants’ shared 
story in this way has provided an understanding of their experiences of living with LAM as 
a progressive illness over time. Mishler (1995, p.90) referred to this model of narrative 
analysis as “reconstructing the told from the telling”.  
Through these levels of interpretation and the construction of the life history this research 
has uncovered and enriched the meaning of the women’s experiences and demonstrated 
Gadamer’s hermeneutic view that understanding continually evolves with new experiences 
and interpretations. Readers of the research will develop meaning further as they bring their 
own prejudices and horizons to their interpretations of the research findings.  
7.12 Summary of key findings  
This study set out to answer the research question: what are women’s experiences of living 
with LAM over their life course? Using life history the study has explored and captured a 
comprehensive view of these experiences. The findings of the study are summarised in 
relation to its specific aims of increasing understanding of the meaning of women’s 
experiences of living with LAM over time across the illness trajectory, understanding how 
the rarity of LAM affected the women’s experiences, and identifying issues of concern for 
women living with LAM. This knowledge fulfils the aim of the study to enhance the existing 
body of nursing knowledge to inform the practice of nurses and other healthcare 
professionals. It thereby may facilitate their ability to improve the care and support provided 
to women with LAM. 
7.12.1 The meaning of women’s experiences of living with LAM over time 
 The women experienced turning points of significant life change related to their 
illness or social world over time.  
 Turning points of negative disruptive change were: 
o Being diagnosed  
o Critical illness events such as being in hospital for treatment of 
pneumothorax, chylothorax or renal angiomyolipoma 
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o Starting oxygen therapy and advancing to continuous oxygen therapy 
o Being listed for transplant – signified the late stage of LAM 
o Experiencing respiratory failure 
o Stopping work due to illness progression 
o Social changes such as a death in the family, losing a valued work role 
 Positive turning points included: 
o Starting sirolimus therapy – stabilised lung function, resolved 
lymphangioleiomyomas and chylothorax, and provided a sense of hope. 
o Receiving meaningful social support e.g. affordable home services 
o Receiving compassionate care at late stage 
o Receiving a transplant 
o Social change such as a birth in the family or adopting a child. 
 Being diagnosed was associated with a sense of life disruption and feelings of shock, 
loss, uncertainty, isolation and a shifting sense of self, and emotions of fear, sadness, 
grief and anger.  
 Diagnosis was less disruptive for women who had experienced significant illness or 
adversity through their lives, or who were mildly affected by LAM with minimal 
impact on their daily life. 
 Turning points initiated a period of transition in which the women learned to live 
with changes they experienced physically, personally, emotionally and socially.  
 Living with LAM was characterised by three transitional experiences: 
o Adaptive coping 
o Avoidance coping  
o Living with struggle and suffering at the late stage of LAM – a transition to 
transplant or end of life 
 Adaptation was a process of learning to live with change. It involved: 
o Mobilising personal resources of personal qualities, existing resilience, and 
spirituality; economic resources; and social resources of social support and 
connectedness. Participants preferred support that was positive and focused 
on wellness. 
o Problem-focused learning to self-manage their illness, including managing 
symptoms, relationships, responsibilities, emotions and identity, and 
communicate with healthcare professionals through personal agency and 
self-advocacy. 
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o Self-learning in the transitional state of liminality created meaning and 
reconstructed a sense of self through a process of reflecting on their 
existence. It involved negative feelings of instability and ambiguity, and 
positive experiences of personal growth and deepened spirituality which 
assisted in managing their emotions and realising a renewed sense of self and 
purpose, expressed as empathy and altruism. Not all experienced liminality 
as an aspect of adaptation. 
 Using oxygen therapy at the advanced stage of LAM held paradoxical meanings for 
the women. Meaning shifted with shifts in their perception at turning points. 
o Negative meaning of disruption, associated with themes of loss and 
limitation, burden, and feeling stigmatised. 
o Positive meaning of enabling, associated with staying alive, preserving 
normality, and feeling liberated. 
 The participants developed resilience through their experiences of living with LAM 
over time. 
o Resilience was the complex learning that developed throughout life as a 
result of adaptation to situations of change and adversity, and as a process of 
everyday life. 
o Resilience learning involved making meaning of change, and gaining 
knowledge and competence in managing their illness over time. 
o Everyday life experiences built resilience through managing minor daily 
disruptions and experiencing positive emotions, for example in experiences 
of social connectedness. 
o Resilience was a dynamic process which shifted with changes in the 
women’s individual health and social world, and reflected personal beliefs 
and perceptions. The women experienced different levels of resilience at 
different stages of their illness according to their individual situations of 
change and perception of need. 
o The outcome of resilience learning was the ability to experience wellness and 
positive beliefs of self-efficacy, self-esteem and self-worth, and later to cope 
with struggle and suffering at late stage. 
 Avoidance coping enabled some to adjust to change while their illness remained 
stable. It was associated with not engaging in the learning processes of adaptation 
and, at late stage, a lower level of resilience and perception of suffering. 
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 The late stage of LAM was characterised by living with struggle and suffering. 
Resilience was a resource which influenced the women’s ability to cope with their 
worsening symptoms and shaped perceptions of their suffering. It was an ongoing 
process through experiences of spirituality, personal growth, and compassion. 
7.12.2 How the rarity of LAM affected the experiences of women living with LAM 
 The process of diagnosis was associated with periods of misdiagnosis, delayed 
diagnosis, and multiple medical consultations due to the lack of knowledge of LAM 
amongst physicians.  
 Many participants received their diagnosis in an insensitive manner: 
o Lack of empathy and emotional support 
o Minimal outdated and inaccurate information sourced from unreliable 
internet sources was provided 
o Lack of referral to the peer support organisation. 
 The rarity of LAM created feelings of uncertainty and isolation. 
 Women isolated from centres of LAM expertise had difficulty accessing appropriate 
expert care, information and treatment, and contact with other women with LAM. 
There was a lack of communication between general physicians, LAM experts, and 
other healthcare professionals. 
 There was a need for women to be self-reliant in seeking information, and self-
advocate to access appropriate care, treatment, investigations and follow-up of 
investigations. 
 The participants’ interactions with physicians were characterised by a shifting power 
balance influenced by knowledge and attitudes: 
o Women became expert in knowledge of their rare disease and managing their 
illness. 
o Physicians with less knowledge of LAM tended to be less accepting of their 
patient’s expertise and less willing to share decision-making. 
o Physicians expert in LAM were more likely to be collaborative and share 
decision-making with the participants. 
 In the hospital setting, women felt a need to be vigilant and educate healthcare 
professionals. Their self-advocacy was tempered by their increased vulnerability in 
this setting and their perception of needing to be a “good patient”. 
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 There was a lack of knowledge and awareness of LAM in the community which 
created a constant need to explain the illness to others and, at times, feelings of being 
stigmatised in public places and workplaces. 
 The rarity of LAM meant it was difficult to attract funds for research. There were  
few women available to run the peer support organisation, support other women with 
LAM, and advocate in the community through fundraising and public speaking. 
These activities took time and energy and were felt to be a burden. Raising funds 
through friendship networks while looking healthy created feelings of guilt. 
7.12.3 Issues of concern for women living with LAM 
 The limited knowledge and awareness of LAM among healthcare professionals and 
in the community. 
 Difficulties receiving a timely diagnosis and accurate, appropriate information and 
emotional support. 
 The limited number of physicians with expertise in LAM in Australia and poor 
communication between physicians created difficulties in accessing expert care, and 
appropriate information, investigations and treatment for women isolated 
geographically or by their health status. 
 The need to be vigilant in monitoring their care and educate healthcare professionals 
in the hospital setting was a burden. 
 Fatigue, a problem for some women, was not addressed by healthcare professionals. 
 Lack of ongoing emotional support and advice regarding social services. 
 Sexuality and contraception were significant issues for pre-menopausal women. The 
women felt sexuality was a difficult subject to raise with physicians. They received 
inadequate and inconsistent advice concerning contraception. 
 Inequities in funding for oxygen therapy across different states 
 Lack of funding for portable oxygen concentrators which would facilitate 
engagement in exercise, work and social activities. 
 Non-availability of liquid oxygen 
 Need for further education on managing supplementary oxygen therapy. 
 Need for educational resources suited to younger women and for children whose 
mothers are living with LAM and using oxygen therapy. 
 Some expressed a desire for a health coaching style of support after diagnosis. 
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 Lack of public funding for research into LAM created a need to fundraise while 
managing their illness. 
 Few women were available to run peer support organisation, fundraise, and support 
other women living with LAM – need for community support with these activities. 
 
7.13 Conclusion 
This chapter has discussed the findings of the study in relation to resilience which emerged 
as the overarching theme of the women’s experiences of living with LAM across their life 
course. This research extends previous concepts of resilience by adopting a broad view of 
resilience as learning. The participants revealed that this enabled them to manage their 
physical, mental, emotional and spiritual health while living with LAM in their individual 
changing social contexts throughout the course of their illness. The women emphasised their 
emotional and social concerns and the importance of achieving wellness by gaining 
autonomy and a sense of coherence. The concept of resilience as lifelong learning identifies 
the mechanisms by which the participants reached these outcomes as the interplay of 
meaning, agency, knowledge, competence, and positive emotions, in times of change and 
adversity as well as times of stability. Finding meaning was a particularly significant aspect 
of their resilience learning. 
This research has demonstrated that resilience is not an inbuilt quality but is accessible to 
anyone and can develop at any stage at a level suited to a person’s individual situation and 
their perception of their needs.  As such, resilience learning is a constructive, strength-based 
concept which healthcare professionals can utilise in planning interventions to improve 
people’s ability to manage and live well with chronic illness in the context of their life. The 
following chapter concludes the thesis. It will discuss the significance of the findings for 
practice in more detail, reflect on the life history method used in the study, consider 
limitations and directions for future research, and offer a personal reflection on the research 
journey. 
  
  
 
 
226 
 
Chapter 8  
CONCLUSION 
 
8.1 Introduction 
This chapter concludes the thesis. Specific findings of this research, including issues of 
concern to the participants, are discussed in relation to their implications for practice. The 
limitations of the study are acknowledged and possibilities for future research are suggested. 
I reflect on the life history method that has been used and offer a personal reflection on the 
research journey.  
Consistent with its aims, this study has explored and captured a comprehensive 
understanding of the experiences of women living with LAM over time, from the onset of 
symptoms to the late stage of their illness, and how these were affected by the rarity of 
LAM. Diagnosis, a long hospital admission, starting oxygen therapy, receiving a transplant, 
and experiencing respiratory failure were significant turning points of disruptive change for 
the participants.  
This study illuminated resilience as an important aspect of the participants’ experiences of 
living with LAM across their life course. Resilience was revealed as the complex learning 
that developed throughout life as a result of both adaptation to situations of change and 
adversity, and as a process of everyday life. Resilience learning involved making meaning 
of change, and gaining knowledge and competence in managing their illness over time. The 
outcome of these processes was the ability to move from an experience of disruption to one 
of wellness, and later to cope with struggle and suffering if their health deteriorated to a late 
stage. In everyday life, resilience accumulated as positive beliefs of self-efficacy, self-
esteem and self-worth. These were generated as they experienced both the fluctuations and 
positive aspects of daily life. Resilience was a dynamic process which shifted with changes 
in the women’s individual health and social world, and reflected their personal beliefs and 
perceptions. While dispositional qualities of optimism, curiosity, flexibility and 
resourcefulness facilitated the participants’ resilience, learning processes played a more 
significant role.  
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The rarity of LAM had paradoxical influences on the participants’ experiences. Negatively, 
it created uncertainty and feelings of being stigmatised and isolated. Accessing appropriate 
medical care, information, and treatment was a problem for women if they were unable to 
travel to specialist centres for management of their LAM. Additionally, needing to educate 
healthcare professionals and advocate for services and funds for research was perceived to 
be a burden. Positively, having a rare disease increased the women’s knowledge and 
communication skills as a consequence of their self-reliance and self-advocacy. While this 
empowered them to engage in collaborative relationships with researchers and their care 
providers, shared decision-making regarding their medical care was dependent on the 
attitude of their physician. When decision-making was shared, a sense of control and 
feelings of autonomy and competence were enhanced. In turn, their satisfaction with their 
medical management improved.  
8.2 Implications for practice 
The participants of this study revealed a number of issues related to their experiences of 
living with LAM that have implications for practice and public policy. These may also be 
relevant to people living with other chronic conditions.  
In common with other rare diseases, the period from onset of symptoms to diagnosis was a 
time of delay, misdiagnosis and uncertainty due to physicians’ lack of awareness and 
knowledge of LAM. There remains a need to raise awareness among physicians of the 
possibility of a woman having LAM when presenting with unexplained breathlessness and 
reduced exercise tolerance, rather than attributing symptoms to other causes. A woman’s 
experience of being diagnosed improved if she was provided with accurate information and 
explanation by an expert physician.  
The issue of unequal power balances in patient/physician relationships is well recognised in 
the literature. This study has demonstrated the power differential was reduced when both 
patients and physicians increased their knowledge about LAM, and when physicians 
listened to and acknowledged the patient’s understanding of their illness. This tended to be 
the case with LAM experts who were generally more willing to engage in collaborative 
interactions with their patients and accept their input in decision-making. The findings of 
this study reinforce the need for all healthcare professionals to be constantly mindful of 
power balances in their interactions with patients. 
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Nurses have a role to play in addressing the concerns of women living with LAM and 
helping improve their healthcare experiences. Nurses may encounter these women or other 
people with rare diseases in community and hospital inpatient and outpatient settings as they 
are treated for their condition or undergo investigations. Within a multidisciplinary team, a 
nurse specialist can potentially undertake a leadership role coordinating care for these 
patients. There are at present no multidisciplinary centres of expertise in rare disease in 
Australia (Molster et al. 2016). While a specialist nursing role may potentially be funded if 
such a centre was established, in the context of the difficulty in attracting government 
funding for research into rare diseases, it is unlikely that a specialist nursing position would 
be publicly funded in the current Australian healthcare system.  Rather, it is feasible that a 
nursing role supporting women with LAM and people with other rare lung diseases could 
be encompassed within the scope of practice of respiratory nurse consultants or nurse 
practitioners practising throughout Australia. Specialist nurses would therefore be available 
to patients with rare diseases and the healthcare professionals caring for them at a more local 
level. 
A specialist nursing role would involve acting as a conduit to physicians, nurses and other 
service providers. The nurse could advocate to facilitate appropriate investigations, 
treatment, oxygen supplies and equipment, as well as affordable home help. In addition, the 
nurse could provide specific education on LAM to nurses who may be caring for these 
women in hospital or community settings or direct them to appropriate educational 
resources. In this way, a specialist nurse can raise awareness of LAM and other rare diseases 
among nurses and other healthcare professionals who may have infrequent contact with 
these patients. The specialist nurse can assist them in developing skills to access accurate 
literature on both the biomedical facts as well as people’s lived experiences of rare 
conditions to increase their knowledge of issues of concern for these people and inform their 
practice when needed.  
Women can be isolated from healthcare centres proficient in managing LAM by distance or 
their poor health status. They are consequently disadvantaged in their ability to access 
appropriate care and treatment. This includes sirolimus medication which the participants 
in this study reported as significantly enhancing their quality of life. Establishing pathways 
of consultation and communication using technology, such as phone, email, internet, and 
social media, may improve dialogue between women, their general physicians, nurses, and 
LAM experts.  This may enable women who are isolated to access expert medical and 
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nursing management without relocating and travelling long distances. In addition, a 
specialist nurse could incorporate technology to provide educational resources for 
healthcare professionals in smaller and remote health facilities if they are caring for women 
with LAM. 
Turning points were periods when the participants needed most support. From the time of 
diagnosis, an educated nurse could provide information, education, resources, and emotional 
support to women, their partners, and families. The nurse may provide an opportunity for 
open discussion, as well as advice and support, regarding specific areas of concern such as 
fatigue, emotional and sexual health, contraception, and managing the impact of illness on 
relationships, friends, and family and work responsibilities. When necessary, referrals could 
be made to other members of the healthcare team, for example, psychologists, dieticians and 
social workers. The nurse may also respond to women seeking advice on more minor matters 
not warranting a medical appointment but nonetheless of concern to them. Additionally, the 
nurse could connect women with peer support groups if desired, being sensitive to 
connecting them with women who are at a similar stage of LAM and managing their illness 
well.  
The understanding of the learning processes of adaptation and resilience provided by this 
study can guide an informed nurse in supporting women with LAM to independently 
manage their illness. In the context of LAM as a chronic illness, resilience incorporated a 
cognitive and practical aspect of learning the skills necessary to manage the illness, and an 
emotional and spiritual component of making meaning to re-establish a sense of self and 
relatedness to the world in the context of living with illness. Resilience was enhanced by 
care focused on health, wellness, autonomy in illness management, and participation in 
shared decision-making. Active listening enables a patient to voice their concerns and reveal 
their personal life meaning, goals, priorities, past experiences, and social context. Knowing 
these, the nurse can provide individualised care and assist a woman to identify her own 
strengths and coping style, and reframe her goals to reflect her new reality. An 
understanding of resilience can assist healthcare professionals in encouraging their patients, 
particularly those with an avoidance style of coping, to engage in the learning processes 
which build resilience.  
Managing their emotions was an important aspect of the participants’ resilience. This study 
uncovered self-learning as a mechanism of emotional stability and showed how it occurred 
as the women found meaning in their experiences and developed positive self-beliefs. The 
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nurse can utilise this understanding to support patients in managing their emotional health 
and social interactions throughout their illness. For example, the nurse can be aware of and 
identify when a woman is experiencing liminality, such as through her use of metaphor, and 
provide additional emotional support and reassurance of the positive benefits of this self-
learning for integrating illness into life. Many women try alternative therapies and the nurse 
needs to be open to discussing these options.  
The concept of resilience learning revealed by this study may additionally inform specialist 
nurses and other healthcare professionals involved in health coaching for people living with 
chronic illness and disability in a variety of healthcare settings. According to Palmer et al. 
(2003), health coaching facilitates learning in health education and health promotion to 
enable a person to achieve their health-related goals and wellbeing. It includes emotional 
support and assistance in developing self-management skills (Bennett et al. 2010). This 
study provides an understanding of the factors that influenced the participants’ motivation, 
as well as the processes involved in learning to self-manage their health and achieve 
wellness. This may be relevant to the motivational interviewing and goal-setting that Olsen 
and Nesbitt (2010) claimed are involved in health coaching.  
An informed nurse can provide education to women living with oxygen therapy, particularly 
those using oxygen intermittently who demonstrated misunderstandings regarding their 
oxygen use. While attending a pulmonary rehabilitation program in a hospital clinic is an 
option that can be offered to women with LAM, these are attended mainly by older people 
with COPD. The participants indicated they preferred exercising at home, outdoors or with 
people their own age at a gym. The nurse can teach and assess women’s skills in self-
monitoring their breathing and oxygen saturations to enable them to exercise in these 
environments. This encourages personal autonomy and self-management, and enhances 
resilience. In addition, educational material currently available on living with chronic 
respiratory disease is directed to people with COPD and there is a need both for resources 
suitable for younger women, and to assist mothers living with oxygen therapy in educating 
their children. Within the acute care setting, the contrasting experiences of Patricia and Vidu 
explain why some patients find it so difficult to relinquish their oxygen after transplant and 
emphasises the need for nurses to show patience and empathy in educating these patients. 
An expert nurse who has been caring for women prior to transplant can liaise with hospital 
nurses to inform them of a patient’s previous coping style so that any difficulties can be 
anticipated and managed. 
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This study has revealed the need to address policy issues concerning oxygen therapy in the 
Australian context. These include inequities in funding for oxygen in different states, non-
availability of liquid oxygen, and lack of funding for portable concentrators which facilitate 
exercise and activity. Most policy is based on research regarding older people with COPD 
and does not take account of the needs of the younger LAM population who in this study 
showed they were highly motivated to engage in exercise, work and social activity. 
Furthermore, assessment criteria determining oxygen supplies needs to take into account the 
function and activity levels of younger women. Factors of inequity need to be addressed so 
as not to compound the hardship which single women living alone, who are particularly 
vulnerable, can face in the advanced stages of their illness. A nurse coordinating care could 
maintain contact with these women and assess their health and need for additional services 
and support. 
The findings of this study have uncovered a role for an expert nurse in providing 
collaborative, person-centred care to support women living with LAM to manage their 
illness effectively throughout their life. In addition, using technology, a specialist nurse can 
inform and educate nurses caring for women with LAM in other locations. Further to this, 
the understanding of resilience illuminated by this research may assist nurses in facilitating 
a patient’s engagement in the learning processes which build resilience. These findings may 
be applicable also to people living with other rare and chronic conditions. 
8.2.1 Summary of recommendations for practice 
It is proposed that a specialist nursing role in rare lung disease is developed within the scope 
of practice of a respiratory nurse consultant or nurse practitioner. It is recommended that a 
specialist nurse: 
 Co-ordinate care of women with LAM or other rare lung diseases within a 
multidisciplinary team, referring women to multidisciplinary healthcare services 
when needed. 
 Establish pathways of communication using technology to improve dialogue 
between women living with LAM, general physicians, nurses and LAM experts. 
 Provide education on LAM to nurses and healthcare professionals. Assist them 
in developing skills to access accurate literature on rare disease that can inform 
their professional practice. Incorporate technology to provide educational 
resources for healthcare professionals in smaller and remote health facilities. 
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 Provide appropriate information, education, resources and emotional support to 
women with LAM, their partners and families at diagnosis, later turning points 
and as needed throughout their illness. 
o Provide education to women living with oxygen therapy. 
o Develop educational resources suitable for women living with LAM, 
including mothers living with oxygen therapy in educating their children. 
 Develop an understanding of the learning processes of adaptation and resilience 
to support women with LAM to independently manage their illness and achieve 
their health-related goals and wellbeing. 
 Connect women diagnosed with LAM with peer support groups if desired.  
 Liaise with hospital nurses when patients are admitted to hospital to inform them 
of a patient’s coping style so that this can be incorporated into individual care 
plans. 
 Maintain contact with women at the late stage of LAM and assess their health 
and need for additional services and support. 
 Advocate policy makers to address issues of: 
o Inequities in funding for oxygen in different states of Australia 
o Non-availability of liquid oxygen 
o Lack of funding for portable oxygen concentrators 
8.3 Reflection on the method 
The life history method used in this study has been effective in achieving its aim of exploring 
women’s experiences of living with LAM across the life course. The strength of this method 
was its holistic character and ability to capture the complexity of multiple aspects of illness 
experience, including the biological, physical effect of LAM; personal meaning and social 
context; and the temporal dimension of the participants’ experiences. It revealed the 
dynamic interaction between these aspects of human experience in response to the day to 
day changes of everyday life, as well as significant life changes related to illness progression 
or social context.  
Constructing the collective life history of the participants around turning points and 
significant aspects of their illness revealed how the meaning of their experiences changed 
over time, as well as issues of concern and their changing support needs. It also allowed the 
participants’ experiences to be situated in historical time to reveal the influence of events 
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on the women’s experiences, including the establishment of the LAM Foundation, and the 
discovery of the pathogenesis of LAM and subsequent effectiveness of sirolimus as a 
treatment for LAM. As well as common themes, life history demonstrated individual 
differences and complexities and paradoxes in the women’s experiences and how they were 
influenced by the rarity of LAM. The life course and contextual character of life history 
provided new insights into resilience in the context of chronic illness and demonstrated its 
multidimensional, transactional and developmental qualities. 
Accessing the participants’ medical records and constructing the biographical accounts of 
their illness provided, as Rosenthal (1993) intended, a database and factual details with 
which to compare the women’s subjective narratives. It revealed meaning in the different 
emphases the participants’ placed on aspects of their experience compared to their 
physicians, and the absence of areas of significance, such as fatigue and sexuality, in their 
medical records. This lends support for qualitative research of this nature to inform 
healthcare professionals so that management is focused and meets patients’ needs. 
Life history is intensely personal. Taking an empathic stance and allowing the women’s 
stories to permeate me meant there was a need to be reflexive and manage my own responses 
to the participants’ situations. As a nurse researcher, at times it was difficult separating 
myself as nurse from myself as researcher. For example, witnessing Margaret’s 
vulnerability and hardship at the late stage of LAM elicited a response of wanting to care 
for her and improve her situation. I gave her the contact details of the social worker who 
had agreed to be available while interviews were being conducted so that she might explore 
options for additional services and funding, but, as a researcher, I was not entitled to provide 
her with nursing care. I dealt with these conflicting feelings by reflecting on them, writing 
about them, and discussing them with my research supervisors.  
This life history study was hermeneutic as it was deeply infused with meaning, making 
meaning, and shifts in meaning as the participants’ experienced their illness in changing 
circumstances over time, and interpreted their lives and experiences as they narrated their 
life stories. Reflecting on their lives allowed some, in turn, to reach deeper levels of meaning 
in their experiences, a process which they indicated was therapeutic in giving them a fresh 
perspective on their illness. It was, in Gadamer’s (2004) words, a “fusion of horizons”. The 
collective life history within this thesis represents an additional level of meaning as my 
perspectives and interpretations were fused with those of the participants. The reader of this 
research will further enrich the meaning with their own perspectives. 
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8.4 Limitations and directions for future research 
This study concerned the experiences of women living with LAM in the Australian context. 
The nineteen participants recruited to the study represent 18% of women known to be 
currently living with LAM in Australia. However, the numbers are small and only three 
participants experienced the late stage of the illness. While this study has provided valuable 
insights into the experience of living with LAM, the findings cannot be generalised to other 
contexts.  
Further research is required to explore the experiences of women living with LAM in other 
contexts and at the advanced and late stages of the illness. The participants identified that 
their partners, children and parents were emotionally and physically affected by their 
diagnosis. No studies have sought the perspectives of family members and this remains an 
area to be explored. Future research, eliciting the views of both patients and healthcare 
professionals, could examine the applicability and usefulness of technology in providing 
access to expert medical and nursing management for women with LAM who are 
geographically isolated.  
Resilience emerged as a finding of this study and could form a focus of research into 
people’s experiences of other chronic illnesses. Additionally, resilience learning, as 
conceptualised in this study, could be examined for its applicability to both health coaching 
interventions and training for nurses and other healthcare professionals conducting health 
coaching.  
8.5 A Personal reflection 
Characteristic of life history research, this study has been a complex and winding research 
journey. There were no simple formulas to follow and few examples of life history studies 
in chronic illness research. Yet it seemed an approach that would suit an exploration of 
human experience that extended over the course of a person’s life. The rarity of LAM made 
the process more challenging with the difficulties in recruitment, ethical issues, and 
logistical factors of time, distance and expense as discussed earlier. 
Despite the turns in the road, conducting this life history research has been rewarding and 
deeply satisfying. It was a privilege to meet each participant and share her life story. I have 
always considered listening and talking to patients to be the best aspect of my nursing role. 
As a researcher, to be able to do so uninterrupted and completely focused on an individual 
woman was a rare and special experience. My intention was to provide a deeper 
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understanding of the women’s experiences, to represent each woman’s unique story 
truthfully while revealing the common threads of their narratives in a way that would inform 
healthcare professionals who may care for them so they may be better supported throughout 
their illness. Life history has been a pathway towards achieving that goal. 
This research has also been a deeply personal experience for me. It is not possible to enter 
people’s lives and become immersed in their stories without being touched. Analysing the 
women’s narratives and writing my findings was itself a liminal experience. It involved 
separating myself from familiar life and becoming, in Turner’s (1967, p.95) words, a 
“liminal persona”. There is the physical act of taking oneself to a quiet place on one’s own 
to think and write. It is a journey that no one else can take and this makes it a lonely time of 
isolation. Much of normal life is put aside, on hold. The liminality of being in the women’s 
lives was an unsettling and at times emotional experience and I needed to draw on my own 
personal resources and cultivate my own resilience. It has been a time of professional and 
personal learning – gaining understanding, knowledge and research skills, finding meaning, 
and experiencing personal growth through exploring the women’s experiences. I have 
gratitude that I have been able to take this journey and give the women’s voices a place in 
the literature on LAM and chronic illness. 
8.6 Concluding remarks 
This study explored the experience of women living with LAM across the life course. The 
women’s experiences were complex and varied, reflecting the differing manifestations, 
stages and progress of their illness, and their personal life meaning and individual social 
contexts. While each woman’s experience was unique, the majority of participants 
positively adapted to their illness over time and developed resilience in the process. 
Exploring the women’s experiences in the context of their whole lives revealed that 
resilience was the learning that evolved over the course of their lives through both adaptation 
to situations of change and adversity, and in their everyday experiences. The participants 
demonstrated that their learning was associated with acquiring knowledge and competency 
in managing their illness and health, finding meaning in their experiences, and personal 
growth. It was influenced by their social interactions, changes in their social environment, 
and the rarity of their illness. These learning processes generated positive self-beliefs and 
positive emotions which enabled the women to experience wellness while living with LAM, 
and accumulated as a resource they drew on to cope with struggle and suffering in the late 
stages of their illness. 
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Living with Lymphangioleiomyomatosis – A Life History Project 
 
 
Interview Schedule  [Version 2 - 17 March 2010] 
 
 
The interviews will be conversation/narrative style (tell me about……) and will 
focus on the following areas: 
 
Interview 1 
 How life was leading up to diagnosis 
 The process of diagnosis 
 How life has changed with diagnosis. 
 
Interview 2 
 How life is now 
 What the issues are for you living with a rare disease 
 Further exploration of issues raised in Interview 1 or this interview. 
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Table 2.1   Literature related to the experiences/perspectives of women living with LAM 
Author 
Year 
Country 
Aims Design Participants Findings 
Belkin et 
al. 2014 
US 
Capture patients’  
perceptions of how  
LAM affects their lives 
Qualitative study 
7 semi-structured  
focus groups, data 
analysed 
 for themes using 
content methods and 
reflexive team analysis. 
37 women 
aged 34-68 
years living 
with LAM (0.4-
39 years) who 
were attending 
LAMposium 
in Cincinnati 
2013 
(5 focus groups 
of 5 women 
each, 2 focus 
groups of 6 
women) 
Experiencing and 
managing  symptoms 
– fatigue prominent 
and severely impairing 
Psychological 
experience one of 
“getting stuck with 
LAM”: frustration and 
resentment, worry 
and fear, loss of 
identity, 
embarrassment and 
guilt. 
Some adapted and 
showed defiance and 
resilience. 
 
Carel et al. 
2010 
UK 
Describe personal  
patient journey 
Personal narrative of 
illness experience with 
comments by two 
physicians  
 
Short description of 
experience. Expanded 
narrative contained in 
her book (2008/2013) 
– two editions 
 
Carel 
2013b 
UK 
Reflect on broad 
experience 
 of illness using 
author’s personal 
experience   
Book of personal 
narrative and 
philosophical reflection 
using 
phenomenological 
framework (mainly 
Merleau-Ponty and 
Heiddeger) 
 
At diagnosis, lack of 
information, empathy 
and support, need to 
do own research. Post 
diagnosis HCPs 
generally showed lack 
of understanding and 
empathy. Need to 
become own 
advocate. 
Post diagnosis was 
process of adapting, 
transformation, and 
learning to live in the 
present. Author was 
able to experience 
health and wellbeing. 
 
Cohen et 
al. 2005 
Canada 
Provide update of 
clinical 
 picture of LAM 
Quantitative study 
Cross-sectional 
questionnaire survey 
analysed statistically 
448 women on 
US LAM 
Foundation 
database 
59 women 
listed with UK 
LAM Action. 
Participants 
were from US, 
UK, Canada and 
other countries 
More women over 40 
are being diagnosed 
with LAM 
Fatigue was common 
symptom, affected 
quality of life, 
overlooked by 
physicians 
Women with TSC-LAM 
were younger than 
non-TSC LAM 
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patients, had more 
symptoms, were more 
likely to have AML, 
had less dyspnoea 
There was a 
relationship between 
patient reported 
symptoms and 
reduced lung function 
results. 
Authors conclude 
research is needed to 
explain and reduce 
fatigue experienced 
by women with LAM 
 
Cohen et 
al. 2009 
Canada 
Determine pregnancy  
and health outcomes 
 in LAM to assist  
counselling patients  
re pregnancy 
Quantitative study. 
Questionnaire survey 
analysed statistically 
448 women on 
US LAM 
Foundation 
database 
59 women 
listed with UK 
LAM Action 
Women with LAM can 
have uncomplicated 
pregnancies. 
Respiratory 
complications and 
adverse pregnancy 
outcomes more 
common for those 
who experience 
exacerbation of LAM 
or are diagnosed 
during pregnancy. 
Pregnancy may affect 
lung function long 
term but did not 
increase dyspnoea or 
reduce quality of life. 
 
Haylen et 
al. 2009 
Australia 
To gain an 
understanding  of 
LAM and, in 
particular, the lived 
experience of persons 
living with LAM 
Literature review  
4 studies using 
quantitative methods 
were found that 
sought women’s 
views on some 
aspects of living with 
LAM (QoL, 
measurement of 
respiratory function, 
clinical management, 
dyspnoea and 
fatigue). 
No qualitative studies 
exploring the 
experience of living 
with LAM were 
located at that time. 
 
Hoy 2016 
US 
To raise awareness of 
LAM 
Personal narrative of 
author’s experience of 
living with LAM as a 
trainee physician 
 
Author was medically 
trained, partner also a 
physician – access to 
expert facilities and 
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investigations. 
Diagnosed in six days. 
Diagnosis – emotional 
rollercoaster (feelings 
of fear, sadness, 
denial, confusion, 
anger, grief); “kept 
going” as usual with 
life to retain sense of 
normality. 
Adjusted in year after 
diagnosis – accepted 
new normalcy 
(benefited from 
sirolimus – stabilise 
lung function; 
research gave hope; 
feelings of gratitude 
and optimism) 
 
Pollock-
BarZiv 
2005 
Canada 
To explore and 
describe the lung 
transplant (Tx) 
experiences of 
women with LAM, 
including QoL, 
psychosocial impact, 
and specific needs, 
concerns and issues of 
women with LAM 
who are transplant 
candidates or 
recipients 
PhD thesis, mixed 
methods study 
Quantitative: survey-
statistical analysis. 
Qualitative: in-depth 
interviews, grounded 
theory 
31 waitlisted 
and 43 
transplanted 
women 
answered 
surveys. 
11 post 
transplant 
women were 
interviewed 
For most delays in 
diagnosis, 
misdiagnosis, multiple 
doctors and tests 
before diagnosis 
received. 
Deterioration in 
physical function prior 
to Tx led to changed 
social roles and 
perceptions of 
changed identity. 
Most were unable to 
adjust. 
Study focused on 
women with severe 
disease. 
Lung transplantation 
improved QoL of 
women with LAM. 
Difficulties pre-
transplant: impaired 
function, fatigue, 
anxiety, isolation. 
Post transplant issues: 
depression, adverse 
drug effects 
 
Pollock-
BarZiv et 
al. 2005 
Canada 
To evaluate the 
relationship between 
objective and 
subjective functional 
status 
Quantitative cross 
sectional study 
including survey of 
demographic data, 
objective lung function 
tests, and in survey 
subjective Functional 
Performance Inventory 
31 lung 
transplant 
candidates and 
43 women post 
transplant from 
LAM 
Foundation 
database 
Certain aspects of 
spirometry/6 min 
walk do not correlate 
well with patients’ 
perceptions of their 
function. 
Considering subjective 
aspects of function 
may focus 
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interventions and 
improve QoL 
 
Ryu et al. 
2006 
US 
To describe the 
clinical characteristics 
of women with 
pulmonary LAM 
Quantitative 
observational study 
using demographic 
data, lung function 
tests, laboratory results 
and quality of life 
instruments (SF-36, 
SGRQ) 
230 women 
with LAM 
enrolled in the 
US LAM 
Registry 
between 1998 
and 2001 
Women with LAM 
experience impaired 
QoL. 
SF-36 mental and 
physical component 
scores were worse 
than the normal 
population but better 
than people with 
COPD. 
Results suggested 
both groups develop 
coping mechanisms 
 
Vafamand 
2014 
US 
To investigate the 
knowledge, attitude 
and practices of 
women living with 
sporadic LAM and the 
relationship of these 
to quality of life 
PhD thesis 
Quantitative study. 
Data from online 
survey questionnaires. 
Analysed statistically. 
Transtheoretical model 
used to describe the 
relationship between 
variables.  
143 sporadic 
LAM patients 
registered with 
the LAM 
Foundation 
There was a 
significant positive 
relationship between 
attitude, lifestyle 
practices and QoL, 
and a negative 
relationship between 
knowledge and QoL 
Walker et 
al. 2015 
US 
To develop and 
conduct initial testing 
of ATAQ-LAM (A Tool 
to Assess Quality 
 of Life in LAM). 
Phase 1. Guided by 
qualitative content 
analysis of the 
transcripts from a focus 
group study (Belkin et 
al. 2014) and clinical 
experience, a pool of 56 
items was developed 
comprising a 
preliminary version of 
ATAQ-LAM (A Tool to 
Assess Quality of life in 
LAM) 
Phase 2. Item reduction 
and validation of tool  
A convenience 
sample of 69 
LAM patients 
were recruited 
at the 
2014 
LAMposium in 
Chicago, 
Illinois, to test 
tool. 
ATAQ-LAM (“A Tool to 
Assess Quality of Life 
in LAM”), a 32-item 
questionnaire to 
assess HRQL in 
patients with LAM 
was developed. 
Higher ATAQ-LAM 
score = more impaired 
HRQL 
Subjects requiring 
supplemental oxygen 
had higher ATAQ-LAM 
scores than subjects 
not requiring supple- 
mental oxygen; 
ATAQ-LAM scores 
were significantly 
higher for subjects 
with the lowest 
FEV1% 
compared with 
subjects with the 
highest FEV1% values 
(measure of lung 
function). 
 
Young et 
al. 2006 
US 
To evaluate patients’ 
perspectives 
regarding 
23-item questionnaire 
314 
respondents 
from LAM 
One third of patients 
believed their 
physicians did not 
consider their 
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pneumothorax (PTx) 
treatment 
Foundation 
database 
preferences for PTx 
management. 
LAM patients and 
their physicians held 
different views, most 
patients favouring 
more conservative 
management initially.  
Authors concluded 
understanding 
patients’ perspectives 
will facilitate shared 
decision-making and 
may ultimately 
improve clinical 
outcomes in LAM for 
PTx 
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Table 2.2     Literature related to the experiences/perspectives of people living with a rare lung 
disease – pulmonary hypertension (PAH) and idiopathic pulmonary fibrosis (IPF) 
Author 
Year 
Country 
Aim Design Participants Findings 
Armstrong et 
al. 2012 
UK 
To investigate the 
patient’s 
experience 
 of the trajectory 
to diagnosis of 
PAH  
and inform 
provision of care 
Qualitative study 
using in-depth 
interviews and 
pictorial  
representations 
Thematic analysis  
30 patients with 
 PAH (18F) 
 26-80 yrs 
 (mean 56 yrs)   
Lack of awareness of HCPs led to 
misdiagnosis and delays in 
diagnosis. Multiple tests and 
doctors.  
Emotional impact – frustration, 
anger, uncertainty 
Poor communication .Patients 
perceived lack of empathy when 
they received diagnosis. Lack of 
information. 
Internet used to search for 
information 
Lack of guidelines for diagnosis. 
 
Belkin & 
Swigris 2014 
US 
To better 
understand the 
experiences and 
perceptions across 
the spectrum of 
IPF severity. 
Literature review 
5 studies 
reviewed 
Delayed diagnosis, misdiagnsosis, 
multiple medical consultations. 
Diagnosis: lack of competence of 
HCPs, emotional support, 
information and resources. QoL 
impaired; feelings of depression, 
anxiety and isolation. Higher 
levels of satisfaction reported 
when treated at centre of 
excellence. 
 
Collard et al. 
2007 
US 
To describe the 
attitudes and 
experiences of 
patients with IPF 
regarding 
diagnosis and 
management of 
their disease 
A survey of 52 
defined-choice 
and open-ended 
questions 
1448 
respondents 
who were 
members of the 
Coalition for 
Pulmonary 
Fibrosis (CPF) 
Lack of information and 
resources at diagnosis. Less than 
half of respondents felt well-
informed about treatment 
options, the role of supplemental 
oxygen, pulmonary 
rehabilitation, and 
transplantation. 
Need for improved patient 
education. 
 
De Vries et 
al. 2001 
The 
Netherlands 
To study the 
relationship 
between QOL, 
depressive 
symptoms, and 
breathlessness in 
patients with IPF 
Quantitative study 
using World Health 
Organisation Quality 
of Life Assessment 
instrument 
Forty-one IPF 
patients (aged 
38-80 years; 15 
M, 26 F) and 41 
healthy persons 
matched for age 
and sex 
QoL was impaired in domains of 
“physical health” and 
“independence”. Subjective 
breathlessness was associated 
with depressive mood and QoL. 
It was not associated with 
objective breathlessness 
measures. Major QoL problems 
were fatigue, mobility, activities 
of daily living and working 
capacity. 
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Duck et al. 
2015 
UK 
To understand the 
perceptions, 
needs and 
experiences of 
patients with IPF 
Qualitative study  
Semi-structured 
interviews 
Framework Analysis 
(Ritchie & Spencer 
1994) 
17 patients 
(7M, 10F) with 
moderate to 
severe IPF and 6 
of their informal 
carers 
12 patients 
were using 
oxygen therapy 
 
Experience of struggle and loss 
Struggle to get diagnosis 
(delayed diagnosis, misdiagnosis, 
symptoms trivialised), lack of 
information 
Disruption - World turned upside 
down 
Loss of independence, control, 
social roles, sense of self, 
spontaneity 
Struggle to live with IPF 
(breathlessness, cough, fatigue, 
oxygen). Need for support. 
Hoping for effective treatment. 
Oxygen enabled activities, sense 
of control 
Need for specialist ILD centres 
and nurses 
 
 
Flattery et al. 
2005 
US 
To describe 
patient 
experiences of 
living with PAH 
and identify 
factors that may 
have an impact on 
QOL. 
Qualitative study 
Semi-structured 
interviews 
Phenomenology 
(Colizzi’s 7-step 
process of analysis) 
11 participants 
(8F, 3M) 40-72 
years with PAH  
from outpatient 
setting of 
tertiary care 
hospital 
Participants experienced 
uncertainty related to illness but 
learned to cope with uncertainty 
(seeking information, making 
memories, humour, spirituality, 
finding support) and move on 
with their lives (adjusted to 
treatment, resumed life’s 
activities) 
 
Kingman et 
al. 2014 
US,Germany, 
UK, Brazil, 
France, Italy, 
Korea 
To better 
understand the 
patient’s 
perspective of 
PAH, including the 
impact of living 
with PAH, disease 
management and 
treatment. 
Qualitative 
ethnographic study 
using observational 
video footage, 
supplemented by 
field 
notes and patient 
diaries 
34 patients with 
PAH, 5 with 
chronic 
thrombo-
embolic PH in 7 
countries, 10M 
29F, 19-91 
years 
Delayed diagnosis 
Increasing dependency as 
disease progressed – change in 
social roles. 
Access to medication improved 
QoL 
Invisible nature of PAH -  
Matura et al. 
2012 
US 
To determine how 
people with PAH 
are using an 
online Discussion 
Board 
 
Qualitative 
descriptive 
methodology was 
used to analyze a 
convenience sample 
of self-identified 
patients with PAH. 
Internet posts to an 
online Discussion 
Board were analyzed 
for common themes. 
549 people with 
PAH who 
posted to the 
online board 
(142 F – 92%, 
19-78 years 
where 
demographic 
detail available) 
Used online board to seek 
guidance re treatments and 
testing, validate feelings, support 
through communication. 
Adjusted to living with PAH by 
refocusing their lives (paced 
activities, dealt with employment 
and interests) – sense of control 
 
McDonough 
et al. 2011 
US 
To describe 
symptoms 
experienced by 
PAH patients and 
the impact these 
symptoms on 
their lives. 
Qualitative 
descriptive study 
Telephone 
interviews analysed 
for themes 
10 patients 
from PAH clinic 
of large 
academic 
medical centre 
(7F 3M, 38-81 
Experience of symptoms: Holding 
back (fear, anticipation of 
symptoms worsening, treatment 
effects) – lack of spontaneity 
How they adapted to change: 
Redefining life (activity 
restrictions – continuous oxygen, 
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years, avg 65 
years) 
IV medications - uncertainty, 
making the best of it) – 
incorporated illness and 
treatment into lives, learned to 
live with symptoms 
 
Overgaard et 
al. 2016 
Denmark 
To increase 
knowledge of life 
with IPF for 
patients and 
carers 
Qualitative 
descriptive study. 
In-depth dyadic 
interviews with IPF 
patients and 
caregivers. 
Five-step analysis for 
themes from 
framework method 
29 patients (15 
M, 10 F),  
24 caregivers 
Recruited from 
specialist clinics 
at two 
university 
hospitals 
Prolonged period of misdiagnosis 
Diagnosis – stages of shock, 
denial, acceptance 
Became alert to symptoms. 
Oxygen experienced as a 
limitation and necessity. Loss of 
social role with increasing 
dependency on caregiver 
Adapted coping strategies: Tried 
to maintain as normal a life as 
possible while preparing for 
death. Avoided talking about 
death 
 
Pulmonary  
Hypertension 
Association 
Europe 2016 
France, 
Germany, 
Italy, UK, 
Spain 
 
To explore the 
impact of PAH on 
the lives of 
patients and 
carers 
Mixed methods 
study 
1. Qualitative one-
to-one interviews 
with patients and 
carers – themes 
identified 
2. Quantitative 
survey using online 
or postal 
questionnaires – 
informed by 
qualitative 
interviews 
1. 25 PAH 
patients 
15 carers (5 
countries) 
2. 326 patients 
(avg age 52 
years 74% F) 
129 carers (avg 
age 52 years, 
52% F) 
Recruited from 
local PAH 
patient 
organisations 
Problems: breathlessness, 
fatigue, dizziness, syncope, 
peripheral oedema, chest pain 
PAH had significant impact, on 
daily life, serious limitations, : 
physical activity (difficulty 
walking short distances), 
employment and work (loss of 
income), social life (invisibility of 
condition, lack of understanding, 
isolation), relationship issues 
(decrease in sexual relations, loss 
of libido) 
Wide range of negative emotions 
(fear, guilt, loss, worry, feelings 
of uselessness and frustration) – 
lack of psychological support 
 
Schoenheit 
et al. 2011 
US 
To gain insights 
regarding the 
perspectives of 
people living with 
IPF on the 
diagnostic 
process, disease 
education, 
emotional well-
being, and quality 
of life 
Qualitative study 
In-depth interviews 
45 IPF patients 
(22 M, 23 F, avg 
age 67 years) 
from France, 
Germany, Italy, 
Spain, UK 
Delayed diagnosis (2-12 years), 
initially symptoms dismissed, 
misdiagnosis, many doctors. 
Diagnosis – lack of empathy, 
emotional support, and 
perceived competence of HCPs, 
insufficient time given for 
questions. 
General lack of awareness and 
understanding in community 
Post diagnosis: greater 
satisfaction when treated in 
recognised centre of excellence. 
Unmet needs: access to specialist 
care, educational resources, 
family support/counselling, 
patient advocacy and public 
education. 
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Loss of income, feelings of being 
a burden, difficulty maintaining 
social relationships 
 
Swigris et al. 
2005 
US 
To gain insight 
into patients’ 
perspectives on 
how IPF affects 
their lives and QoL 
Qualitative study 
Focus groups and 
individual interviews. 
Analysed for 
conceptual 
categories of IPF-
related QoL using 
Nvivo 
20 IPF patients 
(13 M, 7 F, 44-
82 years) 
QoL impaired by cough, 
breathlessness, fatigue, oxygen 
therapy:  
Sleep disturbance, need for 
planning and preparation, loss of 
income, loss of independence, 
feelings of being unattractive, 
decreased libido and sexual 
activity, social participation 
curtailed. 
Life turned upside down – need 
to adjust life goals and refocus 
lives. Feelings of fear, worry, 
anxiety and panic 
 
Taichman et 
al. 2005 
US 
To assess health-
related QoL 
(HRQoL) in 
patients with PAH 
Quantitative cross 
sectional survey of 
HRQoL 
155 outpatients 
with PAH (81% 
F aged 18 to 84 
years) 
Patients had severe impairments 
in both physical and emotional 
domains of HRQoL. It is 
associated with functional status. 
 
Yorke et al. 
2014 
UK 
To explore the 
experience of 
living with PAH 
Qualitative study, 
semi-structured one-
to-one interviews, 
thematic analysis 
30 people with 
PAH through 
Pulmonary 
Hypertension 
Association (18 
F, 12 M, aged 
26-80 years) 
Having invisible, rare illness → 
lack of knowledge of HCPs, lack 
of understanding from others 
(legitimacy of illness not 
recognised, stigma), difficulty 
claiming sickness and disability 
benefits (anxiety, frustration) 
Treatment: a burden, need to 
adjust, financial burden, side 
effects, new treatment 
engendered optimism and sense 
of control, perception that 
educational needs and individual 
circumstances not taken into 
account by HCPs when 
prescribing treatments 
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Table 2.3       Comparison of characteristics of LAM, idiopathic pulmonary fibrosis and 
pulmonary hypertension 
 
Lymphangioleiomyomatosis 
(LAM) 
Idiopathic 
Pulmonary 
Fibrosis (IPF) 
Pulmonary Hypertension 
(PAH) 
Disease 
Rare, multisystem disease 
characterised by progressive 
cystic lung disease 
(Ryu et al. 2006) 
Rare, 
progressive, 
fibrotic 
interstitial lung 
disease 
(Overgaard et al. 
2016) 
Rare disease characterised by 
progressive narrowing of the 
pulmonary arteries leading to right 
heart failure and eventually death  
(Kiely et al. 2013) 
Population 
Prevalence of 3.3-7.7 per million 
Affects almost exclusively women 
(pre- and post-menopausal) 
(Harknett et al. 2011; Taveira-DaSilva & 
Moss 2015) 
Prevalence of 13 
per million in 
Denmark 
Affects men and 
women 
(Overgaard et al. 
2016) 
Incidence of 1.3-3 per million per 
year (idiopathic PAH) - higher 
incidence of PAH caused by severe 
lung and heart disease  
Affects men and women 
(Kiely et al. 2013) 
Cause 
Non-inherited gene mutations 
(Taveira-DaSilva et al. 2006) 
 
Unknown 
(Overgaard et al. 
2016) 
Genetic mutations (idiopathic and 
familial PAH), mechanical 
obstruction (chronic 
thromboembolic PAH - CTEPH), 
severe lung and heart disease, 
multiple/unclear factors  
(Kiely et al. 2013) 
Diagnosis 
HRCT 
Lung biopsy 
(Johnson et al. 2010) 
HRCT 
Lung biopsy 
(Overgaard et al. 
2016) 
Clinical evaluation, exercise tests, 
biochemical markers, 
echocardiogram, haemodynamic 
assessments 
(European PAH Association 2015) 
 
Symptoms 
Breathlessness, fatigue, 
recurrent pneumothoraces, 
chylous effusions, 
lymphangioleiomyomas, 
angiomyolipomas (kidney and 
abdomen), cough, chest pain, 
chyloptysis, wheeze 
(Taveira-DaSilva & Moss 2015; Ryu et al. 
2006; LAM Foundation 2015) 
Breathlessness, 
dry cough, 
fatigue, anxiety, 
depression 
(Overgaard et al. 
2016) 
Breathlessness, fatigue, dizziness, 
syncope, chest pain, abdominal 
distension, peripheral oedema, 
anxiety, depression 
(European PAH Association 2015) 
Treatment 
Medication 
(sirolimus/everolimus) 
Oxygen therapy 
Lung transplantation 
(Taveira-DaSilva & Moss 2014) 
Oxygen therapy 
(Schoenheit et al. 
2011) 
Medication (calcium channel 
blockers, prostanoids, endothelin 
receptor antagonists, 
phosphodiesterase-5 inhibitors), 
Treatment of underlying 
condition, 
Oxygen therapy 
Lung transplantation 
(Kiely et al. 2013) 
Median 
survival 
time  
29 years (variable rate of 
progression) from onset of 
symptoms 
No cure 
(Oprescu et al. 2013; Taveira-DaSilva & 
Moss 2014) 
3-5 years 
No cure 
(Overgaard et al. 
2016) 
2.8 years untreated 
> 7 years with treatment 
No cure 
(Benza et al. 2012) 
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Table 2.4   Literature related to the experiences/perspectives of people living with a rare disease 
Author 
Year 
Country 
Aim Design Participants Findings 
Budych et 
al. 2012 
Germany 
To describe the 
experiences of 
patient–physician 
interaction in rare 
diseases, to 
develop a 
typology of 
interaction 
patterns and to 
explore the 
antecedents of 
these interaction 
patterns, with a 
special focus on 
role behaviour 
 
Qualitative study, 
semi-structured 
interviews, thematic 
analysis 
107 
participants 
with 6 rare 
diseases (73 
adults, 34 
parents of ill 
children; 42 F, 
65 M), mean 
age 36.2 
years 
The low prevalence of the disease 
and HCPs lack of expertise created 
challenges for treating these 
diseases. A patient-directed 
interaction pattern with physicians 
was identified: patients became 
experts in their disease and drove the 
information-seeking and treatment 
processes. Traditional patient-
physician roles were altered and 
tended to be resisted by physicians 
rather than patients. 
Caputo 
2014 
Italy 
To identify 
common themes 
that 
characterized the 
illness experience 
and quality of life 
of patients 
affected by rare 
disease (RD). 
Quantitative with 
qualitative 
component. Content 
analysis of patient’s 
written illness 
stories (avg 700 
words) using 
Emotional Text 
Analysis (Carli & 
Paniccia, 2002). 
 Statistical analysis 
with text analysis 
software (T-LAB) 
 
32 adult 
patients (8 M, 
24 F) 
 with 4 RD 
diagnoses, 
recruited 
from 
database of  
 Italian 
National 
Centre for 
Rare Diseases, 
Thematic domains: hopelessness,  
need for autonomy, search for 
normalcy, expectations of recovery. 
Latent themes: the relationship with  
social and medical HCPs, adjustment 
processes to disease and social 
limitations, self-beliefs and coping. 
Cohen & 
Biesecker 
2010 
US 
To summarize 
and integrate 
research findings 
to help elucidate 
how healthcare 
providers can 
more effectively 
enhance the QoL 
of patients 
affected with rare 
genetic 
conditions. 
 
Systematic literature 
review 
58 QoL 
studies of 30 
rare genetic 
conditions 
Although genetic conditions can 
negatively affect individuals’ lives, 
having a genetic condition does not 
necessarily entail poor QoL. 
Psychological wellbeing, coping, and 
illness perceptions, influence QoL.  
 
Dockser 
Marcus 
2010 
Illness narrative 
describing 
author’s mother’s 
experience of 
gallbladder 
cancer and search 
for effective 
treatment 
 
Personal narrative  
Funding for rare cancer research 
comes from money raised by patients 
themselves. 
Patient advocates can speed up 
therapies. 
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EURORDIS 
2009 
Europe 
To collect 
information on 
the healthcare 
needs and 
expectations of 
RD patients and 
their families to 
inform public 
health decision-
making 
Book presenting the 
results of the 
EurordisCare Survey 
Programme (3 
surveys between  
2002 and 2008 
12,000 people 
with 18 rare 
diseases in 17 
European 
countries. 
Surveys 
conducted by 
patient 
organisations 
RD patients face barriers to equitable 
health care: (1) lack of scientific 
knowledge of their disease, (2) lack of 
access to correct diagnosis, (3) delays 
in diagnosis, (4) lack of appropriate 
multidisciplinary healthcare, (5) lack 
of quality information and support at 
the time of diagnosis, (6) undue 
social consequences, (7) inequities 
and difficulties in access to 
treatment, rehabilitation and care, 
(8) dissatisfaction with and loss of 
confidence in medical and social 
services and (9) rejection by health 
professionals. 
 
Feinberg et 
al. 2013 
Canada 
To understand 
the patient 
experience of 
having a rare 
malignancy 
(neuroendocrine 
tumours (NET)). 
Qualitative study 
Telephone 
interviews 
Grounded theory 
 
18 
participants 
(8 F, 10M, 
aged 45-77 
years) 
recruited 
through 
specialised 
NET clinic 
Themes: (1) difficulty with obtaining 
a diagnosis; (2) difficulty finding 
appropriate information about NETs 
from physicians; (3) difficulty finding 
treatment centres with knowledge of 
NETs and (4) difficulty finding disease 
specific support. 
Attending a specialised clinic was a 
positive experience – information 
needs met. 
 
Garau 2016 
Letter to the 
Editor of 
Orphanet Journal 
of Rare Disease 
describing the 
experience of 
author’s mother 
and her family 
when diagnosed 
with a rare 
cancer, 
leiomyosarcoma 
Personal narrative  
Story illustrates the main challenges 
that people with rare diseases and 
their families face: delay in diagnosis, 
lack of appropriate support and 
information, and impaired access to 
treatment. 
Garrino et 
al. 2015 
Italy 
 
To explore the 
impact of the rare 
disease on 
patients’ lives and 
the experience of 
the health 
professionals 
caring for the 
patients, and also 
to highlight the 
positive and the 
critical aspects of 
the health care 
services. 
Qualitative study 
Autobiographical 
narrative interviews 
Phenomenology 
22 patient 
participants 
(16 F, 6 M 
aged 21-79 
years) with a 
variety of rare 
diseases who 
attended a 
Regional 
Centre for 
Reference of 
Rare Diseases 
Diagnosis: delayed diagnosis, 
multiple doctors and tests, hospital 
admissions, sense of isolation and 
disorientation, uncertainty. 
Post diagnosis rarity not seen as 
problem – focus on symptoms and 
accepting and learning to live with 
disease (stay positive, try to live a 
normal life, alter habits) – improves 
QoL. Satisfied with care at RD Centre 
– information needs met. 
Gordon 
2013 
US 
To understand 
the lived 
experience of 
men with penile 
PhD thesis 
Qualitative study – 
Heiddeger’s 
13 men with 
penile cancer 
aged 41-78 
years 
Rarity influenced diagnosis: period of 
misdiagnosis and lack of information 
and support. 
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cancer, a rare 
cancer 
hermeneutic 
phenomenology 
Analysis: Colaizzi’s 
(1978) method 
 
Study mainly focused on the 
experience of living with the disease 
itself. 
 
Huyard 
2009 
France 
To establish (1) to 
what extent 
people with RD 
think that their 
disease’s rarity 
causes particular 
difficulties, 
(2)to what extent 
these difficulties 
relate to other 
causes than rarity 
(i.e. other 
characteristics of 
the disease or 
other 
components of 
the illness 
experience), 
(3) to what extent 
the rarity of the 
disease may 
relate to other 
components of 
their experience  
 
Qualitative study 
Semi-structured 
interviews 
Data analysis drew 
on French pragmatic 
sociology 
29 patients 
and 15 
parents of 
children with 
6 rare 
diseases 
Participants did not regard rarity as 
the major source of their difficulties 
when HCPs behaved in a way that 
met their moral needs. 
Difficult rare disease experience was 
related to the failure of HCPs to meet 
these expectations. 
Jaeger et al. 
2015 
Sweden 
To investigate the 
experiences of 
adults living with 
different rare 
diagnoses, how 
they perceived 
their difficulties, 
needs and 
participation in 
everyday life, and 
to identify some 
common issues 
and problems. 
 
Descriptive 
qualitative study 
4 focus groups of 4 
RD  
Content analysis 
1. 9 F aged 
22-57 years 
2. 9 F 2 M 
aged 18-67 
years 
3. 5 F 5 M 
aged 18-39 
years 
4. 8 M aged 
17-69 years 
Main problems related to: 
Lack of knowledge among HCPs and 
healthcare providers 
Lack of knowledge and 
understanding in the community 
affected activity and participation 
Lack of communication and 
cooperation within healthcare 
system and between medical HCPs, 
and social insurance system 
Jefferies & 
Clifford 
2009, 2011 
UK 
Two papers from 
single study 
exploring the 
experience of 
women with 
cancer of the 
vulva who 
underwent 
surgical 
treatment 
Qualitative study 
using hermeneutic 
phenomenological 
approach 
(Heidegger, van 
Manen), framework 
analysis 
13 British 
women aged 
27-53 years, 6 
months to 5 
years post 
surgery 
Rarity caused lack of awareness and 
knowledge: sense of isolation, few to 
share experiences, search for 
information and control of 
symptoms, delay in diagnosis, 
invisibility (of condition and lack of 
awareness). Need for more 
information and emotional support. 
Impact of disease: varying levels of 
disruption/change physically, socially, 
emotionally 
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Jessop 
2014 
UK 
To explore the 
extent to which 
people with rare 
diseases 
structured their 
narrative 
accounts of their 
search for 
diagnosis as a 
quest 
Deductive narrative 
typology using 
Booker’s (2004) 
schema to search for 
quest structure 
within 16 narratives 
of people living with 
a variety of RD 
published 2007-2013 
in BMJ as ‘A 
Patient’s Journey’. 
 
 
There was a quest for diagnosis. GPs 
acted as helpers, consultant doctors 
as opponents (factor of ignorance). 
Diagnosis represented the final 
ordeal. Any boon came later as the 
person accepted and adapted to their 
illness. 
Joachim & 
Acorn 2003 
Canada 
To understand, 
from the 
individual’s 
perspective, the 
experience of 
living with 
scleroderma. 
Qualitative study – 2 
focus groups of 
people living with 
scleroderma 
recruited through 
the Scleroderma 
Association. Data 
pooled and analysed 
thematically 
Group 1: 4 
women aged 
46-58 years, 
diagnosed 2-
14 years. 
Group 2: 9 
women aged 
53-79 years, 
diagnosed 5-
17 years. 
Physical manifestations were both 
visible and invisible. 
Disclosure- for invisible was managed 
to minimise stigma. 
Living with disease: impacted on 
activities of daily living. 
Perception of living a normal life, 
able to cope (some used humour), 
hoped for more effective treatments. 
Living with a rare disease: makes 
experience more complex, face lack 
of understanding and knowledge, 
burden of having to explain condition 
to others. 
 
Molster et 
al. 2016 
Australia 
To explore the 
healthcare 
experiences of 
Australian adults 
living with rare 
diseases 
Quantitative study. 
Online survey via the 
networks and 
mailing lists of the 
Office of Population 
Health Genomics, 
within the Western 
Australian 
Department of 
Health and the four 
peak bodies in the 
Australian rare and 
genetic disease 
sector: Rare Voices 
Australia, Genetic 
Alliance Australia, 
Genetic Support 
Network Victoria 
and the Genetic and 
Rare Diseases 
Network. The survey 
link was initially 
distributed to over 
300 patient support 
groups across 
Australia, as well as 
individuals 
registered with any 
of the collaborating 
organisations 
744 
respondents 
with various 
RD (568 F, 
176 M aged > 
18 years) 
Healthcare needs were not being 
met. 
Experienced delayed diagnosis (50%), 
misdiagnosis (50%), and multiple 
medical consultations (66%). 
Perception of treatment not being 
holistic (lack of communication 
between specialities). 
Experiences influenced by 
inefficiencies/gaps in diagnostic 
process (may be contributed to by 
structural aspects of healthcare 
systems – fragmentation in the 
Australian context. 
Respondents were more likely to use 
health services and wished to be 
involved in research into their 
condition. 
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Oksel & 
Gunduzoglu 
2014 
Turkey 
To explore 
individuals’ 
personal 
experiences of 
living with 
scleroderma and 
present a view of 
scleroderma 
patients and their 
nursing care. 
Exploratory 
descriptive 
qualitative study 
using 
phenomenology 
(Colaizzi) 
20 women 
living with 
scleroderma, 
average age 
50.85 years 
Themes: 
1. Self-perception (lowered self-
esteem, fear, anxiety. 
2. Relationship role: altered family 
and social process, altered role 
performance. 
3. Activity/exercise – activity 
intolerance, fatigue, physical 
difficulties. 
4. Sexual dysfunction – sexual lives 
disrupted due to disruption in self-
respect, altered body image, physical 
symptoms, altered attitude of 
partner. 
 
Rare 
Disease UK  
2016 
To provide insight 
into the patient 
and family 
experience of RD 
Survey of 85 
questions conducted 
in 2015 (followup to 
survey conducted in 
2010) 
1203 
respondents 
form UK with 
over 450 
different rare 
diseases 
Little had changed since previous 
survey: 
Patients still experiencing difficulties 
in diagnosis (misdiagnosis – some as 
psychological, delayed diagnosis, 
multiple consultations), accessing 
information (left alone to do their 
own research), receiving appropriate 
coordinated care, accessing 
treatments and finding out about 
research. 
Patients become expert and 
educated HCPs. 
Rare disease affects many aspects of 
an individual’s life including their 
social, educational and employment 
opportunities. Increased awareness 
and understanding, including 
adjustments where needed, can help 
to reduce this impact. 
 
Rare Voices 
Australia 
2013 
To highlight the 
experience of 
living with a rare 
disease. 
27 personal 
vignettes illustrating 
aspects of living with 
a rare disease. 
Australian 
people and 
their families 
living with a 
variety of rare 
diseases 
Diagnosis often difficult and delayed, 
misdiagnosis is common. Access to 
testing is difficult, expensive and 
inconsistent from one state or 
territory to the next.  
RD patients are not always seen as 
sick - lack of understanding of what is 
a RD impacts individuals in their daily 
lives. 
Less than 1% of the Australian rare 
disease population can access an 
effective therapy. Clinical trials are 
difficult to access. 
Multiple medical consultations cause 
financial struggle. 
There is no national RD registry in 
Australia. 
Information limited and varies from 
one state/territory to another. 
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Vitale 2005 
US 
To explore the 
experience of 
living with the 
rare disease, 
mycosis 
fungoides (a skin 
lymphoma) 
PhD thesis 
Qualitative 
phenomenological 
study 
12 people 
living with 
mycosis 
fungoides (7 
F, 5 M aged 
34 – 79 years, 
diagnosed 4-
23 years) 
Rarity: lengthy period of misdiagnosis 
and ineffective treatment 
-delivery of diagnosis mixed (limited 
information, wait for referral, 
multiple health providers, 
fragmented service, treatment 
delayed) 
-unmet information needs →quest 
for information (internet, peer 
support group, emotional distress, 
frustration, disappointment 
-difficulty finding others with disease 
-lack of understanding – 
unpredictable reactions from other 
(stigma) 
-became experts 
-frustration with perceived limited 
research 
-process of long term adjustment, 
striving for normality. 
 
Wallenius 
et al. 2009 
Sweden 
To describe the 
physical, 
psychosocial, 
emotional and 
financial 
consequences of 
having a rare 
diagnosis from 
the individual and 
the family 
perspective. 
Quantitative study 
Questionnaire 
survey of members 
of Rare Diseases 
Sweden Association 
1660 
respondents 
from 30 RD 
organisations 
(62% F, aged 
<6 years to 
>65 years, 
most 21-64 
years 
- Problems searching for support 
within healthcare system (lack of 
knowledge of HCPs) – cooperation 
limited 
-Complex nature of some rare 
diseases necessitated contact with 
multiple HCPs 
-clinical pathways not available for 
RD 
-family stressed – need for support 
-treated arbitrarily by social service 
system 
-added financial burden for some 
-meeting others through support 
group was a positive experience. 
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APPENDIX 3 
Biographical account of Margaret 
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Margaret is a 45 year old woman, born in 1965 in Europe. She has a sister three years older. 
Her family moved to Australia when she was seven years old. Margaret developed asthma 
when she was three years old triggered by animal danders such as horses and cats. She also 
had a history of menorrhagia, pre-menstrual tension, benign breast lumps, benign skin lesions, 
oesophagogastric erosions and gastro oesophageal reflux disease. She had fibroids and kidney 
stones removed between the ages of 40 and 45. She was an ex-smoker, having smoked 15 per 
day for 20 years until she was 37, three years after she was diagnosed with LAM. 
Margaret experienced a gradual onset of LAM. She found it harder to do things from 27 years 
of age. She was first investigated for abdominal pain and increasing shortness of breath while 
climbing 12 stairs in 1998, aged 33 years. She was able to walk only slowly on the flat. She 
had a wheeze, was productive of sputum, coughed up some blood and experienced central 
chest pain and daily renal pain. She was diagnosed with LAM in 1999, aged 34 years, 
following a kidney ultrasound and a CT of the thorax and abdomen which showed lung cysts 
and multiple renal angiomyolipomas. 
Margaret attended a LAM clinic three years after she was diagnosed. Her LAM was 
progressing slowly but at that time she was still working and was independent with activities 
of daily living. She was single and lived alone. She stopped work four years after diagnosis 
and moved to a Department of Housing villa in an outer urban suburb one year later. In the 
same year she completed a Pulmonary Rehabilitation Programme at a Respiratory 
Ambulatory Care Clinic. At this time she was able to walk her dog daily, exercise on a 
treadmill for 15 minutes a day at 2.2 km/hr and use hand weights at home. She was noted to 
have good knowledge of her disease and support from her family (mother, step-father and 
sister) and close friends. 
Seven years post diagnosis, Margaret’s dyspnoea on exertion had increased and she was now 
unable to walk her dog. She also had blood in her urine and pain due to her kidney lesions. 
She commenced home oxygen and was on a disability pension. Over the following three years 
her LAM slowly progressed. Nine years after diagnosis, she was noted to be unsuitable for 
transplant due to multi organ system problems. Medications included puffers (ventolin, 
atrovent, seretide, bricanyl, spiriva), prednisone, losec, perindopril (for hypertension), 
effexor, MS Contin and endone.  
Eleven years post diagnosis, five months prior to her first interview for this study, she was 
admitted to a local hospital with acute respiratory failure and an acute exacerbation of asthma 
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following a four day history of fever, productive cough and increasing dyspnoea. Vital signs 
were respiratory rate 40/min, blood pressure 220/100, heart rate 140/min, SpO2 95% on 30% 
venturi mask. Blood gases: pH 7.295, pCO2 49.1, pO2 79.5 HCO3 23.1. She was admitted to 
a high dependency unit and treated with hourly nebulisers, IV hydrocortisone, IV and oral 
antibiotics, and oxygen therapy to keep her SpO2 88-92%. She refused non-invasive 
ventilation. Multiple medical emergency calls were made for increasing respiratory distress, 
mostly triggered by anxiety. Morphine and lorazepam were administered with good effect. 
An NFR (not for resuscitation) order was in place. She was discharged home 17 days after 
admission. It was noted that she had borderline pulmonary hypertension and that her SpO2 
was 67% on room air. This was the last entry as a discharge letter in her medical record at the 
hospital where she had attended a LAM clinic. 
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APPENDIX 4 
Tables summarising the social and medical backgrounds  
of the participants 
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Table 4.1 Social background 
Participant 
(nationality) 
Education Family Living 
Arrangements 
Identified  
Spiritual 
Beliefs 
Work Pre-illness health/ 
disposition/ 
experiences/ 
interests 
Aiko 
(Asian) 
University Only child, 
parents deceased 
Married, husband 
88, one child, one 
grandchild 
Lived with 
husband, later 
with daughter, 
city 
Personal 
spirituality 
retired Fit and healthy 
Death of son-in-law 
Yoga/painting 
Anna 
(Australian, 
Parents 
European) 
University Parents, 2 siblings 
(close family) 
Divorced post 
diagnosis, new 
partner 
Lives with 
partner and 
pet dog, city 
Christian, 
Personal 
spirituality 
FT (full 
time) 
Fit and healthy. 
Fashion, makeup, 
walking, sewing 
Carol 
(Australian) 
Business 
college 
3 siblings. 
Divorced, 
remarried and 
now widow. 2 
adult children, 2 
grandchildren 
Lives alone, 
city 
Christian Retired, 
Voluntary 
work 
Fit and healthy, 
Walking, singing, 
yoga, craft 
Clare 
(Australian) 
Diploma Parents, 1 sibling. 
Single, no 
children 
Lives with 
parents, rural 
area 
Personal 
spirituality 
PT (part 
time) 
Fit and healthy, 
inquisitive nature, 
Separated from 
partner after 
diagnosis, 
Walking, painting 
Deb 
(Australian) 
Professional 
training 
Parents deceased. 
5 siblings 
Divorced, 3 adult 
children 
Lives alone, 
regional town 
- FT Fit and healthy, 
Hiking, camping, 
gardening 
Eva 
(European) 
University Parents 
separated, 
mother, sibling in 
Australia.Married,  
no children 
Lives with 
husband, city 
Buddhism FT Fit and healthy, 
Inquisitive nature, 
Escaped civil war 
and came to 
Australia aged 19, 
Meditation, yoga, 
waling 
Helen 
(European) 
University Father deceased, 
mother and 2 
siblings live 
overseas.Partner, 
2 children (3 yrs, 
16 months) 
 
 
 
 
 
Lives with 
partner and 
children, city 
- PT Fit and healthy, 
Gym, yoga, bike 
riding 
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Irena 
(Australian, 
European 
parents) 
 
 
 
University Parents (mother 
in nursing home), 
1 sibling (close 
family) 
Married, 1 
stepchild 
Lives with 
husband and 
stepchild, city 
Christian Retired Fit and healthy, 
Optimistic nature, 
Mother recently 
diagnosed with 
Alzheimer’s 
 
Dancing, walking 
(pre LAM) 
Cooking 
Jess 
(Australian) 
University Father deceased, 
mother and 
stepfather 
divorced. 1 
brother. 
Estranged from 
mother. 
Partner, no 
children. 
Lives with 
partner, city 
- FT Fit and healthy 
Bike riding (pre 
LAM) walking, 
reading, television 
Julie 
(Australian) 
 
Business 
college 
Parents. Husband, 
2 adolescent 
children 
Lives with 
husband and 
children, rural 
town 
- PT Snorkelling, 
swimming, hiking, 
sports (pre LAM); 
Walking, bike riding  
Louise 
(Australian) 
University Parents deceased, 
2 siblings. 
Partner, 2 adult 
stepchildren 
Lives with 
partner and 
pet dogs, city 
- Currently 
not 
working 
Fit and healthy, 
Walking, art 
reading, pets, 
gardening  
Margaret 
(European) 
High school Parents divorced, 
mother 
remarried, one 
sibling. Single 
Lives alone 
with pet dogs, 
city 
Reincarnation Retired, 
previous 
dog rescue 
work 
Asthma since 
childhood, 
optimistic, sense of 
humour, 
Art, knitting, music, 
meditation 
Mia 
(South 
American) 
University Parents 
separated,mother 
in Australia, 
father overseas. 
Married, one 
adopted child 
since diagnosis 
Lives with 
husband and 
child, city 
- PT Asthma, bronchitis, 
Gym, travel, art, 
photography 
Patricia 
(Australian) 
Professional 
training 
Mother alive, 
father deceased. 
Married, 2 adult 
children. 
Lives with 
husband, city 
Personal 
spirituality 
retired TS epilepsy, 
hearing impaired 
Optimistic, flexible 
nature, 
Son – TS autism – 
lives in supported 
accommodation. 
Husband travelled 
overseas for work. 
Exercise (walking, 
gym, bowling, 
swimming) 
Ruth 
(Australian) 
University Married. 2 adult 
children, 2 
grandchildren. 
 
Lives with 
husband, city 
Formal 
religion 
PT, 
voluntary 
work 
Fit and healthy, 
walking 
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Sarah 
(Australian) 
University Parents, sibling 
(close family) 
Married, 2 
children (7 and 4 
years) 
 
 
 
Lives with 
husband and 
children, city 
Formal 
religion 
PT Fit and healthy, 
Gym, hiking, 
pilates,walking, 
tennis, skiing, 
painting, travel 
Ursula 
(Australian) 
High school Parents, sibling. 
Married, 3 adult 
children 
Lives with 
husband and 
children, city 
- PT Fit and healthy, 
Painting, walking 
Veronica 
(Australian) 
Professional 
training 
Married, 2 adult 
children, 1 
grandchild 
Lives with 
husband, city 
- Retired Fit and healthy, 
Gentle, timid 
nature, 
walking 
Vidu 
(South 
Asian) 
University Parents, 2 siblings 
live overseas,  
(close family). 
Married, 1 adult 
child. 
Lives with 
husband and 
child, city 
Buddhism Currently 
not 
working 
Fit and healthy, 
Negative 
disposition, 
Walking, yoga 
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Table 4.2: Onset of symptoms to diagnosis 
Participant  
(age  at 
interview) 
Onset of symptoms Misdiagnosed 
(by) 
Diagnosis of 
LAM (age at 
diagnosis) 
Diagnosed 
by 
Years 
from  
onset to 
diagnosis 
Aiko (64)  Breathlessness some years pre Dx, 
Yr 0 [1998-2001] pneumonia, 
 low SpO2, lung biopsy, renal AMLs 
 
 Yr 0 lung biopsy 
(52) 
 
Respiratory 
physician 
< 1 
Anna (37)  Yr 0 [Pre 2001] (L) PTx 
Yr +1 (R) PTx, mediastinal PTx 
Yr +2 (L) PTx, pleuradesis/lung 
biopsy 
Yr +5 breathlessness 
Yr +8 abdominal 
lymphangioleiomyoma, 
 Haemoptysis 
 
 Yr 2 lung biopsy 
(25) 
 
Surgeon 2 
Carol (66)  Yr 0 [Post 2001] breathless while 
talking 
asthma Yr 0 chest CT 
(57) 
 
Respiratory 
physician 
< 1 
Clare (34)  Yr 0 [Post 2001] fatigue, breathless 
on exertion, 
 CXR – pleural effusion (chyle) 
 
chest infection 
(GP) 
Yr +1 chest CT 
(32) 
 
GP 1 
Deb (52)  Yr 0 [Post 2001] breathless walking 
uphill,chest pain 
cardiac origin 
(GP) 
Yr +1 chest CT, 
lung biopsy (49) 
 
Respiratory 
physician 
1 
Eva (38)  Yr 0 [Post 2001] breathless, chest 
pain,  
↓exercise tolerance 
Yr +1 severe breathlessness during 
flight,  
bilateral PTx/pleuradesis/lung 
biopsy 
Yr +3 abdominal 
lymphangioleiomyomas 
 
Yr 0 nerve pain 
(GP) 
Yr +1 lung 
biopsy (32) 
Respiratory 
physician 
1 
Helen (40) Yr 0 [Post 2001] breathless 1st 
pregnancy 
Yr +1 breathless 2nd pregnancy 
Yr +2 cough/back pain during 
labour,  
severe back pain 3/12 later (SpO2-
88%) 
Yr 0 anxiety; 
Yr +1 
depression 
(gynaecologist) 
Yr +2 chest CT 
(39) 
 
Respiratory 
registrar 
2 
Irena (47) Yr 0 [1998- 2001]  intermittent 
haemoptysis 6/12 
 Yr 0 HRCT scan 
(37) 
Respiratory 
physician 
<1 
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Jess (41)  Yr 0 [Post 2001] abdominal 
bloating 
Yr +4 abdominal bloating/pain with 
period 
Yr +5 abdominal pain 
Yr +8 breathlessness, wheeze, 
chylothorax 
Yr 0 gut 
infection (GP); 
psychosomatic 
pain (GP); 
Yr +4 appendix, 
Endometriosis 
(gynaecologist) 
 
 
Yr +5 abdominal 
ultrasound, lung 
biopsy 
(36) 
 
General 
surgeon, 
confirmed 
by LAM 
expert 
5 
Julie (46) Yr 0 [Pre 2001] chest/back pain – 
multiple PTx 
Yr +1 pleuradesis, ongoing shoulder 
pain 
Yr +7 chest pain 2nd pregnancy, PTx, 
pleuradesis/lung biopsy 
Yrs +7-+11 ongoing pain 
Yr +11 breathless steps/hills 
Yr +14 severe bronchitis, ↓lung 
function 
Yr +16 renal AML 
Yr +1 CT-small 
cysts – NAD; 
Yrs +7-+11 pain 
psychosomatic; 
Yr +14 
emphysema 
(respiratory 
specialist) 
Yr +16 chest CT 
(results of Yr +7 
lung biopsy 
showing LAM 
found, had not 
been 
communicated) 
(41) 
Respiratory 
physician 
16 
 
Louise (57)  
 
Yr 0 [Pre 2001] thoracic back pain 
Yr +1 breathless swimming, 
haemoptysis – bronchoscopy NAD 
Yr +3 bronchoscopy NAD 
 
  
Yr +3 chest CT 
(41) 
 
 
Junior 
doctor 
 
3 
Margaret 
(45)  
Yr 0 [1998-2001] abdominal pain, 
breathless stairs, wheeze, 
haemoptysis, chest/kidney pain 
 Yr +1 CT chest / 
abdomen – LAM 
Kidney 
ultrasound- 
multiple AMLs 
(34) 
 
Respiratory 
physician 
1 
Mia (38)  Yr 0 [Pre 2001] Breathless/cough 
for 13 years  
Yr +13 breathlessness and cough 
worsened 
 
Asthma, chronic 
bronchitis 
(respiratory 
specialists) 
Yr +15  HRCT 
(34) 
Respiratory 
physician 
15 
Patricia 
(62)  
Yr 0 [Pre 2001] bleeding (L) kidney, 
r/o tumour 
Yr +8  diagnosis of tuberous 
sclerosis 
Yr +19 breathless stairs [1998-
2001] 
 Yr +19 HRCT 
(51) 
 
Respiratory 
physician 
< 1 
(from onset 
of 
respiratory 
symptoms 
Ruth (64) Yr 0 [Post 2001] acute (L) flank pain 
– ruptured AML 
Yr +4 acute (R) flank pain – 
ruptured AML 
 Yr +4 chest CT 
following breast 
cancer (58) 
 
Respiratory 
physician 
4 
Sarah (36)  Yr 0 [Post 2001] breathless on 
exertion and fatigue during and 
after 2nd pregnancy, cough, 
haemoptysis 
Yr 0 - +2 altered menstrual periods, 
ongoing breathless on exertion, 
haemoptysis 
 
Depression 
(gynaecologist) 
Asthma (GP) 
Yr +3 chest CT, 
lung biopsy (32) 
 
Respiratory 
physician 
(LAM 
expert) 
3 
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Ursula (51) 
 
Yr 0 [Pre 2001] breathless during 
3rd pregnancy, PTx x 2, pleuradesis 
– multiple cysts, no biopsy 
Yr +7 – PTx, pleuradesis, lung 
biopsy 
 
 Yr +7 lung 
biopsy (37) 
 
Respiratory 
physician 
7 
Veronica  
(68)  
Yr 0 [Post 2001] CT post r/o skin  
lesion – renal AML, (L) 
nephrectomy; breathless uphill  
post discharge – bilateral chylous 
pleural effusions – bilateral 
pleuradesis, thoracic duct ligation 
 
 
 
 Unknown (not 
documented in 
medical record) 
(62) 
 
oncologist < 1 
Vidu (48) Yr 0 [Pre 2001] sudden back pain – 
PTx 
Yr +1 breathless/fatigue uphill, PTx 
Yr +5 ongoing 
breathlessness/fatigue on exertion 
Yr +14 abdominal 
lymphangioleiomyoma 
 
Yr +1 asthma 
(respiratory 
specialist) 
Yr +5 chest CT 
(36) 
 
Respiratory 
physician 
5 
 
KEY 
Dx  diagnosis 
GP local doctor 
(L)  left 
 
 
NAD  no abnormalities detected 
PTx  pneumothorax 
 
 
(R)  right 
r/o  removal of 
 
 
SpO2  oxygen saturation 
AML angiomyolipoma 
Note: Specific dates are not supplied to preserve privacy. Each participant’s year of onset of their symptoms is designated as Year 0,  
pre or post 2001. Subsequent milestones are labelled as +years from this initial point in time. The year 2001 is significant as it represents 
 the time when the LAM Foundation was well established, and knowledge and awareness of LAM had increased through 40 research 
 projects and 38 published articles (LAM Foundation 2015). 
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Table 4.3: Medical and surgical treatments 
Participant Problem Surgery/ 
Procedure 
Doxycycline Sirolimus Oxygen 
Aiko     Yes, current Yes, intermittent 
Anna Pneumothorax. 
haemoptysis,  abdominal 
lymphangioleiomyoma 
Pleuradesis, lung 
biopsy 
 
 Yes, current  
Carol      
Clare Chylothorax Pleuradesis, 
pleurectomy 
 Yes, current Yes, intermittent 
for 6 weeks 
Deb  Lung biopsy Yes, current    
Eva Pneumothorax, abdominal 
lymphangioleiomyoma  
Pleuradesis  Yes, current Intermittent, now 
not using 
Helen    Yes, current Yes, continuous 
Irena Haemoptysis   Yes, current Yes, intermittent 
Jess Chylothorax,  
abdominal 
lymphangioleiomyoma 
Lung biopsy, 
Radiotherapy, 
Pleuradesis 
Yes, stopped Yes, current  
Julie Renal angiomyolipoma, 
pneumothorax 
Partial 
nephrectomy, 
Pleuradesis, lung 
biopsy 
 Yes, current  
Louise   Yes, stopped Yes, stopped  
Margaret Renal angiomyolipomas    Yes, continuous 
Mia      
Patricia Renal angiomyolipoma 
 
Lung transplant   Pre transplant 
Ruth Renal angiomyolipomas Embolisations    
Sarah  Lung biopsy Yes, stopped Yes, current Yes, intermittent  
(not medically 
required) 
Ursula Pneumothorax Pleuradesis    
Veronica Renal angiomyolipomas, 
chylothorax 
Nephrectomy, 
Pleuradesis 
   
Vidu Pneumothorax, abdominal 
lymphangioleiomyoma 
Lung transplant   Pre transplant 
 
Summary 
Treatment Number 
Pleuradesis 7 
Pleurectomy 1 
Nephrectomy/partial nephrectomy 2 
Lung transplant 2 
Doxycycline 4  (3 stopped, 1 current) 
  
Sirolimus  9 
Oxygen continuous current 2 
Oxygen intermittent current 3 
Embolisation 1 
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Table 4.4: Effects of sirolimus  
Participant Lung 
function 
Abdominal 
lymphangioleiomyoma 
Haemoptysis Chylothorax Quality  
of life 
Side  
Effects 
Aiko      Commenced  
4 weeks ago –  
too soon to  
assess effects 
Anna improved resolved resolved N/A improved Nil 
Clare improved N/A N/A resolved improved Nil reported 
Eva improved almost completely  
resolved 
N/A N/A improved Nil 
Helen stabilised N/A N/A N/A less 
improvement 
 due to side 
effects 
Fatigue, 
bloating,  
mouth ulcers,  
delayed wound  
healing, joint 
pain,  
raised 
cholesterol,  
irregular 
menstrual  
periods 
Irena stabilised reduced in size  resolved N/A improved Irregular 
menstrual  
periods 
Jess improved resolved N/A resolved improved Nil 
Julie improved N/A N/A N/A less 
improvement 
due to side 
effects 
Fatigue,  
hoarse voice,  
cough, shaking, 
 nausea, 
diarrhoea 
Sarah improved N/A resolved N/A improved Nil 
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APPENDIX 5 
Glossary 
Asthma, a respiratory disorder characterised by recurring episodes of shortness of breath, 
wheezing, coughing and thick airway secretions. 
Chyle, the cloudy products of digestion containing mainly fats carried from the small intestine 
in the lymphatic system. 
Chyloptysis, coughing up chyle. 
Chylothorax/ chylous pleural effusion, a collection of chyle in the pleural space of the lungs. 
COPD, chronic obstructive pulmonary disease, lung disease involving increased airway 
resistance, for example, emphysema or chronic bronchitis. 
CT scan, computerised axial tomography, a medical imaging procedure which produces cross-
sectional images of the body using x-rays and digital computer technology. High resolution CT 
scanning (HRCT) is used to investigate the lungs for the presence of cysts indicative of LAM. 
Emphysema, an abnormal condition of the lungs, characterised by over inflation and 
destructive changes in the walls of the air sacs (alveoli) at the end of the small airways of the 
lung. It results in a loss of lung elasticity and a decreased exchange of oxygen and carbon 
dioxide in the lung. A person with emphysema may experience shortness of breath and frequent 
respiratory tract infections. 
GP, general practitioner, local doctor. 
Haemoptysis, coughing up blood. 
HCP, healthcare professional 
ICU, intensive care unit 
Intercostal catheter (ICC), a chest tube inserted into the pleural space between the lining of 
the lung and the lining of the chest wall to remove air and fluid from this space and to restore 
normal intrapleural pressure so that the lung can re-expand. 
Lymphangiogram, a special x-ray of the lymph nodes and lymph vessels. 
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Lymphangioleiomyomas, a chyle-filled masses occurring most frequently in the peritoneum, 
pelvis or mediastinum. They can cause abdominal pain and bloating.  
Mediastinal, pertaining to the mediastinum, the space in the chest between the lungs. 
Nephrectomy, the surgical removal of one or both kidneys. 
Peritoneum, the membrane lining the pelvic cavity and covering the abdominal organs. 
Pleurectomy, a surgical procedure done to remove part of the pleura, the linings of the lung. 
Pleurodesis, the creation of a fibrous adhesion between the pleura (the lining of the lung and 
the lining of the chest wall) to obliterate the pleural space. It is performed surgically by 
abrading the pleura or be inserting a sterile irritant into the pleural space and is used to treat 
recurrent spontaneous pneumothorax. 
Pneumothorax, the presence of air in the pleural space, that is, the space between the lining of the 
lung and the lining of the chest wall. Normally the pressure in this space is less than atmospheric and 
the lung is expanded. When air enters the space and the pressure is equal to that of the atmosphere the 
lung collapses. A spontaneous pneumothorax occurs when air accumulates in the pleural space without 
an apparent preceding event. 
Renal angiomyolipoma, a benign tumour of the kidney containing smooth muscle and fatty tissue. 
Sirolimus, an immunosuppressant medication which has been found to stabilise lung function and 
reduce the size of chylous effusions, lymphangioleiomyomas, and angiomyolipomas in relation to 
LAM.  
Six minute walk test (6MWT), a test measuring the distance a person is able to walk over six minutes 
on a flat surface. It is used to test exercise tolerance in chronic respiratory disease. 
Spirometry, laboratory evaluation of the air capacity of the lungs to assess lung function by means of 
an instrument called a spirometer. 
SpO2, oxygen saturation. A measurement of the percentage of oxygen carried by haemoglobin in the 
red blood cells compared to the total amount of haemoglobin in the blood. Normal SpO2 is between 
95 and 100%. SpO2 can be measured with a pulse oximeter placed on the finger. 
